WorldWideScience

Sample records for australian peritoneal dialysis

  1. [Assisted peritoneal dialysis].

    Science.gov (United States)

    Klarić, Dragan; Prkačin, Ingrid

    2014-04-01

    According to the National Registry of Renal Replacement Therapy (RRT), the incidence of chronic kidney disease (end-stage renal disease) and the need of RRT have declined in the last decade renal. One of the reasons for this tendency certainly is transplantation as the best choice. However, transplant procedure has limitations in elderly patients due to the number of comorbidities. This study was designed as retrospective analysis of outcomes in patients treated with peritoneal dialysis for a period of eleven years. Patients were divided into those who had been assisted or unassisted. Out of 100 patients treated with peritoneal dialysis (PD), 77 completed the treatment, including 26 assisted and 51 unassisted patients. Peritonitis was recorded in 20 assisted and 26 unassisted patients. Peritonitis was more common in unassisted patients, who were more frequently lost from PD. Assisted PD could be a good and safe choice of RRT in this special group of patients.

  2. Peritoneal dialysis peritonitis: risk factors and effects

    Directory of Open Access Journals (Sweden)

    Alikari V.

    2013-07-01

    Full Text Available Introduction: Peritonitis is the most frequent complication of peritoneal dialysis. It is the main cause of failure of the method and inclusion of patients in hemodialysis Purpose: The purpose of this study is to explore the risk factors of peritoneal dialysis peritonitis as well as the acute and long-term effects of peritonitis on peritoneal membrane function and success of the method. Methods: Literature review of relevant articles in the database Pubmed as well as the official website of the International Society of Peritoneal Dialysis (ISPD was carried out. The search included articles published during the period 1986 -2012.Results: Lack of patient compliance with the peritoneal changes protocol, lack of social support, systemic diseases and connection systems are risk factors of peritonitis. Peritonitis causes transient increase of peritoneum permeability, loss of the ability of the peritoneum for ultrafiltration and, consequently, overhydration. Long-term, recurrent episodes of peritonitis resulting in permanent loss of peritoneum capacity for ultrafiltration even fibrosis that leads to failure of the method. Finally, its effect on the reduction of the residual renal function seems to be remarkable. Conclusions: Peritonitis is the most common infectious complication of peritoneal dialysis and the main cause of morbidity associated with the method. Moreover, it is the major cause of failure of the method and patients accession in hemodialysis. Any attempt to prevent peritonitis passes through the careful patient selection and effective patient education on compliance with the rules of asepsis during peritoneal changes.

  3. Output of peritoneal cells during peritoneal dialysis.

    Science.gov (United States)

    Fakhri, O; Al-Mondhiry, H; Rifaat, U N; Khalil, M A; Al-Rawi, A M

    1978-01-01

    Peritoneal dialysis provides a good source for the collection of macrophages. Six patients with chronic renal failure undergoing peritoneal dialysis for the first time were studied, and maximum cell egress, mostly macrophages, occurred at 24-48 hours and diminished after 48 hours. PMID:670419

  4. Fungal peritonitis in children on peritoneal dialysis.

    NARCIS (Netherlands)

    Raaijmakers, R.; Schroder, C.; Monnens, L.A.H.; Cornelissen, E.A.M.; Warris, A.

    2007-01-01

    Fungal peritonitis is a rare but serious complication in children on peritoneal dialysis (PD). In this study, risk factors were evaluated, and therapeutic measures were reviewed. A retrospective, multi-centre study was performed in 159 Dutch paediatric PD patients, between 1980 and 2005 (3,573 month

  5. Peritonitis during continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Rubin, J; Rogers, W A; Taylor, H M; Everett, E D; Prowant, B F; Fruto, L V; Nolph, K D

    1980-01-01

    We initiated a therapeutic program of continuous ambulatory peritoneal dialysis for patients with chronic renal failure. Our program resulted in many episodes of peritonitis arising from contamination due to the technical aspects of the procedure. Microbiologic evaluation showed that 73% of 97 episodes were culture positive, with gram-positive organisms causing most of the cases, especially early in dialysis. Gram-negative rods tended to occur later. Gram stains of dialysate effluent resulted in a disappointingly low yield of only 9% positivity. Cell counts were a dependable indicator of the presence of peritoneal inflammation and also of therapeutic success. Most patients responded well to intraperitoneal cephalothin, 125 mg/L for 10 to 14 d. The occurrence of peritonitis resulted in 0.93 years of hospitalization during the total of 15.45 patient-years on dialysis, which essentially negated the financial advantages of this method of treatment of chronic renal failure. For this to be a successful mode of therapy, advances in the prevention of peritonitis must be made. PMID:6985785

  6. Peritoneal Dialysis (Beyond the Basics)

    Science.gov (United States)

    ... but not excessive, amount of protein and certain minerals. People who use peritoneal dialysis lose protein with every exchange, which usually means that they must eat an increased amount of protein in the diet. Protein is found in meat, milk, chicken, fish, and eggs; lower-quality protein is ...

  7. Peritoneal dialysis solution and nutrition.

    Science.gov (United States)

    Verger, Christian

    2012-01-01

    20-70% of peritoneal dialysis patients have some signs of malnutrition. Anorexia, protein and amino acid losses in dialysate, advanced age of elderly patients, inflammation and cardiac failure are among the main causes. Modern dialysis solutions aim to reduce these causes, but none of them is without side effects: glucose is relatively safe and brings additional energy but induces anorexia and lipid abnormalities, amino acids compensate dialysate losses but may increase uremia and acidosis, icodextrin helps control hyperhydration and chronic heart failure and minimizes glucose side effects, but may sometimes cause inflammation, and poly chamber bags allow the replacement of lactate by bicarbonate and are more biocompatible, decrease GDP, induce less inflammation and have a better effect on nutritional status. However, it appears that the management of nutrition with the different solutions available nowadays necessitates various combinations of solutions adapted to different patient profiles and there is not actually a single universal solution to minimize malnutrition in peritoneal dialysis patients. PMID:22652708

  8. Animal models in peritoneal dialysis

    Science.gov (United States)

    Nikitidou, Olga; Peppa, Vasiliki I.; Leivaditis, Konstantinos; Eleftheriadis, Theodoros; Zarogiannis, Sotirios G.; Liakopoulos, Vassilios

    2015-01-01

    Peritoneal dialysis (PD) has been extensively used over the past years as a method of kidney replacement therapy for patients with end stage renal disease (ESRD). In an attempt to better understand the properties of the peritoneal membrane and the mechanisms involved in major complications associated with PD, such as inflammation, peritonitis and peritoneal injury, both in vivo and ex vivo animal models have been used. The aim of the present review is to briefly describe the animal models that have been used, and comment on the main problems encountered while working with these models. Moreover, the differences characterizing these animal models, as well as, the differences with humans are highlighted. Finally, it is suggested that the use of standardized protocols is a necessity in order to take full advantage of animal models, extrapolate their results in humans, overcome the problems related to PD and help promote its use. PMID:26388781

  9. Animal Models in Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    OLGA eNIKITIDOU

    2015-09-01

    Full Text Available Peritoneal dialysis (PD has been extensively used over the past years as a method of kidney replacement therapy for patients with end stage renal disease. In an attempt to better understand the properties of the peritoneal membrane and the mechanisms involved in major complications associated with PD, such as inflammation, peritonitis and peritoneal injury, both in vivo and ex vivo animal models have been used. The aim of the present review is to briefly describe the animal models that have been used, and comment on the main problems encountered while working with these models. Moreover, the differences characterizing these animal models, as well as, the differences with humans are highlighted. Finally, it is suggested that the use of standardized protocols is a necessity in order to take full advantage of animal models, extrapolate their results in humans, overcome the problems related to PD and help promote its use.

  10. Peritonitis in peritoneal dialysis patients after renal transplantation

    NARCIS (Netherlands)

    Bakir, N; Surachno, S; Sluiter, WJ; Struijk, DG

    1998-01-01

    Background. The occurrence of peritonitis in peritoneal dialysis patients after renal transplantation during immunosuppression might increase morbidity and mortality. Hence the timing of catheter removal is still controversial. The associated risk factors of this complication have not been analyzed.

  11. Peritoneal dialysis in hypernatraemic, ketoacidotic diabetic coma.

    Science.gov (United States)

    Køolendorf, K; Møoller, B B

    1976-01-01

    Hypertonic dehydration in a 13-year-old boy with ketoacidotic diabetic coma has been treated successfully with peritoneal dialysis and isotonic fluids. Modes of treatment with either hypotonic or isotonic fluids are discussed, as is the feasibility of peritoneal dialysis. We recommend isotonic solutions composed of equal parts of 5.5% glucose and 0.9% sodium chloride combined with peritoneal dialysis in order to secure a relatively slow correction of the hypertonic state.

  12. Clinical reports for peritoneal dialysis-related peritonitis

    Institute of Scientific and Technical Information of China (English)

    任海滨

    2014-01-01

    Objective To investigate causes and risk factors of peritoneal dialysis-related peritonitis,explore the pathogenic bacteria and drug sensitivity.Methods CAPD patients suffered peritoneal dialysis-related peritonitis were recruited in the First Affiliated Hospital of Nanjing Medical University in 2012.Gender,age and possible risk factors were analyzed by unvaried and multivariate logistic regression analysis.The causes,pathogenic bacteria,

  13. Water channels in peritoneal dialysis.

    Science.gov (United States)

    Devuyst, Olivier

    2010-01-01

    Peritoneal dialysis involves diffusive and convective transports and osmosis through the highly vascularized peritoneal membrane. Several lines of evidence have demonstrated that the water channel aquaporin-1 (AQP1) corresponds to the ultrasmall pore predicted by the modelization of peritoneal transport. Proof-of-principle studies have shown that up-regulation of the expression of AQP1 in peritoneal capillaries is reflected by increased water permeability and ultrafiltration, without affecting the osmotic gradient and the permeability for small solutes. Inversely, studies in Aqp1 mice have shown that haploinsufficiency in AQP1 is reflected by significant attenuation of water transport. Recent studies have identified lead compounds that could act as agonists of aquaporins, as well as putative binding sites and potential mechanisms of gating the water channel. By modulating water transport, these pharmacological agents could have clinically relevant effects in targeting specific tissues or disease states. These studies on the peritoneal membrane also provide an experimental framework to investigate the role of water channels in the endothelium and various cell types.

  14. Diαgnostic approaches of peritoneal dialysis in peritonitis

    Directory of Open Access Journals (Sweden)

    Alikari V.

    2014-03-01

    Full Text Available Introduction: Peritonitis is the most important and frequent infectious complication of peritoneal dialysis. It is the most common cause of failure of the method and inclusion of patients in hemodialysis. Purpose: Τhe purpose of this study is to explore the diagnostic approaches of peritoneal dialysis peritonitis. Methods: Literature review of relevant articles in the database Pubmed as well as the official website of the International Society of Peritoneal Dialysis (ISPD was carried out. The search included articles published during 1996-2013. Results: According to the International Society of Peritoneal Dialysis, peritonitis requires the presence of two of the following criteria: (a cloudy peritoneal fluid, (b symptoms of inflammation of the peritoneum and (c the presence of microorganisms in the peritoneal fluid (> 100 leukocytes / μL of the solution of which most (> 50 % are polymorphnuclear. Some rules of sampling peritoneal fluid for culture and Gram staining are important for the right and immediate treatment of peritonitis: a the first cloudy peritoneal bag is the best sample b sending of the first bag for cultures should be done as early as possible in order to begin the appropriate antibiotic therapy. Gram stain, although in most cases is negative, it is particularly useful for the diagnosis of fungal peritonitis. Conclusions: Patient education, mainly of new Peritoneal Dialysis patients, about the early recognizing of cloudy fluids and exit-site infection, must be the primary concern of a Peritoneal Dialysis Unit. Careful use of antibiotics will reduce the frequency of negative cultures in order not to exceed the limit of 20% of the tests, as recommended by the International Society of Peritoneal Dialysis.

  15. Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.

    Science.gov (United States)

    Morinelli, Thomas A; Luttrell, Louis M; Strungs, Erik G; Ullian, Michael E

    2016-08-01

    The vasoactive hormone angiotensin II initiates its major hemodynamic effects through interaction with AT1 receptors, a member of the class of G protein-coupled receptors. Acting through its AT1R, angiotensin II regulates blood pressure and renal salt and water balance. Recent evidence points to additional pathological influences of activation of AT1R, in particular inflammation, fibrosis and atherosclerosis. The transcription factor nuclear factor κB, a key mediator in inflammation and atherosclerosis, can be activated by angiotensin II through a mechanism that may involve arrestin-dependent AT1 receptor internalization. Peritoneal dialysis is a therapeutic modality for treating patients with end-stage kidney disease. The effectiveness of peritoneal dialysis at removing waste from the circulation is compromised over time as a consequence of peritoneal dialysis-induced peritoneal fibrosis. The non-physiological dialysis solution used in peritoneal dialysis, i.e. highly concentrated, hyperosmotic glucose, acidic pH as well as large volumes infused into the peritoneal cavity, contributes to the development of fibrosis. Numerous trials have been conducted altering certain components of the peritoneal dialysis fluid in hopes of preventing or delaying the fibrotic response with limited success. We hypothesize that structural activation of AT1R by hyperosmotic peritoneal dialysis fluid activates the internalization process and subsequent signaling through the transcription factor nuclear factor κB, resulting in the generation of pro-fibrotic/pro-inflammatory mediators producing peritoneal fibrosis. PMID:27167177

  16. 21 CFR 876.5630 - Peritoneal dialysis system and accessories.

    Science.gov (United States)

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Peritoneal dialysis system and accessories. 876... Peritoneal dialysis system and accessories. (a) Identification. (1) A peritoneal dialysis system and... peritoneal dialysis, a source of dialysate, and, in some cases, a water purification mechanism. After...

  17. Resistant Yersinia Enterocolitica Peritonitis in a Peritoneal Dialysis Patient

    Directory of Open Access Journals (Sweden)

    Mehmet ÖZDEN

    2012-09-01

    Full Text Available Peritonitis is an important problem of peritoneal dialysis patients. Although Gram (+ bacteria are more frequent, Gram (- bacteria can rarely be the cause of peritonitis. Yersinia enterocolitica is a Gram (- enteric bacteria that especially causes gastrointestinal infections via contaminated food intake in immunosuppressive situations such as haemochromatosis, desferroxamine therapy or chronic hepatitis. We report a 51-year-old man who had been undergoing SAPD because of chronic renal failure for 2 years. We evaluated his peritoneal fl uid because of symptoms of peritonitis. His peritoneal cellular composition was consistent with peritonitis and after the microbiological culture of the fl uid we determined Yersinia enterocolitica as the pathogenic agent. The peritonitis persisted despite the administration of long term combined antibiotherapy and we removed the peritoneal catheter. In conclusion, Yersinia enterocolitica peritonitis is resistant to conventional antibiotic therapy and an indication for catheter removal.

  18. Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients

    OpenAIRE

    Jacek Waniewski; Stefan Antosiewicz; Daniel Baczynski; Jan Poleszczuk; Mauro Pietribiasi; Bengt Lindholm; Zofia Wankowicz

    2016-01-01

    During peritoneal dialysis (PD), the peritoneal membrane undergoes ageing processes that affect its function. Here we analyzed associations of patient age and dialysis vintage with parameters of peritoneal transport of fluid and solutes, directly measured and estimated based on the pore model, for individual patients. Thirty-three patients (15 females; age 60 (21–87) years; median time on PD 19 (3–100) months) underwent sequential peritoneal equilibration test. Dialysis vintage and patient ag...

  19. Capnocytophaga cynodegmi peritonitis in a peritoneal dialysis patient

    DEFF Research Database (Denmark)

    Pers, Charlotte; Tvedegaard, Erling; Christensen, Jens Jørgen;

    2007-01-01

    The first reported case of peritonitis caused by Capnocytophaga cynodegmi is presented. The patient was treated with peritoneal dialysis and had contact with a cat. C. cynodegmi is part of the normal oral flora of dogs and cats but is very rarely isolated in clinical specimens from humans....

  20. Encapsulating peritoneal sclerosis: Common or rare in peritoneal dialysis?

    OpenAIRE

    Konstantina Triga

    2013-01-01

    Encapsulating peritoneal sclerosis (EPS) is a serious and often fatal complication of long-term peritoneal dialysis (PD) with severe malnutrition and poor prognosis. It causes progressive obstruction and encapsulation of the bowel loops. As EPS becomes more prevalent with longer duration of PD, large multicenter prospective studies are needed to establish its incidence and identify risk factors, therapeutic approach, and prognosis.

  1. Peritoneal Dialysis Registry With 2012 Survey Report.

    Science.gov (United States)

    Hasegawa, Takeshi; Nakai, Shigeru; Moriishi, Misaki; Ito, Yasuhiko; Itami, Noritomo; Masakane, Ikuto; Hanafusa, Norio; Taniguchi, Masatomo; Hamano, Takayuki; Shoji, Tetsuo; Yamagata, Kunihiro; Shinoda, Toshio; Kazama, Junichiro; Watanabe, Yuzo; Shigematsu, Takashi; Marubayashi, Seiji; Morita, Osamu; Wada, Atsushi; Hashimoto, Seiji; Suzuki, Kazuyuki; Kimata, Naoki; Wakai, Kenji; Fujii, Naohiko; Ogata, Satoshi; Tsuchida, Kenji; Nishi, Hiroshi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu; Nakamoto, Hidetomo

    2015-12-01

    Since 2009, the peritoneal dialysis (PD) registry survey has been carried out as part of the annual nationwide survey conducted by the Statistical Survey Committee of the Japanese Society for Dialysis Therapy with the cooperation of the Japanese Society for Peritoneal Dialysis. In this report, the current status of PD patients is presented on the basis of the results of the survey conducted at the end of 2012. The subjects were PD patients who lived in Japan and participated in the 2012 survey. Descriptive analysis of various items was performed, which included the current status of the combined use of PD and another dialysis method such as hemodialysis (HD) or hemodiafiltration (HDF), the method of exchanging dialysate, the use of an automated peritoneal dialysis (APD) machine, and the rates of peritonitis and catheter exit-site infection. From the results of the facility survey in 2012, the number of PD patients was 9514, a decrease of 128 from 2011. Among the entire dialysis patient population, 3.1% were PD patients, a decrease of 0.1%. Among the studied patients, 347 had a peritoneal catheter and underwent peritoneal lavage, 175 were started on PD in 2012 but introduced to other blood purification methods in the same year, and 1932 underwent both PD and another dialysis method such as HD or HDF. The percentage of patients who underwent PD and another dialysis method increased with PD vintage: vintage of ≥2 years. The mean rate of peritonitis was 0.22 per patient per year. The mean rate of catheter exit-site infections was 0.36 per patient per year.

  2. Peritoneal dialysis in developing countries.

    Science.gov (United States)

    Nayak, K S; Prabhu, M V; Sinoj, K A; Subhramanyam, S V; Sridhar, G

    2009-01-01

    Peritoneal dialysis (PD) is acknowledged worldwide as a well-accepted form of renal replacement therapy (RRT) for end-stage renal disease (ESRD). Ideally, PD should be the preferred modality of RRT for ESRD in developing countries due to its many inherent advantages. Some of these are cost savings (especially if PD fluids are manufactured locally or in a neighboring country), superior rehabilitation and quality of life (QOL), home-based therapy even in rural settings, avoidance of hospital based treatment and the need for expensive machinery, and freedom from serious infections (hepatitis B and C). However, this is not the ground reality, due to certain preconceived notions of the health care givers and governmental agencies in these countries. With an inexplicable stagnation or decline of PD numbers in the developed world, the future of PD will depend on its popularization in Latin America and in Asia especially countries such as China and India, with a combined population of 2.5 billion and the two fastest growing economies worldwide. A holistic approach to tackle the issues in the developing countries, which may vary from region to region, is critical in popularizing PD and establishing PD as the first-choice RRT for ESRD. At our center, we have been pursuing a 'PD first' policy and promoting PD as the therapy of choice for various situations in the management of renal failure. We use certain novel strategies, which we hope can help PD centers in other developing countries working under similar constraints. The success of a PD program depends on a multitude of factors that are interlinked and inseparable. Each program needs to identify its strengths, special circumstances, and deficiencies, and then to strategize accordingly. Ultimately, teamwork is the 'mantra' for a successful outcome, the patient being central to all endeavors. A belief and a passion for PD are the fountainhead and cornerstone on which to build a quality PD program. PMID:19494625

  3. Tuberculous peritonitis in a child undergoing continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Tsai, T C; Hsu, J C; Chou, L H; Lee, M L

    1994-01-01

    We present a 13-year-old girl with Arnold-Chiari syndrome and uremia secondary to neurogenic bladder. She had been treated with continuous ambulatory peritoneal dialysis (CAPD) for 13 months prior to the development of peritonitis. The patient demonstrated no improvement with a 3-day therapy of intraperitoneal vancomycin and netilmicin. Meanwhile, smear of centrifuged dialysate revealed acid fast bacilli on two occasions. We, then, started anti-TB therapy with oral isoniazid (INAH), rifampin and ethambutal. The symptoms subsided within three days. In the first week, the patient lost her peritoneal ultrafiltration and needed daytime automatic peritoneal dialysis. At the last follow-up examination, 12 months after treatment, she remained well on standard CAPD.

  4. Encapsulating peritoneal sclerosis: Common or rare in peritoneal dialysis?

    Directory of Open Access Journals (Sweden)

    Konstantina Triga

    2013-01-01

    Full Text Available Encapsulating peritoneal sclerosis (EPS is a serious and often fatal complication of long-term peritoneal dialysis (PD with severe malnutrition and poor prognosis. It causes progressive obstruction and encapsulation of the bowel loops. As EPS becomes more prevalent with longer duration of PD, large multicenter prospective studies are needed to establish its incidence and identify risk factors, therapeutic approach, and prognosis.

  5. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis

    DEFF Research Database (Denmark)

    Nielsen, H; Espersen, F; Kharazmi, A;

    1992-01-01

    In a prospective study of intraperitoneal opsonins in 30 patients undergoing continuous ambulatory peritoneal dialysis (CAPD), the IgG concentration, the fibronectin concentration, the specific antistaphylococcal antibody level, and the opsonic activity against Staphylococcus epidermidis were...

  6. Bidirectional peritoneal transport of albumin in continuous ambulatory peritoneal dialysis

    DEFF Research Database (Denmark)

    Joffe, P; Henriksen, Jens Henrik Sahl

    1995-01-01

    The present study was undertaken in order to assess bidirectional peritoneal kinetics of albumin after simultaneous i.v. and i.p. injection of radioiodinated albumin tracers (125I-RISA and 131I-RISA) in eight clinically stable uraemic patients undergoing continuous ambulatory peritoneal dialysis...... (CAPD). The plasma volume, intravascular albumin mass (IVM), and overall extravasation rate of albumin were not significantly different from that found in healthy controls. Albumin flux from the plasma into the peritoneal cavity was 3.71 +/- 0.82 (SD) mumol/h, which was only 3% of the overall...... extravasation rate (137 +/- 52 mumol/h). Albumin flux from the peritoneal cavity into the plasma was substantially lower (0.22 +/- 0.07 mumol/h, P peritoneal accumulation of the albumin from plasma over 4 h was 14 +/- 3.2 mumol, which was significantly lower than the intraperitoneal albumin...

  7. CT features of peritonitis associated with continuous ambulatory peritoneal dialysis

    Energy Technology Data Exchange (ETDEWEB)

    Yun, Ji Young; Byun, Jae Young; Lee, Sang Hoon; Kwon, Tae Ahn; Kim, Yeon Kil; Kim, Young Ok; Song, Kyung Sup [The Catholic Univ. of Korea College of Medicine, Seoul (Korea, Republic of)

    1999-01-01

    To evaluate the CT findings of peritonitis associated with continuous ambulatory peritoneal dialysis(CAPD). We retrospectively analyzed CT scans of 14 symptomatic patients with peritonitis after CAPD. Diffuse abdominal pain was present in 11, fever in two, and abdominal mass with vomiting in one. The mean duration of CAPD ranged from 10 months to 5 years(mean : 3.9 years). On abdominal CT, we evaluated the presence and location of ascites, bowel wall thickening, cocoon formation, the pattern of enhancement of peritoneal thickening, the presence of calcifications in the peritoneum, and mesenteric and omental change. On enhanced CT, multiloculated ascites was observed in all cases(n=14) ; it was located mainly in the pelvic cavity with small multi-loculated fluid collections in the peritoneal cavity(n=13), including the lesser sac(n=3). In one patient, ascites was located in the space between the greater omentum and anterior peritoneal surface. CT showed ileus in 12 cases, small bowel wall thickening in 11, and cocoon formation in five. Uneven but smooth thickening of the peritoneum, with contrast enhancement, was seen in eight cases, and in five of these, peritoneal thickening was more prominent in the anterior peritoneum. Other findings included reticular opacity in two cases, hematoma of the rectus muscle in one, and umbilical hernia in one. Multiloculated fluid collection, ileus, small bowel wall thickening, uneven but smooth peritoneal thickening, and cocoon formation appear to be CT features of CAPD peritonitis.

  8. CT features of peritonitis associated with continuous ambulatory peritoneal dialysis

    International Nuclear Information System (INIS)

    To evaluate the CT findings of peritonitis associated with continuous ambulatory peritoneal dialysis(CAPD). We retrospectively analyzed CT scans of 14 symptomatic patients with peritonitis after CAPD. Diffuse abdominal pain was present in 11, fever in two, and abdominal mass with vomiting in one. The mean duration of CAPD ranged from 10 months to 5 years(mean : 3.9 years). On abdominal CT, we evaluated the presence and location of ascites, bowel wall thickening, cocoon formation, the pattern of enhancement of peritoneal thickening, the presence of calcifications in the peritoneum, and mesenteric and omental change. On enhanced CT, multiloculated ascites was observed in all cases(n=14) ; it was located mainly in the pelvic cavity with small multi-loculated fluid collections in the peritoneal cavity(n=13), including the lesser sac(n=3). In one patient, ascites was located in the space between the greater omentum and anterior peritoneal surface. CT showed ileus in 12 cases, small bowel wall thickening in 11, and cocoon formation in five. Uneven but smooth thickening of the peritoneum, with contrast enhancement, was seen in eight cases, and in five of these, peritoneal thickening was more prominent in the anterior peritoneum. Other findings included reticular opacity in two cases, hematoma of the rectus muscle in one, and umbilical hernia in one. Multiloculated fluid collection, ileus, small bowel wall thickening, uneven but smooth peritoneal thickening, and cocoon formation appear to be CT features of CAPD peritonitis

  9. Peritoneal Dialysis Dose and Adequacy

    Science.gov (United States)

    ... cavity are lined with a membrane called the peritoneum. During PD, a mixture of dextrose (sugar), salt, ... the permeability, or speed of diffusion, of the peritoneum—cannot be controlled. Dialysis solution comes in 1. ...

  10. Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis

    Directory of Open Access Journals (Sweden)

    Julia Kerschbaum

    2012-01-01

    Full Text Available Background. Peritonitis represents a major complication of peritoneal dialysis (PD. The aim of this paper was to systematically collect data on patient-related risk factors for PD-associated peritonitis, to analyze the methodological quality of these studies, and to summarize published evidence on the particular risk factors. Methods. Studies were identified by searches of Pubmed (1990–2012 and assessed for methodological quality by using a modified form of the STROBE criteria. Results. Thirty-five methodologically acceptable studies were identified. The following nonmodifiable risk factors were considered valid and were associated with an increased risk of peritonitis: ethnicity, female gender, chronic lung disease, coronary artery disease, congestive heart failure, cardiovascular disease, hypertension, antihepatitis C virus antibody positivity, diabetes mellitus, lupus nephritis or glomerulonephritis as underlying renal disease, and no residual renal function. We also identified the following modifiable, valid risk factors for peritonitis: malnutrition, overweight, smoking, immunosuppression, no use of oral active vitamin D, psychosocial factors, low socioeconomic status, PD against patient’s choice, and haemodialysis as former modality. Discussion. Modifiable and nonmodifiable risk factors analyzed in this paper might serve as a basis to improve patient care in peritoneal dialysis.

  11. Increasing sodium removal on peritoneal dialysis: applying dialysis mechanics to the peritoneal dialysis prescription.

    Science.gov (United States)

    Fischbach, Michel; Schmitt, Claus Peter; Shroff, Rukshana; Zaloszyc, Ariane; Warady, Bradley A

    2016-04-01

    Optimal fluid removal on peritoneal dialysis (PD) requires removal of water coupled with sodium, which is predominantly achieved via the small pores in the peritoneal membrane. On the other hand, free-water transport takes place through aquaporin-1 channels, but leads to sodium retention and over hydration. PD prescription can be adapted to promote small pore transport to achieve improved sodium and fluid management. Both adequate dwell volume and dwell time are required for small pore transport. The dwell volume determines the amount of "wetted" peritoneal membrane being increased in the supine position and optimized at dwell volumes of approximately 1400 ml/m(2). Diffusion across the recruited small pores is time-dependent, favored by a long dwell time, and driven by the transmembrane solute gradient. According to the 3-pore model of conventional PD, sodium removal primarily occurs via convection. The clinical application of these principles is essential for optimal performance of PD and has resulted in a new approach to the automated PD prescription: adapted automated PD. In adapted automated PD, sequential short- and longer-dwell exchanges, with small and large dwell volumes, respectively, are used. A crossover trial in adults and a pilot study in children suggests that sodium and fluid removal are increased by adapted automated PD, leading to improved blood pressure control when compared with conventional PD. These findings are not explained by the current 3-pore model of peritoneal permeability and require further prospective crossover studies in adults and children for validation. PMID:26924063

  12. Humicola sp. as a Cause of Peritoneal Dialysis-Associated Peritonitis.

    Science.gov (United States)

    Burns, Nathan; Arthur, Ian; Leung, Michael; Ketharanathan, Selva; Sandoval-Denis, Marcelo; Gené, Josepa; Guarro, Josep; Chakera, Aron

    2015-09-01

    Peritoneal dialysis is the renal replacement modality used by ∼20% of patients with end-stage kidney disease (S. McDonald, P. Clayton, and K. Hurst, p. 6.2-6.27, in ANZDATA 2012 Annual Report, 35th ed., 2012). A major complication of peritoneal dialysis is the development of peritonitis. We describe a case of Humicola sp. causing peritoneal dialysis (PD)-associated peritonitis, successfully treated with a prolonged course of antifungal therapy.

  13. Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients.

    Science.gov (United States)

    Waniewski, Jacek; Antosiewicz, Stefan; Baczynski, Daniel; Poleszczuk, Jan; Pietribiasi, Mauro; Lindholm, Bengt; Wankowicz, Zofia

    2016-01-01

    During peritoneal dialysis (PD), the peritoneal membrane undergoes ageing processes that affect its function. Here we analyzed associations of patient age and dialysis vintage with parameters of peritoneal transport of fluid and solutes, directly measured and estimated based on the pore model, for individual patients. Thirty-three patients (15 females; age 60 (21-87) years; median time on PD 19 (3-100) months) underwent sequential peritoneal equilibration test. Dialysis vintage and patient age did not correlate. Estimation of parameters of the two-pore model of peritoneal transport was performed. The estimated fluid transport parameters, including hydraulic permeability (LpS), fraction of ultrasmall pores (α u), osmotic conductance for glucose (OCG), and peritoneal absorption, were generally independent of solute transport parameters (diffusive mass transport parameters). Fluid transport parameters correlated whereas transport parameters for small solutes and proteins did not correlate with dialysis vintage and patient age. Although LpS and OCG were lower for older patients and those with long dialysis vintage, αu was higher. Thus, fluid transport parameters--rather than solute transport parameters--are linked to dialysis vintage and patient age and should therefore be included when monitoring processes linked to ageing of the peritoneal membrane. PMID:26989432

  14. Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients

    Directory of Open Access Journals (Sweden)

    Jacek Waniewski

    2016-01-01

    Full Text Available During peritoneal dialysis (PD, the peritoneal membrane undergoes ageing processes that affect its function. Here we analyzed associations of patient age and dialysis vintage with parameters of peritoneal transport of fluid and solutes, directly measured and estimated based on the pore model, for individual patients. Thirty-three patients (15 females; age 60 (21–87 years; median time on PD 19 (3–100 months underwent sequential peritoneal equilibration test. Dialysis vintage and patient age did not correlate. Estimation of parameters of the two-pore model of peritoneal transport was performed. The estimated fluid transport parameters, including hydraulic permeability (LpS, fraction of ultrasmall pores (αu, osmotic conductance for glucose (OCG, and peritoneal absorption, were generally independent of solute transport parameters (diffusive mass transport parameters. Fluid transport parameters correlated whereas transport parameters for small solutes and proteins did not correlate with dialysis vintage and patient age. Although LpS and OCG were lower for older patients and those with long dialysis vintage, αu was higher. Thus, fluid transport parameters—rather than solute transport parameters—are linked to dialysis vintage and patient age and should therefore be included when monitoring processes linked to ageing of the peritoneal membrane.

  15. Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients.

    Science.gov (United States)

    Waniewski, Jacek; Antosiewicz, Stefan; Baczynski, Daniel; Poleszczuk, Jan; Pietribiasi, Mauro; Lindholm, Bengt; Wankowicz, Zofia

    2016-01-01

    During peritoneal dialysis (PD), the peritoneal membrane undergoes ageing processes that affect its function. Here we analyzed associations of patient age and dialysis vintage with parameters of peritoneal transport of fluid and solutes, directly measured and estimated based on the pore model, for individual patients. Thirty-three patients (15 females; age 60 (21-87) years; median time on PD 19 (3-100) months) underwent sequential peritoneal equilibration test. Dialysis vintage and patient age did not correlate. Estimation of parameters of the two-pore model of peritoneal transport was performed. The estimated fluid transport parameters, including hydraulic permeability (LpS), fraction of ultrasmall pores (α u), osmotic conductance for glucose (OCG), and peritoneal absorption, were generally independent of solute transport parameters (diffusive mass transport parameters). Fluid transport parameters correlated whereas transport parameters for small solutes and proteins did not correlate with dialysis vintage and patient age. Although LpS and OCG were lower for older patients and those with long dialysis vintage, αu was higher. Thus, fluid transport parameters--rather than solute transport parameters--are linked to dialysis vintage and patient age and should therefore be included when monitoring processes linked to ageing of the peritoneal membrane.

  16. Dialysis vintage, body composition, and survival in peritoneal dialysis patients.

    Science.gov (United States)

    Avram, Morrell M; Mittman, Neal; Fein, Paul A; Agahiu, Samuel; Hartman, William; Chattopadhyay, Neil; Matza, Betty

    2012-01-01

    The relationship between dialysis vintage (length of time on dialysis), body composition, and survival has been reported in hemodialysis patients. In the present study, we examined the association ofdialysis vintage with body composition and survival in peritoneal dialysis (PD) patients. At enrollment, body composition in 65 PD patients was determined by bioelectrical impedance analysis. Patients (mean age at enrollment: 54 years) were followed for up to 11 years maximum. At enrollment, the mean, median, and maximum dialysis vintages were 51, 34, and 261 months respectively. After adjusting for age, race, sex, and diabetes status, dialysis vintage was indirectly correlated (partial correlation coefficients) with body weight (r = -0.40, p = 0.001), body mass index (r = -0.40, p = 0.002), body surface area (r = -0.39, p = 0.002), body cell mass (r = -0.39, p = 0.002), total body fat weight (r = -0.30, p = 0.02), and fat percentage of body weight (r = -0.31, p = 0.018), and directly correlated with extracellular mass to body cell mass ratio (r = 0.27, p = 0.039). The observed cumulative survival was significantly higher (p = 0.007) in patients with a dialysis vintage at enrollment of 35 months or less, than in patients with dialysis vintage at enrollment of more than 35 months. In the multivariate Cox regression analysis, adjusting for age, race, sex, and diabetes, dialysis vintage at enrollment remained an independent predictor of mortality (relative risk: 1.010; p = 0.002). Increase in relative risk of death with increasing dialysis vintage may be partly explained by the association of vintage with unfavorable changes in body composition and the nutrition status of patients over time.

  17. The Effect of Ligustrazine on Peritoneal Transport in Peritoneal Dialysis

    Institute of Scientific and Technical Information of China (English)

    朱忠华; 彭维毅; 王玉梅; 朱红艳; 杨晓; 邓安国

    2002-01-01

    Summary: In order to investigate the effect of ligustrazine (Lig) i.p. on peritoneal permeability inperitoneal dialysis and its side effects, creatinine was given intravenously and continuously tomaintain the high plasma creatinine level. All the rabbits were divided into three groups: normalcontrol group (group A), group B treated with 0. 12 % Lig and group C treated with 0. 24 % Lig.The peritoneal dialysis of all rabbits lasted 2 h. The plasma and dialysate levels of glucose, proteinand creatinine were observed immediate, 30 min, 60 min, 90 min,120 min after dialysis. Creasti-nine dialysate/plasma ratio (D/P), protein D/P ratio, glucose D/Do at different time points afterdialysis and creatinine mass transfer area coefficient (MTAC) at 120 min were calculated. Thestructures of peritoneum were observed under optical microscope and electron microscope aftercontinuously intraperitoneal injection of Lig for 14 days. The results showed that the 90-min and120-min creatinine D/P ratios in the group C were higher than in the group A. The 120-min creatinine MATC in the group C was higher than in the group A. The rabbits treated with Lig did notshow significant structure changes of peritoneum and signs of peritoneal irritation. It was suggest-ed that Lig could increase mass transfer ability of peritoneum without significant side effects.

  18. Gene delivery in peritoneal dialysis related peritoneal fibrosis research

    Institute of Scientific and Technical Information of China (English)

    LI Xie-jia; SUN Lin; XIAO Li; LIU Fu-you

    2012-01-01

    Objective To summarize the development of gene delivery vectors in peritoneal fibrosis research and discuss the feasibility and superiority of lentiviral vectors.Data sources The data in this article were collected from PubMed database with relevant English articles published from 1995 to 2011.Study selection Articles regarding the gene therapy in peritoneal fibrosis research using non-viral vectors,adenoviral vectors,ratroviral vectors,and lentiviral vectors were selected.Data were mainly extracted from 60 articles,which are listed in the reference section of this review.Results Non-viral vector-mediated gene delivery (including naked DNA for ex vivo,oligonucleotides,ultrasoundcontrast agent mediated naked gene delivery,etc.) and viral vector-mediated gene delivery (including adenovirus,helper-dependant adenovirus,and retrovirus vectors) have been successfully applied both in the mechanistic investigation and the potential prevention and treatment of peritoneal fibrosis.Conclusions Peritoneal fibrosis is a major complication of peritoneal dialysis (PD).Recently,the wide use of the gene delivery technique made it possible to access and further research peritoneal fibrosis.The use of lentiviral vector is expected to be widely used in PD research in the future due to its advantages in gene delivery.

  19. Biocompatible Peritoneal Dialysis Fluids: Clinical Outcomes

    Directory of Open Access Journals (Sweden)

    Yeoungjee Cho

    2012-01-01

    Full Text Available Peritoneal dialysis (PD is a preferred home dialysis modality and has a number of added advantages including improved initial patient survival and cost effectiveness over haemodialysis. Despite these benefits, uptake of PD remains relatively low, especially in developed countries. Wider implementation of PD is compromised by higher technique failure from infections (e.g., PD peritonitis and ultrafiltration failure. These are inevitable consequences of peritoneal injury, which is thought to result primarily from continuous exposure to PD fluids that are characterised by their “unphysiologic” composition. In order to overcome these barriers, a number of more biocompatible PD fluids, with neutral pH, low glucose degradation product content, and bicarbonate buffer have been manufactured over the past two decades. Several preclinical studies have demonstrated their benefit in terms of improvement in host cell defence, peritoneal membrane integrity, and cytokine profile. This paper aims to review randomised controlled trials assessing the use of biocompatible PD fluids and their effect on clinical outcomes.

  20. Clinical effects of icodextrin in peritoneal dialysis.

    Science.gov (United States)

    Cnossen, Trijntje T; Konings, Constantijn J; van der Sande, Frank M; Leunissen, Karel M; Kooman, Jeroen P

    2008-10-01

    Objective. This study reviews the relevant publications on the clinical effects of icodextrin in peritoneal dialysis (PD). Design. The study provides a systematic review of the literature (MEDLINE search with icodextrin as the keyword). Results. Icodextrin induces sustained transcapillary ultrafiltration during long dwell periods. It also stimulates increased removal of sodium by the peritoneal membrane, reduction of extracellular water (ECW) and total body water (TBW). Effects of icodextrin on blood pressure control and residual renal function are discrepant. Icodextrin induces a reduction in the formation of advanced glycation end-products, while the longitudinal changes in the peritoneal membrane transport are less prominent. Conclusions. Use of icodextrin in PD improves the sodium and fluid balance. Icodextrin is potentially more biocompatible, when compared with the conventional glucose solutions. The side effects are rare.

  1. Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time.

    Directory of Open Access Journals (Sweden)

    Chia-Ter Chao

    Full Text Available Acinetobacter species are assuming an increasingly important role in modern medicine, with their persistent presence in health-care settings and antibiotic resistance. However, clinical reports addressing this issue in patients with peritoneal dialysis (PD peritonitis are rare.All PD peritonitis episodes caused by Acinetobacter that occurred between 1985 and 2012 at a single centre were retrospectively reviewed. Clinical features, microbiological data, and outcomes were analysed, with stratifications based upon temporal periods (before and after 2000.Acinetobacter species were responsible for 26 PD peritonitis episodes (3.5% of all episodes in 25 patients. A. baumannii was the most common pathogen (54%, followed by A. iwoffii (35%, with the former being predominant after 2000. Significantly more episodes resulted from breaks in exchange sterility after 2000, while those from exit site infections decreased (P = 0.01. The interval between the last and current peritonitis episodes lengthened significantly after 2000 (5 vs. 13.6 months; P = 0.05. All the isolates were susceptible to cefepime, fluoroquinolone, and aminoglycosides, with a low ceftazidime resistance rate (16%. Nearly half of the patients (46% required hospitalisation for their Acinetobacter PD-associated peritonitis, and 27% required an antibiotic switch. The overall outcome was fair, with no mortality and a 12% technique failure rate, without obvious interval differences.The temporal change in the microbiology and origin of Acinetobacter PD-associated peritonitis in our cohort suggested an important evolutional trend. Appropriate measures, including technique re-education and sterility maintenance, should be taken to decrease the Acinetobacter peritonitis incidence in PD patients.

  2. Automated peritoneal dialysis in Brunei Darussalam.

    Directory of Open Access Journals (Sweden)

    Ishrat KAMAL

    2011-04-01

    Full Text Available Introduction: Chronic kidney disease in Brunei Darussalam is a growing problem. The number of patients reaching end stage kidney failure has increased dramatically in the last ten years. Currently, most are managed with haemodialysis while a smaller proportion is managed with continuous ambulatory peritoneal dialysis (CAPD. Automated peritoneal dialysis (APD is a form of peritoneal dialysis and has been used in Brunei Darussalam since May 2008. Materials and Methods: Eight patients participated in this prospective clinical trial. As all APD patients were previously on CAPD, comparisons are made between the outcomes of APD against CAPD. Results: The median and mean age of APD patients were 42 and 45.5 ± 12.73 years respectively. After switching to APD, the serum haemoglobin and albumin improved from 10.56 ± 1.95 gm/L and 27.88 ± 7.71 gm/dL to 12.26 ± 1.82 gm/L and 33.63 ± 6.89 gm/dL respectively (p values <0.05. This corresponded to improvements in seven (87.5% and six (75% patients respectively in both parameters. Erythropoietin requirement was reduced in six (75% patients, including three (37.5% patients who were able to stop erythropoietin completely. There was no peritonitis encountered. All patients reported improved quality of life with better sleep, appetite and general well-being. Conclusions: Our study showed that APD was as good as CAPD with improvement seen in both laboratory and quality of life parameters. There was also reduction in erythropoietin requirement. Based on these findings, we will actively encourage and promote APD usage as oppose to CAPD usage in our population.

  3. Peritoneal membrane characteristics in patients on peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Jamal Al-wakeel

    2011-01-01

    Full Text Available Peritoneal dialysis (PD is a well-established modality for treatment of patients with end-stage renal disease, giving excellent patient and technique survival rates. In Saudi Arabia, data collected by the Saudi Center for Organ Transplantation showed that in 2008, patients on PD accounted for a mere 4.8% of total patients on renal replacement therapy, including hemodialysis and renal transplantation. This study was conducted to identify the characteristics of membrane per-meability in the Saudi population and to assess the role of various factors affecting solute transport across the peritoneal membrane. We followed up a total of 52 patients on Continuous Ambulatory Peritoneal Dialysis (CAPD as well as Automated Peritoneal Dialysis (APD, being treated in the PD unit of the King Khalid University Hospital, Riyadh. There were 30 female and 22 male patients; 14 patients were using CAPD while 38 patients were on APD. The mean age of the patients was 50.5 years, with a range of 14-86 years. The average body mass index (BMI was 27.1 kg/m 2 and the mean body surface area (BSA of the study patients was 1.71 m 2 . A standardized PET test was performed on all patients, 4-6 weeks after initiation of regular PD. The Kt/V and creatinine clearance measured 6-8 weeks after initiation of dialysis were 1.96 and 56.59 L/week, respectively. Residual renal function was assessed on the basis of daily urine output, using 24-hour urine collection. The mean serum urea con-centration was 16.91 mmol/L and mean serum creatinine was 702 μmol/L. According to the Peritoneal Equiliberation Test (PET, 8% of the subjects belonged to the high trans-porter category, 44% patients belonged to the high-average transport group, 46% to the low-average category and 2% came in the low transporter category. Our study suggests that the patient characteristics and demographic para-meters seen in the Saudi population are comparable to those seen in other studies from the Middle East and

  4. Spirometric Parameters: Hemodialysis Compared to Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Fariba Rezaeetalab

    2015-06-01

    Full Text Available Introduction: Renal failure affects the mechanical and the ventilatory function of the lungs. A few studies have evaluated the ventilatory and pulmonary function in dialysis patients. The present study aimed to compare Pulmonary Function Test (PFT results in patients undergoing Hemodialysis (HD and Peritoneal Dialysis (PD. Materials and Methods: We conducted a cross-sectional study on 50  patients with hemodialysis (HD and 50 cases with PD who  underwent PFT in Ghaem and Imam Reza hospitals Mashhad, Iran from November 2010 to July 2012. Spirometric parameters including forced expiratory volume in 1s (FEV1, FEV1/forced vital capacity (FVC, forced expiratory flow 25-75% (FEF and peak expiratory flow (PEF were compared between the two groups of patients. Results: Approximately 68% of the HD patients, 66% of the PD patients, and 67% of all the studied cases showed a normal spirometric pattern. Moreover, there were no significant differences between the two groups considering the mean of the aforementioned spirometric parameters(restrictive ,obstructive pattern (P=0.969. However, an insignificant inverse correlation was observed between the duration of dialysis with FEV1 (r=0.381, P=0.008, FVC (r=-0.298, P=0.04, FEF 25-75% (r=0.43, P=0.003, PEF (r= 0.349, P=0.02 and FEV1/FVC (r=-0.363, P=0.01, in the HD patients and between the patients’ age with FEV1/FVC (r=0.03, P=0.02 in the PD patients. Conclusion: This study showed no significant difference in pulmonary function in hemo and peritoneal dialysis,so according this result ,both of the dialysis had the same affect on the lung function.

  5. Escherichia coli Peritonitis in Peritoneal Dialysis: The Prevalence, Antibiotic Resistance and Clinical Outcomes in a South China Dialysis Center

    OpenAIRE

    FENG, XIAORAN; Yang, Xiao; Yi, Chunyan; Guo, Qunying; Mao, Haiping; Jiang, Zongpei; Li, Zhibin; Chen, Dongmei; Cui, Yingpeng; Yu, Xueqing

    2014-01-01

    ♦ Introduction: Escherichia coli (E. coli) peritonitis is a frequent, serious complication of peritoneal dialysis (PD). The extended-spectrum β-lactamase (ESBL)-producing E. coli peritonitis is associated with poorer prognosis and its incidence has been on continuous increase during the last decades. However, the clinical course and outcomes of E. coli peritonitis remain largely unclear.

  6. Effectiveness of Home Visits to Pediatric Peritoneal Dialysis Patients

    OpenAIRE

    Ellis, Eileen N.; Blaszak, Christine; Wright, Sherida; Van Lierop, Andrea

    2012-01-01

    Home visits by trained personnel to patients undergoing home dialysis are required, but little is reported about the effectiveness of such home visits. We retrospectively reviewed home visits to 22 pediatric patients undergoing continuous cycling peritoneal dialysis (PD) at home. A trained dialysis nurse completed each home visit. An average of 1.5 pertinent dialysis findings and 1 pertinent medication finding was noted for each home visit to these patients. The interdisciplinary dialysis tea...

  7. [A new view on pathochemical mechanisms of prolonged peritoneal dialysis].

    Science.gov (United States)

    Petrovich, Iu A; Iarema, I V; Terekhina, N A; Kichenko, S M

    2010-01-01

    New data on etiology, pathogenesis, clinics, quantity estimation, treatment and complications of peritoneal dialysis are observed. The role of aquaporine, nitric oxide, NO-synthase, inflammation and sepsis markers (procalcitonine, C-reactive protein) in pathochemical mechanism of peritoneal dialysis is discussed. PMID:20734476

  8. Vitamin K Status of Canadian Peritoneal Dialysis Patients

    Science.gov (United States)

    Vitamin K –dependent proteins have been implicated in the regulation of vascular calcification, a condition that is prevalent among peritoneal dialysis patients. Vitamin K status in this patient population is unknown. In a cross-sectional study of 22 peritoneal dialysis patients selected from a Can...

  9. Acute hydrothorax complicating peritoneal dialysis: a case report

    Directory of Open Access Journals (Sweden)

    Ranganathan Dwarkanathan

    2010-11-01

    Full Text Available Abstract Introduction Acute hydrothorax is an uncommon but a well-recognized complication of peritoneal dialysis. No single test is definitive for diagnosis. Although it is not a life-threatening condition, hydrothorax often requires abandonment of peritoneal dialysis. Delay in diagnosis can lead to worsening of the clinical status. Case Presentation A 33-year-old Caucasian woman with lupus, who was successfully treated with temporary peritoneal dialysis 17 years previously, presented with acute dyspnea and a right pleural effusion after recommencing peritoneal dialysis. Investigations eliminated infective, cardiac, and primary respiratory causes. Peritoneal dialysis-related hydrothorax was suggested by biochemistry, and a pleuroperitoneal leak was definitively confirmed by using a Tc-99 m DTPA (diethylene triamine penta-acetic acid scintigraphy scan. Subsequently, she underwent video-assisted thoracoscopy-guided talc pleurodesis and was able to return successfully to peritoneal dialysis. Conclusion Although our case is not the first report that describes the occurrence of acute hydrothorax in peritoneal dialysis, it is an important condition to recognize for the wider general medical community. Furthermore, this case demonstrates that peritoneal dialysis can be continued with a hydrothorax, provided the underlying cause can be corrected. We review the literature pertaining to the utility and reliability of different diagnostic approaches to hydrothorax.

  10. Peritonitis due to Brevibacterium otitidis in a patient undergoing continuous ambulatory peritoneal dialysis.

    OpenAIRE

    Wauters, Georges; Van Bosterhaut, B; Avesani, V; Cuvelier, R.; Charlier, Jacqueline; Janssens, Michèle; Delmée, Michel

    2000-01-01

    Brevibacterium otitidis is a coryneform rod and, as far as is known, is isolated only from infected ears. We report the first known case of peritonitis caused by B. otitidis in a patient undergoing continuous ambulatory peritoneal dialysis.

  11. Peritonitis by Scedosporium apiospermum in a patient undergoing continuous ambulatory peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    SEVERO Luiz Carlos

    1999-01-01

    Full Text Available A case of peritonitis due to Scedosporium apiospermum in a boy undergoing continuous ambulatory peritoneal dialysis is reported. The finding of suggestive tissual form of the fungus in the effluent hastened the diagnosis of the infection.

  12. Peritoneal Dialysis Tailored to Pediatric Needs

    Directory of Open Access Journals (Sweden)

    C. P. Schmitt

    2011-01-01

    Full Text Available Consideration of specific pediatric aspects is essential to achieve adequate peritoneal dialysis (PD treatment in children. These are first of all the rapid growth, in particular during infancy and puberty, which must be accompanied by a positive calcium balance, and the age dependent changes in body composition. The high total body water content and the high ultrafiltration rates required in anuric infants for adequate nutrition predispose to overshooting convective sodium losses and severe hypotension. Tissue fragility and rapid increases in intraabdominal fat mass predispose to hernia and dialysate leaks. Peritoneal equilibration tests should repeatedly been performed to optimize individual dwell time. Intraperitoneal pressure measurements give an objective measure of intraperitoneal filling, which allow for an optimized dwell volume, that is, increased dialysis efficiency without increasing the risk of hernias, leaks, and retrofiltration. We present the concept of adapted PD, that is, the combination of short dwells with low fill volume to promote ultrafiltration and long dwells with a high fill volume to improve purification within one PD session. The use of PD solutions with low glucose degradation product content is recommended in children, but unfortunately still not feasible in many countries.

  13. Analysis of microbial spectrum and antibiotic resistance in patients of peritoneal dialysis related peritonitis

    Institute of Scientific and Technical Information of China (English)

    詹周兵

    2014-01-01

    Objective To investigate the microbial spectrum and antibiotic resistance of continuous ambulatory peritoneal dialysis(CAPD)related peritonitis and guide the clinical rational use of antimicrobial agents.Methods A retrospective analysis was made of CAPD related peritonitis in236 cases with peritoneal dialysate culture results in the

  14. Bladder perforation in a peritoneal dialysis patient.

    Science.gov (United States)

    Ounissi, M; Sfaxi, M; Fayala, H; Abderrahim, E; Ben Abdallah, T; Chebil, M; Ben Maiz, H; Kheder, A

    2012-05-01

    The dysfunction of the catheter in peritoneal dialysis (PD) is a frequent complication. However, perforation of organs are rare, particularly that of the urinary bladder. This requires an early diagnosis and prompt treatment of patients. We report here the case of a 38-year-old woman having end-stage renal disease due to autosomal-dominant polycystic kidney disease treated by PD since November 2000. Three years later, she was treated for Staphylococcal peritonitis. Four months later, she presented with a severe urge to urinate at the time of the fluid exchanges. The biochemical analysis of the fluid from the bladder showed that it was dialysis fluid. Injection of contrast through the catheter demonstrated the presence of a fistula between the bladder and the peritoneal cavity. She underwent cystoscopic closure of the fistulous tract and the PD catheter was removed. Subsequently, the patient was treated by hemodialysis. One month later, a second catheter was implanted surgically after confirming the closure of the fistula. Ten days later, she presented with pain at the catheter site and along the tunnel, which was found to be swollen along its track. The injection of contrast produced swelling of the subcutaneous tunnel but without extravasation of the dye. PD was withdrawn and the patient was put back on hemodialysis. Bladder fistula is a rare complication in PD and diagnosis should be suspected when patient complains of an urge to pass urine during the exchanges, which can be confirmed by contrast study showing presence of dye in the bladder. PD may be possible after the closure of the fistula, but recurrence may occur. PMID:22569443

  15. Bladder perforation in a peritoneal dialysis patient

    Directory of Open Access Journals (Sweden)

    M Ounissi

    2012-01-01

    Full Text Available The dysfunction of the catheter in peritoneal dialysis (PD is a frequent compli-cation. However, perforation of organs are rare, particularly that of the urinary bladder. This re-quires an early diagnosis and prompt treatment of patients. We report here the case of a 38-year-old woman having end-stage renal disease due to autosomal-dominant polycystic kidney disease treated by PD since November 2000. Three years later, she was treated for Staphylococcal peritonitis. Four months later, she presented with a severe urge to urinate at the time of the fluid exchanges. The biochemical analysis of the fluid from the bladder showed that it was dialysis fluid. Injection of contrast through the catheter demonstrated the presence of a fistula between the bladder and the peritoneal cavity. She underwent cystoscopic closure of the fistulous tract and the PD catheter was removed. Subsequently, the patient was treated by hemodialysis. One month later, a second catheter was implanted surgically after confirming the closure of the fistula. Ten days later, she presented with pain at the catheter site and along the tunnel, which was found to be swollen along its track. The injection of contrast produced swelling of the subcutaneous tunnel but without extravasation of the dye. PD was withdrawn and the patient was put back on hemodialysis. Bladder fistula is a rare complication in PD and diagnosis should be suspected when patient complains of an urge to pass urine during the exchanges, which can be confirmed by contrast study showing presence of dye in the bladder. PD may be possible after the closure of the fistula, but recurrence may occur.

  16. Oral Tori in Chronic Peritoneal Dialysis Patients.

    Directory of Open Access Journals (Sweden)

    Chia-Lin Hsu

    Full Text Available The pathogenesis of oral tori has long been debated and is thought to be the product of both genetic and environmental factors, including occlusal forces. Another proposed mechanism for oral tori is the combination of biomechanical forces, particularly in the oral cavity, combined with cortical bone loss and trabecular expansion, as one might see in the early stages of primary hyperparathyroidism. This study investigated the epidemiology of torus palatinus (TP and torus mandibularis (TM in peritoneal dialysis patients, and analyzed the influences of hyperparathyroidism on the formation of oral tori.In total, 134 peritoneal dialysis patients were recruited between July 1 and December 31, 2015 for dental examinations for this study. Patients were categorized into two subgroups based on the presence or absence of oral tori. Demographic, hematological, biochemical, and dialysis-related data were obtained for analysis.The prevalence of oral tori in our sample group was high at 42.5% (57 of 134, and most patients with oral tori were female (61.4%. The most common location of tori was TP (80.7%, followed by TP and TM (14.0%, then TM (5.3%. All 54 TP cases were at the midline, and most were <2 cm (59.3%, flat (53.7%, and located in the premolar region (40.7%. Of the 11 TM cases, all were bilateral and symmetric, mostly <2 cm (81.9%, lobular (45.4%, and located at premolar region (63.6%. Interestingly, patients with oral tori had slightly lower serum levels of intact parathyroid hormones than those without oral tori, but the difference was not statistically significant (317.3±292.0 versus 430.1±492.6 pg/mL, P = 0.126. In addition, patients with oral tori did not differ from patients without tori in inflammatory variables such as serum high sensitivity C-reactive protein levels (6.6±8.2 versus 10.3±20.2 mg/L, P = 0.147 or nutritional variables such as serum albumin levels (3.79±0.38 versus 3.77±0.45 g/dL, P = 0.790. Furthermore, there were no

  17. Peritonitis and catheter exit-site infection in patients on peritoneal dialysis at home1

    Science.gov (United States)

    Abud, Ana Cristina Freire; Kusumota, Luciana; dos Santos, Manoel Antônio; Rodrigues, Flávia Fernanda Luchetti; Damasceno, Marta Maria Coelho; Zanetti, Maria Lúcia

    2015-01-01

    Objective: to analyze the complications related to peritonitis and catheter exit-site infections, in patients on peritoneal dialysis at home. Method: quantitative and cross-sectional study, carried out with 90 patients on peritoneal dialysis at home, in a municipality in the Northeast region of Brazil. For data collection, it was used two structured scripts and consultation on medical records. Descriptive analysis and comparison tests among independent groups were used, considering p<0.05 as level of statistical significance. Results: by comparing the frequency of peritonitis and the length of treatment, it was found that patients over two years of peritoneal dialysis were more likely to develop peritonitis (X²=6.39; p=0.01). The number of episodes of peritoneal catheter exit-site infection showed association with the length of treatment (U=224,000; p=0.015). Conclusion: peritonitis and catheter exit-site infection are associated with the length of treatment. PMID:26487141

  18. Imaging features of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.

    LENUS (Irish Health Repository)

    Ti, Joanna P

    2010-07-01

    OBJECTIVE: The purpose of this article is to present the spectrum of radiologic findings of encapsulating peritoneal sclerosis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). CONCLUSION: Although a rare diagnosis, encapsulating peritoneal sclerosis in patients undergoing CAPD has a high morbidity and mortality. Diagnosis is often delayed because clinical features are insidious and nonspecific. Radiologic imaging may be helpful in the early diagnosis of encapsulating peritoneal sclerosis and in facilitating timely intervention for CAPD patients with encapsulating peritoneal sclerosis.

  19. Tamoxifen Ameliorates Peritoneal Membrane Damage by Blocking Mesothelial to Mesenchymal Transition in Peritoneal Dialysis

    OpenAIRE

    Jesús Loureiro; Pilar Sandoval; Gloria del Peso; Guadalupe Gónzalez-Mateo; Vanessa Fernández-Millara; Beatríz Santamaria; Maria Auxiliadora Bajo; José Antonio Sánchez-Tomero; Gonzalo Guerra-Azcona; Rafael Selgas; Manuel López-Cabrera; Aguilera, Abelardo I.

    2013-01-01

    Mesothelial-to-mesenchymal transition (MMT) is an auto-regulated physiological process of tissue repair that in uncontrolled conditions such as peritoneal dialysis (PD) can lead to peritoneal fibrosis. The maximum expression of peritoneal fibrosis induced by PD fluids and other peritoneal processes is the encapsulating peritoneal sclerosis (EPS) for which no specific treatment exists. Tamoxifen, a synthetic estrogen, has successfully been used to treat retroperitoneal fibrosis and EPS associa...

  20. Difficult peritonitis cases in children undergoing chronic peritoneal dialysis: relapsing, repeat, recurrent and zoonotic episodes.

    Science.gov (United States)

    Bakkaloglu, Sevcan A; Warady, Bradley A

    2015-09-01

    Despite technological improvements in dialysis connectology and dialysis technique, peritonitis remains the most common and most significant complication of peritoneal dialysis (PD) in children. Most children undergoing chronic PD experience none or only one peritonitis episode, while others have multiple episodes or episodes secondary to unusual organisms. Knowledge of potential risk factors and likely patient outcome is imperative if treatment is to be optimized. In this review we will, in turn, describe episodes of peritonitis that are characterized as either relapsing, recurrent, repeat or zoonosis-related to highlight the clinical issues that are commonly encountered by clinicians treating these infections.

  1. [99mTc-MAA peritoneal scintigraphy in pleuroperitoneal comunication in peritoneal dialysis patients].

    Science.gov (United States)

    Hernández Martínez, A C; Marín Ferrer, M D; Coronado Poggio, M; Escabias Del Pozo, C; Coya Viña, J; Martín Curto, L

    2010-01-01

    Peritoneal dialysis is a fully-contrasted alternative for the treatment of end-stage renal disease although it is not exempt of complications. Peritonitis and exit-site infections are among the most frequent complications found. Pleural effusion secondary to pleuroperitoneal communication (PPC) is a serious and uncommon complication in these patients. We present the case of a 50-year old man diagnosed of end-stage renal disease undergoing treatment with peritoneal dialysis who presented progressive dyspnea and right pleural effusion. The peritoneal scintigraphy with (99m)Tc-MAA makes it possible to confirm communication of intraperitoneal dialysis fluid to the pleural cavity. PMID:20117860

  2. Gastrointestinal Non-Infectious Complications in Patients on Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Kostović Milica

    2016-06-01

    Full Text Available Gastrointestinal complications are common among patients on peritoneal dialysis. Risk factors for the development of gastrointestinal complications in this patient population include: toxic effects of uremic toxins, frequent use of nonsteroidal anti-inflammatory drugs, Helicobacter pylori infection, angiodysplasia, increased intra-abdominal pressure, use of bioincompatible solution for peritoneal dialysis, increased glucose in solutions for peritoneal dialysis, secondary hyperparathyroidism (hypercalcemia, a disorder of lipid metabolism (hypertriglyceridemia, and the duration of peritoneal dialysis treatment. The most important non-infectious gastrointestinal complications in patients on peritoneal dialysis are: gastrointestinal bleeding, herniation and leaking of the dialysate from the abdomen (increased intra-abdominal pressure, impaired lung function (intra-abdominal hypertension, acute pancreatitis, and encapsulating sclerosis of the peritoneum. Intra-abdominal hypertension is defined as IAP ≥ 12 mmHg. Pouring the peritoneal dialysis solution leads to increased intra-abdominal pressure, which results in the development of hernias, pleuro-peritoneal dialysate leakage (hydrothorax, and restrictive pulmonary dysfunction. Risk factors for the development of acute pancreatitis in this patient population include: uraemia, secondary hyperparathyroidism with hypercalcemia, hypertriglyceridemia, features of the peritoneal dialysis solution (osmolarity, acidity, glucose, chemical irritation, and calcium in the solution for peritoneal dialysis lead to “local hypercalcemia”, toxic substances from the dialysate, the bags and tubing, and peritonitis and treatment of peritonitis with antibiotics and anticoagulants. Encapsulating sclerosis of the peritoneum is rare and is the most serious complication of long-term peritoneal dialysis. It is characterized by thickening of the peritoneum, including cancer, and signs and symptoms of obstructive ileus

  3. Peritonitis and catheter exit-site infection in patients on peritoneal dialysis at home

    OpenAIRE

    Ana Cristina Freire Abud; Luciana Kusumota; Manoel Antônio dos Santos; Flávia Fernanda Luchetti Rodrigues; Marta Maria Coelho Damasceno; Maria Lúcia Zanetti

    2015-01-01

    Objective: to analyze the complications related to peritonitis and catheter exit-site infections, in patients on peritoneal dialysis at home. Method: quantitative and cross-sectional study, carried out with 90 patients on peritoneal dialysis at home, in a municipality in the Northeast region of Brazil. For data collection, it was used two structured scripts and consultation on medical records. Descriptive analysis and comparison tests among independent groups were used, considering p

  4. Pathophysiology of the peritoneal membrane during peritoneal dialysis: the role of hyaluronan

    OpenAIRE

    Susan Yung; Tak Mao Chan

    2011-01-01

    During peritoneal dialysis (PD), constant exposure of mesothelial cells to bioincompatible PD solutions results in the denudation of the mesothelial monolayer and impairment of mesothelial cell function. Hyaluronan, a major component of extracellular matrices, is synthesized by mesothelial cells and contributes to remesothelialization, maintenance of cell phenotype, and tissue remodeling and provides structural support to the peritoneal membrane. Chronic peritoneal inflammation is observed in...

  5. Peritonitis in children on peritoneal dialysis in Cape Town, South Africa : epidemiology and risks

    NARCIS (Netherlands)

    Raaijmakers, R.; Gajjar, P.; Schroder, C.; Nourse, P.

    2010-01-01

    Peritonitis is a frequent complication of peritoneal dialysis (PD) in children as well in adults. Data on PD and peritonitis in pediatric patients are very scarce in developing countries. A retrospective cohort study was performed between 2000 and 2008 with the aim to evaluate PD treatment and perit

  6. Raoultella planticola peritonitis in a patient on continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Kim, Sun Woo; Kim, Ji Eun; Hong, Yu Ah; Ko, Gang Jee; Pyo, Heui Jung; Kwon, Young Joo

    2015-12-01

    A 65-year-old man on continuous ambulatory peritoneal dialysis was admitted with peritonitis. Empirical antibiotic therapy was initiated, and Raoultella planticola was identified in the peritoneal fluid culture. We treated the patient with intraperitoneally administered ciprofloxacin and ceftazidime according to the antibiotic susceptibility. His condition improved, and he was well treated with a 2-week antibiotic course.

  7. Disaster planning for peritoneal dialysis programs.

    Science.gov (United States)

    Kleinpeter, Myra A; Norman, Lisa D; Krane, N Kevin

    2006-01-01

    Because of increased intensity of hurricanes in the Gulf Coast region of the United States, peritoneal dialysis (PD) programs have been disrupted and patients relocated temporarily following these catastrophic events. We describe the disaster planning, implementation, and follow-up that occurred in one such PD program in New Orleans following Hurricane Katrina. Each year at the beginning of the North American hurricane season, the PD program's disaster plan is reviewed by clinic staff and copies are distributed to patients. Patients are instructed to assemble a disaster kit and are provided with contact numbers for dialysis suppliers and for a PD program in their planned evacuation city. In July 2005, this disaster plan was tested when an early tropical storm and hurricane entered the Gulf and several patients briefly relocated or evacuated because of power loss and then returned without incident. However, when Hurricane Katrina, a category 5 storm, was predicted to strike the metropolitan area, patients were notified by telephone to evacuate, and contact information, including their evacuation city and telephone and cellular phone numbers, was obtained. Patients were also reminded to take all medications, bottled water, antibacterial soap, hand sanitizer, and 4-5 days of PD supplies. Following the storm, telephone and cellular phone services were severely disrupted. However, text messaging was available to contact patients to confirm safety and to provide further instructions. Arrangements with the major dialysis suppliers to ship emergency supplies to new locations were made by the PD nurse and the patients. Only 2 of 22 patients required hospitalization because of complications resulting from evacuation failure, contamination, and inability to perform dialysis for a prolonged period of time. Both of these patients were quickly released and have continued PD. Following the event, all patients remained on PD, and most have planned to return to their home PD

  8. PERITONEAL DIALYSIS AFTER REPAIR OF CONGENITAL HEART DISEASE IN CHILDREN

    Institute of Scientific and Technical Information of China (English)

    罗新锦; 许建屏; 沈向东; 陈霞

    2003-01-01

    Objective. To investigate the effect of peritoneal dialysis on fluid balance and outcome in childrenwho receive cardiac operation.Methods. From July to Dec. 2000, 12(2.08%) patients of 576 consecutive children who underwentheart operation required peritoneal dialysis because of acute renal failure. The mean age of these 12 pa-tients was (2.9±2.0) years (range, 5 months~7 years) and the mean body weight was (12±3) kg (range,7.4~18.5 kg ).Results. The interval between the operation and the initiation of peritoneal dialysis was (21.2±11.4)hours (4.4~42 hours). The duration of peritoneal dialysis was (6.3±4.8) days (0.47~15 days). Mortality inthese 12 patients was 25%. Fluid removed by peritoneal dialysis was(34.7±17.8) ml@kg1@day-1@ Asymop-tomatic hypokalemia, thrombocytopenia and hyperglycemia were frequent complications, which were easilymanaged. Hemodynamics and pulmonary function improved during the study period.Conclusion. The early initiation of peritoneal dialysis is an effective and safe method totreat acute renal failure after cardiac operation in children.

  9. Inflammation and the Peritoneal Membrane: Causes and Impact on Structure and Function during Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Gilberto Baroni

    2012-01-01

    Full Text Available Peritoneal dialysis therapy has increased in popularity since the end of the 1970s. This method provides a patient survival rate equivalent to hemodialysis and better preservation of residual renal function. However, technique failure by peritonitis, and ultrafiltration failure, which is a multifactorial complication that can affect up to 40% of patients after 3 years of therapy. Encapsulant peritoneal sclerosis is an extreme and potentially fatal manifestation. Causes of inflammation in peritoneal dialysis range from traditional factors to those related to chronic kidney disease per se, as well as from the peritoneal dialysis treatment, including the peritoneal dialysis catheter, dialysis solution, and infectious peritonitis. Peritoneal inflammation generated causes significant structural alterations including: thickening and cubic transformation of mesothelial cells, fibrin deposition, fibrous capsule formation, perivascular bleeding, and interstitial fibrosis. Structural alterations of the peritoneal membrane described above result in clinical and functional changes. One of these clinical manifestations is ultrafiltration failure and can occur in up to 30% of patients on PD after five years of treatment. An understanding of the mechanisms involved in peritoneal inflammation is fundamental to improve patient survival and provide a better quality of life.

  10. Nutritional status over time in hemodialysis and peritoneal dialysis

    NARCIS (Netherlands)

    Jager, KJ; Merkus, MP; Huisman, RM; Boeschoten, EW; Dekker, FW; Korevaar, JC; Tijssen, JGP; Krediet, RT

    2001-01-01

    Malnutrition is a risk factor for mortality in the dialysis population. So far, prospective studies comparing the time course of nutritional status in new hemodialysis (HD) and peritoneal dialysis (PD) patients have not been published. The aims of this study were to compare the time course of nutrit

  11. Hemoperitoneum in a peritoneal dialysis patient from a retroperitoneal source.

    Science.gov (United States)

    Balsera, Cristina; Guest, Steven

    2013-01-01

    Hemoperitoneum in peritoneal dialysis patients is a known but infrequent complication. Hemoperitoneum is more frequent in women because of its association with a variety of gynecologic presentations such as reflux menstruation, ovulation, endometrial tissue implants within the peritoneal cavity (endometriosis), and bleeding follicular cysts. Other intraperitoneal causes of hemoperitoneum include minor catheter or abdominal trauma, vascular anomalies, or hepatic or splenic cysts. Less frequently encountered is a presentation of hemoperitoneum from a retroperitoneal source. These presentations result either from peritoneal inflammation and subsequent peritoneal bleeding or retroperitoneal cavity pathology rupturing into the peritoneal cavity. Here, we present the case of a peritoneal dialysis patient presenting with hemoperitoneum several days after undergoing cardiac catheterization. The catheterization was complicated by a large retroperitoneal hematoma. Details of the case are reported, and other retroperitoneal causes of hemoperitoneum are reviewed.

  12. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients

    OpenAIRE

    Cho, Yeoungjee; Johnson, David W.; Vesey, David A; Hawley, Carmel M; Pascoe, Elaine M.; Clarke, Margaret; Topley, Nicholas

    2014-01-01

    Background Repeated exposure to peritoneal dialysis (PD) solutions contributes to cumulative intraperitoneal inflammation and peritoneal injury. The present study aimed to explore the capacity of dialysate interleukin-6(IL-6) to a) predict peritoneal membrane function and peritonitis in incident PD patients, and b) to evaluate the influence of neutral pH, low glucose degradation product (GDP) PD solution on dialysate IL-6 levels. Methods The study included 88 incident participants from the ba...

  13. Pharmacokinetics of amikacin during hemodialysis and peritoneal dialysis

    DEFF Research Database (Denmark)

    Regeur, L; Colding, H; Jensen, H;

    1977-01-01

    The pharmacokinetics of amikacin were examined in six bilaterally nephrectomized patients undergoing hemodialysis and in four patients with a minimal residual renal function undergoing peritoneal dialysis. The mean elimination half-life before the dialysis was 86.5 h in the anephric patients and 44...... renal function. During hemodialysis the half-life decreased to less than 10% (5.6 h) of the pretreatment value. The effectiveness of peritoneal dialysis was less as the half-life decreased to only about 30% (17.9 h) of the pretreatment value. During the dialyses a significant correlation between...... the half-life of amikacin and the decrease in blood urea and serum creatinine was demonstrated. The pharmacokinetic data were used to make dosage regimen recommendations for the treatment of patients undergoing intermittent hemodialysis or peritoneal dialysis....

  14. Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

    Directory of Open Access Journals (Sweden)

    Juan Pérez-Martínez

    Full Text Available The benefits of long-term peritoneal dialysis (PD in patients with end-stage renal failure are short-lived due to structural and functional changes in the peritoneal membrane. In this report, we provide evidence for the in vitro and in vivo participation of the renin-angiotensin-aldosterone system (RAAS in the signaling pathway leading to peritoneal fibrosis during PD. Exposure to high-glucose PD fluids (PDFs increases damage and fibrosis markers in both isolated rat peritoneal mesothelial cells and in the peritoneum of rats after chronic dialysis. In both cases, the addition of the RAAS inhibitor aliskiren markedly improved damage and fibrosis markers, and prevented functional modifications in the peritoneal transport, as measured by the peritoneal equilibrium test. These data suggest that inhibition of the RAAS may be a novel way to improve the efficacy of PD by preventing inflammation and fibrosis following peritoneal exposure to high-glucose PDFs.

  15. A case study: telemedicine technology and peritoneal dialysis in children.

    Science.gov (United States)

    Ghio, Luciana; Boccola, Salvatore; Andronio, Laura; Adami, Daniele; Paglialonga, Fabio; Ardissino, Gianluigi; Edefonti, Alberto

    2002-01-01

    We investigated the feasibility and effectiveness of a telemedicine system for monitoring pediatric patients undergoing automated peritoneal dialysis (APD) at home. The system uses modem-based communication between the patient's cycler and a computer in the dialysis unit, which allows data transmission and storage, and live patient-physician interaction by ISDN lines, modem, microphone with stereo speakers, and digital cameras for private video-conferencing and image capture. Two children aged 10 and 12 years, who live 1500 and 40 km from the dialysis unit, respectively, have been using the system for 7 months. All of the APD treatment data were stored and examined; 122 televisits were performed. The APD data show that both patients have complied with their dialysis prescription. The telemedicine system broadens patient/physician interchange and increases the quality of care and the life of children on peritoneal dialysis. PMID:12626104

  16. Diabetes Influences Peritoneal Morphology in Uremic Patients at the Initiation of Peritoneal Dialysis

    OpenAIRE

    Mizumasa, Tohru; Hirakata, Hideki; Kuroki, Yusuke; Katafuchi, Ritsuko; Yotsueda, Hideki; Mitsuiki, Koji; Nakashima, Yutaka; Tsuruya, Kazuhiko

    2013-01-01

    ♦ Background: The peritoneum begins to undergo morphologic changes before the start of peritoneal dialysis (PD), particularly in diabetic patients. The present study was conducted to investigate the effects of diabetes on the peritoneum.

  17. Morphological changes of the peritoneum in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    方炜; 钱家麒; 余志远; 陈诗书

    2004-01-01

    Background Long-term peritoneal dialysis (PD) requires that the peritoneal membrane remain effective for dialysis. Research directed toward human peritoneal morphology and structure is limited. The present study was performed to investigate morphological changes of the human peritoneal membrane during PD and to elucidate the possible mechanisms of its functional deterioration. Methods A total of 32 peritoneal biopsies were performed in normal subjects (n=10), uremic nondialysis patients (n=12) at the time of catheter insertion, and PD patients (n=10) at the time of catheter removal or reinsertion or at the time of renal transplantation. Peritoneal morphology was examined by light microscopy, scanning electron microscopy, and transmission electron microscopy. Results The peritoneal membrane in normal subjects consisted of a monolayer of mesothelial cells on a basement membrane and a layer of connective tissue containing cells, blood vessels, and lymphatic vessels. Mesothelial cells were polygonal, often elongated, and had numerous microvilli on their luminal surface. There were lots of oval or roundish pinocytotic vesicles in the cytoplasm of the mesothelial cells. The peritoneal morphology of uremic nondialysis patients was similar to that of normal subjects. However, significant abnormalities of the peritoneal membrane were observed in PD patients, and the changes were found to be progressive. Microvilli were the first site of damage which involved microvilli shortening, a gradual reduction in their number, and, eventually, the total disappearance of microvilli. Mesothelial cells then detached from the basement membrane, disappearing completely in some cases. In the end, the peritoneal membrane consisted only of submesothelial connective tissue without any cells.Conclusions PD can modify peritoneal morphology and structure. The morphological change is progressive and may be one of the important causes of peritoneal failure. Peritoneal biopsies can provide lots of

  18. Clinical outcome of 371 episodes of peritoneal dialysis related peritonitis

    Institute of Scientific and Technical Information of China (English)

    唐碧雯

    2014-01-01

    Objective To analyze the clinical outcome of PD related peritonitis in our center.Methods All patients who developed PD related peritonitis between January 2004and December 2010 in Renji Hospital of Shanghai Jiao Tong University School of Medicine were included.Outcomes of PD related peritonitis were analyzed.Results A total of 220 patients developed 371

  19. [Anemia treatment in peritoneal dialysis patients].

    Science.gov (United States)

    Janković, Nikola; Janković, Mateja

    2009-09-01

    Anemia is highly prevalent among chronic kidney disease (CKD) patients and patients receiving renal replacement therapy. In this paper we will outline the prevention and treatment of anemia in patients treated with peritoneal dialysis (PD). PD patients are less anemic and more sensitive to erythropoesis-stimulating agent (ESA) than their hemodialysis (HD) counterparts and, in general, dosages required for achieving similar hemoglobin levels to those achieved in HD patients are remarkably less. Before starting with ESA treatment we have to evaluate the degree of anemia and excluded other causes which are not connected with CKD and method of treatment. Patient's compliance is crucial for a successful therapy and it can be improved by decreasing frequency of administration of ESA. Since ESAare expensive, "cost-effectivnes" studies represent an important factor in choosing a distinct drug. Subcutaneous administration provides better long-term utilization of ESA in comparison to intravenous administration and is therefore preferred in PD patients. Intraperitoneal administration is not recommended due to poor bioavailability. In some patients we can observe the reduced response to ESA therapy. The definition of reduced response is generally regarded as a failure to achieve target hemoglobin concentration of >11 g/dL. Identification of underlying cause is not always easy but every attempt should be made to investigate every patient with resistance to therapy because some causes are easily corrected. Since 2005 particular ESA drugs have been approved by Croatian Institute for Health Insurance and registered for use in Croatia. For PD patients the ESAcan be prescribed by general practitioner. The list of available drugs is available in the official government newspaper Nardone novine No.27, March 2nd, 2009. PMID:20232548

  20. [THE RISK FACTORS OF THE DIALYSIS PERITONITIS (THREE-YEARS PROSPECTIVE INVESTIGATION)].

    Science.gov (United States)

    Mishalov, V G; Zavodovskiy, E S; Markulan, L Yu; Goyda, S M

    2015-09-01

    The risk factors of the dialysis peritonitis occurrence were determined in patients with chronic renal disease, to whom a substitute renal therapy, using peritoneal dialysis, was conducted. The results of a three-year prospective investigation and treatment of 73 patients in Kyiv City Oleksandrivska Clinical Hospital on the base of the general surgery and nephrology departments in 2007 - 2010 yrs were studied. The dialysis peritonitis (first episode) have occurred in 42 (57.5%) patients. Cumulative rate of a dialysis peritonitis in accordance to a censored data (the dialysis peritonitis suspension or other causes) have constituted 67.7%. Due to the dialysis peritonitis occurrence the peritoneal dialysis was stopped in 14 (19.2%) patients. The obesity, raising of a serum albumin level, constipation, preliminary injection into the site of the catheter exit site we consider a risk factors for the dialysis peritonitis occurrence.

  1. Morganella Morganii - A Rare Cause of Continuous Ambulatory Peritoneal Dialysis Peritonitis

    Directory of Open Access Journals (Sweden)

    Savaş SİPAHİ

    2014-05-01

    Full Text Available Nephrology professionals have selected continuous ambulatory peritoneal dialysis (CAPD as the best initial therapy for patients who have chronic renal failure. Among complications, peritonitis continues to be one of the most important complications of CAPD. The typical spectrum of organisms causing peritonitis include Gram-positives (67%, Gram-negative rods (28%, fungi (2.5%, and anaerobics (2.5 %. Among Gram-negative bacterial species, Escherichia coli, Acinetobacter species, and Enterobacter are the most seen pathogens. In this report, we present a case of CAPD peritonitis due to Morganella morganii. To our knowledge, this presentation is the second report of CAPD peritonitis due to M. morganii.

  2. Transperitoneal transport of sodium during hypertonic peritoneal dialysis

    DEFF Research Database (Denmark)

    Graff, J; Fugleberg, S; Brahm, J;

    1996-01-01

    The mechanisms of transperitoneal sodium transport during hypertonic peritoneal dialysis were evaluated by kinetic modelling. A total of six nested mathematical models were designed to elucidate the presence or absence of diffusive, non-lymphatic convective and lymphatic convective solute transport....... Experimental results were obtained from 26 non-diabetic patients undergoing peritoneal dialysis. The model validation procedure demonstrated that only diffusive and non-lymphatic convective transport mechanisms were identifiable in the transperitoneal transport of sodium. Non-lymphatic convective sodium...... transport was the most important quantitative transport mechanism during the first 90 min of the dwell. Significant sodium sieving was demonstrated and explains the observation of hypernatremia in dialysis with hypertonic dialysis fluid....

  3. A case of peritoneal dialysis-associated peritonitis caused by Sphingomonas paucimobilis

    OpenAIRE

    Lee, Jae Un; Kim, Joong Keun; Yun, So Hee; Park, Moon Sik; Lee, Na Eun; Sun, In O; Lee, Kwang Young

    2012-01-01

    Sphingomonas paucimobilis is an aerobic Gram-negative bacillus found in soil and water. Knowledge regarding the role of this infectious agent is limited because it is rarely isolated from human material. Furthermore, it is an unusual pathogen in cases of peritoneal dialysis (PD)-associated peritonitis. The clinical courses and outcomes of peritonitis caused by S. paucimobilis are variable. Whereas some patients were cured with appropriate antibiotic therapy, others required catheter removal. ...

  4. Aspergillus niger peritonitis in a patient on continuous ambulatory peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Usha Kalawat

    2013-07-01

    Full Text Available Fungal peritonitis is an uncommon condition which is associated with high morbidity and mortality in patients on continuous ambulatory peritoneal dialysis (CAPD. It is associated with several complications and many of the patients who develop this condition are unable to resume CAPD treatment and have to shift to haemodialysis. Here we report the rare occurrence of fungal peritonitis due to Aspergillus niger in a patient on CAPD.

  5. Regulation of Synthesis and Roles of Hyaluronan in Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Timothy Bowen

    2015-01-01

    Full Text Available Hyaluronan (HA is a ubiquitous extracellular matrix glycosaminoglycan composed of repeated disaccharide units of alternating D-glucuronic acid and D-N-acetylglucosamine residues linked via alternating β-1,4 and β-1,3 glycosidic bonds. HA is synthesized in humans by HA synthase (HAS enzymes 1, 2, and 3, which are encoded by the corresponding HAS genes. Previous in vitro studies have shown characteristic changes in HAS expression and increased HA synthesis in response to wounding and proinflammatory cytokines in human peritoneal mesothelial cells. In addition, in vivo models and human peritoneal biopsy samples have provided evidence of changes in HA metabolism in the fibrosis that at present accompanies peritoneal dialysis treatment. This review discusses these published observations and how they might contribute to improvement in peritoneal dialysis.

  6. Patients in assisted automated peritoneal dialysis develop strategies for selfcare

    DEFF Research Database (Denmark)

    Holch, Kirsten

      Patients in Assisted Automated Peritoneal Dialysis develop strategies for self-care Background: Since 2000 a model for Assisted Automated Peritoneal Dialysis (AAPD) in the patients own home has been developed at Aarhus University Hospital, Skejby. The patient group consists of physically...... Henderson's areas of need and Dorothea Orem's self - care theory combined with problems and symptoms in End Stage Renal Disease (ESRD) patients. Results The results showed that patients in their own home improve their self-care capacity in the period between three and six months after starting AAPD...

  7. Changes of serum leptin levels and the influential factors in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    晏焕青

    2014-01-01

    Objective To investigate the changes of serum leptin levels and the influential factors in maintenance peritoneal dialysis patients.Methods Seventy-six peritoneal dialysis patients were chosen at the time before,and 3months,6 months,12 months,18 months and 24months after they began the peritoneal dialysis therapy,to examine body mass index(BMI),

  8. The Association Between Peritoneal Charge Barrier Dysfunction and Protein Lost During Continuous Ambulatory Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Guo-Qing Yu

    2013-07-01

    Full Text Available Background/Aims: The main purpose of the present study was to determine the effect of peritoneal charge barrier dysfunction on hypoalbuminemia during CAPD. Methods: We measured the association of dialysis dose, peritoneal equilibration test (PET results (ratio of dialysate and plasma creatinine, and peritoneal charge barrier index (ratio of pancreatic and salivary α-amylase clearance on protein loss in 33 patients on maintenance CAPD. All patients were from a single institution and were diagnosed with chronic nephritis (n = 18 cases, diabetic nephropathy (n = 8, hypertension (n = 5, and hepatitis B virus-associated glomerulonephritis (n = 2. Results: The mean (± SD dialysate protein loss was 4.04 g (± 1.97 per day. Protein loss was positively correlated with dialysis dose (r = 0.438, p = 0.01 but was not significantly correlated with PET results. The mean (± SD peritoneal charge barrier index was 6.12 (± 21.20 and was inversely correlated with protein loss into the peritoneal dialysate (r = -0.532, p Conclusions: Taken together, our study of CAPD patients indicates that protein loss into the peritoneal dialysate increases with peritoneal dialysis dose and with disruption of the peritoneal charge barrier.

  9. A Report of Peritonitis from Aeromonas sobria in a Peritoneal Dialysis (PD) Patient with Necrotizing Fasciitis.

    Science.gov (United States)

    Janma, Jirayut; Linasmita, Patcharasarn; Changsirikulchai, Siribha

    2015-11-01

    A 70-years of age, male patient with underlying type 2 diabetes mellitus, hypertension, dyslipidemia and ischemic heart disease had undergone continuous ambulatory peritoneal dialysis (CAPD)for 3 years without any episodes of peritonitis. He was diagnosed with necrotizing fasciitis and later developed peritonitis after receiving a laceration from an aquatic injury suffered during the flood disaster of 2011. The blood culture, necrotic tissue and the clear dialysate collected upon admission had shown Aeromonas sobria. The route of peritonitis may be from the hematogenous spread of A. sobria resulting in necrotizing fasciitis. A. sobria should be considered as the pathogen of peritonitis in PD patients who have history of wounds from contaminated water. We suggest that the PD patients who present with septicemia and did not meet the criteria for peritonitis, the initial dialysate effluent should be sent for culture. The benefit of this is to allow early recognition and treatment of peritonitis.

  10. Preventive effect of continuous quality improvement on the malnutrition,inflammation,peritoneal dialysis adequacy and cardiovascular events in elderly peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    赵班

    2013-01-01

    Objective To investigate the preventive effect of continuous quality improvement (CQI) on malnutrition,inflammation,peritoneal dialysis adequacy and cardiovascular events in elderly patients undergoing peritoneal dialysis.Methods A single-center prospective self-controlled study was performed.32 stable elderly patients to undergo continuous ambulatory peritoneal dialysis (CAPD) were included.The continuous quality improvement program was conducted by using the 4-step problem-solving

  11. Peritoneal dialysis in an ageing population: a 10-year experience.

    LENUS (Irish Health Repository)

    Smyth, Andrew

    2012-02-01

    Chronic kidney disease (CKD) is becoming increasingly prevalent and there are increasing numbers of older patients with advanced CKD. Peritoneal dialysis (PD) is a potential treatment. This study aims to compare PD outcomes in age-defined populations in the largest PD centre in the Republic of Ireland over 10 years.

  12. Evaluation of Peritonitis Incidence, Etiology, Associated Factors and Prognosis of Continuous Ambulatory Peritoneal Dialysis Patients

    Directory of Open Access Journals (Sweden)

    Nefise ÖZBALCI

    2013-05-01

    Full Text Available OBJECTIVE: Peritonitis is the most important complication of peritoneal dialysis (PD. We evaluated the incidence of peritonitis, active microorganisms and their susceptibility profile and determine prognosis. MATERIAL and METHODS: One hundred fifty three PD patients were evaluated for aetiology, drug usage, accompanying disease, type, duration and personal preference for PD, care-giver, protein catabolic rate (PCR, residual urine volume, ultrafiltration volume, type of peritoneal membrane transport and baseline laboratory values. RESULTS: The incidence of peritonitis was 0,284 attack/patient/year. The most common organisms were coagulase negative staphylococci (18.3% followed by S. aureus (14.8% and gram-negative bacillus (13.1%. Peritonitis was more common in elderly, those with longer PD duration, low residual urine volume, patients with low PCR and hepatitis C. However, patients using erythropoietin and automated PD had low incidence of peritonitis compared to others. Mortality rate was higher in gram-negative and fungal peritonitis and prognosis was worse in gramnegative peritonitis CONCLUSION: Peritonitis incidence and aetiology were compatible with literature. One must be careful to protect residual renal function (RRF as peritonitis incidence was significantly reduced in patients with RRF. PCR values were significantly lower in peritonitis. Adequate protein intake and nutritional support may be important in this respect.

  13. Optimising intraperitoneal gentamicin dosing in peritoneal dialysis patients with peritonitis (GIPD study

    Directory of Open Access Journals (Sweden)

    Lipman Jeffrey

    2009-12-01

    Full Text Available Abstract Background Antibiotics are preferentially delivered via the peritoneal route to treat peritonitis, a major complication of peritoneal dialysis (PD, so that maximal concentrations are delivered at the site of infection. However, drugs administered intraperitoneally can be absorbed into the systemic circulation. Drugs excreted by the kidneys accumulate in PD patients, increasing the risk of toxicity. The aim of this study is to examine a model of gentamicin pharmacokinetics and to develop an intraperitoneal drug dosing regime that maximises bacterial killing and minimises toxicity. Methods/Design This is an observational pharmacokinetic study of consecutive PD patients presenting to the Royal Brisbane and Women's Hospital with PD peritonitis and who meet the inclusion criteria. Participants will be allocated to either group 1, if anuric as defined by urine output less than 100 ml/day, or group 2: if non-anuric, as defined by urine output more than 100 ml/day. Recruitment will be limited to 15 participants in each group. Gentamicin dosing will be based on the present Royal Brisbane & Women's Hospital guidelines, which reflect the current International Society for Peritoneal Dialysis Peritonitis Treatment Recommendations. The primary endpoint is to describe the pharmacokinetics of gentamicin administered intraperitoneally in PD patients with peritonitis based on serial blood and dialysate drug levels. Discussion The study will develop improved dosing recommendations for intraperitoneally administered gentamicin in PD patients with peritonitis. This will guide clinicians and pharmacists in selecting the most appropriate dosing regime of intraperitoneal gentamicin to treat peritonitis. Trial Registration ACTRN12609000446268

  14. Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis.

    Science.gov (United States)

    Snyder, Richard W; Ruhe, Jorg; Kobrin, Sidney; Wasserstein, Alan; Doline, Christa; Nachamkin, Irving; Lipschutz, Joshua H

    2004-08-01

    Here the authors report a case of refractory peritonitis leading to multiple hospitalizations and the loss of peritoneal dialysis access in a patient on automated peritoneal dialysis, caused by Asaia bogorensis, a bacterium not previously described as a human pathogen. This organism was identified by sequence analysis of the 16S ribosomal RNA gene. Unusual microbial agents may cause peritonitis, and molecular microbiological techniques are important tools for identifying these agents.

  15. Morganella morganii Peritonitis Associated with Continuous Ambulatory Peritoneal Dialysis (CAPD) after Colonoscopy.

    Science.gov (United States)

    Kimura, Yukihiro; Ito, Ayano; Miyamoto, Kanyu; Suga, Norihiro; Miura, Naoto; Kasagi, Tomomichi; Yamagishi, Yuka; Mikamo, Hiroshige; Imai, Hirokazu

    2016-01-01

    A 79-year-old man on continuous ambulatory peritoneal dialysis (CAPD) developed abdominal pain and cloudy peritoneal fluid two days after colonoscopy that revealed multiple diverticula. The white blood cell count was 9,000 cells/μL, C-reactive protein level was 6.86 mg/dL, and the white blood cell count of the peritoneal fluid was 7,800 cells/μL, suggesting acute peritonitis. Empiric therapy consisting of cefazolin and ceftazidime slowly improved the patient's symptoms. The initial microbiological examination of the peritoneal fluid demonstrated Morganella morganii. He was changed from CAPD to hemodialysis. It is important to consider M. morganii peritonitis in patients with colonic diverticula.

  16. Evaluation of continuous ambulatory peritoneal dialysis fluid C-reactive protein in patients with peritonitis.

    Science.gov (United States)

    Ramanathan, Kumaresan; Padmanabhan, Giri; Vijayaraghavan, Bhooma

    2016-05-01

    Severe peritonitis causing death is one of the most devastating complications of peritoneal dialysis (PD). Since the predictive value of C-reactive protein (CRP) in PD fluid has not been assessed, the objective of the present study is to evaluate its predictive value and clinical correlation in patients on PD with peritonitis. One hundred and twenty patients on continuous ambulatory PD (CAPD) were enrolled and their serum and fluid CRP (Fl. CRP) were evaluated at the start of CAPD. All patients who developed peritonitis were further evaluated for serum and fluid CRP. The patients were categorized into four groups, namely: normal patients (control group), patients with peritonitis, patients with peritonitis leading to catheter removal, and death due to peritonitis. Sixty-five patients developed peritonitis of whom, catheter removal was performed in eight patients. Five patients died due to peritonitis-related complications. Fl. CRP showed a significant difference among the three groups, unlike S. CRP. Estimation of CRP in the peritoneal fluid may be a useful marker to monitor the onset of peritonitis.

  17. [Protozoan infection (Blastocystis hominis) concomitant with Pseudomonas sp. peritonitis in continuous ambulatory peritoneal dialysis (CAPD)].

    Science.gov (United States)

    Boccardo, G; De Prisco, O; Ettari, G; Donato, G; Maurino, D; Savoia, D

    1996-03-01

    Case-report of protozoal infection (Blastocystis bominis) during Pseudomonas peritonitis in male patient with intestinal diverticulosis on continuous ambulatory peritoneal dialysis (CAPD) treatment for chronic renal failure (CRF). Microscopic morphology and cultural characteristics are summarized from current literature. Photographic images in phase contrast from fresh-observation of faeces and peritoneal fluid are reported. Although other Protozoa (e.g. Acanthamoeba free-living) have already been found in dialysis fluid, this is the first case, referred in literature, of Blastocystis bominis infection in CAPD patients. Some pathogenetic hypothesis are done involving Blastocystis bominis in peritoneal infection, especially in immunodepressed patients like dialysed ones. Although many chemotherapeutics are provided for this protozoiasis during enteritis, in our case no supplement was required except specific antibiotic therapy for Pseudomonas infection. Symbion or pathogen? Is now-a-day the question which troubles parasitologists. Systemic research of Protozoa in dialysed patients is anyhow advisable. PMID:8848771

  18. PI3K / Akt signaling regulates epithelialmesenchymal transition of peritoneal mesothelial cells in peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    彭翔

    2014-01-01

    Objective To investigate the role of PI3K/Akt signaling in the regulation of epithelial-mesenchymal transition(EMT)of peritoneal mesothelial cells(PMCs)in peritoneal dialysis in vitro and in vivo.Methods The level of phosphorylated serine/threonine kinase Akt and the expression of EMT associated gene and protein,including ZO-1,Vimentin and FN,were measured in mice EMT model.In vitro study,phosphorylation level and

  19. Hemodialysis versus peritoneal dialysis: epidemiologic and demographic characteristics

    Directory of Open Access Journals (Sweden)

    Hekmat R

    2008-10-01

    Full Text Available "n Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Arial; mso-bidi-theme-font:minor-bidi;} Background: The preferred modality of dialysis is a controversial issue in nephrology. In this study we compare some demographic and epidemiological characteristics of hemodialysis and peritoneal dialysis patients in an attempt to analyze this issue."n"n Methods: The results of the research protocol "A survey of the epidemiological characteristics of chronic dialyzed patients in Khorassan province", was used to compare some demographic and epidemiological aspects of chronic hemodialysis and peritoneal dialysis patients in search of any statistically significant difference."n"n Results: A total of 836 chronic dialysis patients entered this study, 802 (95.9% of which were under chronic hemodialysis, and 34 (4.1% patients were undergoing peritoneal dialysis, with 339 (42.3% and 12 (35.3% being female, respectively. The mean age for each group was 47.57 and 46.75 years, respectively. The causes of end-stage renal disease in hemodialzed patients were most commonly hypertension (32.2%, followed by diabetes mellitus (22.3%, unknown causes (19.6% and chronic glomeru-lonephritis (10.2%. In the peritoneal dialysis group, chronic glomerulonephritis (32.4% was the most common reason for dialysis, followed by diabetes mellitus (26

  20. Extended dosing of darbepoetin alfa in peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Bridges Ian

    2011-03-01

    Full Text Available Abstract Background Anemia is common among peritoneal dialysis (PD patients, and most patients require erythropoiesis-stimulating agents (ESA to maintain their hemoglobin concentrations within current guideline recommendations. Darbepoetin alfa is an ESA with a 3-fold longer half-life and greater in vivo biological activity than recombinant human erythropoietin, allowing less frequent dosing that may simplify anemia management in these patients, providing benefits to patients, care givers and health care providers. Clinical studies have confirmed the efficacy and safety of darbepoetin alfa administered at extended dosing intervals. However, there are limited data on the management of anemia with ESAs in PD patients in routine clinical practice. The aim of this multicenter observational study in European and Australian dialysis patients was to evaluate darbepoetin alfa administered once every 2 weeks (Q2W in routine clinical practice for 12 months. Methods PD patients ≥18 years old and converting to treatment with darbepoetin alfa Q2W were eligible for enrollment regardless of previous or current ESA use. Patients enrolled in the study were treated according to local usual clinical practice. Data were collected up to 6 months prior to and 12 months after conversion to darbepoetin alfa Q2W. The primary endpoint was hemoglobin concentration 12 months after conversion to darbepoetin alfa Q2W. Results Of the 741 eligible PD patients (mean age, 61 years; male, 57%, 640 (86% completed the study. Mean hemoglobin concentration (g/dL was 11.69 (95% CI, 11.53-11.86 6 months before the conversion, 12.25 (95% CI, 12.13-12.38 at conversion, and 11.88 (95% CI, 11.74-12.02 12 months after conversion to darbepoetin alfa Q2W. The weekly equivalent ESA dose (μg/wk was a geometric mean of 25.24 (95% CI, 23.46-27.15 6 months before conversion, 20.90 (95% CI, 19.13-22.83 immediately before conversion, 18.89 (95% CI, 18.13-19.68 at conversion and 19.04 (95% CI, 17

  1. Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis.

    Directory of Open Access Journals (Sweden)

    Amanda L McGuire

    Full Text Available A major complication of peritoneal dialysis is the development of peritonitis, which is associated with reduced technique and patient survival. The inflammatory response elicited by infection results in a fibrin and debris-rich environment within the peritoneal cavity, which may reduce the effectiveness of antimicrobial agents and predispose to recurrence or relapse of infection. Strategies to enhance responses to antimicrobial agents therefore have the potential to improve patient outcomes. This study presents pre-clinical data describing the compatibility of tPA and DNase in combination with antimicrobial agents used for the treatment of PD peritonitis. tPA and DNase were stable in standard dialysate solution and in the presence of antimicrobial agents, and were safe when given intraperitoneally in a mouse model with no evidence of local or systemic toxicity. Adjunctive tPA and DNase may have a role in the management of patients presenting with PD peritonitis.

  2. Sclerosing encapsulating peritonitis in chronic ambulatory peritoneal dialysis;preoperative catheter drainage : a case report

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Tae Hoon [Dankook Univ. Hospital, Seoul (Korea, Republic of)

    1996-10-01

    Sclerosing encapsulating peritonitis is a well recognized, but uncommon, complication of chronic ambulatory peritoneal dialysis. I report a case of sclerosing encapsulating peritonitis in which percutaneous catheter drainage was performed preoperatively. Ultrasonography(US) and computed tomography(CT) showed a large multi-septated cystic mass which occupied nearly all the peritoneal cavity. Percutaneous drainage with two 8.5 French catheters was preoperatively performed under fluoroscopy and about 2100 ml of bloody fluid was drained for 20 days. On follow-up CT, the size of the cyst had significantly decreased and anoperation was performed. It is considered that percutaneous catheter drainage is useful in the preoperative decompression of sclerosing encapsulating peritonitis.

  3. The importance of ultrasonographic measurement of peritoneal wall thickness in pediatric chronic peritoneal dialysis patients.

    Science.gov (United States)

    Yavaşcan, Önder; Aksu, Nejat; Alparslan, Caner; Sarıtaş, Serdar; Elmas, Cengiz Han; Eraslan, Ali Nihat; Duman, Soner; Mir, Sevgi

    2015-04-01

    Loss of peritoneal function due to peritoneal fibrosing syndrome (PFS) is a major factor leading to treatment failure in chronic peritoneal dialysis (PD) patients. Although the precise biologic mechanisms responsible for these changes have not been defined, the general assumption is that alterations in peritoneal function are related to structural changes in the peritoneal membrane. Studies of the peritoneal membrane by non-invasive ultrasonography (US) in chronic PD patients are limited. The aim of the present study is to assess the relationship between functional parameters of peritoneum and peritoneal thickness measured by US in children treated by chronic PD. We recruited two groups of patients: 23 subjects (13 females, 10 males) on chronic PD (patient group) and 26 (7 females, 19 males) on predialysis out-patient follow-up (creatinine clearance: 20-60 mL/min/1.73 m(2)) (control group). Age, sex, weight, height, body mass index (BMI), chronic PD duration, episodes of peritonitis and the results of peritoneal equilibration test (PET) were recorded. Hemoglobin (Hb), blood pressure (BP), left ventricular mass index (LVMI) and renal osteodystrophy (ROD) parameters were also obtained. The thickness of the parietal peritoneum was measured by trans-abdominal US in all children. Statistical analyses were performed by using Student's t and Pearson's correlation tests. Mean peritoneal thickness in chronic PD patients (1028.26 ± 157.26 μm) was significantly higher than control patients (786.52 ± 132.33). Mean peritoneal thickness was significantly correlated with mean body height (R(2) = 0.93, p thickness and Hb, BP, LVMI and ROD parameters. In conclusion, ultrasonographic measurement of peritoneal membrane thickness is a simple and non-invasive method in chronic PD children. This diagnostic tool likely enables to assess peritoneal structure and function in these patients.

  4. The importance of ultrasonographic measurement of peritoneal wall thickness in pediatric chronic peritoneal dialysis patients.

    Science.gov (United States)

    Yavaşcan, Önder; Aksu, Nejat; Alparslan, Caner; Sarıtaş, Serdar; Elmas, Cengiz Han; Eraslan, Ali Nihat; Duman, Soner; Mir, Sevgi

    2015-04-01

    Loss of peritoneal function due to peritoneal fibrosing syndrome (PFS) is a major factor leading to treatment failure in chronic peritoneal dialysis (PD) patients. Although the precise biologic mechanisms responsible for these changes have not been defined, the general assumption is that alterations in peritoneal function are related to structural changes in the peritoneal membrane. Studies of the peritoneal membrane by non-invasive ultrasonography (US) in chronic PD patients are limited. The aim of the present study is to assess the relationship between functional parameters of peritoneum and peritoneal thickness measured by US in children treated by chronic PD. We recruited two groups of patients: 23 subjects (13 females, 10 males) on chronic PD (patient group) and 26 (7 females, 19 males) on predialysis out-patient follow-up (creatinine clearance: 20-60 mL/min/1.73 m(2)) (control group). Age, sex, weight, height, body mass index (BMI), chronic PD duration, episodes of peritonitis and the results of peritoneal equilibration test (PET) were recorded. Hemoglobin (Hb), blood pressure (BP), left ventricular mass index (LVMI) and renal osteodystrophy (ROD) parameters were also obtained. The thickness of the parietal peritoneum was measured by trans-abdominal US in all children. Statistical analyses were performed by using Student's t and Pearson's correlation tests. Mean peritoneal thickness in chronic PD patients (1028.26 ± 157.26 μm) was significantly higher than control patients (786.52 ± 132.33). Mean peritoneal thickness was significantly correlated with mean body height (R(2) = 0.93, p measurement of peritoneal membrane thickness is a simple and non-invasive method in chronic PD children. This diagnostic tool likely enables to assess peritoneal structure and function in these patients. PMID:25594613

  5. Association between blood cadmium levels and malnutrition in peritoneal dialysis

    OpenAIRE

    Hsu, Ching-Wei; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Huang, Wen-Hung; Chen, Kuan-Hsing; Yen, Tzung-Hai

    2014-01-01

    Background Malnutrition is associated with an increased risk of cardiovascular death and may cause protein-energy wasting in individuals with chronic kidney disease. A previous study demonstrated that blood cadmium levels (BCLs) were associated with malnutrition in maintenance hemodialysis (MHD) patients. However, the correlation between cadmium exposure and malnutrition remains unclear in chronic peritoneal dialysis (CPD) patients. This study examined the possible adverse effects of environm...

  6. Risk factors for the first episode of peritonitis in Southern Chinese continuous ambulatory peritoneal dialysis patients.

    Directory of Open Access Journals (Sweden)

    Xiaoguang Fan

    Full Text Available The first episode of peritonitis affects survival of the peritoneal membrane as a medium for dialysis as well as survival of patients. The aim of this study is to investigate risk factors associated with the first episode of peritonitis in Southern Chinese continuous ambulatory peritoneal dialysis (CAPD patients.This is a single-center, retrospective, cohort study. All incident CAPD patients from 1 January 2006 to 31 December 2010 were recruited, and followed up until their first episode of peritonitis or 31 December, 2012. Baseline demographic, socioeconomic, clinical and laboratory data were collected. Cox proportional model was used to determine the factors associated with the first episode of peritonitis.In a cumulative 30756.5 patient-months follow-up (the median vintage 26.1 months of 1117 CAPD patients, 309(27.7% patients presented the first episodes of peritonitis. The cumulative peritonitis-free survival was 86.2%, 78.1%, 71.4% and 57.8% at 1, 2, 3 and 5 year, respectively. The multivariate analysis showed that factors associated with risk for the first episode of peritonitis were elderly patients (>65 years [hazard ratio (HR = 1.427, 95% confidence interval (CI = 1.051 to 1.938, P = 0.023], male(HR = 1.315, 95% CI = 1.028 to 1.684, P = 0.030, lower education level (HR = 1.446, 95% CI: 1.127 to 1.855, P = 0.004 and albumin <38g/L (HR = 1.425, 95% CI: 1.112 to 1.825, P = 0.005.Older age, male, lower educational level and hypoalbuminemia at the commencement of PD were the risk factors associated with the first episode of peritonitis in Southern Chinese CAPD patients.

  7. Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.

    Science.gov (United States)

    Jörres, A; Jörres, D; Topley, N; Gahl, G M; Mahiout, A

    1991-01-01

    During continuous ambulatory peritoneal dialysis (CAPD), peritoneal host defence mechanisms are repeatedly exposed to dialysis solutions (with unphysiological composition) which may compromise peritoneal immune cell functions. In this context, the current study focused on the capacity of peripheral and peritoneal PMN to release leukotrienes following exposure to conventional CAPD dialysates. PMN were obtained from peripheral blood of healthy volunteers and from the peritoneal effluent of CAPD patients with acute peritonitis. Following isolation, cells were incubated in fresh CAPD dialysates or control buffer, and calcium ionophore A23187-stimulated leukotriene synthesis was measured. Additional experiments included RP-HPLC analysis and radioactivity monitoring of lipoxygenase products in PMN labelled with 14C-arachidonic acid. Leukotriene B4 and leukotrienes C4/D4/E4 were determined by radioimmunoassay. Ionophore-triggered leukotriene release from cells exposed to control buffer was pronounced in inflammatory peritoneal PMN (70.4 +/- 31.3 ng/5 x 10(6) cells LTB4 and 13.4 +/- 19.8 ng/5 x 10(6) cells LTC4/D4/E4, mean +/- SD, n = 14) when compared to healthy peripheral PMN (26.6 +/- 16.9 ng/ml LTB4 and 6.3 +/- 6.6 ng/ml LTC4/D4/E4, n = 12). Incubation in fresh solutions for peritoneal dialysis severely depressed leukotriene release from both cell populations. These results indicate a severe inhibition of cellular responsiveness as a consequence of dialysate exposure which could contribute to the impairment of host defence early in the CAPD cycle.

  8. Automated Peritoneal Dialysis Is Associated with Better Survival Rates Compared to Continuous Ambulatory Peritoneal Dialysis: A Propensity Score Matching Analysis.

    Directory of Open Access Journals (Sweden)

    Gabriela de Carvalho Beduschi

    Full Text Available The impact of peritoneal dialysis modality on patient survival and peritonitis rates is not fully understood, and no large-scale randomized clinical trial (RCT is available. In the absence of a RCT, the use of an advanced matching procedure to reduce selection bias in large cohort studies may be the best approach. The aim of this study is to compare automated peritoneal dialysis (APD and continuous ambulatory peritoneal dialysis (CAPD according to peritonitis risk, technique failure and patient survival in a large nation-wide PD cohort.This is a prospective cohort study that included all incident PD patients with at least 90 days of PD recruited in the BRAZPD study. All patients who were treated exclusively with either APD or CAPD were matched for 15 different covariates using a propensity score calculated with the nearest neighbor method. Clinical outcomes analyzed were overall mortality, technique failure and time to first peritonitis. For all analysis we also adjusted the curves for the presence of competing risks with the Fine and Gray analysis.After the matching procedure, 2,890 patients were included in the analysis (1,445 in each group. Baseline characteristics were similar for all covariates including: age, diabetes, BMI, Center-experience, coronary artery disease, cancer, literacy, hypertension, race, previous HD, gender, pre-dialysis care, family income, peripheral artery disease and year of starting PD. Mortality rate was higher in CAPD patients (SHR1.44 CI95%1.21-1.71 compared to APD, but no difference was observed for technique failure (SHR0.83 CI95%0.69-1.02 nor for time till the first peritonitis episode (SHR0.96 CI95%0.93-1.11.In the first large PD cohort study with groups balanced for several covariates using propensity score matching, PD modality was not associated with differences in neither time to first peritonitis nor in technique failure. Nevertheless, patient survival was significantly better in APD patients.

  9. microRNA Regulation of Peritoneal Cavity Homeostasis in Peritoneal Dialysis

    Science.gov (United States)

    Lopez-Anton, Melisa; Bowen, Timothy; Jenkins, Robert H.

    2015-01-01

    Preservation of peritoneal cavity homeostasis and peritoneal membrane function is critical for long-term peritoneal dialysis (PD) treatment. Several microRNAs (miRNAs) have been implicated in the regulation of key molecular pathways driving peritoneal membrane alterations leading to PD failure. miRNAs regulate the expression of the majority of protein coding genes in the human genome, thereby affecting most biochemical pathways implicated in cellular homeostasis. In this review, we report published findings on miRNAs and PD therapy, with emphasis on evidence for changes in peritoneal miRNA expression during long-term PD treatment. Recent work indicates that PD effluent- (PDE-) derived cells change their miRNA expression throughout the course of PD therapy, contributing to the loss of peritoneal cavity homeostasis and peritoneal membrane function. Changes in miRNA expression profiles will alter regulation of key molecular pathways, with the potential to cause profound effects on peritoneal cavity homeostasis during PD treatment. However, research to date has mainly adopted a literature-based miRNA-candidate methodology drawing conclusions from modest numbers of patient-derived samples. Therefore, the study of miRNA expression during PD therapy remains a promising field of research to understand the mechanisms involved in basic peritoneal cell homeostasis and PD failure. PMID:26495316

  10. microRNA Regulation of Peritoneal Cavity Homeostasis in Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Melisa Lopez-Anton

    2015-01-01

    Full Text Available Preservation of peritoneal cavity homeostasis and peritoneal membrane function is critical for long-term peritoneal dialysis (PD treatment. Several microRNAs (miRNAs have been implicated in the regulation of key molecular pathways driving peritoneal membrane alterations leading to PD failure. miRNAs regulate the expression of the majority of protein coding genes in the human genome, thereby affecting most biochemical pathways implicated in cellular homeostasis. In this review, we report published findings on miRNAs and PD therapy, with emphasis on evidence for changes in peritoneal miRNA expression during long-term PD treatment. Recent work indicates that PD effluent- (PDE- derived cells change their miRNA expression throughout the course of PD therapy, contributing to the loss of peritoneal cavity homeostasis and peritoneal membrane function. Changes in miRNA expression profiles will alter regulation of key molecular pathways, with the potential to cause profound effects on peritoneal cavity homeostasis during PD treatment. However, research to date has mainly adopted a literature-based miRNA-candidate methodology drawing conclusions from modest numbers of patient-derived samples. Therefore, the study of miRNA expression during PD therapy remains a promising field of research to understand the mechanisms involved in basic peritoneal cell homeostasis and PD failure.

  11. Pleuroperitoneal leak complicating peritoneal dialysis: a case series.

    LENUS (Irish Health Repository)

    Kennedy, C

    2012-02-01

    Pressure related complications such as abdominal wall hernias occur with relative frequency in patients on peritoneal dialysis. Less frequently, a transudative pleural effusion containing dialysate can develop. This phenomenon appears to be due to increased intra-abdominal pressure in the setting of congenital or acquired diaphragmatic defects. We report three cases of pleuroperitoneal leak that occurred within a nine-month period at our institution. We review the literature on this topic, and discuss management options. The pleural effusion resolved in one patient following drainage of the peritoneum and a switch to haemodialysis. One patient required emergency thoracocentesis. The third patient developed a complex effusion requiring surgical intervention. The three cases highlight the variability of this condition in terms of timing, symptoms and management. The diagnosis of a pleuroperitoneal leak is an important one as it is managed very differently to most transudative pleural effusions seen in this patient population. Surgical repair may be necessary in those patients who wish to resume peritoneal dialysis, or in those patients with complex effusions. Pleuroperitoneal leak should be considered in the differential diagnosis of a pleural effusion, particularly a right-sided effusion, in a patient on peritoneal dialysis.

  12. Pleuroperitoneal Leak Complicating Peritoneal Dialysis: A Case Series

    Directory of Open Access Journals (Sweden)

    C. Kennedy

    2011-01-01

    Full Text Available Pressure related complications such as abdominal wall hernias occur with relative frequency in patients on peritoneal dialysis. Less frequently, a transudative pleural effusion containing dialysate can develop. This phenomenon appears to be due to increased intra-abdominal pressure in the setting of congenital or acquired diaphragmatic defects. We report three cases of pleuroperitoneal leak that occurred within a nine-month period at our institution. We review the literature on this topic, and discuss management options. The pleural effusion resolved in one patient following drainage of the peritoneum and a switch to haemodialysis. One patient required emergency thoracocentesis. The third patient developed a complex effusion requiring surgical intervention. The three cases highlight the variability of this condition in terms of timing, symptoms and management. The diagnosis of a pleuroperitoneal leak is an important one as it is managed very differently to most transudative pleural effusions seen in this patient population. Surgical repair may be necessary in those patients who wish to resume peritoneal dialysis, or in those patients with complex effusions. Pleuroperitoneal leak should be considered in the differential diagnosis of a pleural effusion, particularly a right-sided effusion, in a patient on peritoneal dialysis.

  13. Causes for Withdrawal in an Urban Peritoneal Dialysis Program

    Directory of Open Access Journals (Sweden)

    Biruh Workeneh

    2015-01-01

    Full Text Available Background. Peritoneal dialysis (PD is an underutilized dialysis modality in the United States, especially in urban areas with diverse patient populations. Technique retention is a major concern of dialysis providers and might influence their approach to patients ready to begin dialysis therapy. Methods. Records from January 2009 to March 2014 were abstracted for demographic information, technique duration, and the reasons for withdrawal. Results. The median technique survival of the 128 incident patients during the study window was 781 days (2.1 years. The principle reasons for PD withdrawal were repeated peritonitis (30%; catheter dysfunction (18%; ultrafiltration failure (16%; patient choice or lack of support (16%; or hernia, leak, or other surgical complications (6%; and a total of 6 patients died during this period. Of the patients who did not expire and were not transplanted, most transferred to in-center hemodialysis and 8% transitioned to home-hemodialysis. Conclusions. Our findings suggest measures to ensure proper catheter placement and limiting infectious complications should be primary areas of focus in order to promote technique retention. Lastly, more focused education about home-hemodialysis as an option may allow those on PD who are beginning to demonstrate signs of technique failure to stay on home therapy.

  14. Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    McKinnie, J J; Bourgeois, R J; Husserl, F E

    1985-06-01

    This article reports the treatment with continuous ambulatory peritoneal dialysis of a patient with intractable congestive heart failure secondary to an ischemic cardiomyopathy. Although the use of peritoneal dialysis to treat refractory heart failure is not new, the advent of an effective continuous peritoneal dialysis system has allowed its use over prolonged periods of time. The two-year treatment interval described herein represents the longest reported application of this technique, to the best of our knowledge.

  15. Bioimpedance Spectroscopy for the Detection of Fluid Overload in Chinese Peritoneal Dialysis Patients

    OpenAIRE

    Kwan, Bonnie Ching-Ha; Szeto, Cheuk-Chun; Chow, Kai-Ming; Law, Man-Ching; Cheng, Mei Shan; Leung, Chi-Bon; Pang, Wing-Fai; Kwong, Vickie Wai-Ki; Li, Philip Kam-tao

    2014-01-01

    ♦ Background: Fluid overload probably contributes to the cardiovascular risk of peritoneal dialysis (PD) patients. We studied the relationship between over-hydration as determined by bioimpedance spectroscopy and dialysis adequacy, nutritional status, and arterial stiffness in Chinese PD patients.

  16. Hypomagnesemia Is Associated with Increased Mortality among Peritoneal Dialysis Patients

    Science.gov (United States)

    Dai, Zhiwei; Zhu, Beixia; Fei, Jinping; Xue, Congping; Wu, Dan

    2016-01-01

    Objective Hypomagnesemia has been associated with an increase in mortality among the general population as well as patients with chronic kidney disease or those on hemodialysis. However, this association has not been thoroughly studied in patients undergoing peritoneal dialysis. The aim of this study was to evaluate the association between serum magnesium concentrations and all-cause and cardiovascular mortalities in peritoneal dialysis patients. Methods This single-center retrospective study included 253 incident peritoneal dialysis patients enrolled between July 1, 2005 and December 31, 2014 and followed to June 30, 2015. Patient’s demographic characteristics as well as clinical and laboratory measurements were collected. Results Of 253 patients evaluated, 36 patients (14.2%) suffered from hypomagnesemia. During a median follow-up of 29 months (range: 4–120 months), 60 patients (23.7%) died, and 35 (58.3%) of these deaths were attributed to cardiovascular causes. Low serum magnesium was positively associated with peritoneal dialysis duration (r = 0.303, p < 0.001) as well as serum concentrations of albumin (r = 0.220, p < 0.001), triglycerides (r = 0.160, p = 0.011), potassium (r = 0.156, p = 0.013), calcium(r = 0.299, p < 0.001)and phosphate (r = 0.191, p = 0.002). Patients in the hypomagnesemia group had a lower survival rate than those in the normal magnesium groups (p < 0.001). In a multivariate Cox proportional hazards regression analysis, serum magnesium was an independent negative predictor of all-cause mortality (hazard ratio [HR] = 0.075, p = 0.011) and cardiovascular mortality (HR = 0.003, p < 0.001), especially in female patients. However, in univariate and multivariate Cox analysis, △Mg(difference between 1-year magnesium and baseline magnesium) was not an independent predictor of all-cause mortality and cardiovascular mortality. Conclusion Hypomagnesemia was common among peritoneal dialysis patients and was independently associated with all

  17. Effluent Tenascin-C Levels Reflect Peritoneal Deterioration in Peritoneal Dialysis: MAJOR IN PD Study

    Directory of Open Access Journals (Sweden)

    Ichiro Hirahara

    2015-01-01

    Full Text Available Peritoneal deterioration causing structural changes and functional decline is a major complication of peritoneal dialysis (PD. The aim of this study was to explore effluent biomarkers reflecting peritoneal deterioration. In an animal study, rats were intraperitoneally administered with PD fluids adding 20 mM methylglyoxal (MGO or 20 mM formaldehyde (FA every day for 21 days. In the MGO-treated rats, tenascin-C (TN-C levels in the peritoneal effluents were remarkably high and a cluster of TN-C-positive mesothelial cells with epithelial-to-mesenchymal transition- (EMT- like change excessively proliferated at the peritoneal surface, but not in the FA-treated rats. Effluent matrix metalloproteinase-2 (MMP-2 levels increased in both the MGO- and FA-treated rats. In a clinical study at 18 centers between 2006 and 2013, effluent TN-C and MMP-2 levels were quantified in 182 PD patients with end-stage renal disease. Peritoneal function was estimated using the peritoneal equilibration test (PET. From the PET results, the D/P Cr ratio was correlated with effluent levels of TN-C (ρ = 0.57, p<0.001 and MMP-2 (ρ = 0.73, p<0.001. We suggest that TN-C in the effluents may be a diagnostic marker for peritoneal deterioration with EMT-like change in mesothelial cells in PD.

  18. The potential role of HMGB1 release in peritoneal dialysis-related peritonitis.

    Directory of Open Access Journals (Sweden)

    Shirong Cao

    Full Text Available High mobility group box 1 (HMGB1, a DNA-binding nuclear protein, has been implicated as an endogenous danger signal in the pathogenesis of infection diseases. However, the potential role and source of HMGB1 in the peritoneal dialysis (PD effluence of patients with peritonitis are unknown. First, to evaluate HMDB1 levels in peritoneal dialysis effluence (PDE, a total of 61 PD patients were enrolled in this study, including 42 patients with peritonitis and 19 without peritonitis. Demographic characteristics, symptoms, physical examination findings and laboratory parameters were recorded. HMGB1 levels in PDE were determined by Western blot and ELISA. The concentrations of TNF-α and IL-6 in PDE were quantified by ELISA. By animal model, inhibition of HMGB1 with glycyrrhizin was performed to determine the effects of HMGB1 in LPS-induced mice peritonitis. In vitro, a human peritoneal mesothelial cell line (HMrSV5 was stimulated with lipopolysaccharide (LPS, HMGB1 extracellular content in the culture media and intracellular distribution in various cellular fractions were analyzed by Western blot or immunofluorescence. The results showed that the levels of HMGB1 in PDE were higher in patients with peritonitis than those in controls, and gradually declined during the period of effective antibiotic treatments. Furthermore, the levels of HMGB1 in PDE were positively correlated with white blood cells (WBCs count, TNF-α and IL-6 levels. However, pretreatment with glycyrrhizin attenuated LPS-induced acute peritoneal inflammation and dysfunction in mice. In cultured HMrSV5 cells, LPS actively induced HMGB1 nuclear-cytoplasmic translocation and release in a time and dose-dependent fashion. Moreover, cytosolic HMGB1 was located in lysosomes and secreted via a lysosome-mediated secretory pathway following LPS stimulation. Our study demonstrates that elevated HMGB1 levels in PDE during PD-related peritonitis, at least partially, from peritoneal mesothelial cells

  19. Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.

    Science.gov (United States)

    Azzam, Omar; Crowe, Amy; Sajiv, Cherian; Pawar, Basant

    2015-01-01

    A 33-year-old Caucasian man with end-stage renal disease secondary to biopsy-proven IgA nephropathy, managed with continuous ambulatory peritoneal dialysis (PD), presented with PD-related peritonitis, the causal organism being a non-branching Gram-positive bacillus, Rhodococcus equi. Initial empirical Gram positive and negative coverage with cefazolin and ceftazidime was unsuccessful, but following isolation of the organism, and conversion to intraperitoneal vancomycin and oral ciprofloxacin, the peritonitis episode resolved. At day 10, vancomycin was switched to azithromycin for a total of 6 weeks of antimicrobial therapy. The PD catheter was preserved, and the patient remained peritonitis-free at 6 months of follow-up.

  20. Pathophysiology of the Peritoneal Membrane during Peritoneal Dialysis: The Role of Hyaluronan

    Directory of Open Access Journals (Sweden)

    Susan Yung

    2011-01-01

    Full Text Available During peritoneal dialysis (PD, constant exposure of mesothelial cells to bioincompatible PD solutions results in the denudation of the mesothelial monolayer and impairment of mesothelial cell function. Hyaluronan, a major component of extracellular matrices, is synthesized by mesothelial cells and contributes to remesothelialization, maintenance of cell phenotype, and tissue remodeling and provides structural support to the peritoneal membrane. Chronic peritoneal inflammation is observed in long-term PD patients and is associated with increased hyaluronan synthesis. During inflammation, depolymerization of hyaluronan may occur with the generation of hyaluronan fragments. In contrast to native hyaluronan which offers a protective role to the peritoneum, hyaluronan fragments exacerbate inflammatory and fibrotic processes and therefore assist in the destruction of the tissue. This paper will discuss the contribution of mesothelial cells to peritoneal membrane alterations that are induced by PD and the putative role of hyaluronan in these processes.

  1. A case of peritoneal dialysis-associated peritonitis by Rothia mucilaginosa.

    Science.gov (United States)

    Kim, Byeong Gwan; Cho, A Young; Kim, Sang Sun; Lee, Seong Hee; Shin, Hong Shik; Yoon, Hyun Ju; Kim, Jeong Gwan; Sun, In O; Lee, Kwang Young

    2015-09-01

    Rothia muciliaginosa (R. mucilaginosa) is a facultative, Gram-positive coccus that is considered to be part of the normal flora of the mouth and respiratory tract. There are sporadic reports of the organism causing endocarditis in patients with heart valve abnormalities, as well as meningitis, septicemia, and pneumonia associated with intravenous drug abuse. However, it is an unusual pathogen in cases of peritoneal dialysis (PD)-associated peritonitis. Although R. mucilaginosa is generally susceptible to penicillin, ampicillin, cefotaxime, imipenem, rifampicin, and glycopeptides, there are no guidelines for the treatment of PD-associated peritonitis. Herein, we report a case of PD-associated peritonitis due to R. mucilaginosa that was resolved with intraperitoneal antibiotic treatment. PMID:26484045

  2. A Case Report of Rash at Peritoneal Dialysis Exit Site

    Directory of Open Access Journals (Sweden)

    Elvira O. Gosmanova MD, FASN

    2015-11-01

    Full Text Available The International Society for Peritoneal Dialysis recommends the regular application of topical antibiotic-containing preparations in addition to a routine exit site care to reduce the risk of exit site infection (ESI. Among these prophylactic antimicrobial preparations, topical gentamicin is one of the widely used and effective antibiotics for prevention of ESI and peritonitis in peritoneal dialysis (PD patients. Overall, topical gentamicin is well tolerated; however, its use can be associated with the development of allergic contact dermatitis (ACD. We describe a first reported case of PD catheter exit site contact ACD due to topical gentamicin mimicking ESI. The patient in this report developed worsening violaceous in color and pruritic rash surrounding the PD catheter exit site that appeared 3 weeks after the initiation of gentamicin cream. The association between development of rash and initiation of topical gentamicin led to a suspicion of local reaction to gentamicin rather than ESI. Skin biopsy confirmed ACD. Discontinuation of the provoking agent and subsequent treatment with topical hydrocortisone application led to a resolution of the exit site rash. Any rash at a PD catheter exit site should be considered infectious until proven otherwise. However, it is important to be aware of noninfectious etiologies of exit site rashes as the treatment of these 2 conditions differs.

  3. Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.

    Science.gov (United States)

    Ma, Terry King-Wing; Leung, Chi Bon; Chow, Kai Ming; Kwan, Bonnie Ching-Ha; Li, Philip Kam-Tao; Szeto, Cheuk Chun

    2016-08-01

    Peritonitis is a debilitating infectious complication of peritoneal dialysis (PD). Drug-resistant bacterial peritonitis typically has a lower response rate to antibiotics. In the past 15 years, newer antibiotics with activities against drug-resistant Gram-positive bacteria have been developed. In most circumstances, peritonitis due to methicillin-resistant staphylococci responds to vancomycin. If vancomycin cannot be used due to allergy and/or non-susceptibility, there is increasing evidence that linezolid and daptomycin are the drugs of choice. It is reasonable to start linezolid orally or intravenously, but subsequent dose reduction may be necessary in case of myelosuppression. Daptomycin can be given intravenously or intraperitoneally and has excellent anti-biofilm activity. Other treatment options for drug-resistant Gram-positive bacterial peritonitis include teicoplanin, tigecycline and quinupristin/dalfopristin. Teicoplanin is not available in some countries (e.g. the USA). Tigecycline can only be given intravenously. Quinupristin/dalfopristin is ineffective against Enterococcus faecalis and there is only low-quality evidence to support its efficacy in the treatment of peritonitis. Effective newer antibiotics against drug-resistant Gram-negative bacteria are lacking. Polymyxins can be considered, but evidence on its efficacy is limited. In this review, we will discuss the potential use of newer antibiotics in the treatment of drug-resistant bacterial peritonitis in PD patients. PMID:27478608

  4. Consecutive episodes of peritonitis in a patient undergoing peritoneal dialysis caused by unusual organisms: Brevibacterium and Pantoea agglomerans

    OpenAIRE

    Choi, Joon Seok; Kim, Chang Seong; Park, Jeong Woo; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan

    2012-01-01

    A 52-year-old man undergoing continuous ambulatory peritoneal dialysis presented with two consecutive episodes of peritonitis caused by unusual organisms, namely, Brevibacterium and Pantoea agglomerans. The patient was successfully treated with a 2-week course of cefazolin and ceftazidime for the Brevibacterium-associated peritonitis, and a 3-week course of gentamicin for the P. agglomerans-associated peritonitis. Although these environmental organisms are rarely responsible for human infecti...

  5. Severe valproate induced hyperammonemic encephalopathy successfully managed with peritoneal dialysis.

    Science.gov (United States)

    Kumar, Amandeep; Suri, Ashish; Sharma, Bhawani S

    2014-07-01

    Valproic acid (VPA) is a commonly used drug for epilepsy, psychiatric disorders and migraine and is frequently used in neurosurgical intensive care units. Though most of its side-effects are mild and transient, certain idiosyncratic side-effects have been attributed to VPA. Valproate induced hyperammonemia (VIH) is one such side-effect. VIH can produce symptoms of encephalopathy known as valproate induced hyperammonemic encephalopathy (VHE). VIH and VHE usually respond to withdrawal of VPA. However, in some cases VHE can be unresponsive to supportive measures and severe enough to be life-threatening. In such cases, dialysis can be used to rapidly reverse hyperammonemia and VHE and can prove to be a lifesaving measure. We report such a case of VIH and life-threatening VHE in a postoperative neurosurgical patient that was managed successfully with peritoneal dialysis.

  6. Asymptomatic Effluent Protozoa Colonization in Peritoneal Dialysis Patients.

    Science.gov (United States)

    Simões-Silva, Liliana; Correia, Inês; Barbosa, Joana; Santos-Araujo, Carla; Sousa, Maria João; Pestana, Manuel; Soares-Silva, Isabel; Sampaio-Maia, Benedita

    Currently, chronic kidney disease (CKD) is a global health problem. Considering the impaired immunity of CKD patients, the relevance of infection in peritoneal dialysis (PD), and the increased prevalence of parasites in CKD patients, protozoa colonization was evaluated in PD effluent from CKD patients undergoing PD. Overnight PD effluent was obtained from 49 asymptomatic stable PD patients. Protozoa analysis was performed microscopically by searching cysts and trophozoites in direct wet mount of PD effluent and after staining smears. Protozoa were found in PD effluent of 10.2% of evaluated PD patients, namely Blastocystis hominis, in 2 patients, and Entamoeba sp., Giardia sp., and Endolimax nana in the other 3 patients, respectively. None of these patients presented clinical signs or symptoms of peritonitis at the time of protozoa screening. Our results demonstrate that PD effluent may be susceptible to asymptomatic protozoa colonization. The clinical impact of this finding should be further investigated. PMID:27659930

  7. Asymptomatic Effluent Protozoa Colonization in Peritoneal Dialysis Patients.

    Science.gov (United States)

    Simões-Silva, Liliana; Correia, Inês; Barbosa, Joana; Santos-Araujo, Carla; Sousa, Maria João; Pestana, Manuel; Soares-Silva, Isabel; Sampaio-Maia, Benedita

    Currently, chronic kidney disease (CKD) is a global health problem. Considering the impaired immunity of CKD patients, the relevance of infection in peritoneal dialysis (PD), and the increased prevalence of parasites in CKD patients, protozoa colonization was evaluated in PD effluent from CKD patients undergoing PD. Overnight PD effluent was obtained from 49 asymptomatic stable PD patients. Protozoa analysis was performed microscopically by searching cysts and trophozoites in direct wet mount of PD effluent and after staining smears. Protozoa were found in PD effluent of 10.2% of evaluated PD patients, namely Blastocystis hominis, in 2 patients, and Entamoeba sp., Giardia sp., and Endolimax nana in the other 3 patients, respectively. None of these patients presented clinical signs or symptoms of peritonitis at the time of protozoa screening. Our results demonstrate that PD effluent may be susceptible to asymptomatic protozoa colonization. The clinical impact of this finding should be further investigated.

  8. Cardiovascular morbidity and mortality risk factors in peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Jovanović Dijana B.

    2008-01-01

    Full Text Available Cardiovascular (CVS morbidity and mortality in the endstage renal disease (ESRD patients on peritoneal dialysis therapy is 10-30 folds higher than in general population. The prevalence of well known traditional risk factors such as age, sex, race, arterial hypertension, hyperlipidaemia, diabetes, smoking, physical inactivity is higher in the uraemic patients. Besides these, there are specific, nontraditional risk factors for dialysis patients. Mild inflammation present in peritoneal dialysis (PD patients which can be confirmed by specific inflammatory markers is the cause of CVS morbidity and mortality in these patients. Hypoalbuminaemia, hyperhomocysteinaemia and a higher level of leptin are important predictors of vascular complications as well as CVS events in the PD patients. Plasma norepinephrine, an indicator of sympathetic activity, is high in the ESRD patients and higher in the PD patients than in the patients on haemodialysis (HD. Therefore, norepinephrine may be a stronger risk factor in the PD patients. The same applies to asymmetric dimethylargine (ADMA, an endogenous inhibitor of nitric oxide synthase, which is an important risk factor of CVS morbidity and mortality 15 % higher in the PD than the HD patients. Hyperphosphataemia, secondary hyperparathyroidism and high calcium x phosphate product have been associated with the progression of the coronary artery calcification and valvular calcifications and predict all-cause CVS mortality in the PD patients. Residual renal function (RRF declines with time on dialysis but is slower in the PD than the HD patients. RRF decline is associated with the rise of proinflammatory cytokines and the onset of hypervolaemia and hypertension which increase the risk of CVS diseases, mortality in general and CVS mortality. In conclusion, it is very important to establish all CVS risk factors in the PD patients to prevent CVS diseases and CVS mortality in this population.

  9. A proposal on auxiliary business insurance for peritoneal dialysis treatment

    Institute of Scientific and Technical Information of China (English)

    WANG Juan; WANG Tao; FANG Ji-qian

    2008-01-01

    Background The peritoneal dialysis (PD) therapy for end stage renal disease (ESRD) is expensive. The main reason for non-acceptance onto dialysis programs is the great cost. In the present study, we design an auxiliary business insurance program to provide the potential ESRD patients who have no access to governmental medical insurance or can not afford the remaining part besides the limited reimbursement for peritoneal dialysis therapy.Methods The information applied in this study was extracted from the medical records of 641 PD patients, who were treated in two dialysis centers of the first and the third teaching hospitals of the Peking University respectively. A collective risk model was employed to estimate the expenses on PD therapy. Survival analyses were performed to obtain the average survival time of PD patients and the average length of time from the onset of the primary disease to the beginning of PD. An annuity method was used to determine the pure premium.Results For chronic nephritis, diabetes mellitus and hyperpietic as primary diseases, the mean survival time ± standard errors were (55.1±3.7) months, (38.9±3.2) months and (61.4±4.6) months respectively, and they were significantly different from each other (all P=0.000). The expenses of whole PD therapy were 242 159.05 Yuan, 182 525.02 Yuan and 284 579.24 Yuan respectively.Conclusions An auxiliary business insurance for PD patients was designed with the pure premium for any individual who had chronic nephritis, diabetes mellitus or hyperpietic as primary disease was RMB 35.94 Yuan/year, 87.73Yuan/year or 7.71 Yuan/year respectively without considering the additional premium for coping with the business expenditures and accidental risks.

  10. Aquaporin-1: new developments and perspectives for peritoneal dialysis.

    Science.gov (United States)

    Devuyst, Olivier; Yool, Andrea J

    2010-01-01

    Peritoneal dialysis involves diffusive and convective transport and osmosis through the highly vascularized peritoneal membrane. Several lines of evidence have demonstrated that the water channel aquaporin-1 (AQP1) corresponds to the ultrasmall pore predicted by the model of peritoneal transport. Proof-of-principle studies have shown that upregulation of the expression of AQP1 in peritoneal capillaries results in increased water permeability and ultrafiltration, without affecting the osmotic gradient or small solute permeability. Conversely, studies in Aqp1 mice have shown that haplo-insufficiency for AQP1 results in significant attenuation of water transport. Recent studies have demonstrated that AQP1 is involved in the migration of different cell types, including endothelial cells. In parallel, chemical screening has identified lead compounds that could act as antagonists or agonists of AQPs, with description of putative binding sites and potential mechanisms of gating the water channel. By modulating water transport, these pharmacological agents could have clinically relevant effects in targeting specific tissues or disease states.

  11. Dialysis

    Science.gov (United States)

    ... kidney transplant, you will need a treatment called dialysis. There are two main types of dialysis. Both types filter your blood to rid your ... clinic for treatments several times a week. Peritoneal dialysis uses the lining of your abdomen, called the ...

  12. Care of the Patient with Renal Disease: Peritoneal Dialysis and Transplants, Nursing 321A.

    Science.gov (United States)

    Hulburd, Kimberly

    A description is provided of a course, "Care of the Patient with Renal Disease," offered at the community college level to prepare licensed registered nurses to care for patients with renal disease, including instruction in performing the treatments of peritoneal dialysis and continuous ambulatory peritoneal dialysis (CAPD). The first sections of…

  13. Prophylactic antibiotics for endoscopy-associated peritonitis in peritoneal dialysis patients.

    Directory of Open Access Journals (Sweden)

    Hsin-Hsu Wu

    Full Text Available INTRODUCTION: Continuous ambulatory peritoneal dialysis (CAPD peritonitis may develop after endoscopic procedures, and the benefit of prophylactic antibiotics is unclear. In the present study, we investigated whether prophylactic antibiotics reduce the incidence of peritonitis in these patients. PATIENTS AND METHODS: We retrospectively reviewed all endoscopic procedures, including esophagogastroduodenoscopy (EGD, colonoscopy, sigmoidoscopy, cystoscopy, hysteroscopy, and hysteroscopy-assisted intrauterine device (IUD implantation/removal, performed in CAPD patients at Chang Gung Memorial Hospital, Taiwan, between February 2001 and February 2012. RESULTS: Four hundred and thirty-three patients were enrolled, and 125 endoscopies were performed in 45 patients. Eight (6.4% peritonitis episodes developed after the examination. Antibiotics were used in 26 procedures, and none of the patients had peritonitis (0% vs. 8.1% without antibiotic use; p=0.20. The peritonitis rate was significantly higher in the non-EGD group than in the EGD group (15.9% [7/44] vs. 1.2% [1/81]; p<0.005. Antibiotic use prior to non-EGD examinations significantly reduced the endoscopy-associated peritonitis rate compared to that without antibiotic use (0% [0/16] vs. 25% [7/28]; p<0.05. Peritonitis only occurred if invasive procedures were performed, such as biopsy, polypectomy, or IUD implantation, (noninvasive procedures, 0% [0/20] vs. invasive procedures, 30.4% [7/23]; p<0.05. No peritonitis was noted if antibiotics were used prior to examination with invasive procedures (0% [0/10] vs. 53.8% [7/13] without antibiotic use; p<0.05. Although not statistically significant, antibiotics may play a role in preventing gynecologic procedure-related peritonitis (antibiotics, 0% [0/4] vs. no antibiotics, 55.6% [5/9]; p=0.10. CONCLUSION: Antibiotic prophylaxis significantly reduced endoscopy-associated PD peritonitis in the non-EGD group. Endoscopically assisted invasive procedures, such

  14. Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

    Science.gov (United States)

    Losso, Ricardo L M; Minhoto, Gisele R; Riella, Miguel C

    2015-02-01

    Sleep disorders for patients on dialysis are significant causes of a poorer quality of life and increased morbidity and mortality. No study has evaluated patients undergoing automated peritoneal dialysis (APD) to assess their sleep disorders compared to hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). A total of 166 clinically stable patients who had been on dialysis for at least 3 months were randomly selected for the study and divided into HD, CAPD or APD. Socio-demographic, clinical and laboratory parameters and self-administered questionnaires were collected for the investigation of insomnia, restless legs syndrome (RLS), bruxism, rapid eye movement sleep behavior disorder, excessive daytime sleepiness (EDS), obstructive sleep apnea syndrome (OSAS), sleepwalking, sleep hygiene, depression and anxiety. Insomnia was detected in more than 80 % of patients on the three modalities. OSAS was lower for patients on HD (36 %) than on CAPD (65 %) (p sleepwalking, sleep hygiene, depression or anxiety. ESRD patients undergoing any one of the three dialysis modalities studied had a high prevalence of sleep disorders. Patients on HD had a lower proportion of OSAS than those on CAPD and APD, which is most likely attributed to their lower body mass indices. The possible causes of higher RLS rates in APD patients have not been established. PMID:25358390

  15. Sleep disorders in patients with end-stage renal disease undergoing dialysis: comparison between hemodialysis, continuous ambulatory peritoneal dialysis and automated peritoneal dialysis.

    Science.gov (United States)

    Losso, Ricardo L M; Minhoto, Gisele R; Riella, Miguel C

    2015-02-01

    Sleep disorders for patients on dialysis are significant causes of a poorer quality of life and increased morbidity and mortality. No study has evaluated patients undergoing automated peritoneal dialysis (APD) to assess their sleep disorders compared to hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). A total of 166 clinically stable patients who had been on dialysis for at least 3 months were randomly selected for the study and divided into HD, CAPD or APD. Socio-demographic, clinical and laboratory parameters and self-administered questionnaires were collected for the investigation of insomnia, restless legs syndrome (RLS), bruxism, rapid eye movement sleep behavior disorder, excessive daytime sleepiness (EDS), obstructive sleep apnea syndrome (OSAS), sleepwalking, sleep hygiene, depression and anxiety. Insomnia was detected in more than 80 % of patients on the three modalities. OSAS was lower for patients on HD (36 %) than on CAPD (65 %) (p < 0.01) or APD (60 %) (p < 0.04). Patients on APD were more likely to have RLS compared to those on HD or CAPD (p < 0.04) (50 vs. 23 vs. 33 %). No differences among the modalities were found in bruxism, EDS, sleepwalking, sleep hygiene, depression or anxiety. ESRD patients undergoing any one of the three dialysis modalities studied had a high prevalence of sleep disorders. Patients on HD had a lower proportion of OSAS than those on CAPD and APD, which is most likely attributed to their lower body mass indices. The possible causes of higher RLS rates in APD patients have not been established.

  16. [Assisted peritoneal dialysis: home-based renal replacement therapy for the elderly patient].

    Science.gov (United States)

    Wiesholzer, Martin

    2013-06-01

    The number of elderly patients with end stage renal disease is constantly increasing. Conventional hämodiaylsis as the mainstay of renal replacement therapy is often poorly tolerated by frail eldery patients with multiple comorbidities. Although many of these patients would prefer a home based dialysis treatment, the number of elderly patients using peritoneal dialysis (PD) is still low. Impaired physical and cognitive function often generates insurmountable barriers for self care peritoneal dialysis. Assisted peritoneal dialysis can overcome many of these barriers and give elderly patients the ability of a renal replacement therapy in their own homes respecting their needs. PMID:23797681

  17. Psychosocial effects on caregivers for children on chronic peritoneal dialysis.

    Science.gov (United States)

    Tsai, T-C; Liu, S-I; Tsai, J-D; Chou, L-H

    2006-12-01

    The study was designed to explore the psychosocial effects on caretakers of children in Taiwan on chronic peritoneal dialysis (CPD). This is a case-control study, performed with subjects drawn from eight medical centers. The study group consisted of caretakers of 32 children with renal failure being treated with CPD. For comparison, a control group of caretakers of 64 healthy children as well as the regional Taiwanese studies were used. Two instruments were used to explore the presence of probable depression and quality of life (QOL) of the caretakers: the Taiwanese Depression Questionnaire, and the World Health Organization QOL BRIEF-Taiwan Version. In the study group, only 25% of caregivers had full-time jobs, and 66% of families had an annual income of less than US dollar 15,000. Of the 32 families in the study group, 16% had only a single parent. The prevalence of probable depression was significantly more common in the study group compared with control and referent group (28% vs 5% and 9.44%; P = 0.001). QOL scores in four domains were also significantly lower in the study group. In conclusion, even with the advances of peritoneal dialysis techniques, caring for children on CPD in Taiwan has significant adverse psychosocial effects on the primary caregivers. Attention should be paid to the psycho-social status of the caregivers. PMID:16985519

  18. Pharmacokinetics of Quinupristin-Dalfopristin in Continuous Ambulatory Peritoneal Dialysis Patients

    OpenAIRE

    Johnson, Curtis A.; Taylor, Claude A.; Zimmerman, Stephen W.; Bridson, William E.; Chevalier, Paul; Pasquier, Olivier; Baybutt, Robert I.

    1999-01-01

    Quinupristin-dalfopristin may be useful for treatment of organisms causing peritoneal dialysis-related peritonitis, including methicillin-resistant coagulase-negative staphylococci, methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci. The pharmacokinetic profiles of single intravenous doses of this combination streptogramin antibiotic of 7.5 mg/kg of body weight were characterized for eight noninfected patients receiving continuous ambulatory peritoneal dialysis....

  19. Efficacy of bolus intravenous iron treatment in peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Jovanović Nataša

    2005-01-01

    Full Text Available Introduction. Normocytic, normochromic anemia is one of the first signs of chronic renal failure and it is common in patients on chronic dialysis treatment. It causes decrease in oxygen supply to tissues, increases cardiac minute volume, causes left ventricular hyperthrophy, cardiac insufficiency, disorders related to cognitive functions and immune response, and increases morbidity and mortality rates. The leading cause of anemia in patients on chronic peritoneal dialysis (PD is iron depletion and most patients on PD need oral or parenteral iron supplementation. The aim of this study was to evaluate our first experience with bolus intravenous ferrogluconate therapy in patients on chronic peritoneal dialysis at the Nephrology Clinic of the Clinical Center of Serbia (CCS. Material and Methods. We examined 11 patients, 7 males and 4 females, mean-age 49 years (range 31 to 68 years on chronic PD. All patients received blood transfusions, oral or intramuscular iron supplementation before 465 to 665 mg ferrogluconate therapy was given in 500 ml. saline intravenous infusion; 5 of them were on erythropoietin therapy and 2 of them started with EPO therapy after the ferrogluconate therapy. Results. The blood count improved during the first 3 months after application of bolus intravenous iron therapy (ferrogluconate; erythropoietin dose was not increased during the follow-up. Some patients suffered from side effects during infusion and 6 patients received the complete treatment. Discussion. Blood count improves in a number of patients affected by end-stage renal disease during the first months on continuous ambulatory peritoneal dialysis (CAPD treatment. But a large number of patients on chronic CAPD treatment are iron-depleted and they require oral or parenteral substitution. Side effects and complications of intravenous iron therapy were not severe and only one patient suffered from allergic manifestations. Ferremia and blood count improved in patients

  20. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients.

    Science.gov (United States)

    Mahiout, A; Ehlerding, G; Brunkhorst, R

    1996-01-01

    In patients on continuous ambulant peritoneal dialysis (CAPD) treatment, the peritoneal membrane is continuously exposed to the high glucose concentration contained in the dialysate. This may lead to the local generation of advanced glycation end-products (AGEs). To test this hypothesis we evaluated the plasma and dialysate AGE concentrations in five CAPD patients. The dialysate was measured after a 1 h and after a 12 h dwell time. Additionally, in two patients an immunohistochemical investigation of the peritoneal membrane for AGE was performed. For the determination of AGE an ELISA using a polyclonal antibody against AGE bovine serum albumin was used; the immunohistochemical staining was performed using the streptavidin-biotin complex method. We found only low concentrations of AGE in the dialysate after a 1 h dwell time; after 12 h, however, the dialysate AGE was even greater than the plasma concentration. In both peritoneal specimens we found positive staining for AGE in the interstitium of the mesothelial layer. The dialysate AGE contained a high proportion of high-molecular-weight AGE proteins and low-molecular-weight AGE was found to be in the same concentration range as the total serum AGE. We conclude that there is local generation of AGE in the peritoneal membrane and a 'washing out' of AGE from the peritoneal membrane during longer dwell times. We speculate that the accumulation of AGE might lead to some of the functional and morphological alterations observed after long-term CAPD.

  1. Measuring, managing, and improving quality in the end-stage renal disease treatment setting: peritoneal dialysis.

    Science.gov (United States)

    Nissenson, A R

    1994-08-01

    Peritoneal dialysis is now performed as an end-stage renal disease modality in nearly 70,000 patients worldwide. The use of this modality varies widely from less than 5% of all end-stage renal disease patients in Japan to over 95% of patients in Mexico. In addition to medical and psychosocial factors, modality selection involves many other factors, including financial reimbursement, educational deficiencies, resource availability, social mores, and cultural habits. Survival on chronic peritoneal dialysis is similar to that on hemodialysis, although older diabetic patients on peritoneal dialysis may have a higher mortality rate. Hospitalizations and transfer off modality are more common in patients on chronic peritoneal dialysis compared with patients on hemodialysis. The important factors contributing to outcome in patients on chronic peritoneal dialysis are unknown. Results of the Baxter Best-Demonstrated Practice Program suggest that process of care has a strong impact on outcome, at least in retention of patients on chronic peritoneal dialysis. Quality of life is another outcome that has been poorly assessed in chronic peritoneal dialysis patients. Available studies suffer from a lack of standardization of instruments used, no control groups, no random patient allocation to modalities, and short-term, small population groups. When chronic peritoneal dialysis and hemodialysis are compared, subjective quality of life is generally higher with chronic peritoneal dialysis. For objective quality of life, the balance of studies favor hemodialysis. It is clear that there is a dearth of information available on many aspects of delivery of chronic peritoneal dialysis. Future research should target patient factors that are important in morbidity and mortality with chronic peritoneal dialysis, facility factors ("process of care") that are important in morbidity and mortality with chronic peritoneal dialysis, quality of life in chronic peritoneal dialysis patients, and how

  2. Nasal Carriage and Peritonitis by Staphylococcus Aureus in Patients on Continuous Ambulatory Peritoneal Dialysis: a prospective study

    NARCIS (Netherlands)

    G.J.A. Wanten; P. van Oost; P.M. Schneeberger (Peter); M.I. Koolen (Marianne)

    1996-01-01

    textabstractThe objective of this study was to establish whether or not patients on continuous ambulatory peritoneal dialysis (CAPD) using current infection control measures who are nasal carriers of staphylococcus aureus are at risk for the development of S. aureus peritonitis.

  3. Complicated Candida parapsilosis peritonitis on peritoneal dialysis in a neonate with renal failure because of bilateral adrenal abscesses.

    Science.gov (United States)

    Cheng, I; Chen, Yi-Lin; Lin, Cheng-Hui; Jow, Guey-Mei; Mu, Shu-Chi

    2011-10-01

    We present a full-term female infant with a difficult delivery course complicated with Escherichia coli sepsis and bilateral adrenal abscesses. She developed renal failure and received peritoneal dialysis. Peritonitis of Candida parapsilosis developed later. The infant was successfully treated with hemofiltration and a combination of antifungal agents.

  4. [Efficacy of continuous ambulatory peritoneal dialysis in treatment of children with end-stage renal insufficiency].

    Science.gov (United States)

    Sahapozova, E; Ruso, B; Kuzmanovska, D; Tasić, V; Ristoska-Bojkoviska, N

    1998-01-01

    Three children (2 girls and 1 boy) with end-stage renal failure were put in program of continuous ambulatory peritoneal dialysis in the period of 2.5 years (January 1995-September 1997). The age of the children at the treatment onset was 5-12 years. One of three children died due to cardiovascular failure after six-month treatment. Two out of three children had a total of 8 episodes of peritonitis in the period of 37 months during the treatment with peritoneal dialysis. The incidence of peritonitis occurrence in our patients was one episode in 4 patients/months. Most frequent cause for peritonitis occurrence was Staphylococcus aureus in 50% of isolated bacteria. Obtained results in peritoneal equilibration test revealed that the transport and ultrafiltration rate of peritoneal membrane decreased after recurrent peritonitis episodes.

  5. Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?

    OpenAIRE

    Erkan Dervisoglu; Melih Simsek; Ahmet Yilmaz

    2011-01-01

    OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V). METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years) was...

  6. Increasing fill volume reduces cardiac performance in peritoneal dialysis

    DEFF Research Database (Denmark)

    Ivarsen, Per; Povlsen, Johan V; Jensen, Jens Dam

    2007-01-01

    BACKGROUND: It is generally accepted that peritoneal dialysis (PD) affects systemic haemodynamics less than haemodialysis, but little is known about changes in haemodynamics during PD. It is unknown if increasing PD volume causes changes in cardiovascular haemodynamics possibly increasing...... the demand on the heart even during normal daily activities. METHODS: Fifteen stable PD patients were included in this randomized, controlled, open-label crossover study. After drainage, we measured blood pressure, pulse rate and cardiac output (CO) after 30 min in the supine position. The measurements were...... differences were found between drained and 2 l and 3 l fill. CONCLUSION: The present study showed that cardiac performance decreased when increasing fill volume from 2 to 3 l in the supine position. The decreased cardiac performance was already present after 2 l fill in the upright position and did not change...

  7. Acute peritoneal dialysis in a Jehovah's Witness post laparotomy.

    Science.gov (United States)

    Appalsawmy, Usha Devi; Akbani, Habib

    2016-01-01

    A 56-year-old man who was a Jehovah's Witness with an advanced directive against autologous procedures developed acute kidney injury needing renal replacement therapy while he was intubated and ventilated on the intensive care unit. He was being treated for hyperosmolar hyperglycaemic state. He also had a healing laparotomy wound, having undergone a splenectomy less than a month ago following a road traffic accident. His hyperkalaemia and metabolic acidosis were refractory to medical treatment. As he became oligoanuric, decision was taken to carry out acute peritoneal dialysis (PD) by inserting a Tenckhoff catheter in his abdomen using peritoneoscopic technique. The patient was started on automated PD without any complications. His urine output gradually improved, and his renal function eventually recovered. On discharge from hospital, his renal function was within normal range, and he had no abdominal complications from the acute PD. PMID:27581233

  8. Aspects of osseous, peritoneal and renal handling of bisphosphonate during peritoneal dialysis: a methodological study

    DEFF Research Database (Denmark)

    Joffe, P; Henriksen, Jens Henrik Sahl

    1996-01-01

    to continuous ambulatory peritoneal dialysis (CAPD). The aims were: to assess the kinetics of 99m-technetium MBP (99mTc-MBP) in CAPD, and to evaluate the correctness of the assumption that the peritoneal and renal clearances of 99mTc-MBP equal the total plasma clearance of 51-chromium ethylenediamine tetra......-acetic acid (51Cr-EDTA). Eight patients on CAPD were studied cross-sectionally. The mean plasma clearances of 99mTc-MBP and 51Cr-EDTA in the steady state (4h) were 38.2 and 12.2 ml min-1 (p peritoneal clearances (0-4 h) were 5.2 and 7.2 ml min-1 (p ....5 and 2.8 ml min-1 (not significant), respectively. The bone bisphosphonate clearance (BBC) at steady state was 26.0 ml min-1, a value which was significantly higher than that at infinity (16.5 ml min-1, p peritoneal and renal clearances of 99m...

  9. Recurrent Chronic Ambulatory Peritoneal Dialysis-Associated Infection due to Rothia dentocariosa

    Directory of Open Access Journals (Sweden)

    Shaun K Morris

    2004-01-01

    Full Text Available Rothia dentocariosa is a commensal organism of the human oropharynx. Clinical infection due to this organism is rare. A case of recurrent peritoneal dialysis-related peritonitis caused by R dentocariosa and a review of the literature is reported. Isolation of R dentocariosa from dialysate fluid should not be dismissed as a contaminant. Although there are no interpretive criteria for antimicrobial susceptibility testing, R dentocariosa appears to be susceptible to a variety of antibiotics including beta-lactams, vancomycin and aminoglycosides. Optimal therapy of peritoneal dialysis peritonitis caused by this organism may also require removal of the catheter.

  10. Association of body fat with inflammation in peritoneal dialysis.

    Science.gov (United States)

    de Mattos, Andresa Marques; Ovidio, Paula Payão; Jordão, Alceu Afonso; da Costa, José Abrão Cardeal; Chiarello, Paula Garcia

    2013-06-01

    Peritoneal dialysis (PD) frequently leads to body weight gain, which appears to be a potential cause of the chronic inflammation frequently present in these patients. The consequences of this inflammation are impaired nutritional status, accelerated atherosclerosis, and increased mortality. To assess the association between inflammation and body fat in female patients treated with PD. Nineteen female patients on PD for at least 6 months with no infectious complications or malignant or acute inflammatory diseases. Nutritional status was determined by measuring weight, height, body mass index (BMI), waist (WC), and mid-arm circumferences (MAC), mid-arm muscle area, and tricipital fold (TCF). Bioelectrical impedance (BIA) was used to determine body composition. Biochemical evaluation included the determination of serum albumin, urea, creatinine, and C-reactive protein (CRP). The glucose absorbed from the dialysis solution was quantitated. According to BMI, two patients were classified as malnourished and ten as overweight/obese. Sixteen individuals had high WC measurements and 12 had excess body fat (BF) as measured by BIA. High CRP levels were observed in 12 patients, who had higher WC, MAC, BMI, TCF, and BF measurements compared to non-inflamed patients. Positive associations were detected between CRP and BMI, MAC, WC, and TCF. Associations between BF and CRP suggest that adiposity may be a potent exacerbating factor of inflammation in this population, especially visceral fat. Thus, obesity may be considered to be one more factor responsible for the early atherosclerosis and high cardiovascular mortality observed in these patients.

  11. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Helal Imed

    2010-01-01

    Full Text Available Cardiovascular diseases are a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD. The aim of our investigation was the evaluation of an extensive cardiovascular profile in hemodialysis (HD and peritoneal dialysis (PD patients. We studied 74 patients with ESRD (38 males, 36 females, maintained either on chronic HD (n= 50 or chronic PD (n= 24 and age and sex matched 20 healthy subjects as controls. The lipid profile, homo-cysteine (Hcy and C reactive protein (CRP were measured. When compared to a healthy popu-lation, HD patients displayed a marked atherogenic profile, as attested by increased levels of total cholesterol (TC, triglycerides (TG, low-density lipoprotein-cholesterol (LDL-C, apolipoprotein A (Apo A, CRP, Hcy and lower concentrations of high-density lipoprotein-cholesterol (HDL-C, Apo B, albumin (ALB. A significant difference was noted concerning the rates of Apo B, HDL-C, TC, ALB and Hcy. Same biological disorders that those found at HD patients were noted in these PD patients. One also noted lower concentration in Apo A. there were a significant diffe-rence with the reference group concerning the rates of albumin, Apo A, HDL-Cl and Hcy. When compared to PD patients, HD patients had significantly decreased concentration of LDL-C. The peculiar metabolic changes observed in the present study confirm the marked tendency of patients with impaired renal function for developing cardiovascular diseases, irrespectively of the type of dialysis. We suggest including uremia-related risk factors in the panel for evaluation of cardio-vascular risk in dialysis patients.

  12. Strategies to improve clinical outcomes in peritoneal dialysis patients: delivered dose and membrane transport.

    Science.gov (United States)

    Churchill, D N

    1998-12-01

    For patients with end-stage renal disease treated with peritoneal dialysis, prospective cohort studies using multivariate statistical analysis have shown an association between greater urea clearance and a decreased relative risk for death. The recommended weekly Kt/V for urea is 2.0, with the corresponding creatinine clearance (CrCl) of 60 L/1.73 m2. This is considered adequate dialysis but fails to define optimum urea and CrCl targets. The assumption that renal and peritoneal clearances are equivalent has been challenged by circumstantial data and is probably untenable. The relative importance of these clearances requires definition. The suggestion that CrCl is a more important indicator of adequacy of dialysis is confounded by association with renal, rather than peritoneal, clearance and perhaps by the early referral and initiation of dialysis. Recent reports have shown an association between increased peritoneal membrane transport and an increased relative risk for technique failure and/or death. Patients with higher peritoneal transport should have greater clearance of urea and creatinine and better clinical outcomes. Possible explanations for this apparent contradiction include the adverse effects of increased glucose absorption, malnutrition, and fluid overload, the latter caused by decreased ultrafiltration. Available data suggest an important role for the failure of ultrafiltration among patients treated with continuous ambulatory peritoneal dialysis (CAPD). Strategies to improve the clearance of urea and creatinine include the preservation of residual renal function and increased peritoneal clearance. Loss of residual renal function may be delayed by the avoidance of nephrotoxic drugs and angiographic dye. Peritoneal clearance can be enhanced by a combination of increased volume and frequency of peritoneal dialysis cycles. Ultrafiltration failure, but not protein loss, can be addressed with shorter cycles with nocturnal peritoneal dialysis. Development of

  13. Use of biogenic nanomaterials to improve the peritoneal dialysis technique: A Translational Research Perspective

    CERN Document Server

    Kumar, Dinesh

    2015-01-01

    Intraperitoneal and catheter exit site infections are the most common complications associated with prolonged peritoneal dialysis (PD) therapy used for treating the patients with end stage renal failure (ESRF). Recurrent and persistent infections often cause inflammation of the peritoneum, a condition known as infectious peritonitis and to resolve the condition, patients require antibiotic treatment. However, if the treatment is delayed or if it fails due to antibiotic resistance, the peritonitis may lead to permanent malfunctioning of peritoneal membrane causing technique failure and transferring the patients to haemodialysis. Severe and prolonged peritonitis is not only the major cause of technique failure, it is also the leading cause of mortality and morbidity in PD patients. Therefore, there is an urgent need to improve the existing PD technique so that the frequency of PD associated infections could be reduced and infectious peritonitis episodes thereof during prolonged peritoneal dialysis. In this pers...

  14. Solute clearance measurement in the assessment of dialysis adequacy among African continuous ambulatory peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Aliyu Abdu

    2015-01-01

    Full Text Available Solute clearance measurement is an objective means of quantifying the dose of peritoneal dialysis (PD. Despite continued debate on the interpretation and precise prognostic value of small solute clearance in PD patients, guidelines based on solute clearance values are common in clinical practice. There is limited information on the solute clearance indices and PD adequacy parameters among this predominantly low socioeconomic status PD population. We investigated the solute clearance among continuous ambulatory peritoneal dialysis (CAPD patients at the Charlotte Maxeke Johannesburg Academic Hospital and its relationship with other parameters of PD adequacy. Seventy patients on CAPD were studied in this cross-sectional study. Solute clearance was assessed using urea clearance (Kt/V. Linear regression analysis was used to determine factors associated with solute clearance, while analysis of variance was used to test the influence of weekly Kt/V on blood pressure (BP, hemoglobin (Hb and other biochemical parameters. The mean age of the study population was 37.9 ± 12.4 years, 43% were females and 86% were black Africans. The mean duration on CAPD was 19.7 ± 20.8 months. Mean systolic and diastolic BP were 144 ± 28 and 92 ± 17 mm Hg, respectively. The mean Hb was 11.1 ± 2.2 g/dL and the mean weekly Kt/V was 1.7 ± 0.3. Factors like systolic BP, Hb level, serum levels of cholesterol, calcium, phosphate, parathyroid hormone and albumin were not significantly associated with the weekly Kt/V. We conclude that the dose of PD received by the majority of our patients in terms of the weekly Kt/V is within the recommended values and that this finding is significant considering the low socioeconomic background of our patients. There is no significant association between Kt/V and other indices of dialysis adequacy.

  15. [Candida peritonitis and sepsis due to Acinetobacter baumannii in peritoneal dialysis: an association with prognosis not always unfavourable].

    Science.gov (United States)

    Rapisarda, Francesco; Aliotta, Roberta; Pocorobba, Barbara; Portale, Grazia; Ferrario, Silvia; Zanoli, Luca; Fatuzzo, Pasquale

    2015-01-01

    Fungal infections have a high incidence in patients receiving peritoneal dialysis. (1)
Peritoneal dialysis is often complicated by peritonitis which has only minimally mycotic etiology, but nonetheless it is associated with 15-45% mortality (8).
 The opportunistic pathogens such as Candida can cause infection in immunocompromised conditions. Even the Acinetobacter tends to infect immunocompromised individuals and it has the same risk factors for infection as Candida: immunosuppression, malignancy, HIV positivity and all the other conditions of immunosuppression, central venous catheterization, mechanical ventilation and prolonged antibiotic therapy. The sepsis by Acinetobacter predicts a negative prognosis with the mortality rate between 20 to 60% (12), especially in cases of isolation of multi-resistant germs.
 We present a case report of a CKD patient undergoing peritoneal dialysis therapy who was hospitalized for acute pancreatitis, later complicated by the development of pancreatic pseudocysts, C. albicans peritonitis with hematologic spread of the fungus, superimposed Acinetobacter baumannii sepsis and pneumonia. She has been subjected to percutaneous drainage of pseudocysts, to switch from peritoneal dialysis to hemodialysis, to various evacuative thoracentesis, and to polymicrobial therapy (meropenem, teicoplanina, tigeciclina, linezolid, colimicina, fluconazolo, etc.) that allowed the resolution of sepsis. The peculiarity of this case is represented by the numerous morbidity that the patient developed simultaneously, with the genesis of a complex clinical picture, by the combination of infections due to Candida albicans and Acinetobacter baumannii. Successful treatment strategies allowed to fight and cure a medical condition associated with a high mortality rate. PMID:26845211

  16. Removal of the Protein-Bound Solutes Indican and P-Cresol Sulfate by Peritoneal Dialysis

    OpenAIRE

    Pham, Nhat M.; Recht, Natalie S.; Hostetter, Thomas H.; Meyer, Timothy W.

    2008-01-01

    Background and objectives: Protein-bound solutes are poorly cleared by peritoneal dialysis. We examined the hypothesis that plasma concentrations of bound solutes would therefore rise as residual renal function is lost.

  17. Pleuroperitoneal Leak: An Unusual Cause of Acute Shortness of Breath in a Peritoneal Dialysis Patient

    Directory of Open Access Journals (Sweden)

    D. P. Ramaema

    2014-01-01

    Full Text Available Introduction. Pleuroperitoneal leak is an uncommon complication of continuous ambulatory peritoneal dialysis (CAPD, with an estimated incidence of 1.6%. It should be suspected in these patients when they present with recurrent unilateral pleural effusions and/or acute shortness of breath following dialysate infusion. Case Presentation. We present the case of a 25-year-old female patient who had acute hydrothorax as a result of pleuroperitoneal leak complicating continuous ambulatory peritoneal dialysis (CAPD, which was confirmed on peritoneal scintigraphy. Conclusion. Continuous ambulatory peritoneal dialysis patients presenting with acute shortness of breath and/or recurrent unilateral pleural effusion should be investigated with peritoneal scintigraphy to exclude pleuroperitoneal leak.

  18. Parameter estimation in six numerical models of transperitoneal transport of potassium in patients undergoing peritoneal dialysis

    DEFF Research Database (Denmark)

    Graff, J; Fugleberg, S; Joffe, P;

    1995-01-01

    The mechanisms of transperitoneal potassium transport during peritoneal dialysis were evaluated by validation of different mathematical models. The models were designed to elucidate the presence or absence of diffusive, non-lymphatic convective and lymphatic convective solute transport....... Experimental results were obtained from 26 non-diabetic patients undergoing peritoneal dialysis. The validation procedure demonstrated that models including both diffusive and non-lymphatic convective solute transport were superior to the other models. Lymphatic convective solute transport was not identifiable...

  19. Quality of life, mental health and health beliefs: comparison between haemodialysis and peritoneal dialysis patients

    OpenAIRE

    Theofilou P

    2010-01-01

    Aim: The comparative study between in-centre haemodialysis (HD) and continuous ambulatory peritoneal dialysis (PD) patients regarding self-reported quality of life (QoL) as well as some psychological dimensions that may affect and may be affected by the patient’s state of health, like health locus of control beliefs, depression and anxiety. Material and Method: The sample consists of 144 patients in-centre haemodialysis or continuous ambulatory peritoneal dialysis (CAPD). Patient-reported ass...

  20. Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin.

    OpenAIRE

    McCormick, E M; Echols, R M

    1987-01-01

    Ciprofloxacin is active in vitro against most bacteria that cause peritonitis associated with peritoneal dialysis. We compared the effects of pH (5.5 and 7.4) and medium (dialysis fluid) on the bactericidal activity of ciprofloxacin, tobramycin, vancomycin plus rifampin, and rifampin against Pseudomonas aeruginosa, Escherichia coli, and three strains of staphylococci. The bactericidal activity of ciprofloxacin was not significantly affected by pH or medium, in contrast to the activity of tobr...

  1. Inhibiting effect of short hairpin RNA on expression of transforming growth factor-β1 in human peritoneal mesothelial cells induced by peritoneal dialysis solution

    Institute of Scientific and Technical Information of China (English)

    LIU Fu-you; LING Guang-hui; LIU Hong; PENG You-ming; LIU Ying-hong; DUAN Shao-bin

    2005-01-01

    @@ The peritoneum response to peritoneal dialysis can lead to fibrosis. The transforming growth factor-β1 (TGF-β1) plays an important role in regulating tissue repair and remodeling after injury. Excessive synthesis and deposition of matrix proteins by peritoneal mesothelial cells can lead to structural and functional changes in the peritoneal membrane, jeopardizing the long-term efficacy of peritoneal dialysis (PD).

  2. Effects of oral enalapril and verapamil on dialysis adequacy and solute clearance in chronic ambulatory peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Shahnaz Atabak

    2013-01-01

    Full Text Available Peritoneal dialysis offers several advantages such as better clearance of intermediate/large molecules and better preservation of renal residual function when compared with hemodialysis. However, dialysis adequacy is one of the subjects of concern of this modality. There are some drugs that are capable of influencing solute transport in the peritoneum, such as acetyle co-enzyme inhibitors (ACE-I medications and calcium channel blockers. Captopril and Verapamil are often mentioned, but their use has shown varying conclusions and initial studies were performed with the intra-peritoneal administration of these drugs and there are only a few studies on the effect of the oral administration of these drugs. This study was undertaken with the aim to evaluate the effects of oral administration of Verapamil and Enalapril among continuous ambulatory peritoneal dialysis (CAPD patients. The results of this study showed that Verapamil and Enalapril do not have any effects on glucose, creatinine, sodium, potassium and urea clearance (during the 4-h peritoneal equilibration test (PET test. However, it was shown that Enalapril significantly increased the peritoneal urea Kt/V and caused a meaningful decrease in the diastolic and mean blood pressures. Therefore, we feel that Enalapril may be administered as an anti-hypertensive medication of choice in CAPD patients, which can also result in better dialysis adequacy. However, further studies with larger sample sizes are needed in the future.

  3. Gangrenous appendicitis presenting as acute abdominal pain in a patient on automated peritoneal dialysis: a case report

    Directory of Open Access Journals (Sweden)

    Ekart Robert

    2012-09-01

    Full Text Available Abstract Introduction Presentations of abdominal pain in patients on peritoneal dialysis deserve maximal attention and careful differential diagnosis on admittance to medical care. In this case report a gangrenous appendicitis in a patient on automated peritoneal dialysis is presented. Case presentation We report the case of a 38-year-old Caucasian man with end-stage renal disease who was on automated peritoneal dialysis and developed acute abdominal pain and cloudy peritoneal dialysate. Negative microbiological cultures of the peritoneal dialysis fluid and an abdominal ultrasonography misleadingly led to a diagnosis of culture negative peritonitis. It was decided to remove the peritoneal catheter but the clinical situation of the patient did not improve. An explorative laparotomy was then carried out; diffuse peritonitis and gangrenous appendicitis were found. An appendectomy was performed. Myocardial infarction and sepsis developed, and the outcome was fatal. Conclusion A peritoneal dialysis patient with abdominal pain that persists for more than 48 hours after the usual antibiotic protocol for peritoneal dialysis-related peritonitis should immediately alert the physician to the possibility of peritonitis caused by intra-abdominal pathology. Not only peritoneal catheter removal is indicated in patients whose clinical features worsen or fail to resolve with the established intra-peritoneal antibiotic therapy but, after 72 hours, an early laparoscopy should be done and in a case of correct indication (intra-abdominal pathology an early explorative laparotomy.

  4. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children.

    NARCIS (Netherlands)

    Rusthoven, E.; Krediet, R.T.; Willems, J.L.; Monnens, L.A.H.; Schröder, C.H.

    2004-01-01

    Scarce data are available on the use of glucose polymer-based dialysate in children. The effects of glucose polymer-based dialysate on peritoneal fluid kinetics and solute transport were studied in pediatric patients who were on chronic peritoneal dialysis, and a comparison was made with previously

  5. Transperitoneal transport in diabetic and non-diabetic patients on peritoneal dialysis

    DEFF Research Database (Denmark)

    Graff, J; Fugleberg, Steen; Nielsen, S L;

    1999-01-01

    To investigate differences in the transport characteristics of the peritoneal membrane between diabetic and non-diabetic patients on chronic peritoneal dialysis, a study was conducted in 21 non-diabetic and 18 diabetic patients. Transperitoneal transport of small solutes was evaluated in terms...... of the mass transfer area coefficients (urea, creatinine and glucose), ultra-filtration sieving coefficients (urea and creatinine) and by peritoneal equilibration test results. The capacity of the peritoneal membrane to transport macromolecules was evaluated by albumin mass transfer rates and clearances......-labelled human albumin. Despite a significantly increased transcapillary escape rate of albumin in the diabetic patients, no differences in peritoneal membrane characteristics could be demonstrated between diabetic and non-diabetic patients on peritoneal dialysis....

  6. Calciphylaxis in peritoneal dialysis patients: a single center cohort study

    Science.gov (United States)

    Zhang, Yanchen; Corapi, Kristin M; Luongo, Maria; Thadhani, Ravi; Nigwekar, Sagar U

    2016-01-01

    Background Calciphylaxis is a rare but devastating condition in end-stage renal disease (ESRD) patients. Most research in the field of calciphylaxis is focused on hemodialysis (HD) patients; however, data on calciphylaxis incidence, risk factors, and mortality in peritoneal dialysis (PD) patients are limited. Methods In this cohort study, we examined data from adult patients who initiated PD for ESRD management at our institute’s PD unit from January 2001 to December 2015. Associations with the development of calciphylaxis were examined for clinical, laboratory, and medication exposures. Incidence of calciphylaxis and mortality in PD patients who developed calciphylaxis were analyzed. Treatments administered to treat calciphylaxis in PD patients were summarized. Results In this cohort of 63 patients, 7 patients developed calciphylaxis (incidence rate: 9.0 per 1,000 patient-years). Median age of PD patients who developed calciphylaxis was 50 years, 57% were white, 71% females, and 71% were previously on HD. Female sex, obesity, HD as a prior dialysis modality, recurrent hypotension, elevated time-averaged serum phosphorous levels, reduced time-averaged serum albumin levels, and warfarin therapy were associated with increased calciphylaxis risk in univariate logistic regression analyses. Intravenous sodium thiosulfate was administered in 57% of PD patients who developed calciphylaxis. One-year mortality in PD patients who developed calciphylaxis was 71% despite multimodal treatment including sodium thiosulfate, hyperbaric oxygen, cinacalcet, and wound debridement. Conclusion Calciphylaxis is a rare but frequently fatal condition in PD patients. Our study provides critical early insights into calciphylaxis incidence, risk factors, and prognosis in PD patients. Sample size and characteristics of patients included in our study limit generalizability to overall PD population and warrant examination in larger independent studies. PMID:27698566

  7. Course of Encephalopathy in a Cirrhotic Dialysis Patient Treated Sequentially with Peritoneal and Hemodialysis

    Directory of Open Access Journals (Sweden)

    Suleyman Koz

    2015-01-01

    Full Text Available End-stage kidney disease and advanced cirrhosis are sometimes seen concomitantly. There is no consensus on dialysis modality in terms of determining the optimal way of treating these patients. It has been suggested that peritoneal dialysis is a better choice for these patients, but efficacy of hemodialysis in stable cirrhotic patients has not been evaluated sufficiently. We report a case with advanced cirrhosis and end-stage kidney disease who was faced with hepatic encephalopathy episodes up on starting renal replacement therapy. The case is also interesting in that it reveals effects of hemodialysis and peritoneal dialysis on hepatic encephalopathy episodes and quality of life of the patient.

  8. Quality of Life and Self-Efficacy in Three Dialysis Modalities: Incenter Hemodialysis, Home Hemodialysis, and Home Peritoneal Dialysis.

    Science.gov (United States)

    Wright, Linda S; Wilson, Linda

    2015-01-01

    Previous research has demonstrated improved outcomes for patients on dialysis who have better quality of life and self-efficacy, but has focused almost exclusively on those receiving hemodialysis. The goal of this study was to describe the quality of life and self-efficacy of patients receiving incenter hemodialysis versus those receiving a home dialysis modality (hemodialysis or peritoneal dialysis). The study utilized a correlational cross-sectional design and quota sampling methods. Participants were recruited from outpatient dialysis facilities and included 77 community dwelling adult patients who had been on dialysis for at least six months. Quality of life was measured using the Kidney Disease Quality of Life instrument, and self-efficacy was measured using the Strategies Used by People to Promote Health instrument. Findings suggest equal outcomes between treatment groups, with no contraindication to the use of home therapies.

  9. The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Taner Basturk

    2012-08-01

    Full Text Available OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The patients were divided into two groups. Group 1 (n = 34 was treated with angiotensin-converting enzyme inhibitors. Group 2 (n = 20 did not receive any antihypertensive drugs during the entire follow-up. Eleven patients were excluded from the study thereafter. Thus, a total of 30 patients in Group 1 and 13 patients in Group 2 completed the study. We observed the patients for six months. Group 1 patients received maximal doses of angiotensin-converting enzyme inhibitors for six months. Parameters at the beginning of study and at the end of six months were evaluated. RESULTS: At the end of six months, total peritoneal protein loss in 24-hour dialysate effluent was significantly decreased in Group 1, whereas it was increased in Group 2. Compared to the baseline level, peritoneal albumin loss in 24-hour dialysate effluent and 4-hour D/P creatinine were significantly increased in Group 2 but were not significantly changed in Group 1. A covariance analysis between the groups revealed a significant difference only in the decreased amount of total protein loss in 24-hour dialysate. Proteinuria was decreased significantly in Group 1. CONCLUSION: This study suggests that angiotensin-converting enzyme inhibitors reduce peritoneal protein loss and small-solute transport and effectively protect peritoneal membrane transport in peritoneal dialysis patients.

  10. Intraperitoneal pseudocyst formation: Complication of fungal peritonitis in continuous ambulatory peritoneal dialysis

    Science.gov (United States)

    Sahpazova, E; Ruso, B; Kuzmanovska, D

    2007-01-01

    A 14-year-old girl, with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD) the last 4 years, after an episode of Candida albicans was switched to hemodialysis. One month later she came back because of a palpable painful abdominal mass and abdominal distention. Computed tomography (CT) and ultrasound examination demonstrated a demarkated fluid collection in the lower abdomen and pelvis. The cyst was drained percutaneously and the culture disclosed candida albicans which was treated with fluconasole. Two months later, the girl was admitted again with the same symptoms. An investigative laparotomy was undergone and the cyst was drained again. Fluid cultures were negative. CT abdomen examination six months later was negative for cyst relapse. In conclusion, intraperitoneal pseudocyst is a serious complication of CAPD. Surgical intervention may be preferable to percutaneous drainage. PMID:19582199

  11. Intraperitoneal pseudocyst formation: complication of fungal peritonitis in continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Sahpazova, E; Ruso, B; Kuzmanovska, D

    2007-10-01

    A 14-year-old girl, with end-stage renal disease on continuous ambulatory peritoneal dialysis (CAPD) the last 4 years, after an episode of Candida albicans was switched to hemodialysis. One month later she came back because of a palpable-painful abdominal mass and abdominal distention. Computed tomography (CT) and ultrasound examination demonstrated a demarkated fluid collection in the lower abdomen and pelvis. The cyst was drained percutaneously and the culture disclosed candida albicans which was treated with fluconasole. Two months later, the girl was admitted again with the same symptoms. An investigative laparotomy was undergone and the cyst was drained again. Fluid cultures were negative. CT abdomen examination six months later was negative for cyst relapse. In conclusion, intraperitoneal pseudocyst is a serious complication of CAPD. Surgical intervention may be preferable to percutaneous drainage.

  12. Factors influencing skin autofluorescence of patients with peritoneal dialysis.

    Science.gov (United States)

    Mácsai, Emília; Benke, A; Cseh, A; Vásárhelyi, B

    2012-06-01

    Skin autofluorescence (SAF) measurement is a simple, noninvasive method to assess tissue advanced glycation end products (AGE). In patients with end-stage renal disease and in those on hemodialysis AGE production is increased. Less is known about those treated with peritoneal dialysis (PD). In this study we tested if SAF is influenced by clinical and treatment characteristics in PD patients.This cross-sectional study included 198 PD patients (of those, 128 were on traditional glucose-based solutions and 70 patients were partially switched to icodextrin-based PD). SAF measurements were done with a specific AGE Reader device. The impact of patients' age, gender, current diabetes, duration of PD, cumulative glucose exposure, body mass index, smoking habits and use of icodextrin on SAF values were tested with multiple regression analysis.Our analysis revealed that patients' age, current diabetes and icodextrin use significantly increase patients' SAF values (p = 0.015, 0.012, 0.005, respectively). AGE exposure of PD patients with diabetes and on icodextrin solution is increased. Further investigation is required whether this finding is due to the icodextrin itself or for a still unspecified clinical characteristic of PD population treated with icodextrin.

  13. Factors influencing skin autofluorescence of patients with peritoneal dialysis.

    Science.gov (United States)

    Mácsai, Emília; Benke, A; Cseh, A; Vásárhelyi, B

    2012-06-01

    Skin autofluorescence (SAF) measurement is a simple, noninvasive method to assess tissue advanced glycation end products (AGE). In patients with end-stage renal disease and in those on hemodialysis AGE production is increased. Less is known about those treated with peritoneal dialysis (PD). In this study we tested if SAF is influenced by clinical and treatment characteristics in PD patients.This cross-sectional study included 198 PD patients (of those, 128 were on traditional glucose-based solutions and 70 patients were partially switched to icodextrin-based PD). SAF measurements were done with a specific AGE Reader device. The impact of patients' age, gender, current diabetes, duration of PD, cumulative glucose exposure, body mass index, smoking habits and use of icodextrin on SAF values were tested with multiple regression analysis.Our analysis revealed that patients' age, current diabetes and icodextrin use significantly increase patients' SAF values (p = 0.015, 0.012, 0.005, respectively). AGE exposure of PD patients with diabetes and on icodextrin solution is increased. Further investigation is required whether this finding is due to the icodextrin itself or for a still unspecified clinical characteristic of PD population treated with icodextrin. PMID:22849846

  14. Heart rhythm complexity impairment in patients undergoing peritoneal dialysis

    Science.gov (United States)

    Lin, Yen-Hung; Lin, Chen; Ho, Yi-Heng; Wu, Vin-Cent; Lo, Men-Tzung; Hung, Kuan-Yu; Liu, Li-Yu Daisy; Lin, Lian-Yu; Huang, Jenq-Wen; Peng, Chung-Kang

    2016-06-01

    Cardiovascular disease is one of the leading causes of death in patients with advanced renal disease. The objective of this study was to investigate impairments in heart rhythm complexity in patients with end-stage renal disease. We prospectively analyzed 65 patients undergoing peritoneal dialysis (PD) without prior cardiovascular disease and 72 individuals with normal renal function as the control group. Heart rhythm analysis including complexity analysis by including detrended fractal analysis (DFA) and multiscale entropy (MSE) were performed. In linear analysis, the PD patients had a significantly lower standard deviation of normal RR intervals (SDRR) and percentage of absolute differences in normal RR intervals greater than 20 ms (pNN20). Of the nonlinear analysis indicators, scale 5, area under the MSE curve for scale 1 to 5 (area 1–5) and 6 to 20 (area 6–20) were significantly lower than those in the control group. In DFA anaylsis, both DFA α1 and DFA α2 were comparable in both groups. In receiver operating characteristic curve analysis, scale 5 had the greatest discriminatory power for two groups. In both net reclassification improvement model and integrated discrimination improvement models, MSE parameters significantly improved the discriminatory power of SDRR, pNN20, and pNN50. In conclusion, PD patients had worse cardiac complexity parameters. MSE parameters are useful to discriminate PD patients from patients with normal renal function.

  15. Health literacy affects peritoneal dialysis performance and outcomes.

    Science.gov (United States)

    Kleinpeter, Myra A

    2003-01-01

    Health literacy (HL) is the ability to perform the basic reading, writing, and numerical skills required to function in a health care setting. Patients with adequate HL are able to read, interpret, and respond to health care information provided by health care providers and health plans. Several means of assessing HL are available for English- and Spanish-speaking patients. A review of the English-language literature on HL indicated that no prior studies included a subset of peritoneal dialysis (PD) patients. I administered the Rapid Estimate of Adult Literacy in Medicine (REALM) assessment tool to PD patients. I also asked patients for information about their highest education level completed. Following completion of the REALM, patients were classified as having adequate, marginal, or inadequate HL. As other studies have shown, patients with lower levels of education have inadequate HL. Patients with some college education or higher have adequate HL. However, at the average education level of patients, most patients have marginal HL. Relative lack of HL affects a patient's ability to make decisions regarding care as part of a home self-management program for end-stage renal disease (ESRD) and other chronic illnesses. Consequently, relative HL level affects the method of instruction and the time required for instruction during training of PD patients.

  16. Correlation between dialysis solution type and cardiovascular morbidity rate in patients undergoing continuous ambulatory peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Stanković-Popović Verica

    2008-01-01

    Full Text Available Background/Aim. Peritoneal dialysis (PD patients have an increased risk for cardiovascular diseases. The aim of the study was to evaluate the cardiovascular changes in patients undergoing chronic PD and the eventual existing differences depending on biocompatibility of dialysis solutions. Methods. After 3±2 years of starting PD, 21 PD patients on the treatment with bioincompatible dialysis solutions (conventional glucose- based solutions: PDP-1, average age 47.43±12.87 years, and 21 PD patients on the treatment with biocompatible dialysis solutions (neutral solutions with lower level of glucose degradation products, lower concentration of Ca2+ and neutral pH: PDP-2, average age 68.62±13.98 years, participated in the longitudinal study. The average number of episodes of peritonitis was similare in both groups: 1 episode per 36 months of the treatment. The control group included 21 patients with preterminal phase of chronic renal failure (Glomerular Filtration Rate: 22.19±10.73 ml/min, average age 65.29± 13.74 years. All the patients underwent transthoracal echocardiography (in order to detect: eject fraction (EF, left ventricular hypertrophy (LVH, and valvular calcification (VC and B-mode ultrasonography of common carotid artery (CCA: IMT, lumen narrowing, and plaque detection. Results. The values of EF were: in PDP-1 group 62.05±5.65%, in PDP-2 group 53.43±7.47%, and in the control group 56.71±8.12% (Bonferroni test, p = 0.001. The recorded LVH was: in PDP-1 group in 47.6% of the patients; in PDP-2 group in 61.9% of the patients; and in control the group in 52.4% (χ2 test; p = 0.639. The detected VC was: in PDP-1 in 52.4% of the patients, in PDP-2 group in 42.9% of the patients, and in the control group in 23.8% of the patients (χ2 test; p = 0.776. The IMT was: in PDP-1 group 1.26±0.54 mm, in PDP-2 group 1.23±0.32, and in the control group 1.25±0.27 mm (Bonferroni test; p = 0.981. An average lumen narrowing was: in PDP-1 group 13

  17. Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model

    OpenAIRE

    Ichiro Hirahara; Hideki Sato; Toshimi Imai; Akira Onishi; Yoshiyuki Morishita; Shigeaki Muto; Eiji Kusano; Daisuke Nagata

    2015-01-01

    Peritoneal dialysis (PD) is a common treatment for patients with reduced or absent renal function. Long-term PD leads to peritoneal injury with structural changes and functional decline. At worst, peritoneal injury leads to encapsulating peritoneal sclerosis (EPS), which is a serious complication of PD. In order to carry out PD safely, it is important to define the mechanism of progression of peritoneal injury and EPS. We prepared rat models of peritoneal injury by intraperitoneal administrat...

  18. Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    Faezeh Hamidi; Jalal Etemadi; Nader Ghabouli Mehrabani; Mahmoud Mahami Oskouei; Roza Motavalli; Mohammad RezaArdalan

    2015-01-01

    Objective: To compare the seropositivity of Toxoplasma gondii in a group of peritoneal dialysis patients with hemodialysis patients and a general local population as a control group in Tabriz, Northwest Iran. Methods: A total of 176 individuals were participated in the present study. Among them, 42 were peritoneal dialysis patients, 84 were hemodialysis patients and 50 were healthy volunteers. Anti-Toxoplasma immunoglobulin G and immunoglobulin M serologic study was administered on the collected serums and then the obtained data were analyzed using statistical methods. Results: In the present research, 70.2% of hemodialysis patients, 66.6% of peritoneal dialysis patients and 68% of control group had positive results for anti-Toxoplasma immunoglobulin G antibody. All individuals of the groups had negative serologic results for anti-Toxoplasma immunoglobulin M antibody. There was no significant difference between Toxoplasma gondii seropositivity in hemodialysis patients and peritoneal dialysis patients and general population (P> 0.05). Conclusions: The findings showed that either peritoneal dialysis or hemodialysis doesn’t increase the risk of Toxoplasma seropositivity in our region (Northwest Iran). It could be explained by the fact that the present research is carried out in a high seroprevalent area scale in which the majority of normal population had previous exposure to this parasitical infection.

  19. Comparison of Toxoplasma gondii seropositivity in hemodialysis and peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Faezeh Hamidi

    2015-08-01

    Full Text Available Objective: To compare the seropositivity of Toxoplasma gondii in a group of peritoneal dialysis patients with hemodialysis patients and a general local population as a control group in Tabriz, Northwest Iran. Methods: A total of 176 individuals were participated in the present study. Among them, 42 were peritoneal dialysis patients, 84 were hemodialysis patients and 50 were healthy volunteers. Anti-Toxoplasma immunoglobulin G and immunoglobulin M serologic study was administered on the collected serums and then the obtained data were analyzed using statistical methods. Results: In the present research, 70.2% of hemodialysis patients, 66.6% of peritoneal dialysis patients and 68% of control group had positive results for anti-Toxoplasma immunoglobulin G antibody. All individuals of the groups had negative serologic results for anti-Toxoplasma immunoglobulin M antibody. There was no significant difference between Toxoplasma gondii seropositivity in hemodialysis patients and peritoneal dialysis patients and general population (P > 0.05. Conclusions: The findings showed that either peritoneal dialysis or hemodialysis doesn’t increase the risk of Toxoplasma seropositivity in our region (Northwest Iran. It could be explained by the fact that the present research is carried out in a high seroprevalent area scale in which the majority of normal population had previous exposure to this parasitical infection.

  20. Association Between Blood Cadmium Levels and Mortality in Peritoneal Dialysis.

    Science.gov (United States)

    Lee, Cheng-Chia; Weng, Cheng-Hao; Huang, Wen-Hung; Yen, Tzung-Hai; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Chen, Kuan-Hsing; Hsu, Ching-Wei

    2016-05-01

    The negative impact of environmental exposure of cadmium has been well established in the general population. However, the effect of cadmium exposure in chronic peritoneal dialysis (PD) patients remains uncertain.A total of 306 chronic PD patients were included in this 36-month observational study. Patients were stratified into 3 groups by the tertile of baseline blood cadmium levels (BCLs): high (>0.244 μg/L, n = 101), middle (0.130-0.244 μg/L, n = 102), and low (death were recorded for longitudinal analyses.Patients in the high-BCL group were older, more likely to have diabetes mellitus, had lower levels of serum albumin and lower percentage of lean body mass than patients in the low-BCL group. A multivariate logistic regression analysis revealed that logarithmic transformed BCL was independently associated with a higher risk of low turnover bone disease (odds ratio = 3.8, P = 0.005). At the end of the 36-month follow-up, 66 (21.6%) patients died. Mortality rates increased with higher BCLs (P for trend = 0.005). A Cox multivariate analysis showed that, using the low-BCL group as the reference, the high-BCL group had increased hazard ratios (HR) for all-cause mortality in chronic PD patients after adjusting for related variables (HR = 2.469, 95% confidence interval = 1.078-5.650, P = 0.043).In conclusion, BCL showed significant association with malnutrition and low turnover bone disease in chronic PD patients. Furthermore, BCL is an important determinant of mortality. Our findings suggest that avoiding environmental exposure to cadmium as much as possible is warranted in chronic PD patients. PMID:27175714

  1. Influence of peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients on continuous ambulatory peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    YU Xu-fang; ZHOU Yun-fei; FENG Ling; ZHANG Dong-liang; LIU Wen-hu

    2009-01-01

    Background Extra glucose load in peritoneal dialysis is an important cause of newly-occurred diabetic mellitus, which initiates insulin treatment in some of the dialytic patients.The purpose of this study was to discuss the influence of the peritoneal transfer status on fasting blood glucose in non-diabetic nephropathy patients who are on continuous ambulatory peritoneal dialysis (CAPD).Methods One hundred and forty-five patients with total KT/V per week over 2.0 were recruited, including 60 males and 85 females. Fasting blood glucose (FBG), creatinine, blood urea nitrogen (BUN), blood albumin, blood lipid profile and blood C-reactive protein (CRP) were analyzed at the beginning of the peritoneal dialysis and after 12 months. A peritoneal equilibration test (PET) was carried out at the 3rd month of CAPD, and meantime residual renal function, peritoneal solute clearance rate, ultrafiltration volume and urine volume were also evaluated.Results Twenty-one cases were identified as a low transfer group (L), 32 cases as a low average transfer group (LA), 58 cases as a high average transfer group (HA) and 34 cases as a high transfer group (H). At the end of the 12th month, 83 cases had elevated FBG Through stepwise multiple regression analysis we found the FBG level in these patients was positively related to glucose load and CRP, and negatively related to glucose absorption in the peritoneum (D/D_0) and blood albumin (P<0.05). Kaplan-Meier analysis during a 48-month follow-up found the morbidity of hyperglycemia to be 17/34 cases (50.1%) in the high transfer group, 20/58 cases (34.5%) in the high average transfer group, 11/32 cases (34.3%) in the low average transfer group, and 1/21 cases (5.4%) in the low transfer group.Conclusions Patients with high peritoneal transfer capacity might have the highest morbidity from hyperglycemia among patients with these four different peritoneal transfer status. Glucose load, baseline CRP and FBG level before peritoneal dialysis, and

  2. Influence of peritoneal dialysis solution biocompatibility on long-term survival of patients on continuous ambulatory peritoneal dialysis and the technique itself

    Directory of Open Access Journals (Sweden)

    Stanković-Popović Verica

    2013-01-01

    Full Text Available Background/Aim. Morbidity and mortality of continous ambulatory peritoneal dialysis (CAPD patients is still very high. The aim of the study was to evaluate the effects of peritoneal dialysis (PD solutions (standard vs biocompatible on long-term patients’ and the techique survival. Methods. A total of 42 stable patients on CAPD participated in this crosssectional study. They were prospectively followed-up during the twelve years. Patients with severe anemia (Hb 1 mm; carotid narrowing degree > 50%, presence of carotid plaques in both common carotide, ischaemic heart disease, cerebrovascular event and peripheral vascular disease with or without amputation were independent predictors of overall patient survival. Duration of dialysis was only independent predictor of overall technique survival. Conclusion. Although patients treated with biocompatible solutions showed significantly better survival, the role of biocompatibility of CAPD solutions in patients and technique survival have to be confirmed. Namely, multivariate analysis confirmed that duration of dialysis, serum triglyceride and cardiovascular score significantly predicted overall CAPD patients survival, while only duration of dialysis was found to be independent predictor of overall techique survival.

  3. Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis

    OpenAIRE

    Manuel López-Cabrera

    2014-01-01

    Peritoneal dialysis (PD) is a therapeutic option for the treatment of end-stage renal disease and is based on the use of the peritoneum as a semipermeable membrane for the exchange of toxic solutes and water. Long-term exposure of the peritoneal membrane to hyperosmotic PD fluids causes inflammation, loss of the mesothelial cells monolayer, fibrosis, vasculopathy, and angiogenesis, which may lead to peritoneal functional decline. Peritonitis may further exacerbate the injury of the peritoneal...

  4. Residual renal function and nutritional status in patients on continuous ambulatory peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Jovanović Nataša

    2005-01-01

    Full Text Available Introduction During the last years, an increasing number of patients with end-stage renal failure caused by various underlying diseases, all over the world, is treated by renal replacement therapy. Nutritional status Malnutrition is often found in patients affected by renal failure; it is caused by reduced intake of nutritional substances due to anorexia and dietary restrictions hormonal and metabolic disorders, comorbid conditions and loss of proteins, amino-acids, and vitamins during the dialysis procedure itself. Nutritional status significantly affects the outcome of patients on chronic dialysis treatment. Recent epiodemiological trials have proved that survival on chronic continuous ambulatory peritoneal dialysis program depends more on residual renal function (RRF than on peritoneal clearances of urea and creatinine. Material and methods The aim of the study was to analyze the influence of RRF on common biochemical and anthropometric markers of nutrition in 32 patients with end-stage renal failure with various underlying diseases during the first 6 months on continuous ambulatory peritoneal dialysis (CAPD. The mean residual creatinine clearance was 8,3 ml/min and the mean RRF was 16,24 week in our patients at the beginning of the chronic peritoneal dialysis treatment. Results and conclusion During the follow-up, the RRF slightly decreased, while the nutritional status of patients significantly improved. Gender and age, as well as the leading disease and peritonitis didn't influence the RRF during the first 6 months of CAPD treatment. We found several positive correlations between RRF and laboratory and anthropometric markers of nutrition during the follow-up, proving the positive influence of RRF on nutritional status of patients on chronic peritoneal dialysis.

  5. Influence of Peritoneal Transport Characteristics on Nutritional Status and Clinical Outcome in Chinese Diabetic Nephropathy Patients on Peritoneal Dialysis

    Institute of Scientific and Technical Information of China (English)

    Ji-Chao Guan; Wei Bian; Xiao-Hui Zhang; Zhang-Fei Shou; Jiang-Hua Chen

    2015-01-01

    Background:High peritoneal transport status was previously thought to be a poor prognostic factor in peritoneal dialysis (PD) patients.However,its effect on diabetic nephropathy PD patients is unclear in consideration of the adverse impact of diabetes itself.The purpose of this study was to investigate the influence of peritoneal transport characteristics on nutritional status and clinical outcome in diabetic nephropathy patients on PD.Methods:One hundred and two diabetic nephropathy patients on PD were enrolled in this observational cohort study.According to the initial peritoneal equilibration test result,patients were divided into two groups:Higher transport group (HT,including high and high average transport) and lower transport group (LT,including low and low-average transport).Demographic characteristics,biochemical data,dialysis adequacy,and nutritional status were evaluated.Clinical outcomes were compared.Risk factors for death-censored technique failure and mortality were analyzed.Results:Compared with LT group (n =37),serum albumin was significantly lower and the incidence of malnutrition by subjective global assessment was significantly higher in HT group (n =65) (P < 0.05).Kaplan-Meier analyses showed that death-censored technique failure and mortality were significantly increased in HT group compared with that in LT group.On multivariate Cox analyses,higher peritoneal transport status and lower residual renal function (RRF) were independent predictors of death-censored technique failure when adjusted for serum albumin and total weekly urea clearance (Kt/V).Independent predictors of mortality were advanced age,anemia,hypoalbuminemia,and lower RRF,but not higher peritoneal transport status.Conclusions:Higher peritoneal transport status has an adverse influence on nutrition for diabetic nephropathy patients on PD.Higher peritoneal transport status is a significant independent risk factor for death-censored technique failure,but not for mortality in

  6. Chronic Kidney Disease-Mineral Bone Disorder in the Elderly Peritoneal Dialysis Patient

    DEFF Research Database (Denmark)

    Heaf, James Goya

    2015-01-01

    PURPOSE: The purpose of this paper was to review the literature concerning the treatment of chronic kidney disease-mineral bone disorder (CKD-MBD) in the elderly peritoneal dialysis (PD) patient. ♦ RESULTS: Chronic kidney disease-mineral bone disorder is a major problem in the elderly PD patient......, with its associated increased fracture risk, vascular calcification, and accelerated mortality fracture risk. Peritoneal dialysis, however, bears a lower risk than hemodialysis (HD). The approach to CKD-MBD prophylaxis and treatment in the elderly PD patient is similar to other CKD patients, with some...

  7. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD)

    DEFF Research Database (Denmark)

    Joffe, P; Olsen, F; Heaf, J G;

    1989-01-01

    Aluminum (Al) concentration in serum, urine, and dialysate was estimated in 21 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In 12 of the patients bone Al concentration was measured as well. Mean serum Al level was 32.4 +/- 21.0 micrograms/l. The Al concentrations in the d......Aluminum (Al) concentration in serum, urine, and dialysate was estimated in 21 patients undergoing continuous ambulatory peritoneal dialysis (CAPD). In 12 of the patients bone Al concentration was measured as well. Mean serum Al level was 32.4 +/- 21.0 micrograms/l. The Al concentrations...

  8. Quality of Life in Patients Undergoing Hemodialysis or Peritoneal Dialysis Treatment

    OpenAIRE

    Theofilou, Paraskevi

    2011-01-01

    Background “Does the type of dialysis treatment make a difference to the quality of life (QoL) and mental health of renal patients in Athens?” The study investigated the differences in 84 in-center hemodialysis (HD) and 60 continuous ambulatory peritoneal dialysis (CAPD/PD) patients. Methods Patient-reported assessments included: WHOQOL-BREF inventory of World Health Organization, General Health Questionnaire (GHQ-28) of Goldberg, State-Trait Anxiety Inventory, Center for Epidemiologic Studie...

  9. Dialysate leakage into pericardium in an infant on long-term peritoneal dialysis.

    Science.gov (United States)

    Borzych, Dagmara; Ley, Sebastain; Schaefer, Franz; Billing, Heiko; Ley-Zaporozhan, Julia; Schenk, Jens; Schmitt, Claus Peter

    2008-02-01

    We report on a 2-year-old boy on automated peritoneal dialysis (PD) with a history of multiple hernias and dialysate leaks who developed pericardial effusion. Magnetic resonance imaging (MRI) demonstrated a peritoneo-pericardial fistula. Dialysis had to be discontinued, since head-down tilt reproducibly induced significant hypotension. In PD patients with pericardial effusion a peritoneo-pericardial leak should be considered. PMID:17922293

  10. Continuous ambulatory peritoneal dialysis: three-year experience at one center.

    Science.gov (United States)

    Nolph, K D; Sorkin, M; Rubin, J; Arfania, D; Prowant, B; Fruto, L; Kennedy, D

    1980-05-01

    Three years of clinical experience with continuous ambulatory peritoneal dialysis are summarized. Serum urea nitrogen, creatinine, hematocrit, nerve conduction velocity, calcium, inorganic phosphorus, serum proteins, and electrolytes have been maintained in acceptable ranges. Peritonitis, although reduced in incidence because of solutions in plastic bags and a new adapter, is still a problem. Excessive carbohydrate absorption, obesity, and high serum triglyceride concentrations may be long-term problems in some patients. PMID:7387001

  11. Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis

    Science.gov (United States)

    Chuengsaman, Piyatida

    2016-01-01

    Background. Patients with peritoneal dialysis-related peritonitis usually have different responses to initial antibiotic treatment. This study aimed to explore the patterns of response by using the changes of dialysate white blood cell count on the first five days of the initial antibiotic treatment. Materials and Methods. A retrospective cohort study was conducted. All peritoneal dialysis-related peritonitis episodes from January 2014 to December 2015 were reviewed. We categorized the patterns of antibiotic response into 3 groups: early response, delayed response, and failure group. The changes of dialysate white blood cell count for each pattern were determined by multilevel regression analysis. Results. There were 644 episodes in 455 patients: 378 (58.7%) of early response, 122 (18.9%) of delayed response, and 144 (22.3%) of failure episodes. The patterns of early, delayed, and failure groups were represented by the average rate reduction per day of dialysate WBC of 68.4%, 34.0%, and 14.2%, respectively (p value < 0.001 for all comparisons). Conclusion. Three patterns, which were categorized by types of responses, have variable rates of WBC declining. Clinicians should focus on the delayed response and failure patterns in order to make a decision whether to continue medical therapies or to aggressively remove the peritoneal catheter. PMID:27656294

  12. Dialysate White Blood Cell Change after Initial Antibiotic Treatment Represented the Patterns of Response in Peritoneal Dialysis-Related Peritonitis

    Directory of Open Access Journals (Sweden)

    Pichaya Tantiyavarong

    2016-01-01

    Full Text Available Background. Patients with peritoneal dialysis-related peritonitis usually have different responses to initial antibiotic treatment. This study aimed to explore the patterns of response by using the changes of dialysate white blood cell count on the first five days of the initial antibiotic treatment. Materials and Methods. A retrospective cohort study was conducted. All peritoneal dialysis-related peritonitis episodes from January 2014 to December 2015 were reviewed. We categorized the patterns of antibiotic response into 3 groups: early response, delayed response, and failure group. The changes of dialysate white blood cell count for each pattern were determined by multilevel regression analysis. Results. There were 644 episodes in 455 patients: 378 (58.7% of early response, 122 (18.9% of delayed response, and 144 (22.3% of failure episodes. The patterns of early, delayed, and failure groups were represented by the average rate reduction per day of dialysate WBC of 68.4%, 34.0%, and 14.2%, respectively (p value < 0.001 for all comparisons. Conclusion. Three patterns, which were categorized by types of responses, have variable rates of WBC declining. Clinicians should focus on the delayed response and failure patterns in order to make a decision whether to continue medical therapies or to aggressively remove the peritoneal catheter.

  13. Case Report of Cryptococcus Albidus Peritonitis in a Peritoneal Dialysis Patient and a Review of the Literature.

    Science.gov (United States)

    Ragupathi, Loheetha; Reyna, Maria

    2015-01-01

    Cryptococcus albidus is a saprophytic yeast linked to just 26 reports of human infection in the world literature. Here, we report the first case of C. albidus peritonitis, in a patient with end-stage renal disease and hepatitis C-associated cirrhosis who is on peritoneal dialysis. The patient was treated successfully with a week-long course of amphotericin B. Non-neoformans cryptococcal infections present a clinical challenge, because they are difficult to diagnose and lack established guidelines for treatment. We present a review of the literature on C. albidus infections and their treatment.

  14. In vitro and in vivo models for peritonitis demonstrate unchanged neutrophil migration after exposure to dialysis fluids.

    NARCIS (Netherlands)

    Welten, AG; Zareie, M.; Born, van den J.; Wee, P.M. ter; Schalkwijk, C.G.; Driesprong, BA; Mul, FP; Hordijk, PL; Beelen, R.H.J.; Hekking, LH

    2004-01-01

    BACKGROUND: Recurrent infections in peritoneal dialysis (PD) patients may alter the abdominal wall resulting in an impairment of its dialysis capacity. In this study we investigated both in vitro and in vivo the effects of mesothelial exposure to dialysis fluids on the migration of neutrophils and t

  15. Deciphering the contribution of biofilm to the pathogenesis of peritoneal dialysis infections: characterization and microbial behaviour on dialysis fluids

    OpenAIRE

    Sampaio, J.; Machado, Diana; Gomes, Ana Marta; Machado, Idalina; Santos, Cledir; Lima, Nelson; Carvalho, Maria João; Cabrita, António; Rodrigues, Anabela; Martins, Margarida Isabel Barros Coelho

    2016-01-01

    Infections are major complications in peritoneal dialysis (PD) with a multifactorial etiology that comprises patient, microbial and dialytic factors. This study aimed at investigating the contribution of microbial biofilms on PD catheters to recalcitrant infections and their interplay with PD related-factors. A prospective observational study was performed on 47 patients attending Centro Hospitalar of Porto and Vila Nova de Gaia/Espinho to whom the catheter was removed due to infectious (n = ...

  16. Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats

    Directory of Open Access Journals (Sweden)

    Sibel Koçak Yucel

    2014-12-01

    Full Text Available Background/Aims: Continuous ambulatory peritoneal dialysis (CAPD induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT receptor antagonists have been found to be effective to prevent fibrosis in some nonperitoneal tissues. The aim of this study is to investigate the possible beneficial effect of montelukast, a LT receptor antagonist, on peritoneal membrane exposed to hypertonic peritoneal dialysis in uremic rats. Methods: Of the 48 male, 5/6 nephrectomized Wistar rats 29 remained alive and were included in the study. These studied rats were divided into 3 groups: Group I (n=7 was the control group, Group II (n=8 was treated with 20 ml hypertonic PDF intraperitoneally daily and Group III was treated with montelukast and similar PDF treatment protocol. The morphological and functional changes in the peritoneal membrane as well as cytokine expression were compared between groups. Results: Submesothelial thickness and the severity of the degree of hyaline vasculapathy were more prominent in group III when compared to group I. There were no significant differences between group II and other groups in terms of submesothelial thickness and the severity of the degree of hyaline vasculapathy. Increased expressions of TGF-β and VEGF in parietal peritoneal membrane were found in group II and group III when compared to group I. The amount of TGF-β and VEGF expression were similar in group II and group III. Conclusion: This study suggests that montelukast treatment does not prevent the peritoneal membrane from deleterious effects of hyperosmolar PDF in the uremic environment.

  17. Laparoscopic Placement of Peritoneal Dialysis Catheters in CAPD Patients: Complications and Survival

    Directory of Open Access Journals (Sweden)

    A Roueentan

    2008-06-01

    Full Text Available Background: Laparoscopic techniques for the placement of peritoneal dialysis catheters are becoming increasingly popular. Recently, with the improvements in laparoscopic surgery, various methods for the insertion of peritoneal dialysis catheters have been reported, indicating that the laparoscopic insertion is preferred over the open and percutaneous techniques. The aim of this study was to introduce and assess a simplified laparoscopic method for the insertion of peritoneal dialysis catheters in continuous ambulatory peritoneal dialysis (CAPD patients.Methods: We enrolled 79 consecutive end-stage renal patients (46 men and 33 women with a mean age of 50 years (range: 19-83 years in this study. During the surgery, a 5-mm trocar was placed in the left upper quadrant for the optics and another 5-mm trocar was placed to the left of the umbilicus. Using the second trocar, a tunnel was formed 2 cm left of the umbilical plane for the insertion of a Tenckhoff catheter. Under direct vision, the catheter was advanced into the abdomen. The catheter was tested for patency. Catheters of all subjects were capped for two weeks before dialysis initiation.Results: The mean duration of the operation was 15 minutes. Ten patients died during the follow-up period, all due to other medical problems, and six patients underwent renal transplantation; however, no deaths or complications were observed during surgery. Early onset complications were seen in 12 patients (15.1%. The most frequent late-onset medical and mechanical complications were peritonitis (6.3% and hernia (3.7%. During a follow-up period of four years, removal of the catheter was required in two patients as a result of peritonitis.Conclusion: We obtained a low complication rate and a high catheter survival rate with this laparoscopic insertion of the Tenckhoff catheter. We believe future experience will encourage the use of this safe, simple and quick procedure.

  18. Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Morishita Y

    2011-12-01

    Full Text Available Yoshiyuki Morishita, Minami Watanabe, Ichiro Hirahara, Tetsu Akimoto, Shigeaki Muto, Eiji KusanoDivision of Nephrology, Department of Medicine, Jichi Medical University, Tochigi, JapanPurpose: Peritoneal dialysis (PD is a successful renal replacement therapy; however, long-term PD leads to structural and functional peritoneal damage. Therefore, the monitoring and estimation of peritoneal function are important in PD patients. Oxidative stress has been implicated as one possible mechanism of peritoneal membrane damage. The aim of this study was to evaluate the association between an oxidative stress marker, 8-hydroxydeoxyguanosine (8-OHdG, and peritoneal damage in PD patients.Methods: The authors evaluated 8-OHdG in drained dialysate by enzyme immunoassay to investigate the association between 8-OHdG and solute transport rate estimated by peritoneal equilibration test and matrix metalloproteinase-2 (MMP-2 level in 45 samples from 28 PD patients.Results: The 8-OHdG level was significantly correlated with dialysate:plasma creatine ratio (r = 0.463, P < 0.05 and significantly inversely correlated with D/D0 glucose (where D is the glucose level of peritoneal effluents obtained 4 hours after the injection and D0 is the glucose level obtained immediately after the injection (r = -0.474, P < 0.05. The 8-OHdG level was also significantly correlated with MMP-2 level (r = 0.551, P < 0.05, but it was not correlated with the age of subjects, the duration of PD, or blood pressure.Conclusion: The level of 8-OHdG in drained dialysate may be a useful novel marker of peritoneal damage in PD.Keywords: oxidative stress, solute transport rate, MMP-2, peritoneal equilibration test

  19. Correction of malfunctioning peritoneal dialysis catheter with guidewire and stiffener under fluoroscopic guidance

    Energy Technology Data Exchange (ETDEWEB)

    Lee, Seung Ryong; Baek, Kyong Hee; Jung, Gyoo Sik; Huh, Jin Do; Joh, Young Duk; Rim, Hark [Kosin Medical College, Pusan (Korea, Republic of)

    1997-11-01

    To determine the efficacy of correction of a malfunctioning peritoneal dialysis catheter with guidewire and stiffener under fluoroscopic guidance. Between November 1994 and March 1997, we performed 15 manipulations in 12 patients in whom a dual-cuff, straight Tenckhoff peritoneal dialysis catheter had been implanted due to chronic renal failure. The causes of catheter malfunctioning were inadequate drainage of the dialysate(n=14) and painful dialysis(n=1). Under fluoroscopic guidance, adhesiolysis and repositioning of the malfunctioning catheter were performed with an Amplatz Super Stiff guidewire and the stiffener from a biliary drainage catheter. The results of procedures were categorized as either immediate or durable success, this latter being defined as adequate catheter function for at least one month after the procedure. Immediate success was achieved in 14 of 15 procedures (93%), and durable success in 7 of 15(47%). The mean duration of catheter function was 157 (range, 30 to 578) days. After manipulation, abdominal pain developed in eight patients and peritonitis in two, but with conservative treatment, these symptoms improved. The correction of a malfunctioning peritoneal dialysis catheter with guidewire and stiffener under fluoroscopic guidance is an effective means of restoring catheter function and may be an effective alternative to surgical reimplantation of the catheter, or hemodialysis.

  20. Association between endothelial dysfunction and arterial stiffness in continuous ambulatory peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    顾玥

    2014-01-01

    Objective To investigate the association between endothelial dysfunction and arterial stiffness in continuous ambulatory peritoneal dialysis(CAPD)patients.Methods Ninety-four stable CAPD patients from a single center were enrolled in this cross-sectional study.Ultrasound evaluation was conducted on brachial artery to estimate endothelial-dependent

  1. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

    DEFF Research Database (Denmark)

    Evenepoel, Pieter; Selgas, Rafael; Caputo, Flavia;

    2009-01-01

    BACKGROUND: Inadequate phosphorus control is associated with increased morbidity and mortality in patients with CKD stage 5. Although phosphate binders are often used in patients on peritoneal dialysis (PD), no large randomized controlled studies evaluating their use solely in this population have...

  2. Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.

    NARCIS (Netherlands)

    Weiss, L.; Stegmayr, B.; Malmsten, G.; Tejde, M.; Hadimeri, H.; Siegert, C.E.; Ahlmen, J.; Larsson, R.; Ingman, B.; Simonsen, O.; Hamersvelt, H.W. van; Johansson, A.C.; Hylander, B.; Mayr, M.; Nilsson, P.H.; Andersson, P.O.; Los Rios, T. De

    2009-01-01

    BACKGROUND: Novel peritoneal dialysis solutions are characterized by a minimal content of glucose degradation products and a neutral pH. Many studies have shown the biocompatibility of neutral lactate-buffered solutions; however, until now, the effect of purely bicarbonate-buffered solutions has not

  3. Systemic amyloidosis involving the diaphragm and acute massive hydrothorax during peritoneal dialysis.

    Science.gov (United States)

    Gagnon, R F; Thirlweil, M; Arzoumanian, A; Mehio, A

    2002-06-01

    Hydrothorax secondary to trans-diaphragmatic fluid leakage through a peritoneo-pleural communication is an occasional, potentially serious complication of peritoneal dialysis. The etiology of this condition is not clear, being thought to be due either to congenital or acquired diaphragmatic fenestrations or acquired scarcity of muscle fibers in the tendinous part of the diaphragm which are compounded by increased intra-abdominal pressure during the dwell period of peritoneal dialysis. We report a 54-year-old woman who developed irreversible acute renal failure from adjuvant chemotherapy for ovarian cancer previously resected surgically. Three days after the onset of continuous ambulatory peritoneal dialysis, she developed acute respiratory distress associated with a massive right hydrothorax secondary to a peritoneo-pleural communication demonstrated by scintigraphy. At autopsy 2 weeks later, systemic amyloidosis was surprisingly found and histologic examination of the right hemidiaphragm showed the presence of amyloid, among sparse muscle fibers. This is the first case report of a distinct pathological process, i.e. amyloidosis, involving the diaphragm associated with a peritoneo-pleural communication causing massive hydrothorax at the onset of peritoneal dialysis. PMID:12078953

  4. Evaluation of percutaneous radiologic placement of peritoneal dialysis catheters: technical aspects, results, and complications

    Energy Technology Data Exchange (ETDEWEB)

    Hong, Hyun Pyo; Oh, Joo Hyeong; Yoon, Yub; Lee, Tae Won; Ihm, Chun Gyoo [Kyunghee University Hospital, seoul (Korea, Republic of)

    2001-01-01

    To evaluate the technical aspects, results and complications of the percutaneous radiologic placement of peritoneal dialysis catheters. Between December 1999 and April 2001, 26 peritoneal dialysis catheters were placed percutaneously in 26 consecutive patients by interventional radiologists. The patient group consisted of 16 men and ten women with a mean age of 55 (range, 30-77) years. The results and complications arising were reviewed, and the expected patency of the catheters was determined by means of Kaplan-Meier survival analysis. The technical success rate for catheter placement was 100% (26/26 patients). Severe local bleeding occurred in one patient due to by inferior epigastric artery puncture, and was treated by compression and electronic cautery. The duration of catheter implantation ranged from 1 to 510 days and the patency rate was 416{+-}45 days. Catheter malfunction occurred in four patients. In two, this was restored by manipulation in the intervention room, and in one, through the use of urokinase. In three patients, peritonitis occurred. Catheters were removed from four patients due to malfunction (n=2), peritonitis (n=1), and death (n=1). Percutaneous radiologic placement of a peritoneal dialysis catheter is a relatively simple procedure that reduces the complication rate and improves catheter patency.

  5. Acute Hydrothorax Complicating continuous Ambulatory Peritoneal Dialysis: A Case Report and Review of Literature.

    Science.gov (United States)

    Kechrid, M C; Malik, G H; Shaikh, J F; Al-Mohaya, S; Al-Wakeel, J S; El Gamal, H

    1999-01-01

    We describe here hydrothorax that occurred in a patient on continuous ambulatory peritoneal dialysis (CAPD) and highlight the problems of diagnosis and management. A 48 years-old man with history of obstructive uropathy secondary to urolithiasis was stared on CAPD when he reached end-stage renal failure. Two months later, he was admitted with two days history of shortness of breath on exertion and dry cough increasing in supine position. Chest examination was suggestive of right sided pleural effusion confusion confirmed by chest X-ray. Radioisotope Technetium 99m labeled albumin instilled through the peritoneal catheter was detected in the right pleural fluid confirming the peritoneo-pleural leak. The peritoneal dialysis (PD) was discontinued and the patient was switched to hemodialysis. The pleural effusion subsided and has not recurred for the following three years. PMID:18212427

  6. Acute Hydrothorax Complicating continuous Ambulatory Peritoneal Dialysis: A Case Report and Review of Literature

    Directory of Open Access Journals (Sweden)

    Kechrid Mohammad

    1999-01-01

    Full Text Available We describe here hydrothorax that occurred in a patient on continuous ambulatory peritoneal dialysis (CAPD and highlight the problems of diagnosis and management. A 48 years-old man with history of obstructive uropathy secondary to urolithiasis was stared on CAPD when he reached end-stage renal failure. Two months later, he was admitted with two days history of shortness of breath on exertion and dry cough increasing in supine position. Chest examination was suggestive of right sided pleural effusion confusion confirmed by chest X-ray. Radioisotope Technetium 99m labeled albumin instilled through the peritoneal catheter was detected in the right pleural fluid confirming the peritoneo-pleural leak. The peritoneal dialysis (PD was discontinued and the patient was switched to hemodialysis. The pleural effusion subsided and has not recurred for the following three years.

  7. Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?

    Directory of Open Access Journals (Sweden)

    Erkan Dervisoglu

    2011-01-01

    Full Text Available OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V. METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years was administered double doses (20 μg IM in each deltoid muscle of recombinant hepatitis B vaccine at 0, 1, 2, and 6 months. Response to immunization was measured at one to three months after the final dose of vaccine. The subjects were divided into groups according to the level of antibodies to hepatitis B surface antigen (anti-HBs, including non-responders ( 100 IU/L. RESULTS: Among non-responders, weak responders, and good responders, significant differences were found in age (54 ± 12 vs. 56 ± 9 vs. 45¡12 years, respectively; p = 0.049 and recombinant human erythropoietin use (20 vs. 29 vs. 76%, respectively; p = 0.016. No significant differences in weekly total Kt/V (p = 0.704, weekly peritoneal Kt/V (p = 0.064 and residual glomerular filtration rate (p = 0.355 were found across the three groups. CONCLUSIONS: Delivered clearance measured by weekly peritoneal Kt/V and total clearance measured by weekly total Kt/V did not predict the response to hepatitis B virus vaccination in patients on peritoneal dialysis.

  8. Peritoneal dialysis-related peritonitis due to Staphylococcus aureus: a single-center experience over 15 years.

    Directory of Open Access Journals (Sweden)

    Pasqual Barretti

    Full Text Available Peritonitis caused by Staphylococcus aureus is a serious complication of peritoneal dialysis (PD, which is associated with poor outcome and high PD failure rates. We reviewed the records of 62 S. aureus peritonitis episodes that occurred between 1996 and 2010 in the dialysis unit of a single university hospital and evaluated the host and bacterial factors influencing peritonitis outcome. Peritonitis incidence was calculated for three subsequent 5-year periods and compared using a Poisson regression model. The production of biofilm, enzymes, and toxins was evaluated. Oxacillin resistance was evaluated based on minimum inhibitory concentration and presence of the mecA gene. Logistic regression was used for the analysis of demographic, clinical, and microbiological factors influencing peritonitis outcome. Resolution and death rates were compared with 117 contemporary coagulase-negative staphylococcus (CoNS episodes. The incidence of S. aureus peritonitis declined significantly over time from 0.13 in 1996-2000 to 0.04 episodes/patient/year in 2006-2010 (p = 0.03. The oxacillin resistance rate was 11.3%. Toxin and enzyme production was expressive, except for enterotoxin D. Biofilm production was positive in 88.7% of strains. The presence of the mecA gene was associated with a higher frequency of fever and abdominal pain. The logistic regression model showed that diabetes mellitus (p = 0.009 and β-hemolysin production (p = 0.006 were independent predictors of non-resolution of infection. The probability of resolution was higher among patients aged 41 to 60 years than among those >60 years (p = 0.02. A trend to higher death rate was observed for S. aureus episodes (9.7% compared to CoNS episodes (2.5%, (p = 0.08, whereas resolution rates were similar. Despite the decline in incidence, S. aureus peritonitis remains a serious complication of PD that is associated with a high death rate. The outcome of this infection is negatively

  9. Free water transport in children on peritoneal dialysis is higher with more biocompatible dialysis solutions, higher with older age and declines with time.

    NARCIS (Netherlands)

    Raaijmakers, R.; Coester, A.; Smit, W.; Krediet, R.T.; Schroder, C.H.

    2012-01-01

    BACKGROUND: Water transport in peritoneal dialysis occurs through small pores and aquaporins. Free water transport (FWT) occurs through aquaporins only and gives a reflection of peritoneal aquaporin function. In this study, FWT in children was calculated for the first time in different settings. MET

  10. Successful Pregnancy in a 31-Year-Old Peritoneal Dialysis Patient with Bilateral Nephrectomy

    Directory of Open Access Journals (Sweden)

    Ahmed Abu-Zaid

    2013-01-01

    Full Text Available Frequency of pregnancy among childbearing age women with end-stage renal disease (ESRD undergoing long-term periodic dialysis ranges from 1% to 7%. Although pregnancy in dialysis women with ESRD is considered a largely high-risk pregnancy, occurrence of successful pregnancy is not impossible with success rates approaching 70%. Rates of successful pregnancy are greatly impacted by early pregnancy diagnosis and preserved residual renal functions. Herein, to the best of our knowledge, we report the first case of successful pregnancy (despite late diagnosis at 14 weeks of gestation in a 31-year-old peritoneal dialysis patient with bilateral nephrectomy and no whatsoever preserved residual renal function. Moreover, a literature review on pregnancy in dialysis patients is presented.

  11. How are families taught to look after their children on peritoneal dialysis?

    Directory of Open Access Journals (Sweden)

    Reem S Alhameedi

    2016-01-01

    Full Text Available For patients to be started on peritoneal dialysis (PD, they need to be trained on how to perform dialysis at home. Understanding how to carry out dialysis is difficult for adults, but perhaps even more challenging for parents of children. This study was performed to examine the PD teaching programs for parents of children with end-stage renal disease (ESRD and to explore the issues related to educating parents of children with ESRD. A survey method was used to carry out the research through the distribution of self-completed questionnaires to pediatric dialysis units (ten units in Saudi Arabia in both governmental and non-governmental hospitals. The questionnaire content was identified using information gained from other research performed in the field of home PD training. The questionnaire was piloted with experienced renal nurses. Questionnaires were distributed to 87 specialized nurses within the ten PD units. Descriptive statistical analysis SPSS (19.00 was used to analyze the data. Statistical tests were used to distinguish the relationship and the significant effects between variables. The response rate was 72% (n = 63. Peritonitis rates varied in each hospital, and ranged from zero to three episodes per patient-year (median 1.17 episodes per patient-year. There was a significant association between home visits and peritonitis rates (P <0.01. This study has provided an initial overview of pediatric PD training programs in Saudi Arabia and has provided valuable data in this regard.

  12. Peritoneal dialysis solutions low in glucose degradation products: clinical experience and outcomes.

    Science.gov (United States)

    Diaz-Buxo, Jose A

    2007-01-01

    The latest literature describing clinical experiences with peritoneal dialysis solutions low in glucose degradation products (GDPs) is mostly consistent with previous reports suggesting less inflammation, better peritoneal mesothelial mass preservation, a lower rate of decline of residual renal function, and improved patient survival. The data suggest stable peritoneal transport rates, but no definite evidence has yet emerged of superior membrane preservation. Most studies have reported very low peritonitis rates, but without significant differences as compared with rates in patients exposed to conventional solutions. New, appropriately powered randomized clinical trials are needed to confirm the potential benefits of low-GDP solutions and to establish the role of renal function preservation with regard to those benefits.

  13. Relative survival of peritoneal dialysis and haemodialysis patients

    DEFF Research Database (Denmark)

    Heaf, James G; Wehberg, Sonja

    2014-01-01

    INTRODUCTION: Epidemiological studies consistently show an initial survival advantage for PD patients compared to HD. It has recently been suggested that this is due to the fact that many HD patients are referred late, and start dialysis on an acute, in-patient basis. The present study was perfor...

  14. Palliative care for patients with malignancy and end-stage renal failure on peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Lv Jing

    2014-01-01

    Full Text Available Background: Many patients on peritoneal dialysis experience a poor quality of life because of a high burden of comorbid conditions. Dialysists must pay more attention to reducing a patient′s pain and suffering, both physical and psychological and improve the quality of life for the patients as much as possible. A consensus regarding eligibility for palliative care and the delivery of these inventions does not currently exist. Objective: The present study aimed to describe the implementation of palliative care for end-stage renal failure patients on peritoneal dialysis. Design: A report on three cases. Materials and Methods: This study included three outpatients on peritoneal dialysis who received palliative care and died between January 2008 and June 2010. Measurements: The patients′ comorbidities, nutritional status, and functional status were evaluated using the Charlson comorbidity score, subjective global assessment, and Karnofsky Performance Score index, respectively. The Hamilton depression and Hamilton anxiety scales were also employed. The patients′ clinical manifestations and treatments were reviewed. Results: Each patient displayed 11-16 symptoms. The Charlson comorbidity scores were from 11 to 13, the subjective global assessment indicated that two patients were class assigned to "C" and one to class "B", and the mean Karnofsky index was <40. Among these patients, all experienced depression and two experienced anxiety, Low doses of hypertonic glucose solutions, skin care, psychological services, and tranquillizers were intermittently used to alleviate symptoms, after making the decision to terminate dialysis. The patients died 5 days to 2 months after dialysis withdrawal. Conclusion: The considerable burden associated with comorbid conditions, malnutrition, poor functional status, and serious psychological problems are predictors of poor patient prognoses. Withdrawal of dialysis, palliative care, and psychological interventions

  15. Recompensation of heart and kidney function after treatment with peritoneal dialysis in a case of congestive heart failure.

    Science.gov (United States)

    Kihm, Lars P; Hankel, Vinzent; Zugck, Christian; Remppis, Andrew; Schwenger, Vedat

    2011-01-01

    We report the case of a 57-year-old woman suffering from congestive heart failure. Due to refractory congestions despite optimised medical treatment, the patient was listed for heart transplantation and peritoneal dialysis was initiated. Peritoneal dialysis led to a significant weight loss, reduction of hyperhydration and extracellular water obtained by bioimpedance measurement, and a significant improvement in clinical and echocardiographic examination. Furthermore, residual kidney function increased during the long-term followup, and subsequently peritoneal dialysis was ceased. Pulmonary artery pressure and left ventricular ejection fraction remained stable and the patient did well. This case demonstrates the possibility of treating hyperhydration due to congestive heart failure with peritoneal dialysis resulting in recompensation of both heart and kidney functions. PMID:22162698

  16. Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure

    Directory of Open Access Journals (Sweden)

    Lars P. Kihm

    2011-01-01

    Full Text Available We report the case of a 57-year-old woman suffering from congestive heart failure. Due to refractory congestions despite optimised medical treatment, the patient was listed for heart transplantation and peritoneal dialysis was initiated. Peritoneal dialysis led to a significant weight loss, reduction of hyperhydration and extracellular water obtained by bioimpedance measurement, and a significant improvement in clinical and echocardiographic examination. Furthermore, residual kidney function increased during the long-term followup, and subsequently peritoneal dialysis was ceased. Pulmonary artery pressure and left ventricular ejection fraction remained stable and the patient did well. This case demonstrates the possibility of treating hyperhydration due to congestive heart failure with peritoneal dialysis resulting in recompensation of both heart and kidney functions.

  17. Animal Models of Peritoneal Dialysis: Thirty Years of Our Own Experience

    Directory of Open Access Journals (Sweden)

    Krzysztof Pawlaczyk

    2015-01-01

    Full Text Available Experimental animal models improve our understanding of technical problems in peritoneal dialysis PD, and such studies contribute to solving crucial clinical problems. We established an acute and chronic PD model in nonuremic and uremic rats. We observed that kinetics of PD in rats change as the animals are aging, and this effect is due not only to an increasing peritoneal surface area, but also to changes in the permeability of the peritoneum. Changes of the peritoneal permeability seen during chronic PD in rats are comparable to results obtained in humans treated with PD. Effluent dialysate can be drained repeatedly to measure concentration of various bioactive molecules and to correlate the results with the peritoneal permeability. Additionally we can study in in vitro conditions properties of the effluent dialysate on cultured peritoneal mesothelial cells or fibroblasts. We can evaluate acute and chronic effect of various additives to the dialysis fluid on function and permeability of the peritoneum. Results from such study are even more relevant to the clinical scenario when experiments are performed in uremic rats. Our experimental animal PD model not only helps to understand the pathophysiology of PD but also can be used for testing biocompatibility of new PD fluids.

  18. Recompensation of Heart and Kidney Function after Treatment with Peritoneal Dialysis in a Case of Congestive Heart Failure

    OpenAIRE

    Andrew Remppis; Christian Zugck; Vinzent Hankel; Kihm, Lars P; Vedat Schwenger

    2011-01-01

    We report the case of a 57-year-old woman suffering from congestive heart failure. Due to refractory congestions despite optimised medical treatment, the patient was listed for heart transplantation and peritoneal dialysis was initiated. Peritoneal dialysis led to a significant weight loss, reduction of hyperhydration and extracellular water obtained by bioimpedance measurement, and a significant improvement in clinical and echocardiographic examination. Furthermore, residual kidney function ...

  19. Comparison of the Effects of Dialysis Methods (Haemodialysis vs Peritoneal Dialysis) on Diastolic Left Ventricular Function Dialysis Methods and Diastolic Function

    Science.gov (United States)

    Ellouali, Fedoua; Berkchi, Fatimazahra; Bayahia, Rabia; Benamar, Loubna; Cherti, Mohammed

    2016-01-01

    Introduction: In patients undergoing chronic dialysis, several factors appear to influence the occurrence of cardiac abnormalities. The aim of our study was to evaluate the effects of two different methods of renal replacement therapy (chronic haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD)) on left ventricular (LV) diastolic function. Patients and Methods: We enrolled 63 patients: 21 patients on CAPD, and 42 age- and gender-matched patients on HD; 35 patients were men (55.6%). Median of age was 46.4 (35-57) years. The median duration of renal replacement therapy was 3(2-5) years. Results: The two groups (HD vs PD) were similar concerning body mass index, dialysis duration and cardiovascular risk factors. The comparison of echocardiographic parameters showed statistically significant differences between two groups, regarding the presence of calcification, cardiac effusion, severely abnormal left ventricular hypertrophy(LVH) and the ratio of mitral velocity to early diastolic velocity of the mitral annulus (E/e’) >13 (p= 0.001, p= 0.003, p= 0.02, p= 0.004, respectively). In multivariate analysis, an E/e’>13 was higher in PD group ( OR= 5.8, CI [1.3-25.5], p=0.002). Conclusion: The method of dialysis seems to influence LV diastolic function. We observed a higher prevalence of diastolic LV dysfunction in the PD group. Echocardiographic follow up is essential as this could improve the management of cardiovascular complications in dialysis patients. PMID:27583042

  20. New mathematical model for fluid-glucose-albumin transport in peritoneal dialysis

    CERN Document Server

    Cherniha, Roman

    2011-01-01

    A mathematical model for fluid transport in peritoneal dialysis is constructed. The model is based on a three-component nonlinear system of two-dimensional partial differential equations for fluid, glucose and albumin transport with the relevant boundary and initial conditions. Non-constant steady-state solutions of the model are studied. The restrictions on the parameters arising in the model are established with the aim to obtain exact formulae for the non-constant steady-state solutions. As the result, the exact formulae for the fluid fluxes from blood to tissue and across the tissue were constructed together with two linear autonomous ODEs for glucose and albumin concentrations. The analytical results were checked for their applicability for the description of fluid-glucose-albumin transport during peritoneal dialysis.

  1. Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients

    OpenAIRE

    Lee, Mi Jung; Han, Seung Hyeok; Lee, Jung Eun; Choi, Hoon Young; Yoon, Chang-Yun; Kim, Eun Jin; Han, Jae Hyun; Han, Ji Suk; Oh, Hyung Jung; Park, Jung Tak; Kang, Shin-Wook; Yoo, Tae-Hyun

    2014-01-01

    Abstract Endothelial dysfunction is implicated in increased cardiovascular risk in nondialyzed population. However, the prognostic impact of endothelial dysfunction on cardiovascular outcome has not been investigated in peritoneal dialysis (PD) patients. We prospectively determined endothelial function by brachial artery endothelium-dependent vasodilation (flow-mediated dilation [FMD]) in 143 nondiabetic PD patients and 32 controls. Primary outcome was a major adverse cardiac and cerebrovascu...

  2. Evaluation of hepatitis B vaccine responsiveness in hemodialysis and peritoneal dialysis patients

    OpenAIRE

    Salama Elsayed Farag; Tarek A Ghonemy; Sameh A. Soliman; Ahmed Bihery

    2015-01-01

    Background: Hepatitis B Virus (HBV) infection is considered as a major cause of liver cirrhosis and hepatocellular carcinoma. Patients with End Stage Renal Disease (ESRD) are a risk group for HBV infection. The vaccine of hepatitis B has been recommended for prevention of HBV infection in ESRD patient especially on renal replacement therapy. Methods: Eighty seven patients with ESRD on peritoneal dialysis and hemodialysis requiring primary hepatitis B vaccination were enrolled in the stud...

  3. Psychosocial aspects of children and families of children treated with automated peritoneal dialysis

    OpenAIRE

    Kiliś-Pstrusińska, Katarzyna; Wasilewska, Anna; Medyńska, Anna; Bałasz-Chmielewska, Irena; Grenda, Ryszard; Kluska-Jóźwiak, Agnieszka; Leszczyńska, Beata; Olszak-Szot, Ilona; Miklaszewska, Monika; Szczepańska, Maria; Tkaczyk, Marcin; Urzykowska, Agnieszka; Zachwieja, Katarzyna; Zajączkowska, Maria; Ziółkowska, Helena

    2013-01-01

    Background The aim of this study was to analyze psychosocial aspects of chronic kidney disease (CKD) in children treated with automated peritoneal dialysis (APD). Methods The study assessed 41 children > 2  (range 2.1–18) years of age and their parents. Data concerning the illness and sociodemographic parameters were collected. Patients completed the Paediatric Quality of Life Inventory (PedsQL) and their parents the PedsQL-proxy version, General Health Questionnaire (GHQ-12), Berlin Social S...

  4. Gastrointestinal symptoms in patients undergoing peritoneal dialysis: Multivariate analysis of correlated factors

    Institute of Scientific and Technical Information of China (English)

    2010-01-01

    AIM: To investigate gastrointestinal (GI) symptoms in peritoneal dialysis (PD) patients and to explore related factors contributing to GI symptoms. METHODS: One hundred and twelve patients undergoing PD participated in the study. The gastrointestinal symptom rating scale was used for measuring GI symptoms. Information on age, height, weight, body mass index, disease leading to chronic renal failure, history of corticosteroid therapy, presence of predialytic GI symptoms, daily dosage of pills, and duration, ...

  5. Acute Hydrothorax Complicating continuous Ambulatory Peritoneal Dialysis: A Case Report and Review of Literature

    OpenAIRE

    Kechrid Mohammad; Malik Ghulam; Shaikh Jamil; Al-Mohaya Suleiman; Al-Wakeel Jamal; El Gamal Hazem

    1999-01-01

    We describe here hydrothorax that occurred in a patient on continuous ambulatory peritoneal dialysis (CAPD) and highlight the problems of diagnosis and management. A 48 years-old man with history of obstructive uropathy secondary to urolithiasis was stared on CAPD when he reached end-stage renal failure. Two months later, he was admitted with two days history of shortness of breath on exertion and dry cough increasing in supine position. Chest examination was suggestive of right sided pleural...

  6. Rationale and design of the balANZ trial: A randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function

    Directory of Open Access Journals (Sweden)

    Clarke Margaret

    2010-09-01

    Full Text Available Abstract Background The main hypothesis of this study is that neutral pH, low glucose degradation product (GDP peritoneal dialysis (PD fluid better preserves residual renal function in PD patients over time compared with conventional dialysate. Methods/Design Inclusion criteria are adult PD patients (CAPD or APD aged 18-81 years whose first dialysis was within 90 days prior to or following enrolment and who have a residual GFR ≥ 5 ml/min/1.73 m2, a urine output ≥ 400 ml/day and an ability to understand the nature and requirements of this trial. Pregnant or lactating patients or individuals with an active infection at the time of enrolment, a contra-indication to PD or participation in any other clinical trial where an intervention is designed to moderate rate of change of residual renal function are excluded. Patients will be randomized 1:1 to receive either neutral pH, low GDP dialysis solution (Balance® or conventional dialysis solution (Stay.safe® for a period of 2 years. During this 2 year study period, urinary urea and clearance measurements will be performed at 0, 3, 6, 9, 12, 18 and 24 months. The primary outcome measure will be the slope of residual renal function decline, adjusted for centre and presence of diabetic nephropathy. Secondary outcome measures will include time from initiation of peritoneal dialysis to anuria, peritoneal small solute clearance, peritoneal transport status, peritoneal ultrafiltration, technique survival, patient survival, peritonitis rates and adverse events. A total of 185 patients has been recruited into the trial. Discussion This investigator-initiated study has been designed to provide evidence to help nephrologists determine the optimal dialysis solution for preserving residual renal function in PD patients. Trial Registration Australian New Zealand Clinical Trials Registry Number: ACTRN12606000044527

  7. Patients in assisted automated peritoneal dialysis develop strategies for self-care

    DEFF Research Database (Denmark)

    Holch, Kirsten

    2008-01-01

      Background Since 2000, a model for Assisted Automated Peritoneal Dialysis (aAPD) for patients in their own home needing chronic dialysis treatment has been developed at Aarhus University Hospital, Skejby, Denmark. The patient group consists of physically or mentally frail elderly who cannot...... show that patients in their own home strengthen their self-care capacity in the period between three and six months after starting aAPD treatment. Examples of this are initiatives concerning promotion of appetite, sleep, dressing, social contact and prevention of infection and fall. Conclusion Elderly...... people develop their own strategies for adapting aAPD to the way they have met their needs in their own home. The patients experience the treatment as part of the every day life and show increasing creativity to find solutions to satisfy their needs. Technical assistance concerning dialysis makes...

  8. Acute pancreatitis in peritoneal dialysis: a case report with literature review.

    Science.gov (United States)

    Manga, Farhabanu; Lim, Chung Sim; Mangena, Lendaba; Guest, Michael

    2012-01-01

    Abdominal pain with a discoloured dialysate in a patient on peritoneal dialysis (PD) is usually attributed to infective peritonitis. Although acute pancreatitis (AP) is not usually a complication of end-stage renal disease, some studies suggest an increased risk especially in patients on PD. We report a case of idiopathic AP in a 41-year-old female on PD who presented with abdominal pain, fever, vomiting and a clear dark dialysate. Initial diagnosis of PD-associated infective peritonitis was made but dialysate cultures proved negative. Serum amylase showed a mild rise and computed tomography revealed necrotising pancreatitis. No common risk factors for AP were identified and she was successfully treated with conservative therapy. A literature review was carried out using a PubMed search with the words 'acute pancreatitis and peritoneal dialysis'. The literature search found a total of 94 cases of AP in the setting of PD. In more than a quarter, no cause for AP was found. Serum amylase was normal in 12.8% of episodes. Complications developed in 25 cases, and 28 patients died from the condition. Therefore, AP can be a rare, but serious complication of PD with a high mortality and must be considered in the differential diagnosis of abdominal pain in a PD patient.

  9. RISK OF DEMENTIA IN PERITONEAL DIALYSIS PATIENTS COMPARED WITH HEMODIALYSIS PATIENTS

    Science.gov (United States)

    Wolfgram, Dawn F.; Szabo, Aniko; Murray, Anne M.; Whittle, Jeff

    2016-01-01

    Background Compared with similarly aged controls, patients with end-stage renal disease (ESRD) have a higher prevalence of cognitive impairment and more rapid cognitive decline, which is not explained by traditional risk factors alone. Since previous small studies suggest an association of cognitive impairment with dialysis modality, we compared incident dementia among patients initiating hemodialysis (HD) versus peritoneal dialysis (PD) in a large national cohort. Methods This is a retrospective cohort study of incident dialysis patients in the United States from 2006 to 2008 with no diagnosis of dementia prior to beginning dialysis. We evaluated the effect of initial dialysis modality on incidence of dementia, diagnosed by Medicare claims data, adjusted for baseline demographic and clinical data from USRDS registry. Results Our analysis included 121,623 patients, of whom 8,663 initiated dialysis on PD. The mean age of our cohort was 69.2 years. Patients who initiated on PD had a lower cumulative incidence of dementia than those who initiated HD (1.0% versus 2.7%, 2.5% versus 5.3%, and 3.9% versus 7.3% at 1, 2, and 3 years, respectively). The risk of dementia for patients who started on PD was lower compared with those who started on HD, with a hazard ratio (HR) = 0.46 [0.41, 0.53], in an unadjusted model and HR 0.74 [0.64, 0.86] in a matched model. Conclusions Dialysis modality is associated with incident dementia in a cohort of older ESRD patients. This finding warrants further investigation of the effect of dialysis modality on cognitive function and evaluation for possible mechanisms. PMID:25742686

  10. Preditores de peritonite em pacientes em um programa de diálise peritoneal Predictor factors of peritoneal dialysis-related peritonitis

    Directory of Open Access Journals (Sweden)

    João Victor Duarte Lobo

    2010-06-01

    Full Text Available INTRODUÇÃO: Peritonite é a principal complicação relacionada com a diálise peritoneal (DP. OBJETIVO: Avaliar possíveis preditores para o seu desenvolvimento em pacientes em programa crônico na modalidade. MÉTODO: Realizou-se estudo de coorte retrospectivo em 330 pacientes (média de idade 53 ± 19 anos em programa de DP na Clínica de Nefrologia de Sergipe (Clinese, em Aracaju/ SE, Brasil, entre 1.º de janeiro de 2003 e 31 de dezembro de 2007. Variáveis sociodemográficas e clínicas foram avaliadas comparativamente entre pacientes que apresentaram (141% - 42,7% ou não (189% - 57,3% peritonite. Na análise estatística, utilizaramse teste t de Student, qui-quadrado e modelo de regressão com múltiplas variáveis. RESULTADOS : Ocorreu um episódio de peritoniteacada28,4pacientes/mês(0,42episódio/ paciente/ano. O Staphylococcus aureus foi o agente etiológico mais frequente (27,8%. Não se utilizava antibioticoterapia profilática e 136 pacientes (41,2% haviam apresentado previamente infecção de sítio de saída do cateter peritoneal (ISSCP. Identificou-se maior risco de peritonite nos pacientes com albuminemia INTRODUCTION: Peritonitis remains a major complication of peritoneal dialysis (PD. OBJECTIVE: Evaluate peritonitis incidence, etiology and outcome in cronic PD patients. METHODS: A retrospective cohort study was carried out on 330 patients (mean age of 53 ± 19 years who had been treated by PD in a dialysis center in Aracaju/SE, Brazil between January 1st, 2003 and December 31th, 2007. Data of patients with and without peritonitis were compared using Student's ttest, chi-squared statistic and multiple logistic regression. RESULTS: There were 213 peritonitis among 141 patients (1.51 episode/patient resulting in a rate of 28.44 patient/episode/ month (0.42 patient/episode/year. Staphylococcus aureus was the most frequent micro-organism isolated (27.8%, followed by Escherichia coli (13.4% and 32.5% were culture

  11. Recent Development on Home Peritoneal Dialysis in Hainan Province

    Institute of Scientific and Technical Information of China (English)

    陈裕盛

    2001-01-01

    Objective:In order to experience and contrast incidence rate of intection peritonitis. Exit-site infection,lunnitis, patients re cover one's works,still living survival and withdraw rate from CAPD in particular on home PD of Subtropical Zone of China. Method:134 cases patients PD with CRF were from January 1,1981 to February 1998. We used three kinds of device and dialysate to complete CAPD. 134 patients into three groups according to PD device and form. Group Ⅰ: Non o-set 74 cases. Pat to use bottled dialysate/bag dialysate infusion abdominal cavity made by general emulsion tube/or once emulsion tube for CAPD. Group Ⅱ: 60 cases. Made by the o-set(Baxter H. Itd. USA).Group Ⅲ:45 cases. Made by o-set for on home PD. Result: The occur rate of infection peritonitis in Ⅰ,Ⅱ,Ⅲ Group were one/11.17,94.87 and 121.80 patient months. The infec tion rate of exit-site in Ⅰ,Ⅱ,Ⅲ Group were 18.91%,6.66%,6.66%. The lunnitis incidence rate in Ⅰ,Ⅱ,Ⅲ Group were 8.1%, 3.33%, and 4.44%, respectively. The patients recover one's works in group Ⅰ almost come to nought, group Ⅱ 30% and 45.6% in group Ⅲ. Survival still living: Group Ⅰ 12.83. Group Ⅱ≥23.25. Group Ⅲ≥27 months and among them ≥36 months 7 cases (15.55%).About withdraw:Group Ⅰ average 2%/year. Group Ⅱ and Group Ⅲ 1.4%/year. The death rate of average year in Ⅰ and Ⅱ Group patients were 2.66% lower than of HD death rate 10%. Conclusion: o-set it's indeed a device of develop of PD and home PD, because the o-set able to most limit lower occur rate of intection peritonitis especially fit into home PD subtropical zone area.

  12. Evaluation of stability of 99mTc-HSA complex during clinical peritoneal dialysis in vivo (short communication)

    International Nuclear Information System (INIS)

    For the assessment of the intra-dialysis stability of the 99mTc-HSA complex, a scintigraphic scanning of the organs accumulation of the free 99mTcO4- was carried out during peritoneal dialysis. 740 MBg 99mTc-HSA in dialization fluid was administered during kinetic peritoneal examination of the patient. The organs accumulating the free pertechnetion (head and neck), as well as whole body imaging of pt were carried out. The results show that the radioactivity is accumulated mainly in peritoneal cavity. Minimal radioactivity was indicated in the head and neck (∼2.3% of the total whole body radioactivity). Our results show that the 99mTc-HSA complex is stable during 3.5 h peritoneal dialysis in vivo. (author)

  13. SURVIVAL OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS CATHETERS: AN EVALUATION OF SURGICAL AND NON-SURGICAL FACTORS (SINGLE CENTER STUDY

    Directory of Open Access Journals (Sweden)

    A. Keshvari

    2006-06-01

    Full Text Available Peritoneal dialysis is an established form of renal replacement therapy used in many patients with end-stage renal disease. The key to a successful chronic peritoneal dialysis is a permanent and safe access to the peritoneal cavity. This study was conducted in order to evaluate the catheter survival and its related factors in Imam Khomeini Hospital. A total of 80 catheters were inserted into 69 patients (52 men and 28 women with end-stage chronic renal failure during a period of 84 months. Retrospectively the correlation between catheter survival (overall and event free with demographic factors (sex and age, surgical factors (surgeons and surgical methods, nephrologic factors (the causes of peritoneal dialysis selection and the history of hemodialysis and peritonitis factors (the history and number of peritonitis has been evaluated. The mean age of the patients was 48.35 years (16 to 79 years. The overall survival of catheters or the probability of having a functioning catheter after one, two and three years was 53%, 41%, 22%, respectively. The event free survival of the catheter or the probability of having a functioning catheter without any problems after one year was 14%. It has been found out that among all factors in this study only history of hemodialysis had statistically significant effect on the overall survival of continuous ambulatory peritoneal dialysis catheter (P = 0.04. It seems that the overall survival of catheters is better when CAPD is started before any other attempts for hemodialysis.

  14. A comparison of sleep disturbances and sleep apnea in patients on hemodialysis and chronic peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Hamdan Al-Jahdali

    2011-01-01

    Full Text Available Studies have shown that sleep disorders are common among dialysis patients; however, few studies have compared the prevalence of different sleep disorders in patients on peritoneal dialysis (PD and hemodialysis (HD. We used questionnaires to assess the prevalence of common sleep disorders in dialysis patients. We compared the prevalence of sleep apnea (SA risk, restless legs syndrome (RLS, insomnia, and excessive daytime sleepiness (EDS, as well as sleep quality, in both groups. Of the 227 patients who were enrolled in the study, the total number of patients on HD was 188 (82%, while the total number of patients on PD was 39 (18%. There were no significant differences between the two groups regarding age, neck size, or duration on dialysis (all P >0.05. The estimated overall prevalence of SA was significantly higher in PD patients in comparison with HD patients (92% and 67%, respectively; P <0.05. The prevalence of insomnia was similar in both groups. The prevalence of RLS was significantly greater in PD than in HD patients (69% and 46%, respectively; P <0.05. In addition, EDS was significantly higher in PD than in HD patients (77% and 37%, respectively; P <0.05. Our study shows that sleep disorders are common in dialysis patients; however, SA, EDS, and RLS were more common in PD patients than in HD pa-tients. Poor sleep quality and insomnia were comparable in both groups.

  15. Best Practices Consensus Protocol for Peritoneal Dialysis Catheter Placement by Interventional Radiologists

    Science.gov (United States)

    Abdel-Aal, Ahmed K.; Dybbro, Paul; Hathaway, Peter; Guest, Steven; Neuwirth, Michael; Krishnamurthy, Venkat

    2014-01-01

    Peritoneal dialysis (PD) catheters can be placed by interventional radiologists, an approach that might offer scheduling efficiencies, cost-effectiveness, and a minimally invasive procedure. In the United States, changes in the dialysis reimbursement structure by the Centers for Medicare and Medicaid Services are expected to result in the increased use of PD, a less costly dialysis modality that offers patients the opportunity to receive dialysis in the home setting and to have more independence for travel and work schedules, and that preserves vascular access for future dialysis options. Placement of PD catheters by interventional radiologists might therefore be increasingly requested by nephrology practices, given that recent publications have demonstrated the favorable impact on PD practices of an interventional radiology PD placement capability. Earlier reports of interventional radiology PD catheter placement came from single-center practices with smaller reported experiences. The need for a larger consensus document that attempts to establish best demonstrated practices for radiologists is evident. The radiologists submitting this consensus document represent a combined experience of more than 1000 PD catheter placements. The authors submit these consensus-proposed best demonstrated practices for placement of PD catheters by interventional radiologists under ultrasonographic and fluoroscopic guidance. This technique might allow for expeditious placement of permanent PD catheters in late-referred patients with end-stage renal disease, thus facilitating urgent-start PD and avoiding the need for temporary vascular access catheters. PMID:24584622

  16. Water transport across biological membranes: Overton, water channels, and peritoneal dialysis.

    Science.gov (United States)

    Devuyst, O

    2010-01-01

    Peritoneal dialysis involves diffusive and convective transports and osmosis through the highly vascularized peritoneal membrane. Several lines of evidence have demonstrated that the water channel aquaporin-1 (AQP1) corresponds to the ultrasmall pore predicted by the modelization of peritoneal transport. Proof-of-principle studies have shown that upregulation of the expression of AQP1 in peritoneal capillaries is reflected by increased water permeability and ultrafiltration, without affecting the osmotic gradient and the permeability for small solutes. Inversely, studies in Aqp1 mice have shown that haplo-insufficiency in AQP1 is reflected by significant attenuation of water transport. Recent studies have identified lead compounds that could act as agonists of aquaporins, as well as putative binding sites and potential mechanisms of gating the water channel. By modulating water transport, these pharmacological agents could have clinically relevant effects in targeting specific tissues or disease states. These studies on the peritoneal membrane also provide an experimental framework to investigate the role of water channels in the endothelium and various cell types.

  17. Hemodialysis versus continuous ambulatory peritoneal dialysis: effects on the heart.

    Science.gov (United States)

    Canziani, M E; Cendoroglo Neto, M; Saragoça, M A; Cassiolato, J L; Ramos, O L; Ajzen, H; Draibe, S A

    1995-03-01

    In this study we compared the influence of 2 different modalities of treatment, CAPD and hemodialysis, on the prevalence and severity of left ventricular hypertrophy and cardiac arrhythmias of chronic renal failure patients. We compared 27 patients on the CAPD program with 27 patients on the chronic hemodialysis matched for sex, age, and duration of dialysis treatment. The prevalence of hypertension was significantly lower in CAPD than in hemodialysis patient (41% vs. 81%, p = 0.0023). Blood pressure levels were also lower in CAPD than in hemodialysis patients (systolic pressure 124.9 +/- 4.7 vs. 154.8 +/- 4.6 mm Hg, p < 0.0001; diastolic pressure 77.5 +/- 2.9 vs. 93.3 +/- 2.8 mm Hg, p = 0.0001). Left ventricular hypertrophy (LVH) was present in 52% of CAPD and in 93% of hemodialysis patients (p = 0.0008). Severe cardiac arrhythmias (Lown 3-4) occurred in only 4% of CAPD and in 33% of the hemodialysis group (p = 0.0149). The lower frequency of LVH in CAPD might explain the lower incidence of severe arrhythmias. PMID:7779013

  18. Applications of Procalcitonin in Peritoneal Dialysis Related Peritonitis%降钙素原在腹膜透析相关性腹膜炎中的应用

    Institute of Scientific and Technical Information of China (English)

    朱琳(综述); 解汝娟(审校)

    2015-01-01

    降钙素原是一种炎症标志物,其在多种临床感染性疾病中均显示出高度的特异性及敏感性。鉴于传统的腹膜透析相关性腹膜炎的检测手段均具有一定的局限性,国内外学者开始倾向于将降钙素原纳入腹膜透析相关性腹膜炎的诊断指标,研究表明腹膜透析相关性腹膜炎患者的血清降钙素原水平显著升高。因此,降钙素原可以作为腹膜透析相关性腹膜炎患者在诊断和治疗过程中的重要检测指标,其对腹膜透析相关性腹膜炎的指导意义值得进一步探索。%Procalcitonin has been clearly specified as an infection marker for many clinical diagnosis of bacterial infections with high sensitivity and specificity .In view of some certain limitations on traditional diag-nostic standards of peritoneal dialysis related peritonitis, both domestic and foreign scholars tended to intro-duce procalcitonin as one of peritoneal dialysis related peritonitis indicators .A large number of studies showed that patients suffering from peritoneal dialysis related peritonitis gained significantly higher concentra-tion of serum procalcitonin.Therefore, procalcitonin can be used as an important detection index in the diag-nosis and treatment of peritoneal dialysis related peritonitis,the guiding significance of which deserves further exploration.

  19. An analysis of caregiver burden of patients with hemodialysis and peritoneal dialysis.

    Science.gov (United States)

    Cantekin, Işın; Kavurmacı, Mehtap; Tan, Mehtap

    2016-01-01

    Since caregivers have roles and responsibilities in all phases from the diagnosis of the disease to discharge and homecare, their care burdens increase. The problems experienced by caregivers, whose care burden increase and accordingly whose life quality is deteriorated, complicate the treatment-receiving patient's adaptation to the disease. This study was performed to determine the burden to primary caregivers of patients undergoing dialysis. This descriptive study was conducted with the family caregivers of 114 patients from Erzurum Ataturk University's Medical Faculty Nephrology Department: 54 were relatives of patients receiving hemodialysis and 60 were relatives of patients receiving peritoneal dialysis during August to December 2014. The percentage of the patients with low levels of caregiver burden is 13% in the hemodialysis group, while it is 35% in the peritoneal dialysis group. These findings are statistically significant. To conclude, chronic diseases affect not only patients, but also their relatives who care for them. Nursing care needs to include both patients and their relatives and support them. It is hoped that this study will guide nursing care in this direction.

  20. Laparoscopic versus open peritoneal dialysis catheter insertion, the LOCI-trial: a study protocol

    Directory of Open Access Journals (Sweden)

    Hagen Sander M

    2011-12-01

    Full Text Available Abstract Background Peritoneal dialysis (PD is an effective treatment for end-stage renal disease. It allows patients more freedom to perform daily activities compared to haemodialysis. Key to successful PD is the presence of a well-functioning dialysis catheter. Several complications, such as in- and outflow obstruction, peritonitis, exit-site infections, leakage and migration, can lead to catheter removal and loss of peritoneal access. Currently, different surgical techniques are in practice for PD-catheter placement. The type of insertion technique used may greatly influence the occurrence of complications. In the literature, up to 35% catheter failure has been described when using the open technique and only 13% for the laparoscopic technique. However, a well-designed randomized controlled trial is lacking. Methods/Design The LOCI-trial is a multi-center randomized controlled, single-blind trial (pilot. The study compares the laparoscopic with the open technique for PD catheter insertion. The primary objective is to determine the optimum placement technique in order to minimize the incidence of catheter malfunction at 6 weeks postoperatively. Secondary objectives are to determine the best approach to optimize catheter function and to study the quality of life at 6 months postoperatively comparing the two operative techniques. Discussion This study will generate evidence on any benefits of laparoscopic versus open PD catheter insertion. Trial registration Dutch Trial Register NTR2878

  1. Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study.

    Science.gov (United States)

    Kim, Hyunsuk; An, Jung Nam; Kim, Dong Ki; Kim, Myoung-Hee; Kim, Ho; Kim, Yong-Lim; Park, Ki Soo; Oh, Yun Kyu; Lim, Chun Soo; Kim, Yon Su; Lee, Jung Pyo

    2015-01-01

    The outcomes of peritoneal dialysis (PD) in elderly patients have not been thoroughly investigated. We aimed to investigate the clinical outcomes and risk factors associated with PD in elderly patients. We conducted a prospective observational nationwide adult end-stage renal disease (ESRD) cohort study in Korea from August 2008 to March 2013. Among incident patients (n = 830), patient and technical survival rate, quality of life, and Beck's Depression Inventory (BDI) scores of elderly PD patients (≥65 years, n = 95) were compared with those of PD patients aged ≤49 years (n = 205) and 50~64 years (n = 192); and elderly hemodialysis (HD) patients (n = 315). The patient death and technical failure were analyzed by cumulative incidence function. Competing risk regressions were used to assess the risk factors for survival. The patient survival rate of elderly PD patients was inferior to that of younger PD patients (Pelderly HD patients, the patient survival rate did not differ according to dialysis modality (P = 0.987). Elderly PD patients showed significant improvement in the BDI scores, as compared with the PD patients aged ≤49 years (P = 0.003). Low albumin, diabetes and low residual renal function were significant risk factors for the PD patient survival; and peritonitis was a significant risk factor for technical survival. Furthermore, low albumin and hospitalization were significant risk factors of patient survival among the elderly. The overall outcomes were similar between elderly PD and HD patients. PD showed the benefit in BDI and quality of life in the elderly. Additionally, the technical survival rate of elderly PD patients was similar to that of younger PD patients. Taken together, PD may be a comparable modality for elderly ESRD patients.

  2. Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study.

    Directory of Open Access Journals (Sweden)

    Hyunsuk Kim

    Full Text Available The outcomes of peritoneal dialysis (PD in elderly patients have not been thoroughly investigated. We aimed to investigate the clinical outcomes and risk factors associated with PD in elderly patients. We conducted a prospective observational nationwide adult end-stage renal disease (ESRD cohort study in Korea from August 2008 to March 2013. Among incident patients (n = 830, patient and technical survival rate, quality of life, and Beck's Depression Inventory (BDI scores of elderly PD patients (≥65 years, n = 95 were compared with those of PD patients aged ≤49 years (n = 205 and 50~64 years (n = 192; and elderly hemodialysis (HD patients (n = 315. The patient death and technical failure were analyzed by cumulative incidence function. Competing risk regressions were used to assess the risk factors for survival. The patient survival rate of elderly PD patients was inferior to that of younger PD patients (P<0.001. However, the technical survival rate was similar (P = 0.097. Compared with elderly HD patients, the patient survival rate did not differ according to dialysis modality (P = 0.987. Elderly PD patients showed significant improvement in the BDI scores, as compared with the PD patients aged ≤49 years (P = 0.003. Low albumin, diabetes and low residual renal function were significant risk factors for the PD patient survival; and peritonitis was a significant risk factor for technical survival. Furthermore, low albumin and hospitalization were significant risk factors of patient survival among the elderly. The overall outcomes were similar between elderly PD and HD patients. PD showed the benefit in BDI and quality of life in the elderly. Additionally, the technical survival rate of elderly PD patients was similar to that of younger PD patients. Taken together, PD may be a comparable modality for elderly ESRD patients.

  3. To Investigate the Causes of Peritoneal Dialysis Related Peritonitis%探讨腹膜透析相关性腹膜炎的原因

    Institute of Scientific and Technical Information of China (English)

    张翠

    2015-01-01

    目的:对腹膜透析相关性腹膜炎的原因进行探讨,为更好的治疗腹膜炎提供科学依据。方法选取2012年1月~2014年12月到我院肾内科进行治疗的118例发生腹膜炎的尿毒症患者,通过分析其临床资料进一步分析尿毒症患者发生腹膜炎的原因。结果引发腹膜炎的相关因素主要是以下方面:尿毒症患者自身选择继续腹膜透析、操作不规范、治疗环境不符合要求、其他疾病感染以及患者个人卫生原因。结论规范化操作和科学化管理能够有效的防治腹膜透析相关性腹膜炎的发生。%Objective The reason for peritoneal dialysis-related peritonitis were discussed to provide a scientific basis for better treatment of peritonitis. Methods January 2012~December 2014 to our hospital for treatment of Nephrology, 118 cases occurred in patients with uremia peritonitis, by analyzing the clinical data for further analysis of the causes of peritonitis in patients with uremia. Results The relevant factors are mainly caused by peritonitis following aspects: uremic patients choose to continue their peritoneal dialysis, the operation is not standardized, therapeutic environment does not meet the requirements, as well as other infections in patients with personal hygiene reasons. Conclusion The standardized operation and scientiifc management can effectively control peritoneal dialysis-related peritonitis occurs.

  4. Telehealth: Acceptability, clinical interventions and quality of life in peritoneal dialysis

    Science.gov (United States)

    Dey, Vishal; Jones, Audrey; Spalding, Elaine M

    2016-01-01

    Introduction: Telehealth technologies are being widely adopted across the globe for management of long-term conditions. There are limited data on its use, effectiveness and patient experience in end-stage renal disease. The aim of this pilot project was to explore patient acceptability of technology and evaluate its effect on clinical interventions and quality of life in patients undergoing peritoneal dialysis. Methods: Peritoneal dialysis patients were provided with computer tablets (PODs). PODs contained a knowledge database with treatment- and symptom-based questionnaires that generated alerts for the clinical team. Alerts were reviewed daily and followed up by a telephone call or clinic visit. Interventions were at the discretion of clinicians. Data were recorded prospectively and quality of life and Quebec User Evaluation of Satisfaction with assistive Technology questionnaires evaluated at the start and end of the programme. Results: In all, 22 patients have participated over 15 months. The mean age was 61.6 years and PODs were utilised for an average of 341.9 days with 59.1% choosing to continue beyond the study period. We received a total of 1195 alerts with an average of 2.6 alerts per day. A total of 36 admissions were avoided and patients supported to self-manage on 154 occasions. Quebec User Evaluation of Satisfaction with assistive Technology scores remained high throughout the programme although no improvement in quality of life was seen. Discussion: Telehealth is useful to monitor patients with renal failure on peritoneal dialysis. It is acceptable across age groups and provides an additional resource for patients to self-manage. Satisfaction scores and retention rates suggest a high level of acceptability.

  5. Correlational studies on insulin resistance and leptin gene polymorphisms in peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Liou Cao

    2015-09-01

    Full Text Available Objective(s:The aim of the study was to investigate the relationship between insulin resistance (IR and leptin (LEP gene polymorphisms in peritoneal dialysis (PD patients. Materials and Methods: From July 1, 2011 to August 1, 2011, patients who received chronic PD were chosen and divided into three groups (DM, high HOMR-IR, and low HOMR-IR. Two PCR products of LEP were sequenced and aligned and the distribution of polymorphisms was analyzed using χ2 analysis. In addition, serum leptin level, PD conditions, and biochemical parameters according to different genotype of G-2548A and A19G were statistically analyzed (P-value

  6. Abdominal Aortic Dissection in a Patient With Autosomal Dominant Polycystic Kidney Disease After Starting Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Yingying He

    2014-07-01

    Full Text Available Autosomal dominant polycystic kidney disease (ADPKD, one of the most common genetic disorders, is caused by mutations in the PKD1 or PKD2 gene. ADPKD primarily affects the kidneys, causing the development of multiple bilateral cysts that are characteristic of this condition. Besides renal abnormalities, other manifestations of ADPKD include hepatic, pancreatic, and splenic cysts, intracranial aneurysms, aortic aneurysms, and mitral valve prolapse. Reports of ADPKD-associated abdominal aortic dissections are not rare, but there have been no reports of an ADPKD patient developing intestinal obstruction and abdominal aortic dissection after initiating peritoneal dialysis. Herein, we present one such case.

  7. Applications of longitudinal and transversal bioimpedance measurements in peritoneal dialysis at 50 kHz

    OpenAIRE

    Nescolarde Selva, Lexa Digna; Doñate, T.; Casañas Bueno, Roberto; Rosell Ferrer, Francisco Javier

    2010-01-01

    More relevant information of the fluid changes in peritoneal dialysis (PD) might be obtained with segmental bioimpedance measurements rather than whole-body measurement, who hidden information of body composition. Whole-body and segmental bioimpedance measurements were obtained using 5 configurations (whole-body or right-side (RS), longitudinal-leg (L-LEG), longitudinal-abdomen (L-AB), transversal-abdomen (T-AB), and transversal-leg (T-LEG)) in 20 patients: 15 males (56.5 ± 9.4...

  8. Circadian variation of blood pressure in patients with chronic renal failure on continuous ambulatory peritoneal dialysis

    DEFF Research Database (Denmark)

    Clausen, P; Feldt-Rasmussen, B; Ladefoged, Jens

    1995-01-01

    The circadian pattern of blood pressure variation was investigated in 10 patients with advanced chronic renal failure on continuous ambulatory peritoneal dialysis (CAPD) and in an age-matched group of controls without renal disease with similar office blood pressure level. Monitoring was done using....... In patients with chronic renal failure undergoing CAPD, an otherwise unnoticed 24-h hypertension and nocturnal blood pressure elevation can be discovered by use of 24-h blood pressure monitoring and this may indicate a need of earlier start of antihypertensive treatment in CAPD patients with borderline...

  9. Risk factors for the occurrence of cardiac arrhythmias in patients on continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Canziani, M E; Saragoça, M A; Draibe, S A; Barbieri, A; Ajzen, H

    1993-01-01

    In order to evaluate the risk factors for the occurrence of ventricular arrhythmias (VA) in continuous ambulatory peritoneal dialysis (CAPD), we studied 47 patients by echocardiography, dipyridamole-thallium tests, and biochemical profile. We observed that the group with VA had a greater cardiac mass index dependent only on an increased left ventricular internal diameter. Septum and posterior wall thickness, as well as biochemical variables, were not associated with the presence of VA in CAPD patients. In addition, altered myocardial perfusion was not associated with VA in these patients. PMID:8399625

  10. Effect of standard and neutral-pH peritoneal dialysis solutions upon fibroblasts proliferation

    Directory of Open Access Journals (Sweden)

    André Antunes Poitevin

    2014-04-01

    Full Text Available Introduction: Continuous exposition of the peritoneal membrane to conventional dialysis solutions is an important risk factor for inducing structural and functional alterations. Objective: To compare in vitro mouse fibroblast NIH-3T3 cell viability after exposition to a neutral pH dialysis solution in comparison to cells exposed to a standard solution. Methods: Experimental study to compare the effects of a conventional standard or a neutral-pH, low-glucose degradation products peritoneal dialysis solution on the viability of exposed fibroblasts in cell culture. Both solutions were tested in all the commercially available glucose concentrations. Cell viability was evaluated with tetrazolium salt colorimetric assay. Results: Fibroblast viability was significantly superior in the neutral pH solution in comparison to control, in all three glucose concentrations (Optical density in nm-means ± SD: 1.5% 0.295 ± 0.047 vs. 0.372 ± 0.042, p < 0.001; 2.3% 0.270 ± 0.036 vs. 0.337 ± 0.051, p < 0.001; 4.25% 0.284 ± 0.037 vs. 0.332 ± 0.032, p < 0.001; control vs. neutral pH respectively, Student t Test. There was no significant difference in cell viability between the three concentrations of glucose when standard solution was used (ANOVA p = 0.218, although cell viability was higher after exposition to neutral pH peritoneal dialysis fluid at 1.5% in comparison to 2.3 and 4.25% glucose concentrations (ANOVA p = 0.008: Bonferroni 1.5% vs. 2.3% p = 0.033, 1.5% vs. 4.25% p = 0.014, 2.3% vs. 4.25% p = 1.00. Conclusion: Cell viability was better in neutral pH dialysis solution, especially in the lower glucose concentration. A more physiological pH and lower glucose degradation products may be responsible for such results.

  11. Theoretical analysis of osmotic agents in peritoneal dialysis. What size is an ideal osmotic agent?

    Science.gov (United States)

    Rippe, B; Zakaria el-R; Carlsson, O

    1996-01-01

    In this article the difference between osmotic fluid flow (ultrafiltration) as driven by osmotic pressure and diffusion through thin leaky membranes is discussed. It is pointed out that water transport induced by osmosis is fundamentally different from the process of water diffusion. Applying modern hydrodynamic pore theory, the molar solute concentration and the solute concentration in grams per 100 mL, exerting the same initial transmembrane osmotic pressure as a 1% glucose solution, was investigated as a function of solute molecular weight (MW). It was then assumed, base on experimental data, that the major pathway responsible for the peritoneal osmotic barrier characteristics is represented by pores of radius approximately 47 A. With increasing solute radius, the osmotic reflection coefficient (sigma) and, hence, the osmotic efficiency per mole of solute will increase. However, simultaneously, the molar concentration per unit solute weight will decrease. The balance point between these two events apparently occurs at a solute MW of approximately 1 kDa. An additional advantage of using solutes of high MW as osmotic agents during peritoneal dialysis (PD), rather than increased osmotic efficiency per se, lies in the fact that large solutes, due to their low peritoneal diffusion capacity, will maintain a sustained rate of ultrafiltration (osmosis) over a prolonged period. To illustrate this, we have performed computer simulations of peritoneal fluid transport according to the three-pore model of peritoneal permselectivity. According to these simulations, 4% of an 800 Da polymer solution (+50 mmol/L above isotonicity) will produce the same cumulative amount of intraperitoneal fluid volume ultrafiltered (UF) during 360-400 minutes as 4% of a 2 kDa polymer solution (+20 mmol/L) or 6.5% of a 10 kDa polymer solution (+6.5 mmol/L) having the same electrolyte concentration as dialysis solutions conventionally used for PD. Similar cumulative UF volumes (during 400 minutes

  12. Methylglyoxal Induced Basophilic Spindle Cells with Podoplanin at the Surface of Peritoneum in Rat Peritoneal Dialysis Model

    Directory of Open Access Journals (Sweden)

    Ichiro Hirahara

    2015-01-01

    Full Text Available Peritoneal dialysis (PD is a common treatment for patients with reduced or absent renal function. Long-term PD leads to peritoneal injury with structural changes and functional decline. At worst, peritoneal injury leads to encapsulating peritoneal sclerosis (EPS, which is a serious complication of PD. In order to carry out PD safely, it is important to define the mechanism of progression of peritoneal injury and EPS. We prepared rat models of peritoneal injury by intraperitoneal administration of glucose degradation products, such as methylglyoxal (MGO or formaldehyde (FA, chlorhexidine gluconate (CG, and talc. In rats treated with MGO, peritoneal fibrous thickening with the appearance of basophilic spindle cells with podoplanin, cytokeratin, and α-smooth muscle actin at the surface of the peritoneum was observed. These cells may have been derived from mesothelial cells by epithelial-to-mesenchymal transition. In FA- or CG-treated rats, the peritoneum was thickened, and mesothelial cells were absent at the surface of the peritoneum. The CG- or MGO-treated rats presented with a so-called abdominal cocoon. In the talc-treated rats, extensive peritoneal adhesion and peritoneal thickening were observed. MGO-induced peritoneal injury model may reflect human histopathology and be suitable to analyze the mechanism of progression of peritoneal injury and EPS.

  13. Treatment of necrotizing acute pancreatitis with peritoneal lavage and dialysis by a new simplified technique insert catheters

    Science.gov (United States)

    Li, Qi; Zhu, Bai; Zhu, Xueyan; Piao, Chenglin; Cui, Wenpeng; Wang, Yangwei; Sun, Jing; Chen, Wenguo; Miao, Lining

    2016-01-01

    Abstract Peritoneal lavage and dialysis is an approach to treat necrotizing acute pancreatitis as it removes dialyzable toxins and reduces severe metabolic disturbances. Successful catheter implantation is important for delivering adequate peritoneal lavage and dialysis. The aim of the present study was to describe a new modified percutaneous technique for the placement of peritoneal dialysis catheters and assess the effectiveness and safety of peritoneal lavage and dialysis used for treatment of necrotizing acute pancreatitis. We conducted a retrospective data review of 35 patients of necrotizing acute pancreatitis from January 2010 to December 2014 in Jilin City Central Hospital and The First Affiliated Hospital of ZheJiang University. In total, 18 patients underwent peritoneal lavage and dialysis after inserting catheters by our new technique (group A), whereas 17 patients underwent ultrasound-guided percutaneous catheter drainage (group B). By analyzing the patients’ data, the drainage days and mean number of hours between the debut of the symptoms and the hospital admission were lower in group A (P < 0.05, P < 0.05, respectively). The complication rate of 5.6 and 17.6%, respectively (P = 0.261), and a mortality rate of 16.7 and 5.9% for each group, respectively (P = 0.316). Likewise, hospitalization time was similar for the group A: 31 ± 25.3 days compared with 42.8 ± 29.4 days in the group B (P = 0.211). Peritoneal lavage and dialysis can be used in necrotizing acute pancreatitis, and our new modified percutaneous technique offers the same complication and mortality rate as ultrasound-guided drainage but with a shorter drainage days. PMID:27281083

  14. Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Weng CH

    2015-09-01

    Full Text Available Cheng-Hao Weng,1,2 Ching-Chih Hu,3 Tzung-Hai Yen,1,2 Wen-Hung Huang1,2 1Department of Nephrology, Division of Clinical Toxicology, Chang Gung Memorial Hospital, Linkou, 2College of Medicine, Chang Gung University, Taoyuan, 3Liver Research Unit, Department of Hepatogastroenterology, Chang Gung Memorial Hospital, Keelung, Taiwan Background: Secondary hyperparathyroidism (SHPT is a major disorder in patients with chronic renal disease with or without dialysis. Air pollution has been confirmed as being associated with increased incidence of human morbidity and mortality. To our knowledge, investigating air pollution as a dialysis-unrelated factor for SHPT in patients undergoing dialysis is limited. We developed this study to assess the effect of air pollution and other important risk factors on SHPT in patients undergoing peritoneal dialysis (PD. Materials and methods: We recruited a total of 141 patients who did not have diabetes mellitus, were nonsmokers, and were undergoing PD in this cross-sectional study. We analyzed the difference in air quality based on the patients’ living areas. We estimated demographic, hematological, nutritional, inflammatory, biochemical, air pollutant, and dialysis-related data based on this cross-sectional study. Subgroup analysis of the relationship between air pollutants and the clinical variables and having or not having hyperparathyroidism (HPT (intact parathyroid hormone level ≥180 pg/dL was also performed. Results: A total of 141 patients undergoing PD (30 men and 111 women were enrolled in the study. Sixty-eight patients had SHPT. In a binary logistic regression, high environmental CO exposure (odds ratio [OR] 3.22, 95% confidence interval [CI] 1.42–7.28; P=0.005, serum phosphate levels (OR 1.66, 95% CI 1.17–2.37; P=0.005, hypoalbuminemia (OR 3.76, 95% CI 1.29–10.94; P=0.015, and use of calcitriol (OR 8.25, 95% CI 3.43–19.85; P<0.001 were positively associated with SHPT. Conclusion: The findings of

  15. Risk and Prognosis of Bacteremia and Fungemia among Peritoneal Dialysis Patients

    DEFF Research Database (Denmark)

    Dalgaard, Lars S; Nørgaard, Mette; Povlsen, Johan V;

    2016-01-01

    ♦ Background: The incidence of bacteremia and fungemia (BAF) is largely unknown in end-stage renal disease (ESRD) patients initiating peritoneal dialysis (PD). ♦ Objective: The main objective was to estimate and compare incidence rates of first episodes of BAF in incident PD patients and a compar......♦ Background: The incidence of bacteremia and fungemia (BAF) is largely unknown in end-stage renal disease (ESRD) patients initiating peritoneal dialysis (PD). ♦ Objective: The main objective was to estimate and compare incidence rates of first episodes of BAF in incident PD patients...... and a comparison cohort. A secondary objective was to compare causative agents and 30-day post-BAF mortality between PD patients and the comparison cohort. ♦ Methods: Design: Observational cohort study. SETTING: Central and North Denmark regions. PARTICIPANTS: patients who initiated PD during 1995 - 2010. For each...... and population controls. Incidence-rate ratios (IRRs) were calculated to compare these rates. Thirty-day mortality was estimated by Kaplan-Meier analysis. ♦ Results: Among 1,024 PD patients and 10,215 population controls, we identified 75 and 282 episodes of BAF, respectively. Incidence rates of BAF were 4.7 (95...

  16. [Peritoneal dialysis for acute renal failure: Rediscovery of an old modality of renal replacement therapy].

    Science.gov (United States)

    Issad, Belkacem; Rostoker, Guy; Bagnis, Corinne; Deray, Gilbert

    2016-07-01

    Acute renal failure (ARF) in adults in the intensive care unit (ICU) often evolves in a context of multiple organ failure, which explains the high mortality rate and increase treatment needs. Among, two modalities of renal replacement therapy, peritoneal dialysis (PD) was the first modality used for the treatment of ARF in the 1950s. Today, while PD is generalized for chronic renal failure treatment, its use in the ICU is limited, particularly, due to the advent of new hemodialysis techniques and the development of continuous replacement therapy. Recently, a renewed interest in the use of PD in patients with ARF has manifested in several emerging countries (Brazil, Vietnam). A systematic review in 2013 showed a similar mortality in ARF patients having PD (58%) and those treated by hemodialysis or hemodiafiltration/hemofiltration (56.1%). In the International society of peritoneal dialysis (ISPD)'s guideline (2013), PD may be used in adult ARF as the other blood extracorporeal epuration technics (recommendation with grade 1B). PD is the preferred method in cardiorenal syndromes, in frailty patients with hemodynamic instability and those lacking vascular access; finally PD is also an option in elderly and patients with bleeding tendency. In industrial countries, high volume automated PD with a flexible catheter (usually Tenckhoff) is advocated.

  17. Quality of life, mental health and health beliefs: comparison between haemodialysis and peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Theofilou P

    2010-10-01

    Full Text Available Aim: The comparative study between in-centre haemodialysis (HD and continuous ambulatory peritoneal dialysis (PD patients regarding self-reported quality of life (QoL as well as some psychological dimensions that may affect and may be affected by the patient’s state of health, like health locus of control beliefs, depression and anxiety. Material and Method: The sample consists of 144 patients in-centre haemodialysis or continuous ambulatory peritoneal dialysis (CAPD. Patient-reported assessments included: a WHOQOL-BREF, b General Health Questionnaire (GHQ-28, c Multidimensional Health Locus of Control Questionnaire (MHLC, d State - Trait Anxiety Inventory (STAI I, II and e Center for Epidemiologic Studies Depression Scale (CES-D.Results: HD patients presented lower scores in WHOQOL-BREF domain of environment. Furthermore, they reported higher scores in the GHQ-28 sub-scales of anxiety/insomnia and severe depression as well as of the total score of the questionnaire. Regarding health beliefs, statistically significant difference was observed in HD patients, who presented higher scores in the internal health locus of control. Conclusions: Patients in HD treatment modality were experiencing a more compromised QoL indicating greater discontent with different aspects of their environment. Further, they reported more symptoms of anxiety, sleeping problems, depression or suicidal thoughts.

  18. Application of longitudinal and transversal bioimpedance measurements in peritoneal dialysis at 50 kHz

    Science.gov (United States)

    Nescolarde, L.; Doñate, T.; Casañas, R.; Rosell-Ferrer, J.

    2010-04-01

    More relevant information of the fluid changes in peritoneal dialysis (PD) might be obtained with segmental bioimpedance measurements rather than whole-body measurement, who hidden information of body composition. Whole-body and segmental bioimpedance measurements were obtained using 5 configurations (whole-body or right-side (RS), longitudinal-leg (L-LEG), longitudinal-abdomen (L-AB), transversal-abdomen (T-AB), and transversal-leg (T-LEG)) in 20 patients: 15 males (56.5 ± 9.4 yr, 24.2 ± 4.2 kg/m2) and 5 females (58.4 ± 7.1 yr, 28.2 ± 5.9 kg/m2) in peritoneal dialysis (PD). The aim of this study is to analyze the relationship between whole-body, longitudinal-segmental (L-LEG and L-AB) and transversal-segmental (TAB and TLEG) bioimpedance measurement at 50 kHz, with clinical parameters of cardiovascular risk, dyslipidemia, nutrition and hydration. The Kolmogorov-Smirnov test was used for the normality test of all variables. Longitudinal bioimpedance parameters were normalized by the height of the patients. The Spearman correlation was used to analyze the correlation between bioimpedance and clinical parameters. The statistical significance was considered with P bioimpedance measurements have higher correlation with clinical parameters than longitudinal measurements.

  19. Laparoscopic versus open catheter placement in peritoneal dialysis patients: a systematic review and meta-analysis

    Directory of Open Access Journals (Sweden)

    Xie Haiying

    2012-07-01

    Full Text Available Abstract Background Peritoneal dialysis has been proven to be a safe and effective mode of renal replacement therapy for patients with end-stage renal disease. The usage of laparoscopic catheter placement technique was increased in recent years. But the advantages and disadvantages between the laparoscopic catheter placement technique and open laparotomy technique were still http://in controversy. The objective of this study is to access the operation-related data and complications of catheter placement for peritoneal dialysis (PD patients, Then to determine the better method for catheter insertion. Methods We performed a systematic review and meta-analysis on published studies identified by the databases PubMed, EMBASE, Highwire, and the Cochrane Library. Analysis was performed using the statistical software Review Manager Version 5.0. Results We assessed the operation-related data and complications of four randomized controlled trials (RCTs and ten observational studies. The available data showed that laparoscope prolonged the time for catheter insertion in PD patients, however, the two groups did not significantly differ in hospital stays, early and late complications, including infection, dialysate leaks, catheter migration, pericannular bleeding, blockage and hernia. Conclusions The data showed that Laparoscopic catheter placement had no superiority to open surgery. However, this treatment still needs to be confirmed in a large, multi-center, well-designed RCT.

  20. Outcome of percutaneous endoscopic gastrostomy feeding in patients on peritoneal dialysis.

    Science.gov (United States)

    Fein, P A; Madane, S J; Jorden, A; Babu, K; Mushnick, R; Avram, M M; Grosman, I

    2001-01-01

    Protein malnutrition is now well established as an important contributory factor to the high mortality in peritoneal dialysis (PD) patients. Low dietary protein calorie intake is one of the factors leading to protein malnutrition. If PD patients develop difficulty eating, percutaneous endoscopic gastrostomy (PEG) feeding may prove beneficial in providing adequate nutrition. Studies on the effectiveness of PEG feeding in PD patients are limited to pediatric patients. The objective of the present study was to assess the outcome of PEG feeding in adult patients with end-stage renal disease (ESRD) on PD. We retrospectively reviewed charts from May 1992 to February 2000 of 10 consecutive patients in our center who had had feeding tubes inserted. The patients' ages ranged from 37 to 81 years, with mean age of 65. Of the 10 patients, 7 were male, 5 were diabetic, and 1 was infected with the human immunodeficiency virus. Two patients had cerebrovascular accident (CVA) with dysphagia, 3 had multi-infarct dementia, 2 had anoxic encephalopathy, 2 had dementia, and 1 had calciphylaxis with anorexia. Of the 10 patients, 9 failed to eat because of neurologic disorders. Two patients who had functioning PEG feedings before starting PD had no complications. Only 2 of 8 patients already on PD continued with long-term PD after a PEG was inserted. Both patients whose PD was not interrupted at the time of PEG placement immediately developed peritonitis. Of the 6 patients who were maintained on hemodialysis (HD), 2 developed peritonitis within one week of starting PEG feedings. The other 4 had no complications from PEG feedings while being maintained on HD, but 1 developed peritonitis when PD was resumed. Of the 5 patients who developed peritonitis, 3 experienced fungal peritonitis. In PD patients, PEG feeding is associated with frequent complications. However, PEG placement prior to PD initiation appears to be safe. Maintaining patients on HD for at least 6 weeks appears to decrease

  1. Dialysis - peritoneal

    Science.gov (United States)

    ... walls of your abdomen. A membrane called the peritoneum covers the walls of your abdomen. PD involves ... fluid passes from your blood vessels through the peritoneum and into the solution. After a set amount ...

  2. End-stage renal disease use in hurricane-prone areas: should nephrologists increase the utilization of peritoneal dialysis?

    Science.gov (United States)

    Kleinpeter, Myra A

    2007-01-01

    Hurricane Katrina resulted in massive destruction of the gulf coast of the United States in 2005. In the immediate aftermath, displaced dialysis patients required urgent hemodialysis or additional peritoneal dialysis (PD) supplies. Massive damage to the health care infrastructure in these communities disrupted dialysis services for several months. As a result of this event and subsequent storms during the 2005 Atlantic hurricane season, many decisions regarding future services to dialysis patients in hurricane prone communities (HPCs) need to occur. Nephrologists, dialysis nurses, dialysis providers, and patients need to discuss the ramifications of and types of continued dialysis services in HPC. Nephrologists should encourage PD, and efforts to educate on other renal replacement therapies including PD and transplant should occur. With the potential for interruption of electrical, sewerage, and water services, more patients should consider PD. Recovery from future events begins with appropriate disaster planning. Many questions are considered and need answering in planning for dialysis services in HPC and other communities subject to natural disasters. This summary provides the basis to begin discussions when planning for dialysis services in communities prone to natural disasters. PMID:17200049

  3. Peritonite esclerosante encapsulante pós-diálise peritoneal Sclerosing encapsulating peritonitis after peritoneal dialysis

    OpenAIRE

    Alexandre Tagliari Cestari; Marina Lourenço de Conti; João Antonio Gonçalves Garreta Prats; Henri Sato Junior; Hugo Abensur

    2013-01-01

    Pacientes com insuficiência renal crônica terminal em uso de diálise peritoneal (DP) estão sujeitos a diversas complicações da própria terapia de substituição renal. Relatamos uma complicação rara da DP na qual o peritôneo, após anos de contato com a substância hipertônica dialisante, é gradualmente substituído por tecido fibroso. O paciente em questão teve diversas intercorrências após o início da DP, incluindo uma peritonite bacteriana, hiperparatireoidismo terciário (sendo tratado com duas...

  4. The transport of phosphate between the plasma and dialysate compartments in peritoneal dialysis is influenced by an electric potential difference

    DEFF Research Database (Denmark)

    Graff, J; Fugleberg, S; Brahm, J;

    1996-01-01

    Six kinetic models of transperitoneal phosphate transport were formulated and validated on the basis of experimental results obtained from 22 non-diabetic patients undergoing peritoneal dialysis. The models were designed to elucidate the presence or absence of diffusive, non-lymphatic convective,...

  5. Non-adherence in patients on peritoneal dialysis: a systematic review.

    Directory of Open Access Journals (Sweden)

    Konstadina Griva

    Full Text Available BACKGROUND: It has been increasingly recognized that non-adherence is an important factor that determines the outcome of peritoneal dialysis (PD therapy. There is therefore a need to establish the levels of non-adherence to different aspects of the PD regimen (dialysis procedures, medications, and dietary/fluid restrictions. METHODS: A systematic review of peer-reviewed literature was performed in PubMed, PsycINFO and CINAHL databases using PRISMA guidelines in May 2013. Publications on non-adherence in PD were selected by two reviewers independently according to predefined inclusion and exclusion criteria. Relevant data on patient characteristics, measures, rates and factors associated with non-adherence were extracted. The quality of studies was also evaluated independently by two reviewers according to a revised version of the Effective Public Health Practice Project assessment tool. RESULTS: The search retrieved 204 studies, of which a total of 25 studies met inclusion criteria. Reported rates of non-adherence varied across studies: 2.6-53% for dialysis exchanges, 3.9-85% for medication, and 14.4-67% for diet/fluid restrictions. Methodological differences in measurement and definition of non-adherence underlie the observed variation. Factors associated with non-adherence that showed a degree of consistency were mostly socio-demographical, such as age, employment status, ethnicity, sex, and time period on PD treatment. CONCLUSION: Non-adherence to different dimensions of the dialysis regimen appears to be prevalent in PD patients. There is a need for further, high-quality research to explore these factors in more detail, with the aim of informing intervention designs to facilitate adherence in this patient population.

  6. Fibroblast Growth Factor 21 (FGF-21 in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.

    Directory of Open Access Journals (Sweden)

    Elena González

    Full Text Available Human fibroblast growth factor 21 (FGF-21 is an endocrine liver hormone that stimulates adipocyte glucose uptake independently of insulin, suppresses hepatic glucose production and is involved in the regulation of body fat. Peritoneal dialysis (PD patients suffer potential interference with FGF-21 status with as yet unknown repercussions.The aim of this study was to define the natural history of FGF-21 in PD patients, to analyze its relationship with glucose homeostasis parameters and to study the influence of residual renal function and peritoneal functional parameters on FGF-21 levels and their variation over time.We studied 48 patients with uremia undergoing PD. Plasma samples were routinely obtained from each patient at baseline and at 1, 2 and 3 years after starting PD therapy.Plasma FGF-21 levels substantially increased over the first year and were maintained at high levels during the remainder of the study period (253 pg/ml (59; 685 at baseline; 582 pg/ml (60.5-949 at first year and 647 pg/ml (120.5-1116.6 at third year (p<0.01. We found a positive correlation between time on dialysis and FGF-21 levels (p<0.001, and also, those patients with residual renal function (RRF had significantly lower levels of FGF-21 than those without RRF (ρ -0.484, p<0.05. Lastly, there was also a significant association between FGF-21 levels and peritoneal protein losses (PPL, independent of the time on dialysis (ρ 0.410, p<0.05.Our study shows that FGF-21 plasma levels in incident PD patients significantly increase during the first 3 years. This increment is dependent on or is associated with RRF and PPL (higher levels in patients with lower RRF and higher PPL. FGF-21 might be an important endocrine agent in PD patients and could act as hormonal signaling to maintain glucose homeostasis and prevent potential insulin resistance. These preliminary results suggest that FGF-21 might play a protective role as against the development of insulin resistance over

  7. The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: a multi-centre registry study

    Directory of Open Access Journals (Sweden)

    Cho Yeoungjee

    2012-06-01

    Full Text Available Abstract Background The aim of the study was to determine whether distance between residence and peritoneal dialysis (PD unit influenced peritonitis occurrence, microbiology, treatment and outcomes. Methods The study included all patients receiving PD between 1/10/2003 and 31/12/2008, using ANZDATA Registry data. Results 365 (6% patients lived ≥100 km from their nearest PD unit (distant group, while 6183 (94% lived S. aureus peritonitis (adjusted odds ratio [OR] 1.64, 95% CI 1.09-2.47. Distant patients with first peritonitis episodes were less likely to be hospitalised (64% vs 73%, p = 0.008 and receive antifungal prophylaxis (4% vs 10%, p = 0.01, but more likely to receive vancomycin-based antibiotic regimens (52% vs 42%, p  Conclusions Living ≥100 km away from a PD unit was associated with increased risk of S. aureus peritonitis, modified approaches to peritonitis treatment and peritonitis outcomes that were comparable to, or better than patients living closer to a PD unit. Staphylococcal decolonisation should receive particular consideration in remote living patients.

  8. Intraperitoneal Hemorrhage in a Peritoneal Dialysis Patient Using Dabigatran: A Case Report

    Directory of Open Access Journals (Sweden)

    Egemen Cebeci

    2016-06-01

    Full Text Available Dabigatran is used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is still unclear whether the use of dabigatran leads to more bleeding compared with warfarin. In this paper, we present a case of intraperitoneal hemorrhage in a 54-years-old male peritoneal dialysis patient using dabigatran for paroxysmal atrial fibrillation because international normalized ratio level could not be kept at target levels during follow-up. The use of dabigatran in atrial fibrillation has become widespread in recent years. Despite the low risk of intracranial hemorrhage, clinicians should be careful in patients with chronic kidney disease because coagulation monitoring is not possible.

  9. Effect of benfotiamine in podocyte damage induced by peritoneal dialysis fluid

    Directory of Open Access Journals (Sweden)

    Sandra eMüller-Krebs

    2015-03-01

    Full Text Available Background:In peritoneal dialysis (PD residual renal function (RRF fundamentally contributes to improved quality of life and patient survival. High glucose and advanced glycation end-products (AGE contribute locally to peritoneal and systemically to renal damage. Integrity of podocyte structure and function is of special importance to preserve RRF. Benfotiamine could counteract the glucose and AGE mediated toxicity by blocking hyperglycemia associated podocyte damage via the pentose phosphate pathway.Methods: A human differentiated podocyte cell line was incubated with control solution (Control, 2.5% glucose solution (Glucose and 2.5% PD fluid (PDF for 48 h either ± 50 μM benfotiamine.Podocyte damage and potential benefit of benfotiamine were analyzed using immunofluorescence, western blot analysis, and a functional migration assay. For quantitation, a semiquantitative score was used. Results:When incubating podocytes with benfotiamine, Glucose and PDF mediated damage was reduced resulting in lower expression of AGE and intact podocin and ZO-1 localization. The reorganization of the actin cytoskeleton was restored in the presence of benfotiamine as functional podocyte motility reached Control level. Decreased level of inflammation could be shown as well as reduced podocyte apoptosis.Conclusions:These data suggest that benfotiamine protects podocytes from Glucose and PDF mediated dysfunction and damage, in particular with regard to cytoskeletal reorganization, motility, inflammation and podocyte survival.

  10. Chemical and physiological relevance of glucose degradation products in peritoneal dialysis.

    Science.gov (United States)

    Mittelmaier, Stefan; Niwa, Toshimitsu; Pischetsrieder, Monika

    2012-01-01

    Fibrosis and vascular sclerosis are main complications that limit the long-term application of peritoneal dialysis (PD). Low biocompatibility has been largely attributed to the presence of glucose degradation products (GDPs), which are formed during the heat sterilization of PD fluids. GDPs readily modify proteins in the peritoneum, leading to a decline of their biological function. After absorption, GDPs can also promote systemic protein glycation. Additionally, GDPs may augment DNA glycation, a process enhanced in uremia. Apart from their glycating activity, GDPs induce cytotoxicity and interfere with cell signaling in peritoneal mesothelial cells. Targeted screening revealed the nature of the 6 major GDPs with α-dicarbonyl structure as 3-deoxyglucosone, 3-deoxygalactosone, glucosone, glyoxal, methylglyoxal, and 3,4-dideoxyglucosone-3-ene. Valid quantification of these GDPs was achieved by ultrahigh-performance liquid chromatography/diode array detector/tandem mass spectrometry. Identification and quantification of single GDPs allow a structure-dependent risk evaluation. As a consequence, PD fluids and processes can be improved to reduce the GDP burden of patients undergoing PD.

  11. Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease.

    Science.gov (United States)

    Chou, Che-Yi; Wang, Shu-Ming; Liang, Chih-Chia; Chang, Chiz-Tzung; Liu, Jiung-Hsiun; Wang, I-Kuan; Hsiao, Lien-Cheng; Muo, Chih-Hsin; Chung, Chi-Jung; Huang, Chiu-Ching

    2016-01-01

    Peritoneal dialysis (PD) can be an ideal treatment in cirrhotic patients with ascites and chronic kidney disease stage 5 (CKD 5D) who require dialysis. The survival of cirrhotic patients with CKD 5D on PD, however, is not clear. We compared the survival of cirrhotic patients with CKD 5D on PD and the survival of those on HD. Two datasets including a cohort study of China Medical University Hospital (CMUH) from 2004 to 2013 and the Longitudinal National Health Insurance Database for Catastrophic Illness Patients (LHID-CIP) of Taiwan from 1996 to 2011 were analyzed. The survival of cirrhotic patients on PD and the propensity score matched cirrhotic patients on HD were analyzed using Cox proportional hazards regression. In CMUH cohort of 85 PD and 340 HD patients, the all-cause mortality was lower in PD patients compared to it in HD patients (hazard ratio [HR]: 0.48, 95% confidence interval [CI]: 0.31-0.74, P model for end-stage liver disease (MELD) score, however, was not associated with all-cause mortality. In the LHID-CIP cohort of 285 PD and 1140 HD patients, the HR of all-cause mortality in PD patients was 0.61 (95% CI: 0.47 - 0.79, P < 0.01), as compared with HD patients. PD in cirrhotic patients who need dialysis is associated with lower all-cause mortality than HD is. This association is independent of patients' comorbidity, severity of liver cirrhosis, and serum albumin levels.

  12. Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids

    Science.gov (United States)

    Sampaio, Joana; Machado, Diana; Gomes, Ana Marta; Machado, Idalina; Santos, Cledir; Lima, Nelson; Carvalho, Maria João; Cabrita, António

    2016-01-01

    Infections are major complications in peritoneal dialysis (PD) with a multifactorial etiology that comprises patient, microbial and dialytic factors. This study aimed at investigating the contribution of microbial biofilms on PD catheters to recalcitrant infections and their interplay with PD related-factors. A prospective observational study was performed on 47 patients attending Centro Hospitalar of Porto and Vila Nova de Gaia/Espinho to whom the catheter was removed due to infectious (n = 16) and non-infectious causes (n = 31). Microbial density on the catheter was assessed by culture methods and the isolated microorganisms identified by matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry. The effect of conventional and three biocompatible PD solutions on 16 Coagulase Negative Staphylococci (CNS) and 10 Pseudomonas aeruginosa strains planktonic growth and biofilm formation was evaluated. Cultures were positive in 87.5% of the catheters removed due infectious and 90.3% removed due to non-infectious causes. However, microbial yields were higher on the cuffs of catheters removed due to infection vs. non-infection. Staphylococci (CNS and Staphylococcus aureus) and P. aeruginosa were the predominant species: 32% and 20% in the infection and 43.3% and 22.7% in the non-infection group, respectively. In general, PD solutions had a detrimental effect on planktonic CNS and P. aeruginosa strains growth. All strains formed biofilms in the presence of PD solutions. The solutions had a more detrimental effect on P. aeruginosa than CNS strains. No major differences were observed between conventional and biocompatible solutions, although in icodextrin solution biofilm biomass was lower than in bicarbonate/lactate solution. Overall, we show that microbial biofilm is universal in PD catheters with the subclinical menace of Staphylococci and P. aeruginosa. Cuffs colonization may significantly contribute to infection. PD solutions differentially

  13. Deciphering the Contribution of Biofilm to the Pathogenesis of Peritoneal Dialysis Infections: Characterization and Microbial Behaviour on Dialysis Fluids.

    Directory of Open Access Journals (Sweden)

    Joana Sampaio

    Full Text Available Infections are major complications in peritoneal dialysis (PD with a multifactorial etiology that comprises patient, microbial and dialytic factors. This study aimed at investigating the contribution of microbial biofilms on PD catheters to recalcitrant infections and their interplay with PD related-factors. A prospective observational study was performed on 47 patients attending Centro Hospitalar of Porto and Vila Nova de Gaia/Espinho to whom the catheter was removed due to infectious (n = 16 and non-infectious causes (n = 31. Microbial density on the catheter was assessed by culture methods and the isolated microorganisms identified by matrix-assisted laser desorption/ionization time-of-flight intact cell mass spectrometry. The effect of conventional and three biocompatible PD solutions on 16 Coagulase Negative Staphylococci (CNS and 10 Pseudomonas aeruginosa strains planktonic growth and biofilm formation was evaluated. Cultures were positive in 87.5% of the catheters removed due infectious and 90.3% removed due to non-infectious causes. However, microbial yields were higher on the cuffs of catheters removed due to infection vs. non-infection. Staphylococci (CNS and Staphylococcus aureus and P. aeruginosa were the predominant species: 32% and 20% in the infection and 43.3% and 22.7% in the non-infection group, respectively. In general, PD solutions had a detrimental effect on planktonic CNS and P. aeruginosa strains growth. All strains formed biofilms in the presence of PD solutions. The solutions had a more detrimental effect on P. aeruginosa than CNS strains. No major differences were observed between conventional and biocompatible solutions, although in icodextrin solution biofilm biomass was lower than in bicarbonate/lactate solution. Overall, we show that microbial biofilm is universal in PD catheters with the subclinical menace of Staphylococci and P. aeruginosa. Cuffs colonization may significantly contribute to infection. PD solutions

  14. Successfully managing a rapidly growing peritoneal dialysis program in Southern China

    Institute of Scientific and Technical Information of China (English)

    YANG Xiao; MAO Hai-ping; GUO Qun-ying; YU Xue-qing

    2011-01-01

    Background The maximal use of the limited resource to improve peritoneal dialysis (PD) penetration and clinical outcomes is a challenge for all PD centers.In this study,we reported the experience and outcomes in successfully managing a rapidly growing PD center in Southern China.Methods A standard PD program with a team consisted of 6 nephrologists (3 doctors were in charge of catheter insertion and in-patients care,the other 3 doctors focused on PD patients' follow-up and education) and 11 nurses in a PD center at Sun Yat-sen University was established for PD patients follow-up in 2005.A prospective and observational study was conducted in all patients undergoing continuous ambulatory PD (CAPD) at our center from January 1,2006 to December 31,2009.Results The yearly number of prevalent CAPD patients was 297,409,547 and 695 in 2006,2007,2008 and 2009,respectively.The PD catheter insertion was performed by the nephrologists with open surgical procedure and 94% of catheters were patent at one year.In 841 incident CAPD patients,the survival rates at the end of 1,2,3 and 4 years were 94%,87%,83% and 76%,respectively,while cumulative technique survival rates (death-censored) were 98%,95%,91% and 90%,respectively.Peritonitis rate was 1/68.5 patient months.Conclusions Better patient and technical survival rates as well as lower peritonitis episode have been achieved in our rapidly growing PD center.A standardized PD program,well-trained team members of PD doctors and nurses,and continuous quality improvement of PD are important elements in managing a successful PD program.

  15. Impact of heavy proteinuria on clinical outcomes in patients on incident peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Kang Seok Hui

    2012-12-01

    Full Text Available Abstract Background There are few reports on the nutritional status changes and residual renal function (RRF according to proteinuria levels in patients on peritoneal dialysis (PD. Methods A total of 388 patients on PD were enrolled. The patients were divided into 3 groups with respect to initial proteinuria: the A (n = 119; 3,500 mg/day. Results The patients with higher proteinuria levels had a higher incidence of male sex, diabetes mellitus, and icodextrin use than those with lower proteinuria levels. Although initial peritoneal albumin loss in C group was lower than that detected in the other groups, no significant difference was observed in peritoneal albumin loss among the 3 groups at the end of follow-up period. At the time of PD initiation, the Geriatric nutritional risk index (GNRI was lower in the C group than in the other 2 groups. However, at the end of the follow-up period, there was no significant difference in GNRI between the 3 groups. The GNRI increased, and the proteinuria level or RRF decreased more in the C group than in the other 2 groups. There were no significant differences in lean mass index or fat mass index change from the time of PD initiation to the end of the follow-up period. However, fat mass index and nPNA showed greater increases in the C group. The multivariate analysis revealed that proteinuria was negatively correlated with GNRI at the time of PD initiation and at the end of the follow-up period. The initial RRF and proteinuria were negatively correlated with the RRF decline during the follow-up. Conclusion The attenuation of the nephrotic proteinuria, along with the RRF decline, was associated with the improvement of the malnutrition.

  16. Single port laparoscopic and open surgical accesses of chronic peritoneal dialysis in children: A single center experience over 12 years

    Directory of Open Access Journals (Sweden)

    Ünal Biçakci

    2016-01-01

    Full Text Available Introduction: The aim of this study was to evaluate patients with end stage renal failure (ESRD who underwent chronic peritoneal dialysis (CPD. The clinical outcomes of laparoscopic and open placements of catheters were compared. Materials and Methods: We reviewed 49 (18 male and 31 female children with CPD according to age, sex, cause of ESRD, catheter insertion method, kt/V rate, complications, presence of peritonitis, catheter survival rate between January 2002 and February 2014. Results: Thirty-three patients were with open placement and 16 patients were with laparoscopic placement. The rate of the peritonitis is significantly less in patients with laparoscopic access than open access (n = 4 v sn = 25 (P<0.01. Patients with peritonitis were younger than those who had no attack of peritonitis (10.95 ± 0.8 years vs 13.4 ± 0.85 years. According to the development of complications, significant difference has not been found between the open (n = 9 and laparoscopic (n = 3 approaches except the peritonitis. Catheter survival rate for the first year was 95%, and for five years was 87.5%. There was no difference between open and laparoscopic group according to catheter survival rate. The mean kt/V which indicates the effectiveness of peritoneal dialysis was mean 2.26 ± 0.08. No difference was found between laparoscopic and open methods according to kt/V. Conclusion: Laparoscopic placement of CPD results in lower peritonitis rate. Catheter survival rate was excellent in both groups. Single port laparoscopic access for CPD catheter insertion is an effective and safe method.

  17. Study of effect of peritoneal dialysis and cell therapy on syndrome of intestinal insufficiency in necrotizing pancreatitis

    Directory of Open Access Journals (Sweden)

    KebkaloA.B.

    2013-03-01

    Full Text Available The aim was to prove the effectiveness of the use of methods of detoxification and stimulation of reparative processes in the complex treat¬ment of patients with intestinal insufficiency syndrome with necrotizing pancreatitis. For detoxification in patients with necrotizing pancreatitis, we chose the method of fractional peritoneal dialysis, that represents periodic injection of the dosed volumes of dialysate into abdominal cavity, which is removed after a fixed period of time. For stimulation of detoxication pro¬perties of liver and reparative processes in the body, stem cells of cord blood were used. Cord blood at a dose of 10 ml was slowly injected intravenously with dilution with physiological solution 1:1 starting from 2-3 days after the beginning of disease within 3-5 days. Intraabdominal pressure was measured in the bladder using tonometer of low pressure. Material for bacteriological examination was taken during puncture intervention under ultrasound control. Identification of pure culture was performed by the staging of "motley series", and also by bacteriological analyzer VITEK-2. To study the effectiveness of the combined methods of detoxification in toxemia phase, patients with necrotizing pancreatitis were divided into three groups. The control group consisted of 30 patients with necrotizing pancreatitis treated with standard detoxification. The group of comparison consisted of 25 patients with necrotizing pancreatitis, only with fractional peritoneal dialysis, only, and a basic group of 15 patients with the combined use of fractional peritoneal dialysis and the stem cells of cord blood. Basing on this study it was found that in patients of control group intestinal paresis was during 5,82±0,2 days. In application of fractional peritoneal dialysis length of intestinal paresis was 2,82±0,9 days, and in the group with complex treatment including cell therapy 2,39 ± 0,7 days. The combined use of fractional peritoneal dialysis and

  18. Single port laparoscopic and open surgical accesses of chronic peritoneal dialysis in children: A single center experience over 12 years

    Science.gov (United States)

    Bıçakcı, Ünal; Genç, Gürkan; Tander, Burak; Günaydın, Mithat; Demirel, Dilek; Özkaya, Ozan; Rızalar, Rıza; Arıtürk, Ender; Bernay, Ferit

    2016-01-01

    INTRODUCTION: The aim of this study was to evaluate patients with end stage renal failure (ESRD) who underwent chronic peritoneal dialysis (CPD). The clinical outcomes of laparoscopic and open placements of catheters were compared. MATERIALS AND METHODS: We reviewed 49 (18 male and 31 female) children with CPD according to age, sex, cause of ESRD, catheter insertion method, kt/V rate, complications, presence of peritonitis, catheter survival rate between January 2002 and February 2014. RESULTS: Thirty-three patients were with open placement and 16 patients were with laparoscopic placement. The rate of the peritonitis is significantly less in patients with laparoscopic access than open access (n = 4 vs n = 25) (P V which indicates the effectiveness of peritoneal dialysis was mean 2.26 ± 0.08. No difference was found between laparoscopic and open methods according to kt/V. CONCLUSION: Laparoscopic placement of CPD results in lower peritonitis rate. Catheter survival rate was excellent in both groups. Single port laparoscopic access for CPD catheter insertion is an effective and safe method. PMID:27073310

  19. Glucose challenge test (50-g GCT) in detection of glucose metabolism disorders in peritoneal dialysis patients: preliminary study

    OpenAIRE

    Madziarska, Katarzyna; Zmonarski, Slawomir; Penar, Jozef; Krajewska, Magdalena; Mazanowska, Oktawia; Augustyniak-Bartosik, Hanna; Gołebiowski, Tomasz; Klak, Renata; Weyde, Waclaw; Klinger, Marian

    2014-01-01

    Background The aim was to evaluate the clinical utility of the oral glucose tolerance screening test (50-g GCT—glucose challenge test) for the detection of glucose metabolism disorders (GMD) in peritoneal dialysis (PD) patients with normal fasting glucose levels. Methods The 50-g GCT was performed in 20 prevalent patients without history of diabetes before PD treatment onset, who had been on dialysis for a median time of 15.34 months. In addition, other indicators of glucose metabolism were m...

  20. A comparison of the quality of life of the patients undergoing hemodialysis versus peritoneal dialysis and its correlation to the quality of dialysis.

    Science.gov (United States)

    Atapour, Abdolamir; Nasr, Salar; Boroujeni, Amir Momeni; Taheri, Diana; Dolatkhah, Shahaboddin

    2016-03-01

    Over the years, there has been a steady increase in the number of patients requiring dialysis. However, no consensus exists between choosing either hemodialysis (HD) or peritoneal dialysis (PD) as the preferred method of dialysis for patients. In this study, we have compared the quality of life of the patients undergoing either HD or PD. This cross-sectional study was performed in the dialysis center of the Noor and Saint Ali Asghar University Hospital in Isfahan, Iran in 2012. Forty-six patients who underwent PD (28 males and 18 females) and 46 similar patients undergoing HD (26 males and 20 females) were compared. A standardized Persian version of the short form-36 (SF-36) tool was used to assess the quality of life and to assess the quality of dialysis weekly Kt/V in patients undergoing PD and single random Kt/V sampling in HD patients were assessed. Patients undergoing PD reported higher scores in physical functioning. The lowest scores in both groups were reported in mental health section. In physical functioning section, physical role functioning section and overall score of the SF-36 tool, PD patients reported significantly higher scores compared to the HD patients (P qualities of the dialysis in the two patient groups. Aspects of quality of life such as physical functioning, physical role functioning, bodily pain, general health perceptions, and overall score were significantly different between the two groups. If these results are substantiated by subsequent longitudinal studies, then the choice of dialysis could be better guided in patients by the quality of life issues.

  1. A comparison of the quality of life of the patients undergoing hemodialysis versus peritoneal dialysis and its correlation to the quality of dialysis

    Directory of Open Access Journals (Sweden)

    Abdolamir Atapour

    2016-01-01

    Full Text Available Over the years, there has been a steady increase in the number of patients requiring dialysis. However, no consensus exists between choosing either hemodialysis (HD or peritoneal dialysis (PD as the preferred method of dialysis for patients. In this study, we have compared the quality of life of the patients undergoing either HD or PD. This cross-sectional study was performed in the dialysis center of the Noor and Saint Ali Asghar University Hospital in Isfahan, Iran in 2012. Forty-six patients who underwent PD (28 males and 18 females and 46 similar patients undergoing HD (26 males and 20 females were compared. A standardized Persian version of the short form-36 (SF-36 tool was used to assess the quality of life and to assess the quality of dialysis weekly Kt/V in patients undergoing PD and single random Kt/V sampling in HD patients were assessed. Patients undergoing PD reported higher scores in physical functioning. The lowest scores in both groups were reported in mental health section. In physical functioning section, physical role functioning section and overall score of the SF-36 tool, PD patients reported significantly higher scores compared to the HD patients (P <0.05. There was no significant difference between the qualities of the dialysis in the two patient groups. Aspects of quality of life such as physical functioning, physical role functioning, bodily pain, general health perceptions, and overall score were significantly different between the two groups. If these results are substantiated by subsequent longitudinal studies, then the choice of dialysis could be better guided in patients by the quality of life issues.

  2. Change management and partnership: achieving a solution to provide peritoneal dialysis in a long-term care setting.

    Science.gov (United States)

    Yang, Charlie; Campbell, Jill

    2009-01-01

    Health care organizations must respond quickly to today's volatile and changing environment. This article describes how St. Michael's Hospital (acute care hospital) and the Drs. Paul and John Rekai Centre (long-term care facility) collaborated to use an innovative approach to address pressures of change affecting peritoneal dialysis (PD) care delivery for the elderly. The collaborative applied Galpin's (1996) nine-stage Change Management Model to implement the organizational change. Both organizations generated a shared vision to improve timely access to nursing homes for patients requiring both placement and ongoing peritoneal dialysis. They analyzed their current status and committed resources for the collaboration. Both organizations generated general and detailed recommendations for PD care delivery processes. A pilot was implemented and refinement of the collaboration occurred prior to formal roll out. This application of a change management model to establish organizational partnership may be of interest to those seeking to establish similar collaborations.

  3. Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients

    OpenAIRE

    Kosaku Nitta; Shinichiro Oguni; Koji Kataoka; Yukio Hamaguchi; Misao Tsukada; Takahiro Mochizuki; Aya Eguchi; Ken Tsuchiya

    2012-01-01

    Hepcidin is the key mediator of renal anemia, and reliable measurement of serum hepcidin levels has been made possible by the ProteinChip system. We therefore investigated the iron status and serum hepcidin levels of peritoneal dialysis (PD) patients who had not received frequent doses of an erythrocytosis-stimulating agent (ESA) and had not received iron therapy. In addition to the usual iron parameters, the iron status of erythrocytes can be determined by measuring reticulocyte hemoglobin (...

  4. Resorption and tolerance of the high doses of ferrous sulfate and ferrous gluconate in the patients on peritoneal dialysis

    OpenAIRE

    Laušević Mirjana; Jovanović Nataša; Ignjatović Svetlana; Grujić-Adanja Gordana; Stojimirović Biljana

    2006-01-01

    Background/Aim. Iron supplementation plays a crucial role in peritoneal dialysis (PD) patients. Oral iron substitution is more convenient than intravenous therapy in PD patients, but impaired absorption and adverse effects may be limiting factors for oral treatment. The aim of this study was to compare the absorption and side effects of high doses ferrous sulphate and ferrous gluconate in PD patients. Methods. Blood samples were taken from 29 PD patients at baseline, as well as 2, 4 and 8 hou...

  5. THE EFFECTS OF A DIALYSIS SOLUTION WITH A COMBINATION OF GLYCEROL/AMINO ACIDS/DEXTROSE ON THE PERITONEAL MEMBRANE IN CHRONIC RENAL FAILURE

    NARCIS (Netherlands)

    M. de Graaff; A.H. Zegwaard; M.M. Zweers; A. Vlijm; D.R. de Waart; F. Vandemaele; D.G. Struijk; R.T. Krediet

    2010-01-01

    Background: Long-term peritoneal dialysis (PD) with conventional glucose based, lactate-buffered PD fluids may lead to morphological and functional alterations of the peritoneal membrane. It was hypothesized that long-term exposure to a different buffer and a mixture of osmotic agents would cause le

  6. Effect of combining different calcium concentration dialysate on calcium balance in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    ZHAO Hui-ping; WU Bei; LU Li-xia; QIAO Jie; WU Xiang-lan; WANG Mei

    2012-01-01

    Background Calcium and phosphorus metabolic disturbance are common in dialysis patients and associated with increased morbidity and mortality.Therefore,maintaining the balance of calcium and phosphate metabolism and suitable intact parathyroid hormone(iPTH)level has become the focus of attention.We investigated the effects of different peritoneal dialysate calcium concentrations on calcium phosphate metabolism and iPTH in continuous ambulatory peritoneal dialysis(CAPD)patients.Methods Forty stable CAPD patients with normal serum calcium were followed for six months of treatment with 1.25 mmol/L calcium dialysate(DCa1.25,PD4,22 patients)or a combination of 1.75 mmol/L calcium dialysate(DCa1.75,PD2)and PD4(18 patients)twice a day respectively.Total serum calcium(after albumin correction),serum phosphorus,iPTH,alkaline phosphatase(ALP)and blood pressure were recorded before and 1,3 and 6 months after treatment commenced.Results No significant difference was found in baseline serum calcium,phosphorus between the two patient groups,but the levels of iPTH were significantly different.No significant changes were found in the dosage of calcium carbonate and active vitamin D during 6 months.In the PD4 group,serum calcium level at the 1st,3rd,6th months were significantly lower than the baseline(P<0.05).There was no significant difference in serum phosphorus after 6 months treatment.iPTH was significantly higher(P<0.001)at the 1st,3rd,and 6th months compared with the baseline.No differences were seen in ALP and blood pressure.In the PD4+PD2 group,no significant changes in serum calcium,phosphorus,iPTH,ALP and BP during the 6-month follow-up period.Conclusions Treatment with 1.25 mmol/L calcium dialysate for six months can decrease serum calcium,increase iPTH,without change in serum phosphorus,ALP,and BP.The combining of PD4 and PD2 can stabilize the serum calcium and avoid fluctuations in iPTH levels.

  7. Environmental NO2 level is associated with 2-year mortality in patients undergoing peritoneal dialysis.

    Science.gov (United States)

    Lin, Jui-Hsiang; Yen, Tzung-Hai; Weng, Cheng-Hao; Huang, Wen-Hung

    2015-01-01

    An ongoing issue related to global urbanization is the association of air pollution with increased incidences of morbidity and mortality. However, no in-depth study has investigated this issue focusing on peritoneal dialysis (PD) patients. Therefore, this study assessed the effects of traffic-related air pollutants and other important mortality-associated factors on 2-year mortality in PD patients.A total of 160 PD patients were recruited in this 2-year retrospective observational study. Differences in air quality were analyzed with respect to the patients' living areas. The PD patients were categorized into 2 groups according to high (n = 65) and low (n = 95) nitrogen dioxide (NO2) exposure. Demographic, hematological, nutritional, inflammatory, biochemical, air pollutants, and dialysis-related data were analyzed. Univariate and multivariate Cox regression analyses were used for 2-year mortality analysis.A total of 160 PD patients (38 men and 122 women) were enrolled. Fourteen patients (8.8%) died within 2 years; among them, the causes of death were infection (n = 10), malignancy (n = 1), and cardiovascular events (n = 3). Among the 10 patients who died from infection, 5, 4, and 1 died from pneumonia, PD-related peritonitis, and sepsis of unknown origin, respectively. All patients who died from pneumonia were living in high environmental NO2 exposure areas. Multivariate Cox regression analysis showed that age (hazard ratio [HR] 1.073, 95% confidence interval [CI] [1.013-1.137]; P = 0.017), white blood cell count (HR 1.41, 95% CI [1.116-1.781]; P = 0.004), log normalized protein nitrogen appearance (HR 0.0001, 95% CI [0-0.073]; P = 0.005), high cardiothoracic ratio (HR 14.28, 95% CI [1.778-114.706]; P = 0.012), and high environmental NO2 exposure (HR 3.776, 95% CI [1.143-12.47]; P = 0.029) were significantly associated with 2-year mortality.PD patients with high environmental NO2 exposure had a higher 2-year mortality rate

  8. High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.

    Directory of Open Access Journals (Sweden)

    Shou-Hsuan Liu

    Full Text Available INTRODUCTION: An elevated level of serum C-reactive protein (CRP is widely considered an indicator of an underlying inflammatory disease and a long-term prognostic predictor for dialysis patients. This cross-sectional cohort study was designed to assess the correlation between the level of high-sensitivity CRP (HS-CRP and the outcome of peritoneal dialysis (PD patients. METHODS: A total of 402 patients were stratified into 3 tertiles (lower, middle, upper according to serum HS-CRP level and and followed up from October 2009 to September 2011. During follow-up, cardiovascular events, infection episodes, technique failure, and mortality rate were recorded. RESULTS: During the 24-month follow-up, 119 of 402 patients (29.6% dropped out from PD, including 28 patients (7.0% who died, 81 patients (20.1% who switched to hemodialysis, and 10 patients (2.5% who underwent kidney transplantation. The results of Kaplan-Meier analysis and log-rank test demonstrated a significant difference in the cumulative patient survival rate across the 3 tertiles (the lowest rate in upper tertile. On multivariate Cox regression analysis, only higher HS-CRP level, older age, the presence of diabetes mellitus (DM, lower serum albumin level, and the occurrence of cardiovascular events during follow-up were identified as independent predictors of mortality. Every 1 mg/L increase in HS-CRP level was independently predictive of a 1.4% increase in mortality. Multivariate Cox regression analysis also showed that higher HS-CRP level, the presence of DM, lower hemoglobin level, lower serum albumin level, higher dialysate/plasma creatinine ratio, and the occurrence of infective episodes and cardiovascular events during follow-up were independent predictors of technique failure. CONCLUSIONS: The present study shows the importance of HS-CRP in the prediction of 2-year mortality and technique survival in PD patients independent of age, diabetes, hypoalbuminemia, and the occurrence of

  9. What is the place of peritoneal dialysis in the integrated treatment of renal failure?

    Science.gov (United States)

    Coles, G A; Williams, J D

    1998-12-01

    The role of peritoneal dialysis (PD) in renal replacement therapy (RRT) remains unclear. There are no controlled trials to provide hard evidence of its efficacy. Comparative studies with haemodialysis from different centres and countries have given conflicting results even when allowing for case mix. Data from the United States on patients starting or receiving treatment in the late 1980s suggested a worse prognosis for older patients, particularly diabetics receiving PD as compared to HD. Analysis of the USRDS data base for patients starting in the early 1990s shows an improvement in outcome but with no difference in overall mortality. The Canadian registry has recently published data showing a better survival with PD than with HD in the first two years of RRT. Morbidity is similar with both therapies, although hospitalization is increased with PD. Unfortunately long-term technique survival is not as good with PD. However, PD has certain medical advantages, particularly the maintenance of residual renal function that contributes to solute and fluid removal. It may also postpone the onset of amyloidosis. Patients transplanted after previous PD have a decreased risk of early acute renal failure and equally good long-term results when compared to those patients who were on HD before transplantation. The quality of life is as good with PD as with center HD, and there are social advantages to PD including an increased chance of employment, more flexible holidays and avoidance of thrice weekly travel to a dialysis center. PD also has logistical advantages and can be utilized by the majority of new patients. We therefore conclude that PD has potential advantages early in the course of RRT, and should therefore be offered as a first option to all suitable new patients. Whether PD has a major or minor role in later years (> 5) remains unclear. PMID:9853290

  10. A new approach to optimizing urea clearances in hemodialysis and continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Nolph, K D; Keshaviah, P; Emerson, P; Van Stone, J C; Twardowski, Z J; Khanna, R; Moore, H L; Collins, A; Edward, A

    1995-01-01

    Recent studies suggest that the relationship of the net normalized protein catabolic rate (which is the normalized protein equivalent of nitrogen appearance [nPNA]) to the weekly clearance of urea normalized to total body water (Kt/V urea) in patients on continuous ambulatory peritoneal dialysis (CAPD) is curvilinear, rather than linear, as has been thought. The authors have reexamined the relationship of nPNA to weekly Kt/V urea in a CAPD population by cross-sectional analysis to see if the curvilinear definition of the relationship is as good as or better than the usual linear description. They also examined this relationship in the hemodialysis populations at the Dialysis Clinics Inc. in Columbia, Missouri, and in the Renal Kidney Disease Program in Minneapolis, Minnesota. It seems obvious that there should be a plateau of nPNA in each therapy because extension of linear regressions would predict protein intakes of normal individuals exceeding 8 g/kg/body weight/day. The authors compared their findings to other published results. Intuitively and analytically, the curvilinear relationships seem likely. The authors observed that the nPNA plateau is achieved at lower Kt/V in patients on CAPD than in those on hemodialysis, which is compatible with the peak concentration hypothesis. Asymptotes for CAPD and hemodialysis are similar. Weekly Kt/V urea requirements to achieve nPNA values at 95% of the asymptote are greater than those usually delivered. However, such nearly complete elimination of uremic appetite suppression may not be practical or necessary for achieving acceptable nutritional status and long-term survival in most patients. Optimum therapy may be well above adequate therapy relative to minimizing appetite suppression by uremia. PMID:8573843

  11. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM study cohort.

    Directory of Open Access Journals (Sweden)

    Wim Van Biesen

    Full Text Available BACKGROUND: Euvolemia is an important adequacy parameter in peritoneal dialysis (PD patients. However, accurate tools to evaluate volume status in clinical practice and data on volume status in PD patients as compared to healthy population, and the associated factors, have not been available so far. METHODS: We used a bio-impedance spectroscopy device, the Body Composition Monitor (BCM to assess volume status in a cross-sectional cohort of prevalent PD patients in different European countries. The results were compared to an age and gender matched healthy population. RESULTS: Only 40% out of 639 patients from 28 centres in 6 countries were normovolemic. Severe fluid overload was present in 25.2%. There was a wide scatter in the relation between blood pressure and volume status. In a multivariate analysis in the subgroup of patients from countries with unrestricted availability of all PD modalities and fluid types, older age, male gender, lower serum albumin, lower BMI, diabetes, higher systolic blood pressure, and use of at least one exchange per day with the highest hypertonic glucose were associated with higher relative tissue hydration. Neither urinary output nor ultrafiltration, PD fluid type or PD modality were retained in the model (total R² of the model = 0.57. CONCLUSIONS: The EuroBCM study demonstrates some interesting issues regarding volume status in PD. As in HD patients, hypervolemia is a frequent condition in PD patients and blood pressure can be a misleading clinical tool to evaluate volume status. To monitor fluid balance, not only fluid output but also dietary input should be considered. Close monitoring of volume status, a correct dialysis prescription adapted to the needs of the patient and dietary measures seem to be warranted to avoid hypervolemia.

  12. [Conservative treatment, hemodialysis or peritoneal dialysis for elderly patients: The choice of treatment does not influence the survival].

    Science.gov (United States)

    Rouveure, Anne-Cécile; Bonnefoy, Marc; Laville, Maurice

    2016-02-01

    Hemodialysis is the predominant replacement therapy in the 70 year-old French population (18% in peritoneal dialysis, 72% in hemodialysis from the REIN registry). Managing older patients reaching the end stage renal disease poses many ethical questions, since outcomes balanced regarding survival and quality of life. The aim of this study was to compare the survival of patients aged over 70 years according to the ESRD treatment choice: conservative treatment without dialysis (CT), hemodialysis (HD) and peritoneal dialysis (PD). We included all patients over 70 years reaching stade IV CKD integrated in a predialysis information program between 01/01/2005 and 31/12/2010. We compared their survival from the start of their program, in function of their treatment choice: HD, PD or CT. On this period, 148 patients were included, we excluded from analysis 17 patients who had a contraindication to PD, 26 patients who did not make a choice because their kidney function was stabilized, 4 patients lost to follow-up and 12 patients who died before the treatment choice. The average age was 79±6 years, 40% of patients were women, and the mean eGFR was 16±9 mL/min/1.73 m(2) at the entry in the program. Among the 89 patients, 21 choose CT (24%), 68 accepted dialysis (76%), including 48 HD (71%) and 20 PD (29%). No significant eGFR difference at the inclusion time between the groups. The time initiation of dialysis was significantly shorter in the PD group (146 days vs 442 in the HD group; P=0.004). Survival between the groups of patients who accepted or refused dialysis was not statistically different (749 days or 2 years in the HD + PD group vs 562 days, or 1 year and 6 months in the CT group; P=0.95) and between the HD group (760 days or 2 years and 2 months) and the PD group (343 days or 11 months; P=0.32). As measured from the time they entered in the predialysis program, the survival of older patients over 70 years does not seem to depend on

  13. Body composition measurements using bioimpedance analysis in peritoneal dialysis patients are affected by the presence of dialysate.

    Science.gov (United States)

    Kang, Seok Hui; Cho, Kyu Hyang; Park, Jong Won; Yoon, Kyung Woo; Do, Jun Young

    2014-11-01

    The presence of peritoneal dialysate when performing bioimpedance analysis may affect body composition measurements. The aim of this study was to evaluate the impact of dialysate on body composition measurements in Asians. Forty-one patients undergoing maintenance peritoneal dialysis in our hospital peritoneal dialysis unit were included in this study. Dialysate was drained from the abdomen prior to measurement, and bioimpedance analysis was performed using multi-frequency bioimpedance analysis, with each subject in a standing position (D-). Dialysate was then administered and the measurement was repeated (D+). The presence of peritoneal dialysate led to an increase in intracellular water (ICW), extracellular water (ECW), and total body water (D-: 20.33 ± 3.72 L for ICW and 13.53 ± 2.54 L for ECW; D+: 20.96 ± 3.78 L for ICW and 14.10 ± 2.59 L for ECW; P bioimpedance analysis. PMID:25307155

  14. Health-related quality of life in patients on hemodialysis and peritoneal dialysis.

    Science.gov (United States)

    Okpechi, Ikechi G; Nthite, Tebogo; Swanepoel, Charles R

    2013-05-01

    Chronic kidney disease (CKD) is a worldwide public health problem, and its treatment imposes a considerable burden on patients and their families. Limitations in everyday activity may worsen the situation and affect the health-related quality of life (HRQOL) of patients with CKD. There are no studies on the HRQOL of dialysis patients in South Africa. We assessed the HRQOL of patients undergoing hemodialysis (HD) and continuous ambulatory peritoneal dialysis (PD) attending the Groote Schuur Hospital renal unit by using the Kidney Disease Quality of Life-Short Form version 1.3 questionnaire. Baseline demographic and clinical details of the participants were recorded. Analysis was performed (unpaired t test and univariate analysis) to compare the HRQOL between HD and PD patients and to identify factors influencing HRQOL. The HRQOL was low but not significantly different between HD and PD patients. In PD patients, the use of erythropoiesis-stimulating agents (ESA) significantly contributed to the emotional well-being (r 2 = 0.267; P = 0.01) and alleviation of pain (r 2 = 0.073; P = 0.049); in HD patients also, ESA use was associated with emotional well-being (r 2 = 0.258; P <0.0001) as well as improvement in energy/fatigue (r 2 = 0.390; P <0.0001). Systolic and diastolic blood pressures significantly influenced cognitive function in PD patients (P <0.05). Parathyroid hormone level significantly influenced the physical functioning and energy/fatigue domains in HD patients (P <0.0001). Serum ferritin (r 2 = 0.441; P = 0.002) and level of hemoglobin concentration (r 2 = 0.180; P = 0.006) were significantly associated with the domain role emotional in PD and HD patients, respectively. Although HRQOL is low in dialysis patients in Cape Town, the factors that have been identified to be associated with these scores (such as anemia and hyperparathyroidism) if aggressively managed and corrected may assist in improving patients' HRQOL.

  15. Health-related quality of life in patients on hemodialysis and peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Ikechi G Okpechi

    2013-01-01

    Full Text Available Chronic kidney disease (CKD is a worldwide public health problem, and its treatment imposes a considerable burden on patients and their families. Limitations in everyday activity may worsen the situation and affect the health-related quality of life (HRQOL of patients with CKD. There are no studies on the HRQOL of dialysis patients in South Africa. We assessed the HRQOL of patients undergoing hemodialysis (HD and continuous ambulatory peritoneal dialysis (PD attending the Groote Schuur Hospital renal unit by using the Kidney Disease Quality of Life-Short Form version 1.3 questionnaire. Baseline demographic and clinical details of the participants were recorded. Analysis was performed (unpaired t test and univariate analysis to compare the HRQOL between HD and PD patients and to identify factors influencing HRQOL. The HRQOL was low but not significantly different between HD and PD patients. In PD patients, the use of erythropoiesis-stimulating agents (ESA significantly contributed to the emotional well-being (r 2 = 0.267; P = 0.01 and alleviation of pain (r 2 = 0.073; P = 0.049; in HD patients also, ESA use was associated with emotional well-being (r 2 = 0.258; P <0.0001 as well as improve-ment in energy/fatigue (r 2 = 0.390; P <0.0001. Systolic and diastolic blood pressures signifi-cantly influenced cognitive function in PD patients (P <0.05. Parathyroid hormone level signi-ficantly influenced the physical functioning and energy/fatigue domains in HD patients (P <0.0001. Serum ferritin (r 2 = 0.441; P = 0.002 and level of hemoglobin concentration (r 2 = 0.180; P = 0.006 were significantly associated with the domain role emotional in PD and HD patients, respectively. Although HRQOL is low in dialysis patients in Cape Town, the factors that have been identified to be associated with these scores (such as anemia and hyperparathyroidism if aggressively managed and corrected may assist in improving patients′ HRQOL.

  16. 全自动腹膜透析机的设计%Design of automated peritoneal dialysis machine

    Institute of Scientific and Technical Information of China (English)

    汪辉; 何建忠; 赵曼曼

    2014-01-01

    Peritoneal dialysis machine is the treatment of acute renal failure , chronic renal failure and uremia medical equipment .This article describes the LPC1768 processor and μC/OS-Ⅱ real-time operating system for smart peritoneal dialysis machine .The system realizes the automatic control timing quantitative infusion timing drain , guide the user to set the parameters of dialysis overweight , over-temperature , flow rate automatic alarm .The dialysis process design is more reasonable security , good real-time performance .Especially suitable for home dialysis , the dialysis machine has obvious advantages in automation and intelligent direction .%腹膜透析机是治疗急性肾功能衰竭、慢性肾功能衰竭和尿毒症的医疗设备。文中介绍了基于LPC1768处理器和μC/OS-Ⅱ实时操作系统的智能腹膜透析机。该系统实现了全自动控制定时定量输液、定时排液、引导用户设置透析参数、过温过重、流速不足自动报警。透析流程设计更加合理安全,实时性良好。特别适用于家庭透析,该腹透机在自动化和智能化方向优势明显。

  17. Sleep disorders and its related risk factors in patients undergoing chronic peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    Li Han; Li Xiaobei; Feng Sujuan; Zhang Guizhi; Wang Wei; Wang Shixiang

    2014-01-01

    Background The prevalence of sleep disorders has been shown to be high in patients with chronic dialysis patients and may contribute to impaired quality of life and higher mortality in this population.However,there are few data on the relationship of sleep disorders and their risk factors in chronic dialysis patients.The aim of this study was to evaluate the relationship of sleep disorders and their risk factors in chronic dialysis patients.Methods A total of 42 continuous ambulatory peritoneal dialysis (CAPD) patients were involved in this cross-sectional study.Sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI).Restless legs syndrome (RLS) was diagnosed according to the criteria of the International Restless Legs Syndrome Study Group.And depression was assessed by Hamilton depression scale.General information and laboratory data were collected.Results The prevalence of sleep disorders was 47.6% in the CAPD patients.According to the PSQI,the 42 CAPD patients were divided into sleep disturbance group and non-sleep disorders group.There were no significant differences in age,gender,dialysis duration,hemoglobin,serum creatinine,urea nitrogen,β2-microglobulin,parathyroid hormone,calcium,and phosphorus between CAPD patients with sleep disorders and those without sleep disorders.But the level of serum albumin (AIb) in CAPD patients with sleep disorders was significantly lower than that in CAPD patients without sleep disorders (31.3±1.4 vs.34.3±3.7,t=3.603,P=0.001).And the prevalence of RLS and depression was significantly higher than that in CAPD patients without sleep disorders (RLS:11/22 vs.1/20,x2=10.395,P=0.001; depression:7/22 vs.1/20,x2=4.886,P=0.027).In CAPD patients with RLS,the prevalence of sleep disorders was significantly higher than that in CAPD patients without RLS (11/22 vs.11/30,x2=10.395,P=0.001).And in CAPD patients with depression,the prevalence of sleep disorders was significantly higher than that in CAPD patients without

  18. [Treatment of acute renal failure--concepts and controversies. 2. Extracorporeal renal replacement and peritoneal dialysis].

    Science.gov (United States)

    Gabriel, A; Müller, E; Tarnow, J

    2001-04-01

    Therapy of prolonged acute renal failure regularly requires a renal replacement therapy. This can be achieved by different extracorporal renal replacement therapies (ERRT) or by peritoneal dialysis. ERRT are classified according to the physical principle underlying toxin elimination as hemodialysis (diffusion) and hemofiltration (convection). Another classification refers to intermittent or continuous application modes. Biocompatibility of membranes is judged according to their activation of the complement system. Prospective randomized studies did not consolidate the assumptions about the benefit of particular modalities proposed on theoretical foundations. Mortality, duration and complication rates of acute renal failure are not significantly decreased by use of biocompatible membranes. Continuous modalities are not generally preferable but optimize treatment in hemodynamically unstable patients, in whom they endorse fluid balancing and maintenance of sufficient arterial blood pressure. The use of demanding hemofiltration techniques for cytokine removal should be limited to clinical studies. The effects of ERRT-"intensity" and the best timing for initiation of ERRT have not been evaluated sufficiently. The choice of the ERRT modality is subject to clinical judgement (criterion: hemodynamic situation), practical aspects (criteria: availability of equipment and handling experience), and costs. Prior to their general use new and expensive technical modalities and membrane types should be thoroughly evaluated in studies with regard to outcome-related aspects such as patient survival and preservation of renal function. PMID:11386089

  19. Nutritional and behavioural aspects of nasogastric tube feeding in infants receiving chronic peritoneal dialysis.

    Science.gov (United States)

    Warady, B A; Kriley, M; Belden, B; Hellerstein, S; Alan, U

    1990-01-01

    Eight infants initiated chronic peritoneal dialysis and received nasogastric tube feedings during their first month of life. In each case, the nasogastric tube feedings were initiated because of poor oral intake and the desire to avert the development of an aversive feeding interaction between parent and child. The nutritional regimen was designed to allow normal or catch up weight gain appropriate for height age. The caloric and protein intake of the infants averaged 98.5 +/- 10.2 kcal/kg/day and 2.7 gm/kg/day, respectively, during the first year of life. Between 25% and 100% of the formula intake was provided by the nasogastric route. Group standard deviation score for height was -1.74 +/- 0.7 at one year. Five of the infants received behavioral therapy because of persistent food refusal. Therapy consisted of reinforcing prompted food acceptance and ignoring food refusal. This approach was conducted by a multidisciplinary team and successfully converted the non-oral feeder to a total oral feeding regimen in each case. PMID:1982822

  20. Estimating urea volume in amputees on peritoneal dialysis by modified anthropometric formulas.

    Science.gov (United States)

    Tzamaloukas, A H; Murata, G H

    1996-01-01

    Body composition determines body water content (the fraction body water/body weight). With developing obesity, body weight and body water increase, but body water content decreases. The anthropometric formulas for urea volume (body water) for Kt/V computations in nonamputated peritoneal dialysis subjects reflect this fundamental rule of body composition. However, the use of uncorrected anthropometric formulas in amputees provides body water content estimates inconsistent with the estimates of body composition obtained from nutritional assessment. Corrected estimates of urea volume can be obtained in three steps: (1) The non-amputated weight at the same body composition is computed by dividing the weight at the urea kinetic study (postamputation) by (1-the fractional weight loss from the amputation); (2) body water and body water content at this nonamputated weight are obtained from the appropriate anthropometric formula; (3) at the time of the urea kinetic study, post-amputation, body water is equal to the estimate of body water content obtained from step 2 times the body weight at the urea kinetic study. The corrected estimates of urea volume provide body water content values agreeing with the estimates from nutritional assessment.

  1. [Treatment of acute renal failure--concepts and controversies. 2. Extracorporeal renal replacement and peritoneal dialysis].

    Science.gov (United States)

    Gabriel, A; Müller, E; Tarnow, J

    2001-04-01

    Therapy of prolonged acute renal failure regularly requires a renal replacement therapy. This can be achieved by different extracorporal renal replacement therapies (ERRT) or by peritoneal dialysis. ERRT are classified according to the physical principle underlying toxin elimination as hemodialysis (diffusion) and hemofiltration (convection). Another classification refers to intermittent or continuous application modes. Biocompatibility of membranes is judged according to their activation of the complement system. Prospective randomized studies did not consolidate the assumptions about the benefit of particular modalities proposed on theoretical foundations. Mortality, duration and complication rates of acute renal failure are not significantly decreased by use of biocompatible membranes. Continuous modalities are not generally preferable but optimize treatment in hemodynamically unstable patients, in whom they endorse fluid balancing and maintenance of sufficient arterial blood pressure. The use of demanding hemofiltration techniques for cytokine removal should be limited to clinical studies. The effects of ERRT-"intensity" and the best timing for initiation of ERRT have not been evaluated sufficiently. The choice of the ERRT modality is subject to clinical judgement (criterion: hemodynamic situation), practical aspects (criteria: availability of equipment and handling experience), and costs. Prior to their general use new and expensive technical modalities and membrane types should be thoroughly evaluated in studies with regard to outcome-related aspects such as patient survival and preservation of renal function.

  2. Comparison of outcomes between surgically placed and percutaneously placed peritoneal dialysis catheters: A retrospective study.

    Science.gov (United States)

    Sivaramakrishnan, R; Gupta, S; Agarwal, S K; Bhowmik, D; Mahajan, S

    2016-01-01

    There is lack of adequate data on comparison of outcomes between percutaneously placed peritoneal dialysis (PD) catheters inserted by nephrologists and PD catheters placed by surgeons. The aim of this study is to retrospectively analyze the outcomes of PD catheters inserted by surgeons (by open surgical or laparoscopic technique) and compare them with those inserted by nephrologists among ESRD patients who underwent elective PD catheter insertions between January 2009 and December 2012. The primary outcome measure was the proportion of catheters removed because of primary nonfunction. The secondary outcome measures were catheter survival, patient survival, and incidence of complications of catheter insertion. A total of 143 PD catheter insertions (88 by surgeons and 55 by nephrologists) performed in 132 patients were considered for the analysis. The primary nonfunction rate of PD catheter insertions in both groups was comparable (18.2% and 7.3%, P = 0.08). Break-in period was shorter in Group N (p = <0.001). No differences were noted in patient or catheter survival. Percutaneously placed PD catheters performed by nephrologists have comparable outcomes with surgically placed PD catheters among selected cases and have the advantage of lower costs, avoidance of operation theater scheduling issues, smaller incision length, and shorter break-in period. Therefore, more nephrologists should acquire the expertise on percutaneous PD catheter placement as it leads to lesser waiting times and better utilization of PD. PMID:27512299

  3. BIOKID: Randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991

    Directory of Open Access Journals (Sweden)

    Misselwitz Joachim

    2004-10-01

    Full Text Available Abstract Background Peritoneal dialysis (PD is the preferred dialysis modality in children. Its major drawback is the limited technique survival due to infections and progressive ultrafiltration failure. Conventional PD solutions exert marked acute and chronic toxicity to local tissues. Prolonged exposure is associated with severe histopathological alterations including vasculopathy, neoangiogenesis, submesothelial fibrosis and a gradual loss of the mesothelial cell layer. Recently, more biocompatible PD solutions containing reduced amounts of toxic glucose degradation products (GDPs and buffered at neutral pH have been introduced into clinical practice. These solutions contain lactate, bicarbonate or a combination of both as buffer substance. Increasing evidence from clinical trials in adults and children suggests that the new PD fluids may allow for better long-term preservation of peritoneal morphology and function. However, the relative importance of the buffer in neutral-pH, low-GDP fluids is still unclear. In vitro, lactate is cytotoxic and vasoactive at the concentrations used in PD fluids. The BIOKID trial is designed to clarify the clinical significance of the buffer choice in biocompatible PD fluids. Methods/design The objective of the study is to test the hypothesis that bicarbonate based PD solutions may allow for a better preservation of peritoneal transport characteristics in children than solutions containing lactate buffer. Secondary objectives are to assess any impact of the buffer system on acid-base status, peritoneal tissue integrity and the incidence and severity of peritonitis. After a run-in period of 2 months during which a targeted cohort of 60 patients is treated with a conventional, lactate buffered, acidic, GDP containing PD fluid, patients will be stratified according to residual renal function and type of phosphate binding medication and randomized to receive either the lactate-containing Balance solution or the

  4. Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a Cross-Sectional Observational Study.

    Directory of Open Access Journals (Sweden)

    Bruna Guida

    Full Text Available p-Cresol is a by-product of the metabolism of aromatic aminoacid operated by resident intestinal bacteria. In patients with chronic kidney disease, the accumulation of p-cresol and of its metabolite p-cresyl-sulphate causes endothelial dysfunction and ultimately increases the cardiovascular risk of these patients. Therapeutic strategies to reduce plasma p-cresol levels are highly demanded but not available yet. Because it has been reported that the phosphate binder sevelamer sequesters p-cresol in vitro we hypothesized that it could do so also in peritoneal dialysis patients. To explore this hypothesis we measured total cresol plasma concentrations in 57 patients with end-stage renal disease on peritoneal dialysis, 29 receiving sevelamer for the treatment of hyperphosphatemia and 28 patients not assuming this drug. Among the patients not assuming sevelamer, 16 were treated with lanthanum whereas the remaining 12 received no drug because they were not hyperphosphatemic. Patients receiving sevelamer had plasma p-cresol and serum high sensitivity C-reactive protein concentrations significantly lower than those receiving lanthanum or no drug. Conversely, no difference was observed among the different groups either in residual glomerular filtration rate, total weekly dialysis dose, total clearance, urine volume, protein catabolic rate, serum albumin or serum phosphate levels. Multiple linear regression analysis showed that none of these variables predicted plasma p-cresol concentrations that, instead, negatively correlated with the use of sevelamer. These results suggest that sevelamer could be an effective strategy to lower p-cresol circulating levels in peritoneal dialysis patients in which it could also favorably affect cardiovascular risk because of its anti-inflammatory effect.

  5. The impact of interventional nephrologists on the growth of a peritoneal dialysis program: Long-term, single-center experience.

    Science.gov (United States)

    Ros-Ruiz, Silvia; Alonso-Esteve, Ángela; Gutiérrez-Vílchez, Elena; Rudas-Bermúdez, Edisson; Hernández, Domingo

    2016-01-01

    Peritoneal dialysis (PD) is an underutilized form of renal replacement therapy. Although a variety of factors have been deemed responsible, timely insertion of a PD catheter may also be a contributory factor. Furthermore, a good catheter implantation technique is important to allow for effective peritoneal access function and long-term technique survival. Studies regarding results obtained by nephrologists in comparison with surgeons have been limited to small single-center experiences. Thus, the objective of this study was to explore the impact of the peritoneal dialysis (PD) catheter insertion by nephrologists compared to surgeons on early catheter complications and on technique survival. We also examine whether PD catheter insertion by nephrologists has a positive impact on the growth in the number of patients using PD. We performed 313 consecutive procedures: 192 catheter insertions and 121 catheter removal from January 1, 2006 to December 31, 2013. The main reasons for catheter removal were: renal transplantation, 52 (43%) follow of transfer to HD, 48 (40%) and catheter malfunction, 16 (13%). The patients were mostly male (63.4%) with the mean age of 50.8±15.1 years and 23.8 were diabetics. We only observed seven (2.5%) early complications (<4 weeks) associated to peritoneal catheter surgery (3 peritonitis episodes, 2 hemoperitoneum episodes, one complicated hernia and one omental entrapment). There were not significant differences in surgery-related complications in both periods. The penetration ratio of PD after 2006 was 117% higher compared with procedures performing before this date. In conclusions, we have demonstrated a positive impact on the growth of the PD population when catheter insertion is performed by nephrologists with a minimal incidence of complications associated.

  6. Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients

    Directory of Open Access Journals (Sweden)

    Hutchison Alastair J

    2013-02-01

    Full Text Available Abstract Background This short-term study assessed the efficacy and safety of lanthanum carbonate in the treatment of hyperphosphatemia in dialysis patients; here, we report a prespecified subgroup analysis of patients undergoing peritoneal dialysis. Methods Men and women (n = 39 who had received continuous ambulatory peritoneal dialysis for chronic kidney disease for 6 months or more were enrolled in eight renal medicine departments in the United Kingdom. A 2-week washout period was followed by a 4-week dose-titration phase during which patients received lanthanum carbonate titrated up to 2250 mg/day. This was followed by a 4-week, randomized, placebo-controlled, parallel-group phase during which patients continued to receive either lanthanum carbonate at the titrated dose, or a matched dose of placebo. The main outcome measure was control of serum phosphate levels (1.3-1.8 mmol/l at the end of the parallel-group phase. Results Serum phosphate was controlled in 3/39 (8% patients at the beginning of the dose-titration phase (after washout and in 18/31 (58% patients treated with lanthanum carbonate at its end. After the parallel-group phase, 60% of lanthanum carbonate-treated patients and 10% of those receiving placebo had controlled serum phosphate. There was no difference in mean (95% confidence interval serum phosphate levels between groups at randomization: lanthanum carbonate, 1.57 (1.34-1.81 mmol/l; placebo, 1.58 (1.40-1.76 mmol/l (p = 0.96. However, a difference was seen at the end of the parallel-group phase: lanthanum carbonate, 1.56 (1.33-1.79 mmol/l; placebo, 2.25 (1.81-2.68 mmol/l (p = 0.0015. There were no clinically important changes in nutritional parameters and no serious treatment-related adverse events were recorded. Conclusions At doses up to 2250 mg/day, lanthanum carbonate is well tolerated and controls hyperphosphatemia effectively. Treatment with higher doses of lanthanum carbonate may allow patients undergoing

  7. Correlation between visceral fat accumulation, leptin and eating disorder in peritoneal dialysis patients

    International Nuclear Information System (INIS)

    Eating disorder may be a major factor for protein-energy malnutrition occurs in patients with chronic renal failure (CRF). Some peritoneal dialysis (PD) patients demonstrate eating disorder in association with massive visceral fat accumulation. Markedly elevated leptin levels have been documented in CRF patients, especially in those who are treated with PD. Leptin is secreted by adipocytes, regulates both body composition and appetite behavior. This study evaluated the correlation between visceral fat accumulation, leptin and eating disorder in PD patients. Plasma leptin, albumin, insulin-like growth factor-1 (IGF-1), normalized protein catabolic rate (nPCR), C-reactive protein (CRP) and body composition were measured in 46 PD patients (27 males and 19 females; median age 62.7 years). Computed tomography was used for determination of visceral fat area (VFA) and subcutaneous fat area (SFA), at the initial state and during PD. The VFA and the SFA increased during PD treatment, and the ratio of increase in each fat area was significantly higher in VFA than in SFA (1.47±0.63 vs. 1.23±0.41 p<0.01, respectively). Serum leptin elevated (19.5±21.9 ng/mL), and correlated significantly with the percentage of body fat (r=0.584), body mass index (BMI: r=0.574), VFA (r=0.476) and SFA (r=0.684). Dietary intake correlated inversely with the visceral fat mass, and the low nPCR group had a higher VFA/BMI ratio (p<0.05). A negative correlation was found between nPCR and either serum leptin (r=-0.52), leptin/BMI (r=-0.44), or CRP (r=-0.55). Our data suggest that visceral fat accumulation and hyperleptinemia in PD patients are closely associated with eating disorder. Therefore, a new peritoneal solution containing an alternative osmotic agent instead of glucose may be useful to prevent accumulation of visceral fat in PD patients. (author)

  8. Prevalence of hyperlipidemia in a cohort of CAPD patients. Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG).

    Science.gov (United States)

    Cocchi, R; Viglino, G; Cancarini, G; Catizone, L; Favazza, A; Tommasi, A; Salomone, M; Segoloni, G P; Torpia, R; Giangrande, A

    1996-01-01

    An association between hyperlipidemia and cardiovascular disease is well described in the literature. We conducted an observational study in order to evaluate the lipid profile, the prevalence of hyperlipidemia and its relationship with age, sex, duration of CAPD, peritoneal glucose load (PGL), serum albumin (ALB), serum glucose (GLU), and BMI in a large cohort of uremics undergoing long-term treatment with CAPD. 457 nondiabetic patients (245 males, 212 females; mean age 63.8 +/- 11.9 years; mean duration of CAPD: 41.8 +/- 26.9 months) treated during 1992 in 25 centers participating in the Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG) were studied. The serum lipid parameters evaluated were triglycerides (TG), total cholesterol (CHO), HDL-cholesterol (HDL). Indications given in the New England Journal of Medicine, SI Unit Conversion Guide, 1992, were adopted for normal ranges. In the whole population the evaluation of lipid parameters showed: TG 227.4 +/- 123.3 mg/dl, CHO 232.8 +/- 56.0 mg/dl, HDL 40.7 +/- 12.0 mg/dl. No differences were found between the two sexes with regard to age, BMI, duration of CAPD, distribution of renal diseases, TG, ALB, and GLU; whereas CHO and HDL were significantly lower in males than in females (CHO: 222.2 +/- 53.5 vs. 245.0 +/- 56.5 mg/dl, p < 0.001; HDL: 39.3 +/- 11.4 vs. 42.6 +/- 12.6 mg/dl, p < 0.05). The prevalence of hypercholesterolemia was significantly lower in males than in females (19.7 vs. 35.4%; p < 0.001). The multiple regression analysis indicated that TG were directly correlated to PGL (p < 0.05), and HDL was inversely correlated with TG (p < 0.001). The coexistence of the two variables (TG and HDL) may increase the risk of cardiovascular events. Further strategies should therefore be developed to select and manage CAPD patients to reduce the incidence of hyperlipidemia.

  9. Mechanical properties of human autologous tubular connective tissues (human biotubes) obtained from patients undergoing peritoneal dialysis.

    Science.gov (United States)

    Nakayama, Yasuhide; Kaneko, Yoshiyuki; Takewa, Yoshiaki; Okumura, Noriko

    2016-10-01

    Completely autologous in vivo tissue-engineered connective tissue tubes (Biotubes) have promise as arterial vascular grafts in animal implantation studies. In this clinical study of patients undergoing peritoneal dialysis (PD) (n = 11; age: 39-83 years), we evaluated human Biotubes' (h-Biotubes) mechanical properties to determine whether Biotubes with feasibility as vascular grafts could be formed in human bodies. We extracted PD catheters, embedded for 4-47 months, and obtained tubular connective tissues as h-Biotubes (internal diameter: 5 mm) from around the catheter' silicone tubular parts. h-Biotubes were composed mainly of collagen with smooth luminal surfaces. The average wall thickness was 278 ± 178 μm. No relationship was founded between the tubes' mechanical properties and patients' ages or PD catheter embedding periods statistically. However, the elastic modulus (2459 ± 970 kPa) and tensile strength (623 ± 314 g) of h-Biotubes were more than twice as great as those from animal Biotubes, formed from the same PD catheters by embedding in the beagle subcutaneous pouches for 1 month, or beagle arteries. The burst strength (6338 ± 1106 mmHg) of h-Biotubes was almost the same as that of the beagle thoracic or abdominal aorta. h-Biotubes could be formed in humans over a 4-month embedding period, and they satisfied the mechanical requirements for application as vascular grafts. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 104B: 1431-1437, 2016.

  10. Peritoneal dialysis for chronic cardiorenal syndrome:Lessons learned from ultrafiltration trials

    Institute of Scientific and Technical Information of China (English)

    Amir; Kazory

    2015-01-01

    The current models of cardiorenal syndrome(CRS) are mainly based on a cardiocentric approach; they assume that worsening renal function is an adverse consequence of the decline in cardiac function rather than a separate and independent pathologic phenomenon. If this assumption were true,then mechanical extraction of fluid(i.e.,ultrafiltration therapy) would be expected to portend positive impact on renal hemodynamics and function through improvement in cardio-circulatory physiology and reduction in neurohormonal activation. However,currently available ultrafiltration trials,whether in acute heart failure(AHF) or in CRS,have so far failed to show any improvement in renal function; they have reported no impact or even observed adverse renal outcomes in this setting. Moreover,the presence or absence of renal dysfunction seems to affect the overall safety and efficacy of ultrafiltration therapy in AHF. This manuscript briefly reviews cardiorenal physiology in AHF and concludes that therapeutic options for CRS should not only target cardio-circulatory status of the patients,but they need to also have the ability of addressing the adverse homeostatic consequences of the associated decline in renal function. Peritoneal dialysis(PD) can be such an option for the chronic cases of CRS as it has been shown to provide efficient intracorporeal ultrafiltration and sodium extraction in volume overloaded patients while concurrently correcting the metabolic consequences of diminished renal function. Currently available trials on PD in heart failure have shown the safety and efficacy of this therapeutic modality for patients with chronic CRS and suggest that it could represent a pathophysiologically and conceptually relevant option in this setting.

  11. Peritoneal Dialysis Reduces the Number of Hospitalization Days in Heart Failure Patients Refractory to Diuretics

    Science.gov (United States)

    Courivaud, Cécile; Kazory, Amir; Crépin, Thomas; Azar, Raymond; Bresson-Vautrin, Catherine; Chalopin, Jean-Marc; Ducloux, Didier

    2014-01-01

    ♦ Background: Previous small studies have reported favorable results of peritoneal dialysis (PD) in the setting of chronic refractory heart failure (CRHF). We evaluated the impact of PD in a larger cohort of patients with CHRF where end-stage renal disease was excluded. ♦ Methods: All patients who received PD therapy for CRHF between January 1995 and December 2010 in two medical centers in France were included in this retrospective study. Baseline characteristics were compared with clinical parameters during the first year after initiation of PD. Mortality, safety, and sustainability of PD were also analyzed. ♦ Results: The 126 patients included had a mean age of 72 ± 11 years and an estimated glomerular filtration rate of 33.5 ± 15.1 mL/min/1.73 m2. Mean time on PD was 16 ± 16.6 months. During the first year, patients with a left ventricular ejection fraction (LVEF) of 30% or less experienced improvement in cardiac function (30% ± 10% vs 20% ± 6%, p < 0.0001). We observed a significant reduction in the number of days of hospitalization for acute decompensated heart failure after PD initiation (3.3 ± 2.6 days/patient-month vs 0.3 ± 0.5 days/patient-month, p < 0.0001). One-year mortality was 42%. ♦ Conclusions: In CRHF, PD significantly reduces the number of days of hospitalization for acute heart failure. Improved LVEF may have led to the comparatively good 1-year survival in this cohort. PMID:23994842

  12. Patient characteristics and risk factors of early and late death in incident peritoneal dialysis patients.

    Science.gov (United States)

    Liu, Xinhui; Huang, Rong; Wu, Haishan; Wu, Juan; Wang, Juan; Yu, Xueqing; Yang, Xiao

    2016-01-01

    This study was conducted to identify key patient characteristics and risk factors for peritoneal dialysis (PD) mortality in terms of different time-point of death occurrence. The incident PD patients from January 1, 2006 to December 31, 2013 in our PD center were recruited and followed up until December 31, 2015. Patients who died in the early period (the first 3 months) were older, had higher neutrophil to lymphocyte ratio (N/L), serum phosphorus, and uric acid level, and had lower diastolic pressure, hemoglobin, serum albumin, and calcium levels. After adjustment of gender, age, and PD inception, higher N/L level [hazard ratio (HR) 1.115, P = 0.006], higher phosphorus lever (HR 1.391, P < 0.001), lower hemoglobin level (HR 0.596, P < 0.001), and lower serum albumin level (HR 0.382, P = 0.017) were risk factors for early mortality. While, presence of diabetes (HR 1.627, P = 0.001), presence of cardiovascular disease (HR 1.847, P < 0.001) and lower serum albumin level (HR 0.720, P = 0.023) were risk factors for late mortality (over 24 months). In conclusion, patient characteristics and risk factors associated with early and late mortality in incident PD patients were different, which indicated specific management according to patient characteristics at the initiation of PD should be established to improve PD patient survival. PMID:27576771

  13. Evaluation of hepatitis B vaccine responsiveness in hemodialysis and peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Salama Elsayed Farag

    2015-09-01

    Full Text Available Background: Hepatitis B Virus (HBV infection is considered as a major cause of liver cirrhosis and hepatocellular carcinoma. Patients with End Stage Renal Disease (ESRD are a risk group for HBV infection. The vaccine of hepatitis B has been recommended for prevention of HBV infection in ESRD patient especially on renal replacement therapy. Methods: Eighty seven patients with ESRD on peritoneal dialysis and hemodialysis requiring primary hepatitis B vaccination were enrolled in the study. Each of them received 40 and micro;g of recombinant hepatitis B vaccine in a four-dose schedule. Antibody response was determined by the levels of antibodies to the hepatitis B surface antigen (anti-HBs after last doses of the vaccination schedule. Results: We observed three response patterns to the immunizations in all patients after vaccination, the nonresponders (24.7% never reached the minimum protective titer of 10 mIU/mL, the poor responders (18.5% had titers between 10 and 100 mIU/mL, and the good responders (56.8% had antibody titers above 100 mIU/mL. Despite a reduction in anti-HBs over time, the good responders did not become unprotected during the observation period, especially those participants who had titers above 1000 mIU/mL after the initial immunization. Conclusions: We concluded that the immune response of the HBV vaccine was reduced in the HD and PD patients, which need yearly re-evaluation of seroconversion with booster doses of HBV vaccination if needed. [Int J Res Med Sci 2015; 3(9.000: 2259-2263

  14. Percutaneous versus laparoscopic placement of peritoneal dialysis catheters: Simplicity and favorable outcome

    Directory of Open Access Journals (Sweden)

    Abdulla K Al-Hwiesh

    2014-01-01

    Full Text Available Implantation of peritoneal dialysis (PD catheters via the laparoscopic technique is expanding, but none of the studies concerning this technique have compared its outcome with the percutaneous insertion done by the nephrologist. We compared the technical survival and outcome of 52 PD catheters placed in 43 patients with end-stage renal disease (ESRD in our center from March 2006 to October 2007. Of these, 27 PD catheters were inserted percutaneously by a nephrologist (group 1 and 25 were placed by a surgeon using the conventional laparoscopic technique (group 2. Very obese patients, those with previous abdominal surgery, and those who refused local anesthesia were excluded from the study. All catheters were evaluated for mechanical and infectious complications and the overall technique survival was analyzed. The incidence of complications in PD catheters did not largely differ between the two groups. Early catheter-related infection episodes (within two weeks of catheter placement occurred in three of 22 (13.6% patients in group 1, versus three of 21 (14.3% patients in group 2 (P >0.05. The incidence of exit site leak was higher in group 2 (19.0% compared to (4.5% group 1 (P 0.05. We conclude that in our study, the percutaneous bedside placements of PD catheters done by nephrologists were comparable with the laparoscopic insertions performed by surgeons where the high-risk patients were avoided, and the former provided a safer and more reliable access that allowed a rapid initiation of PD.

  15. Vitamin D Status Is an Independent Risk Factor for Global Cognitive Impairment in Peritoneal Dialysis Patients.

    Directory of Open Access Journals (Sweden)

    Gui-Ling Liu

    Full Text Available Vitamin D (VD deficiency is an independent risk factor for cognitive impairment (CI in the general population, but VD status in peritoneal dialysis (PD patients has not been investigated. In this study, we aimed to investigate the relationship between serum VD levels and global and specific cognitive functions in PD patients.Cross-sectional study, simultaneously conducted at two PD centers.Clinically stable patients (n = 273 undergoing PD for at least 3 months were enrolled over a period of one year.Demographic and comorbidity data were recorded, and routine biochemical parameters and serum 25-hydroxyvitamin D (25(OH D levels of overnight fasted patients were determined. Global cognitive function was assessed by the Modified Mini-Mental State Examination (3MS score; executive function, by the trail making tests (Trails A and B; and immediate memory, delayed memory, and language ability by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS sub-tests.In the univariate analysis, serum 25(OH D levels significantly correlated with 3MS scores (r = -0.139; P = 0.02, and Trail A (r = -0.188; P = 0.002 and B (r = -0.154; P = 0.01 completion times. In the multivariate analysis, 25(OH D was found to be independently associated with global CI, but not with executive dysfunction. Serum 25(OH D could not predict scores of immediate/delayed memory and language ability.VD deficiency is highly prevalent in PD patients and is an independent risk factor for global CI in this patient cohort.

  16. Is overhydration in peritoneal dialysis patients associated with cardiac mortality that might be reversible?

    Science.gov (United States)

    Oei, Elizabeth; Paudel, Klara; Visser, Annemarie; Finney, Hazel; Fan, Stanley L

    2016-01-01

    AIM To study the relationship between overhydration (OH) in peritoneal dialysis (PD) patients and cardiac mortality. METHODS OH, as measured by body composition monitor (BCM), is associated with increased mortality in dialysis patients. BCM has been used to guide treatment on the assumption that correcting OH will improve cardiac morbidity and mortality although data demonstrating causality that is reversible is limited. We wished to determine if OH in PD patients predicted cardiac mortality, and if there was a correlation between OH and cardiac troponin-T (cTnT) levels. Finally, we wished to determine if improving OH values would lead to a decrement in cTnT. All prevalent PD patients over the study period of 57 mo who had contemporaneous BCM and cTnT measurements were followed irrespective of transplantation or PD technique failure. We also studied a cohort of patients with who had severe OH (> +2L). The Fresenius Body Composition Monitor was used to obtain hydration parameters. cTnT levels were done as part of routine clinical care. Data was analysed using SPSS version 20.0. RESULTS There were 48 deaths in the 336 patients. The patients that died from cardiac or non-cardiac causes were similar with respect to their age, incidence of diabetes mellitus, gender, ethnicity and cause of renal failure. However, the patients with cardiac causes of death had significantly shorter dialysis vintage (10.3 mo vs 37.0 mo, P < 0.0001) and were significantly more overhydrated by BCM measurement (2.95 L vs 1.35 L, P < 0.05). The mean (standard error of the means) hydration status of the 336 patients was +1.15 (0.12) L and the median [interquartile range (IQR)] cTnT level was 43.5 (20-90) ng/L. The cTnT results were not normally distributed and were therefore transformed logarithmically. There was a statistically significant correlation between Log (cTnT) with the OH value (Spearman r value 0.425, P < 0.0001). We identified a sub-group of patients that were severely overhydrated

  17. Clinical importance of intraperitoneal pressure in peritoneal dialysis and measures to counteract its effect on net ultrafiltration.

    Science.gov (United States)

    Flessner, M F

    1999-01-01

    Experiments in animals and in humans have shown that fluid loss from the peritoneal cavity to the body increases with large increments in the intraperitoneal hydrostatic pressure (IPP). We have demonstrated previously that much of this fluid loss occurs to the abdominal wall and is driven by the hydrostatic pressure gradient (i.p. pressure-skin pressure) that develops across the wall whenever therapeutic or pathologic volumes of fluid reside in the cavity. We hypothesized that eliminating the pressure difference across the wall by applying an equal and opposite pressure [abdominal counterpressure (ACP)] would decrease fluid movement into the wall and decrease fluid movement from the cavity. In addition, we hypothesized that net ultrafiltration or net fluid recovery would increase with ACP. To address these hypotheses, we dialyzed rats for 3 hours in the supine position at constant levels of IPP (4, 6, and 8 cmH2O) with isotonic or hypertonic dialysis solutions containing a protein marker of fluid movement. We measured total fluid loss, fluid marker concentration in the abdominal wall, and lymph flow. In separate animals, we repeated the experiments with ACP. Total fluid loss as determined by protein clearance and fluid marker deposition in the abdominal wall was decreased in all experiments. Lymph flow was unchanged by ACP. While ACP increased the net fluid recovery in isotonic dialysis, no change was observed in the hypertonic case. Analogous experiments were carried out in six dialysis patients with or without ACP during a 4-hour dialysis with 1.5% dextrose solution performed in the supine position at i.p. hydrostatic pressure of 4-6 cmH2O. No significant difference was noted in the measured net ultrafiltration between control and ACP studies. We conclude that the careful application of ACP does decrease fluid loss (particularly to the abdominal wall) during isotonic or hypertonic dialysis in the rat. However, ACP results in improved fluid recovery only with

  18. Efficacy and safety of Changfu peritoneal dialysis solution:a multi-center prospective randomized controlled trial

    Institute of Scientific and Technical Information of China (English)

    ZHOU Jian-hui; NI Zhao-hui; MEI Chang-lin; YU Xue-qing; LIU Fu-you; MIAO Li-ning; LIU Zhi-hong

    2013-01-01

    Background A multi-center large scale study is needed to confirm the efficacy and safety of domestic peritoneal dialysis (PD) solutions.Some researchers believe that 6 L/d is enough for adequate dialysis,but there is no multi-center prospective study on Chinese population to confirm this.In this study,we evaluated the efficacy and safety of domestic PD solution (Changfu) and its difference between 6 L and 8 L dosage.Methods Adult PD patients who had taken PD therapy for at least one month were selected and divided into four groups according to two dialysis solution brands and two dialysis dosages,i.e.,6 L dose with Changfu dialysis solution,6 L dose with Baxter dialysis solution,8 L dose with Changfu dialysis solution,and 8 L dose with Baxter dialysis solution.After 48 weeks,the changes of primary and secondary efficacy indices were compared between different types and different dosages.We also analyzed the changes of safety indices.Results Changes of KW from baseline to 48 weeks between Changfu and Baxter showed no statistical differences; so did those of creatinine clearance rate (Ccr).Normalized protein catabolic rate (nPCR) from baseline to 48 weeks between Changfu and Baxter showed no statistical differences; so did those of net ultrafiltration volume (nUF) and estimated glomerular filtration rate (eGFR).Changes of nPCR from baseline to 48 weeks between 6 L and 8 L showed no statistical differences; so did those of nUF and eGFR.The decline of KW from baseline to 48 weeks in 6 L group was more than that in 8 L group.Change of Ccr was similar.During the 48-week period,the mean Kt/V was above 1.7/w,and mean Ccr was above 50 L·1.73 m-2·w-1.More adverse events were found in Changfu group before Changfu Corporation commenced technology optimization,and the statistical differences disappeared after that.Conclusions The domestic PD solution (Changfu) was proven to be as effective as Baxter dialysis solution.During 48-week period,a dosage of 6 L/d was enough for

  19. [Nutritional and Functional assessment of peritoneal dialysis patients in the clinical practice: Report from MITO-DP Group].

    Science.gov (United States)

    Cupisti, Adamasco; D'Alessandro, Claudia; Caselli, Gian Marco

    2016-01-01

    Nutritional abnormalities and physical inactivity are risk factors of increased morbidity and mortality in patients with ESRD. Identify and define malnutrition, in particular protein-energy depletion (PEW), is an important task in the management of renal patients. The aim of this multicenter observational study was to implement the assessment of nutritional status and functional capacity in patients on peritoneal dialysis, including tests and validated methods which are relatively easy to apply in daily clinical practice. The study includes all the 133 prevalent patients (80 m, 53 f, age 65 14 years), in peritoneal dialysis treatment (vintage 26 19 months) in 9 centers in Tuscany. We performed anthropometry, bioimpedance (BIA), clinical biochemistry, evaluation of habitual physical activity (RAPA tests) and performance (Sit-To-Stand test), appetite-evaluation questionnaire, and indices including the Malnutrition Inflammation Score (MIS), Geriatric Nutrition Risk Index (GNRI), Charlson comorbidity index, Barthel and Karnowsky index. The latter showed a condition of dependence in 7.2% and 19.7% of cases, respectively. Poor appetite was recorded in 48.2%. The majority of patients fell within the overweight / obesity range (51%) with waist circumference values associated with increased cardiovascular risk in 51% of males and 60% of females. At the BIA analysis, a BCMI 11, indicative of PEW, took place in 12.7% of cases. The values of the MIS correlated directly with age and the degree of comorbidity and inversely with the sit-to-stand test, RAPA tests and appetite level. The data in this study show that single tests indicative of malnutrition disorders are frequent to be found in our series of peritoneal dialysis patients. However, a diagnosis of PEW is quite infrequent. A large percentage of patients are overweight with increased abdominal adiposity, and reduced cell mass and protein intake below recommended levels; the level of habitual physical activity is low, and

  20. Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea.

    Directory of Open Access Journals (Sweden)

    Ji-Young Choi

    Full Text Available BACKGROUND: The impact of dialysis modality on survival is still somewhat controversial. Given possible differences in patients' characteristics and the cause and rate of death in different countries, the issue needs to be evaluated in Korean cohorts. METHODS: A nationwide prospective observational cohort study (NCT00931970 was performed to compare survival between peritoneal dialysis (PD and hemodialysis (HD. A total of 1,060 end-stage renal disease patients in Korea who began dialysis between September 1, 2008 and June 30, 2011 were followed through December 31, 2011. RESULTS: The patients (PD, 30.6%; HD, 69.4% were followed up for 16.3 ± 7.9 months. PD patients were significantly younger, less likely to be diabetic, with lower body mass index, and larger urinary volume than HD patients. Infection was the most common cause of death. Multivariate Cox regression with the entire cohort revealed that PD tended to be associated with a lower risk of death compared to HD [hazard ratio (HR 0.63, 95% confidence interval (CI 0.36-1.08]. In propensity score matched pairs (n=278 in each modality, cumulative survival probabilities for PD and HD patients were 96.9% and 94.1% at 12 months (P=0.152 and 94.3% and 87.6% at 24 months (P=0.022, respectively. Patients on PD had a 51% lower risk of death compared to those on HD (HR 0.49, 95% CI 0.25-0.97. CONCLUSIONS: PD exhibits superior survival to HD in the early period of dialysis, even after adjusting for differences in the patients' characteristics between the two modalities. Notably, the most common cause of death was infection in this Korean cohort.

  1. The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

    Science.gov (United States)

    Perl, Jeffrey; Nessim, Sharon J; Bargman, Joanne M

    2011-04-01

    For patients on peritoneal dialysis (PD), the development of peritonitis, the decline of residual kidney function, and the loss of peritoneal membrane function are central events that affect both patient and technique survival. The use of glucose as the osmotic agent in conventional PD solutions may increase the susceptibility to each of these events. However, its use may also be associated with systemic metabolic perturbations and, in turn, an increase in cardiovascular morbidity. Both in vitro and in vivo evidence suggest that both the local peritoneal and systemic toxicity induced by the use of glucose may be in part mediated by the presence of glucose degradation products (GDPs) coupled with the hyperosmolarity, reduced pH, and use of lactate as the buffer in conventional PD solutions. Therefore, the use of neutral pH, low-GDP (NpHL(GDP)), bicarbonate-buffered PD solutions may represent a promising strategy to attenuate some of these adverse effects. However, the impact of these novel solutions on clinical outcomes remains largely unknown. In this review, we will highlight evidence regarding the biocompatibility of NpHL(GDP) PD solutions, review the utility of current biomarkers in the evaluation of biocompatibility, and discuss the clinical outcome data with these solutions.

  2. Research Progress in Chronic Inflammatory State of Peritoneal Dialysis Patients%腹膜透析患者慢性炎症状态研究进展

    Institute of Scientific and Technical Information of China (English)

    白鸽

    2013-01-01

    Peritoneal dialysis is one of the effective treatment of end-stage renal disease,which can substitute parts of renal function.Because not all of the functions of the kidney can be substituted by peritoneal dialysis,many factors in vivo still affect the patients for long-term survival.Chronic inflammation is highly prevalent in long-term peritoneal dialysis population.The causes of inflammation are usually complex and multifactorial,involving both dialysis-related and dialysis-unrelated factors.The elevated inflammatory factors have negative influence on the peritoneal structure and function,cardiovascular system,nutritional status,residual renal function,dialysis sufficiency and quality of life.How to reduce inflammatory state and improve the peritoneal dialysis patients' survival rate are the research hotspots.%腹膜透析(PD)是终末期肾脏疾病治疗的有效方法之一,可替代肾脏的部分功能.由于PD不能代替肾脏的全部功能,体内仍然存在许多影响患者长期生存的因素.长期接受PD的患者体内普遍存在慢性炎症状态,其原因是复杂的、多种因素共同参与的,主要包括透析相关性及非透析相关性因素.体内炎性因子的增高对腹膜结构与功能、心血管系统、营养状况、残肾功能、透析充分性以及生存质量都有不利影响.如何减轻炎症状态,提高PD患者生存率是目前研究的热点.

  3. Peritoneal dialysis related peritonitis:related factors analysis and nursing methods progress review%腹膜透析并发腹膜炎的相关因素分析及护理进展

    Institute of Scientific and Technical Information of China (English)

    卢建发

    2015-01-01

    To control the complications of peritoneal dialysis and to reduce the occurrence rate of peritonitis, improvements in following aspects are to be considered in clinical treatment and nursing of patients receiving peritoneal dialysis: choosing superior peritoneal dialysis tubes and dressing material of good sterilization ability; using appropriate peritoneal dialysate; instruction to the patients and the family members on how to conduct care of the skin and the dialysis tubes; continuous monitoring and evaluating of the patients' nutritional status; regular follow-up and review. The improvement in the above factors can improve the quality of life and extend the lifetime of the patients.%为控制腹膜透析的并发症,选择优等的腹膜透析管、杀菌能力较好的敷料、合适的腹膜透析液,教会患者及家属对皮肤和导管的自我护理,加强对患者营养状况评估、按照规范定期随访、持续的改进和提高腹膜透析质量,是预防和减少腹膜炎的发生、提高患者生存质量、延长生存期限的关键。

  4. Health-related quality of life as a predictor of mortality in patients on peritoneal dialysis1

    Science.gov (United States)

    de Oliveira, Marília Pilotto; Kusumota, Luciana; Haas, Vanderlei José; Ribeiro, Rita de Cássia Helú Mendonça; Marques, Sueli; Oller, Graziella Allana Serra Alves de Oliveira

    2016-01-01

    Objective: to characterize deaths that occurred, and the association between socio-demographic, clinical, laboratory variables and health-related quality of life and the outcome of death in patients on peritoneal dialysis, over a two year period after an initial assessment. Method: observational, prospective population study with 82 patients on peritoneal dialysis. The instruments used for the first stage of data collection were the mini-mental state examination, a sociodemographic, economic, clinical and laboratory questionnaire and the Kidney Disease and Quality of Life-Short Form. After two years, data for characterization and occurrence of death in the period were collected. The relative risk of death outcome was calculated through statistical analysis; the risk of death was estimated by the survival Kaplan-Meier curve, and determined predictors of death by the Cox Proportional Hazards Model. Results: of the 82 original participants, 23 had as an outcome death within two years. The increased risk for the outcome of death was associated with a lower mean score of health-related quality of life in the physical functioning domain. Conclusion: the worst health-related quality of life in the physical functioning domain, could be considered a predictor of death. PMID:27192413

  5. Association of Body Mass Index and Body Mass Index Change with Mortality in Incident Peritoneal Dialysis Patients

    Directory of Open Access Journals (Sweden)

    Liping Xiong

    2015-10-01

    Full Text Available Although high body mass index (BMI appears to confer a survival advantage in hemodialysis patients, the association of BMI with mortality in continuous ambulatory peritoneal dialysis (CAPD patients is uncertain. We enrolled incident CAPD patients and BMI was categorized according to World Health Organization classification for Asian population. BMI at baseline and one year after the initiation of peritoneal dialysis (PD treatment was assessed to calculate the BMI change (∆BMI. Patients were split into four categories according quartiles of ∆BMI. Kaplan-Meier method and Cox regression proportional hazard analysis were performed to assess the association of BMI on outcomes. A total of 1263 CAPD patients were included, with a mean age of 47.8 ± 15.0 years, a mean BMI of 21.58 ± 3.13 kg/m2. During a median follow-up of 25.3 months, obesity was associated with increased risk for cardiovascular diseases (CVD death (adjusted hazard ratio (AHR 2.01; 95% CI 1.14, 3.54, but not all-cause mortality. Additionally, patients with more BMI decline (>0.80% during the first year after CAPD initiation had an elevated risk for both all-cause (AHR: 2.21, 95% CI 1.23–3.95 and CVD mortality (AHR 2.31, 95% CI 1.11, 4.84, which was independent of baseline BMI values.

  6. Expression of aquaporin-1 in the human peritoneum and the effect of peritoneal dialysis on its expression

    Institute of Scientific and Technical Information of China (English)

    方炜; 钱家麒; 余志远; 陈诗书

    2003-01-01

    Objective To investigate the expression of aquaporin-1 (AQP1) in the human peritoneum and to evaluate the effect of peritoneal dialysis (PD) on its expression.Methods Peritoneal biopsies were obtained from normal subjects (n=10), uremic nondialysis patients (n=12) at catheter insertion and PD patients (n=10) at the time of catheter removal, reinsertion or renal transplantation. Western blot, immuno-histochemical staining and reverse transcript-polymerase chain reaction (RT-PCR) techniques were used to investigate AQP1 expression.Results All peritoneal samples expressed AQP1 at both mRNA and protein levels. Western blot revealed a major band at 28 kD as well as more diffuse bands between 35 and 50 kD. The 28 kD band represents the nonglycosylated form of the protein while the 35-50 kD bands correspond to glycosylated AQP1. Immunohistochemical staining found the positive deposits were distributed in the mesothelial cells, endothelial cells of capillaries, venules and small veins, whereas no signal was detected in the arterioles. Semi-quantitative analysis showed that AQP1 expression was remarkably stable in all samples, whatever their origin (P>0.05).Conclusions Our findings suggested that AQP1 is the molecular counterpart of an ultra small pore during PD. Secondly, the peritoneal mesothelial cell might also be involved in peritoneal transcellular water transport. As regards whether or not the structural or distributional alterations of AQP1 in the peritoneum may be more obviously expressed during PD, further study is needed.

  7. Estudo descritivo sobre a prática da diálise peritoneal em domicílio Descriptive study about the practice of home peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Sarah Silva Abrahão

    2010-03-01

    Full Text Available INTRODUÇÃO: A partir da vivência no atendimento de crianças/adolescentes portadores de doença renal crônica (DRC em tratamento dialítico no ambiente hospitalar pensou-se que aspectos seriam relevantes para a aplicação da diálise peritoneal domiciliar. O objetivo deste estudo foi descrever o nível de escolaridade e de informação do cuidador sobre a técnica de diálise peritoneal (DP, a renda familiar e condições gerais do local de realização da diálise e buscar associação com a realização inadequada da técnica. MÉTODO: Trata-se de um estudo descritivo do universo de 30 crianças e adolescentes com DRC assistidos pelo HC/UFMG no período de março de 2004 a maio de 2006. Os dados foram analisados utilizando-se o software SPSS versão 13.0. As seguintes variáveis foram testadas como possíveis fatores de risco para inadequação da técnica de diálise: escolaridade do cuidador, renda familiar, nível de informação do cuidador sobre a técnica de diálise, antissepsia das mãos, ausência de pia no quarto da diálise. RESULTADOS: A qualidade de aplicação da técnica de DP foi considerada inadequada em 18 (60% pacientes. Todos os valores de Odds Ratio estiveram dentro dos limites dos intervalos de confiança (95% e foram > 1, indicando a possibilidade de associação positiva entre a variável independente e a variável pesquisada, embora sem diferença estatística significativa. CONCLUSÕES: A análise estatística não mostrou associação entre as variáveis, entretanto acredita-se que elas exercem um papel positivo para o sucesso da aplicação da técnica dialítica.INTRODUCTION: As experienced with the assistance evaluation of children/adolescents with chronic kidney disease in dialysis treatment on hospital we thought about which aspects could be relevant to the peritoneal dialysis (PD application at home. The objective was to describe the level of schooling and information of the parents about the PD technique

  8. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.

    Science.gov (United States)

    Fan, Yu-Pei; Hsia, Ching-Chih; Tseng, Kuang-Wen; Liao, Chih-Kai; Fu, Tz-Win; Ko, Tsui-Ling; Chiu, Mei-Miao; Shih, Yang-Hsin; Huang, Pei-Yu; Chiang, Yi-Chia; Yang, Chih-Ching; Fu, Yu-Show

    2016-02-01

    A major complication in continuous, ambulatory peritoneal dialysis in patients with end-stage renal disease who are undergoing long-term peritoneal dialysis (PD) is peritoneal fibrosis, which can result in peritoneal structural changes and functional ultrafiltration failure. Human umbilical mesenchymal stem cells (HUMSCs) in Wharton's jelly possess stem cell properties and are easily obtained and processed. This study focuses on the effects of HUMSCs on peritoneal fibrosis in in vitro and in vivo experiments. After 24-hour treatment with mixture of Dulbecco's modified Eagle's medium and PD solution at a 1:3 ratio, primary human peritoneal mesothelial cells became susceptible to PD-induced cell death. Such cytotoxic effects were prevented by coculturing with primary HUMSCs. In a rat model, intraperitoneal injections of 20 mM methylglyoxal (MGO) in PD solution for 3 weeks (the PD/MGO 3W group) markedly induced abdominal cocoon formation, peritoneal thickening, and collagen accumulation. Immunohistochemical analyses indicated neoangiogenesis and significant increase in the numbers of ED-1- and α-smooth muscle actin (α-SMA)-positive cells in the thickened peritoneum in the PD/MGO 3W group, suggesting that PD/MGO induced an inflammatory response. Furthermore, PD/MGO treatment for 3 weeks caused functional impairments in the peritoneal membrane. However, in comparison with the PD/MGO group, intraperitoneal administration of HUMSCs into the rats significantly ameliorated the PD/MGO-induced abdominal cocoon formation, peritoneal fibrosis, inflammation, neoangiogenesis, and ultrafiltration failure. After 3 weeks of transplantation, surviving HUMSCs were found in the peritoneum in the HUMSC-grafted rats. Thus, xenografts of HUMSCs might provide a potential therapeutic strategy in the prevention of peritoneal fibrosis. Significance: This study demonstrated that direct intraperitoneal transplantation of human umbilical mesenchymal stem cells into the rat effectively

  9. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Sesso, R; Parisio, K; Dalboni, A; Rabelo, T; Barbosa, D; Cendoroglo, M; Pignatari, A; Draibe, S; Ajzen, H

    1994-06-01

    The effectiveness of sodium fusidate and ofloxacin to eliminate nasal and catheter exit-site Staphylococcus aureus colonization and to prevent infections was compared in 31 patients on continuous ambulatory peritoneal dialysis (CAPD). In a prospective randomized study, 9 patients were treated with topical 2% sodium fusidate ointment applied in the anterior nares and in the pericatheter skin twice daily for 5 days; 9 subjects received oral ofloxacin 200 mg taken every 48 hours for 5 days and 13 subjects were in the control group. Treatment courses were repeated at one-month intervals. Mean duration of follow-up was 7.8 months (242 patients-month). Follow-up samples from the nares and the catheter exit-site were obtained every month from all participants to determine the presence of S. aureus. Development of S. aureus exit-site infection and peritonitis were assessed. During the study, S. aureus was recovered from 45%, 59% and 52% of the samples from the nares and/or exit-site in the sodium fusidate, ofloxacin and control groups, respectively (p = 0.13). S. aureus grew less frequently (p 0.50). The corresponding figures for exit-site eradication were 43%, 33% and 11%, respectively (p = 0.34). Twenty-four S. aureus-associated infection episodes (12 of exit-site and 12 of peritonitis) were diagnosed in 16 of the 31 patients.(ABSTRACT TRUNCATED AT 250 WORDS) PMID:8076441

  10. A Cost Evaluation of Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil

    OpenAIRE

    de Abreu, Mirhelen Mendes; Walker, David R.; Sesso, Ricardo C; Ferraz, Marcos B

    2013-01-01

    ♦ Objective: Conventional hemodialysis (HD) predominates over peritoneal dialysis (PD) around the world. Prospective and comparative studies comparing the costs of these modalities are scarce. In the present prospective assessment, we describe the resources used and total patient costs for both HD and PD.

  11. Effects of starting hemodialysis with an arteriovenous fistula or central venous catheter compared with peritoneal dialysis: a retrospective cohort study

    Directory of Open Access Journals (Sweden)

    Coentrão Luis

    2012-08-01

    Full Text Available Abstract Background Although several studies have demonstrated early survival advantages with peritoneal dialysis (PD over hemodialysis (HD, the reason for the excess mortality observed among incident HD patients remains to be established, to our knowledge. This study explores the relationship between mortality and dialysis modality, focusing on the role of HD vascular access type at the time of dialysis initiation. Methods A retrospective cohort study was performed among local adult chronic kidney disease patients who consecutively initiated PD and HD with a tunneled cuffed venous catheter (HD-TCC or a functional arteriovenous fistula (HD-AVF in our institution in the year 2008. A total of 152 patients were included in the final analysis (HD-AVF, n = 59; HD-TCC, n = 51; PD, n = 42. All cause and dialysis access-related morbidity/mortality were evaluated at one year. Univariate and multivariate analysis were used to compare the survival of PD patients with those who initiated HD with an AVF or with a TCC. Results Compared with PD patients, both HD-AVF and HD-TCC patients were more likely to be older (pp = 0.017 and cardiovascular disease (p = 0.020. Overall, HD-TCC patients were more likely to have clinical visits (p = 0.069, emergency room visits (ppvs. 0.93 vs. 0.64, per patient-year; pvs. 0.07 vs. 0.14, per patient-year; p = 0.034 than HD-AVF and PD patients, respectively. The survival rates at one year were 96.6%, 74.5% and 97.6% for HD-AVF, HD-TCC and PD groups, respectively (pp = 0.024. Conclusion Our results suggest that HD vascular access type at the time of renal replacement therapy initiation is an important modifier of the relationship between dialysis modality and survival among incident dialysis patients.

  12. Síndrome metabólico en diálisis peritoneal Metabolic syndrome in peritoneal dialysis

    OpenAIRE

    Francisco Cirera Segura; Jesús Lucas Martín Espejo

    2011-01-01

    Introducción: El síndrome metabólico es una agrupación de factores de riesgo cardiovascular de origen metabólico. Nos planteamos: • Determinar la prevalencia del síndrome metabólico en diálisis peritoneal y ver su evolución. • Valorar su influencia sobre la mortalidad. • Revisar las intervenciones de Enfermería destinadas a prevenirlo. Material y Métodos: Se realizó un estudio descriptivo retrospectivo de 5 años. Se utilizó la clasificación de criterios diagnósticos del síndrom...

  13. Metabolite Characterization in Peritoneal Dialysis Effluent Using High-resolution 1H and 1H-13C NMR Spectroscopy

    CERN Document Server

    Guleria, Anupam; Rawat, Atul; Khetrapal, C L; Prasad, Narayan; Kumar, Dinesh

    2014-01-01

    Metabolite analysis of peritoneal dialysis (PD) effluent may provide information regarding onset and progression of complications associated with prolonged PD therapy. In this context, the NMR detectable small metabolites of PD effluent samples were characterized using high resolution 1H and 1H-13C NMR spectroscopy. The various spectra were recorded (at 800 MHz proton frequency) on PD effluent samples obtained after 4 hour (intraperitoneal) dwell time from patients with end stage renal failure (ESRF) and continuing normally on PD therapy. Inspite of devastating spectral feature of PD effluent due to the presence of intense resonances from glucose and lactate, we were able to identify about 53 small endogenous metabolites (including many complex coupled spin systems) and more than 90 % of the total CH cross peaks of 1H-13C HSQC spectrum were identified specific to various metabolites of PD effluent. We foresee that the characteristic fingerprints of various metabolites of control PD effluent samples will be us...

  14. Bowel Obstruction and Peritoneal Dialysis: A Case Report of a Patient with Complications from a Broad Ligament Hernia

    Science.gov (United States)

    Otani-Takei, Naoko; Akimoto, Tetsu; Sadatomo, Ai; Saito, Osamu; Muto, Shigeaki; Kusano, Eiji; Nagata, Daisuke

    2016-01-01

    Abdominal hernias are a common cause of bowel obstruction. The major types of abdominal hernias are external or abdominal wall hernias, which occur at areas of congenital or acquired weakness in the abdominal wall. An alternative entity is internal hernias, which are characterized by a protrusion of viscera through the peritoneum or mesentery. We herein present the case of a female peritoneal dialysis patient with bowel obstruction due to an internal hernia. Although an initial work-up did not lead to a correct diagnosis, an exploratory laparotomy revealed that she had intestinal herniation due to a defect in the broad ligament of the uterus, which was promptly corrected by surgery. The concerns about the perioperative dialytic management as well as the diagnostic problems regarding the disease that arose in our experience with the present patient are also discussed.

  15. The Effectiveness of Local Hypothermia and Peritoneal Lavage-Dialysis in the Treatment of Patients with Acute Destructive Pancreatitis

    Directory of Open Access Journals (Sweden)

    Veniamin I. Shaposhnikov, PhD, ScD

    2012-12-01

    Full Text Available The aim of this study was to improve the principles of the pathogenetic therapy of acute pancreatitis and assess the effectiveness of local hypothermia of the pancreas, as well as peritoneal lavage-dialysis in the treatment of acute destructive pancreatitis. A total of 5889 patients with acute pancreatitis (AP were examined. The leading role played by the lesions of the pancreatic lymphatic system in the development of destructive processes was noted. In experiments done on eight dogs, the first day of experimental acute pancreatitis showed necrosis of the lumbar retroperitoneal lymph nodes with a violation of lymph drainage from the pancreas before the retroperitoneal fat necrosis was initiated. The effectiveness of local hypothermia of the pancreas was experimentally demonstrated. In 32 patients with AP, the perioperative local hypothermia of the pancreas for 20-25 minutes was followed by the reduction of the alpha-amylase activity in the peripheral blood and in the portal system, as well as a significant reduction in the edema of the pancreas, that delayed the progression of the destructive lesions. An effective method of performing lavage-dialysis of the omental bursa, by using a transversely perforated tube with a pollution control device in the lumen, was developed.

  16. The effect of dwell time on dialysate cancer antigen 125 appearance rates in patients on continuous ambulatory peritoneal dialysis.

    Science.gov (United States)

    Akman, Sema; van Westrhenen, Roos; De Waart, Dirk R; Hiralall, Johan K; Zweers, Machteld M; Krediet, Raymond T

    2003-01-01

    The dialysate concentration of cancer antigen 125 (CA125) can be considered a reflection of mesothelial cell mass or turnover in stable continuous ambulatory peritoneal dialysis (CAPD) patients. The effect of dwell times exceeding 4 hours on CA125 appearance rate (CA125AR) is not known. Therefore, our objective in the present study was to analyze the effect of dwell time on CA125AR in stable CAPD patients. In 43 stable CAPD patients, we analyzed standard peritoneal permeability analyses (SPAs) performed with a 3.86% glucose dialysate, and night-dwell effluents from the night dwell prior to the SPA. Dialysate CA125 concentration was measured by radioimmunoassay (RIA II: Fujirebio Diagnostics, Malvern, PA, U.S.A.). Night-dwell CA125 correlated with the duration of the dwell (r = 0.32, p = 0.04) and with the CA125 concentration in the 4-hour dwell (r = 0.83, p < 0.001). The mean CA125AR in the SPA effluent was 97.8 +/- 46.3 U/min; in the overnight effluent, it was 108.8 +/- 73.7 U/min (nonsignificant). A good correlation was present between the CA125AR in the 4-hour dwells and in the overnight dwells (r = 0.82, p < 0.001). We conclude that using night dwells to regularly assess dialysate CA125--for instance, at every out-patient visit--is possible in CAPD patients, provided that appearance rate is calculated.

  17. The Vasopressin 2 Receptor Antagonist Tolvaptan Improves Nutrition and Inflammatory States in Peritoneal Dialysis Patients with Diabetes Mellitus.

    Science.gov (United States)

    Hiramatsu, Takeyuki; Asai, Kazuki; Ozeki, Akiko; Saka, Marie; Hobo, Akinori; Furuta, Shinji

    2015-01-01

    Previously, we reported that, in peritoneal dialysis (PD) patients, tolvaptan preserves residual renal function and ameliorates left ventricular hypertrophy. Here, we evaluated the effect of tolvaptan in terms of nutrition and inflammatory states. Of 24 incident PD patients with diabetes, 12 were assigned to a control group that did not receive tolvaptan, and 12, to a group that, 2 weeks after initiation of PD, received tolvaptan 15 mg daily for 12 months. At baseline and at 6 and 12 months after initiation of PD, we evaluated serum C-reactive protein (CRP), albumin, urine volume, peritoneal ultrafiltration (UF), phosphate elimination, protein uptake, left ventricular mass index (LVMI), and the diameter of the inferior vena cava (IVC). Compared with the control group, the tolvaptan group experienced preserved urine volume and UF, lower LVMI and IVC diameter, and higher protein uptake. The average protein uptake was significantly correlated with urine volume, albumin, and CRP; and serum CRP was significantly correlated with albumin. Our study results suggest that tolvaptan improves not only fluid management, but also nutrition state in PD patients.

  18. Peritoneal

    Institute of Scientific and Technical Information of China (English)

    2008-01-01

    2008071 Effect of overexpression of Smad7 on epithelial-mesenchymal transition of mesothelial cells in rat peritoneal fibrosis model. SUN Yanyan(孙艳艳), et al. Dept Nephrol, 1st Affili Hosp, Sun Yat-sen Univ, Guangzhou 510080. Chin J Nephrol 2007;23(12):784-788. Objective To explore the effect of overexpression of Smad7 on epithelial-mesenehymal transition (EMT) of mesothelial cells in rat peritoneal fibrosis model. Methods Thirty rats were randomly

  19. Comparison of quality of life and causes of hospitalization between hemodialysis and peritoneal dialysis patients in China

    Directory of Open Access Journals (Sweden)

    Sun Ling-Hua

    2007-08-01

    Full Text Available Abstract Background Hemodialysis (HD and peritoneal dialysis (PD are important renal replacement treatment in end stage renal disease (ESRD, but the comparison of quality of life (QOL and causes of hospitalisation between the two modalities in China is lacking. In the present study, we compared the two modalities in a multi-center study. Subjects and methods Six hundred and fifty four HD and 408 PD patients were investigated from 10 hospitals in China from Sept, 2004 to Jan, 2005. Among the HD patients, there were 360 males and 294 females with a mean age of 57.22 ± 12.49 years (18–88 y. Among PD patients, there were 165 males and 243 females, with a mean age of 61.59 ± 12.65 years (22–89 y. Health related 36 items short form questionnaires (SF-36 were used to assess the quality of life. Hospitalisation data were collected and analyzed. Results SF-36 domains of Body Pain (BP, General Health (GH, Role-Emotional (RE, Social Functioning (SF, Vitality (VT and Mental Health (MH were all significantly higher in the PD patients as compared to the HD patients although there was no significant difference in Physical Functioning (PF and Role-Physical (RP between the two groups. The two most common causes of hospitalisation in HD patients were cardiovascular disease (39.8% and pulmonary infection (21.3%, while they were infectious peritonitis (47.6% and cardiovascular disease (31.9% in PD patients. The ever hospitalised patients had lower SF-36 scores in the domains of PF, BP, GH, RE, SF, VT and MH as compared to those of non-hospitalised patients. Conclusion Our study indicated that with the current practice in China, PD patients may enjoy better quality of life than their HD counterparts. Our results also showed that the most common cause of hospitalisation was cardiovascular disease in HD patients and peritonitis in PD patients.

  20. 腹膜透析患者的营养管理%Management of nutrition in patients undergoing peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    李伟

    2015-01-01

    Patients undergoing peritoneal dialysis (PD)generally have malnutrition,which is the main reason for low survival,high hospitalization rate,and high mortality rate.The reasons for malnutrition are complex,including inflammation,inadequate dialysis,protein and calorie intake insufficiency,protein loss in the process of dialysis,high peritoneal transport,residual renal function (RRF)decline,chronic acidosis,high catabolism,and complications,that are all involved in the development and progression of malnutrition of PD patients. Malnutrition assessment requires a comprehensive judgement through a combination of history and examination indicators,such as subjective global assessment (SGA),protein nitrogen appearance rate (PNA),biochemical indicators,dual energy x-ray absorptiometry (DEXA),and bioimpedance analysis (BIA).It requires various comprehensive management to improve malnutrition in PD patients,including managing dietary intake,maintainning adequate dialysis dose,protecting RRF,and correcting acidosis;at the same time,attention should be paid to active prevention and treatment of peritonitis,maintainning the best balance of body fluids,using dialysate with good biocompatibility,and using drugs.%腹膜透析(PD)患者普遍存在营养不良,而营养不良是 PD 患者低生存率、高住院率、高死亡率的主要原因。PD 患者营养不良的原因复杂,炎症、透析不充分、蛋白与热量摄入不足、透析过程中蛋白质丢失、腹膜高转运、残余肾功能下降、慢性酸中毒、高分解代谢、各种并发症等,都参与了营养不良的发生发展。营养不良的评估需要结合病史和检查的各项指标来综合判定,如主观全面营养状态评价(SGA)、生化指标、蛋白质相当的总氮呈现率(PNA)、双能 X 射线吸收法(DEXA)、生物电阻抗分析(BIA)等。改善 PD 患者的营养不良需要进行多方面综合管理,如管理膳食摄入、保持足够的透

  1. Weight change during the first year of peritoneal dialysis: Risk factors and prognostic implications

    Directory of Open Access Journals (Sweden)

    Agnes Shin-Man Choy

    2015-10-01

    Conclusion: Weight gain is common among Chinese patients during the 1st year of PD but is not associated with any adverse clinical outcome. In contrast, weight loss during the 1st year of PD is common amongst PD patients who have peritonitis, and is associated with worse technique survival subsequently.

  2. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes.

    Science.gov (United States)

    Ortiz, Alberto; Wieslander, Anders; Linden, Torbjörn; Santamaria, Beatriz; Sanz, Ana; Justo, Pilar; Sanchez-Niño, Maria-Dolores; Benito, Alberto; Kjellstrand, Per

    2006-01-01

    Breakdown of glucose under physiological conditions gives rise to glucose degradation products (GDPs). GDPs are also formed during heat sterilization of glucose-containing peritoneal dialysis fluids (PD-fluids). In PD-fluids GDPs have been shown in many different in vitro assays to be responsible for adverse effects such as growth inhibition, and impaired leukocyte function and impaired wound healing of peritoneal mesothelial cells. They have been linked to changes in the peritoneal membrane as well as to the decline in residual renal function of PD-patients. In diabetes one of the GDPs, 3-deoxyglucosone (3-DG), has been proposed as responsible for side-effects rather the glucose itself. 3,4-dideoxyglucosone-3-ene (3,4-DGE) was recently identified as the most bio-reactive GDP in PD-fluids. It exists in equilibrium with a pool of precursors, consisting of 3-DG but also of other hitherto unidentified GDPs. In PD-fluids the concentration of GDPs in this pool is 10-20 times as high as that of 3,4-DGE. In vitro 3,4-DGE induces caspase-dependent apoptosis of neutrophils and peripheral blood mononuclear cells. Such induction may explain immunosuppressive properties of 3,4-DGE and contribute to an impaired peritoneal antibacterial defense. 3,4-DGE also induces renal cell apoptosis. This may explain the better preservation of residual renal function in PD patients not exposed to GDPs. The concentration of 3-DG increases with worsening glycemic control and has been implicated in the genesis of diabetic microangiopathy. As 3,4-DGE is much more bio-reactive than 3-DG and as it may be easily recruited from the pool, it seems probable that 3,4-DGE is the molecule involved in the diabetic lesions rather than 3-DG itself. Thus, 3,4-DGE might contribute to diabetic nephropathy and to the impaired antibacterial defenses in diabetics. Unraveling of the pool dynamics of the GDPs and the molecular mechanisms of GDP-mediated cell injury may provide new therapeutic insights in PD and

  3. Association between ambient carbon monoxide and secondary hyperparathyroidism in nondiabetic patients undergoing peritoneal dialysis

    OpenAIRE

    Weng CH; Hu CC; Yen TH; Huang WH

    2015-01-01

    Cheng-Hao Weng,1,2 Ching-Chih Hu,3 Tzung-Hai Yen,1,2 Wen-Hung Huang1,2 1Department of Nephrology, Division of Clinical Toxicology, Chang Gung Memorial Hospital, Linkou, 2College of Medicine, Chang Gung University, Taoyuan, 3Liver Research Unit, Department of Hepatogastroenterology, Chang Gung Memorial Hospital, Keelung, Taiwan Background: Secondary hyperparathyroidism (SHPT) is a major disorder in patients with chronic renal disease with or without dialysis. Air pollution has been confirmed...

  4. [Factors related to residual renal function loss in patients in peritoneal dialysis].

    Science.gov (United States)

    Munguía-Miranda, Catarina; Ventura-García, María de Jesús; Ávila-Díaz, Marcela; Orihuela-Rodríguez, Oscar; Paniagua-Sierra, José Ramón

    2015-01-01

    Introducción: la conservación de la función renal residual (FRR) en los pacientes en diálisis peritoneal (DP) tiene una clara influencia sobre la calidad de vida, independientemente de que su preservación ha demostrado influir en la mayor supervivencia de los pacientes. El objetivo del presente estudio fue conocer los factores relacionados con pérdida de la FRR en un grupo de pacientes prevalentes en diálisis peritoneal continua ambulatoria (DPCA). Métodos: se trata de un estudio de análisis de resultados secundarios. Se incluyeron 43 adultos con diabetes tipo 2 (DT2), con FRR conservada, a quienes se les dio seguimiento durante un año. Resultados: los factores relacionados con la pérdida de la FRR fueron: género masculino (p = 0.042), presión arterial sistólica (p = 0.009) y diastólica (p = 0.006), hemoglobina (p = 0.008), aclaramiento peritoneal de creatinina (p = 0.014), ultrafiltración (p = 0.017), niveles de factor de necrosis tumoral alfa (FNT–alfa) en plasma (p = 0.022) y dializado (p = 0.008). Conclusiones: es importante conocer los factores relacionados con pérdida de la FRR en nuestros pacientes para evitar la pérdida gradual de la misma y sus implicaciones sobre la mortalidad y calidad de vida.

  5. 品管圈活动在降低腹膜透析腹膜炎发生率中的应用%Application of quality control circle activity on reducing the incidence rate of peritoneal dialysis peritonitis

    Institute of Scientific and Technical Information of China (English)

    刘晓晨; 陈秀荣; 张兰

    2016-01-01

    目的:探讨品管圈在降低腹膜透析腹膜炎发生率中的应用效果.方法:选择2013年1~12月在肾内科住院后出院进行居家腹膜透析的患者70例为对照组,选择2014年1~12月在肾内科住院后出院进行居家腹膜透析的患者78例为观察组,两组患者均给予常规的护理措施,观察组在常规护理措施的基础上开展品管圈活动,即成立品管圈活动小组,确定活动主题,进行现状调查、分析原因、设定目标、制定对策并实施,比较两组患者腹膜透析腹膜炎的发生率.结果:观察组患者腹膜透析腹膜炎的发生率低于对照组(P<0.05).结论:将品管圈活动应用于腹膜透析患者的教育培训中,通过成员间的相互协作,找出问题发生的原因并进行分析,设定目标并制定对策进行实施,可以降低患者腹膜炎的发生率,促进护理工作质量的持续改进.%Objective:To discuss the application effect of quality control circle on reducing the incidence rate of peritoneal dialysis peritonitis. Methods:Se-lected 70 cases of patients taking house peritoneal dialysis after being hospitalized in nephrology department in January-December 2013 as control group;selected 78 cases of patients taking house peritoneal dialysis after being hospitalized in nephrology department in January- December 2014 as observation group. Two groups patients were given conventional nursing management. The observation group undertook quality control circle based on the conventional nursing management, namely,established quality control circle activity group,determined activity theme,made status survey, analyzed reason,set objec-tives,developed and carried measures and compared the incidence rate of peritoneal dialysis peritonitis of two groups patients. Results:The incidence rate of peritoneal dialysis peritonitis of observation group was lower than that of control group (P<0. 05). Conclusion:Through the mutual cooperation of members, finding and

  6. Hemodialysis versus Peritoneal Dialysis: A Comparison of Survival Outcomes in South-East Asian Patients with End-Stage Renal Disease.

    Directory of Open Access Journals (Sweden)

    Fan Yang

    Full Text Available Studies comparing patient survival of hemodialysis (HD and peritoneal dialysis (PD have yielded conflicting results and no such study was from South-East Asia. This study aimed to compare the survival outcomes of patients with end-stage renal disease (ESRD who started dialysis with HD and PD in Singapore.Survival data for a maximum of 5 years from a single-center cohort of 871 ESRD patients starting dialysis with HD (n = 641 or PD (n = 230 from 2005-2010 was analyzed using the flexible Royston-Parmar (RP model. The model was also applied to a subsample of 225 propensity-score-matched patient pairs and subgroups defined by age, diabetes mellitus, and cardiovascular disease.After adjusting for the effect of socio-demographic and clinical characteristics, the risk of death was higher in patients initiating dialysis with PD than those initiating dialysis with HD (hazard ratio [HR]: 2.08; 95% confidence interval [CI]: 1.67-2.59; p<0.001, although there was no significant difference in mortality between the two modalities in the first 12 months of treatment. Consistently, in the matched subsample, patients starting PD had a higher risk of death than those starting HD (HR: 1.73, 95% CI: 1.30-2.28, p<0.001. Subgroup analysis showed that PD may be similar to or better than HD in survival outcomes among young patients (≤65 years old without diabetes or cardiovascular disease.ESRD patients who initiated dialysis with HD experienced better survival outcomes than those who initiated dialysis with PD in Singapore, although survival outcomes may not differ between the two dialysis modalities in young and healthier patients. These findings are potentially confounded by selection bias, as patients were not randomized to the two dialysis modalities in this cohort study.

  7. Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study

    OpenAIRE

    Leung, Simon; McCormick, Brendan; Wagner, Jessica; Biyani, Mohan; Lavoie, Susan; Imtiaz, Rameez; Zimmerman, Deborah

    2015-01-01

    Background Removal of phosphate by peritoneal dialysis is insufficient to maintain normal serum phosphate levels such that most patients must take phosphate binders with their meals. However, phosphate ‘counting’ is complicated and many patients are simply prescribed a specific dose of phosphate binders with each meal. Therefore, our primary objective was to assess the variability in meal phosphate content to determine the appropriateness of this approach. Methods In this prospective cohort s...

  8. Lower Residual Renal Function is a Risk Factor for Depression and Impaired Health-Related Quality of Life in Korean Peritoneal Dialysis Patients

    OpenAIRE

    Park, Hayne Cho; Lee, Hajeong; Lee, Jung Pyo; Kim, Dong Ki; Oh, Kook-Hwan; Joo, Kwon Wook; Lim, Chun Soo; Kim, Yon Su; Ahn, Curie; Oh, Yun Kyu

    2011-01-01

    We retrospectively evaluated demographic and biochemical parameters associated with depression and health-related quality of life (HRQOL) in maintenance peritoneal dialysis (PD) patients. This study included 105 patients maintaining PD at Seoul National University Hospital. Data were collected from electronic medical record. Korean Beck's Depression Inventory and Korean version of Kidney Disease Quality of Life short form, version 1.3 were used to evaluate depression and HRQOL, respectively. ...

  9. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment

    OpenAIRE

    Tomaras V; Synodinou C; Theofilou P; Ginieri-Coccossis M; Soldatos C

    2008-01-01

    Abstract Background The study examines differences regarding quality of life (QoL), mental health and illness beliefs between in-centre haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD/PD) patients. Differences are examined between patients who recently commenced treatment compared to patients on long term treatment. Methods 144 End-Stage Renal Disease (ESRD) patients were recruited from three treatment units, of which 135 provided full data on the variables studied. Pat...

  10. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment

    OpenAIRE

    Ginieri-Coccossis, M; Theofilou, P; Synodinou, C; Tomaras, V; Soldatos, C

    2008-01-01

    Background The study examines differences regarding quality of life (QoL), mental health and illness beliefs between in-centre haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD/PD) patients. Differences are examined between patients who recently commenced treatment compared to patients on long term treatment. Methods 144 End-Stage Renal Disease (ESRD) patients were recruited from three treatment units, of which 135 provided full data on the variables studied. Patients con...

  11. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score

    Science.gov (United States)

    Chang, Yu-Tzu; Hwang, Jing-Shiang; Hung, Shih-Yuan; Tsai, Min-Sung; Wu, Jia-Ling; Sung, Junne-Ming; Wang, Jung-Der

    2016-01-01

    Although treatment for the dialysis population is resource intensive, a cost-effectiveness analysis comparing hemodialysis (HD) and peritoneal dialysis (PD) by matched pairs is still lacking. After matching for clinical characteristics and propensity scores, we identified 4,285 pairs of incident HD and PD patients from a Taiwanese national cohort during 1998–2010. Survival and healthcare expenditure were calculated by data of 14-year follow-up and subsequently extrapolated to lifetime estimates under the assumption of constant excess hazard. We performed a cross-sectional EQ–5D survey on 179 matched pairs of prevalent HD and PD patients of varying dialysis vintages from 12 dialysis units. The product of survival probability and the mean utility value at each time point (dialysis vintage) were summed up throughout lifetime to obtain the quality-adjusted life expectancy (QALE). The results revealed the estimated life expectancy between HD and PD were nearly equal (19.11 versus 19.08 years). The QALE’s were also similar, whereas average lifetime healthcare costs were higher in HD than PD (237,795 versus 204,442 USD) and the cost-effectiveness ratios for PD and HD were 13,681 and 16,643 USD per quality-adjusted life year, respectively. In conclusion, PD is more cost-effective than HD, of which the major determinants were the costs for the dialysis modality and its associated complications. PMID:27461186

  12. Cost-effectiveness of hemodialysis and peritoneal dialysis: A national cohort study with 14 years follow-up and matched for comorbidities and propensity score.

    Science.gov (United States)

    Chang, Yu-Tzu; Hwang, Jing-Shiang; Hung, Shih-Yuan; Tsai, Min-Sung; Wu, Jia-Ling; Sung, Junne-Ming; Wang, Jung-Der

    2016-01-01

    Although treatment for the dialysis population is resource intensive, a cost-effectiveness analysis comparing hemodialysis (HD) and peritoneal dialysis (PD) by matched pairs is still lacking. After matching for clinical characteristics and propensity scores, we identified 4,285 pairs of incident HD and PD patients from a Taiwanese national cohort during 1998-2010. Survival and healthcare expenditure were calculated by data of 14-year follow-up and subsequently extrapolated to lifetime estimates under the assumption of constant excess hazard. We performed a cross-sectional EQ-5D survey on 179 matched pairs of prevalent HD and PD patients of varying dialysis vintages from 12 dialysis units. The product of survival probability and the mean utility value at each time point (dialysis vintage) were summed up throughout lifetime to obtain the quality-adjusted life expectancy (QALE). The results revealed the estimated life expectancy between HD and PD were nearly equal (19.11 versus 19.08 years). The QALE's were also similar, whereas average lifetime healthcare costs were higher in HD than PD (237,795 versus 204,442 USD) and the cost-effectiveness ratios for PD and HD were 13,681 and 16,643 USD per quality-adjusted life year, respectively. In conclusion, PD is more cost-effective than HD, of which the major determinants were the costs for the dialysis modality and its associated complications. PMID:27461186

  13. Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.

    Science.gov (United States)

    Jiang, Xiao Lu; Wen, Ji Qiu; Zhang, Long Jiang; Zheng, Gang; Li, Xue; Zhang, Zhe; Liu, Ya; Zheng, Li Juan; Wu, Long; Chen, Hui Juan; Kong, Xiang; Luo, Song; Lu, Guang Ming; Ji, Xue Man; Zhang, Zong Jun

    2016-08-01

    We used arterial-spin labeling (ASL) MR imaging, a non-invasive technique to evaluate cerebral blood flow (CBF) changes in patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD) and hemodialysis (HD), and nondialysis ESRD patients compared with healthy cohort. Ninety seven ESRD patients including 32 PD patients (20 male, 12 female; mean age 33 ± 8 years), 33 HD patients (22 male, 11 female; mean age 33 ± 8 years) and 32 nondialysis patients (20 male, 12 female; mean age 35 ± 7 years) and 31 age- and gender-matched healthy controls (20 male, 11 female; mean age 32 ± 8 years) were included in this study. All subjects underwent ASL MR imaging, neuropsychologic tests, and ESRD patients underwent laboratory testing. CBF values were compared among PD, HD, nondialysis patients and control groups. Correlation analysis and multiple regression analysis were performed to investigate the association between CBF values and hemoglobin, neuropsychologic test results, serum creatinine, urea levels, disease duration, and dialysis duration. Elevated CBFs of whole brain region, gray matter, and white matter were found in all ESRD patient groups compared with healthy controls (all P differences for CBF between PD and HD patient groups. Negative correlations were observed between mean CBFs of whole brain region, gray matter, and white matter and the hemoglobin level in all ESRD patients. Multiple linear regression showed elevated CBF of multiple brain areas correlated with some neuropsychological tests in ESRD patients (all P differences of CBF change and cognitive function between PD and HD ESRD patients with long-term treatment. The degree of anemia may be a predominant risk factor for cognitive impairment in these ESRD patients. PMID:27167984

  14. Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.

    Directory of Open Access Journals (Sweden)

    Szu-Ying Lee

    Full Text Available PURPOSE: Diabetes mellitus (DM is the most common cause of end-stage renal disease and is an important risk factor for morbidity and mortality after dialysis. However, glycemic control among such patients is difficult to assess. The present study examined glycemic control parameters and observed glucose variation after refilling different kinds of fresh dialysate in peritoneal dialysis (PD patients. METHODS: A total of 25 DM PD patients were recruited, and continuous glucose monitoring system (CGMS was applied to measure interstitial fluid (ISF glucose levels at 5-min intervals for 3 days. Patients filled out diet and PD fluid exchange diaries. The records measured with CGMS were analyzed and correlated with other glycemic control parameters such as fructosamine, albumin-corrected fructosamine (AlbF, glycosylated hemoglobin (HbA1c, and glycated albumin levels. RESULTS: There were significant correlations between mean ISF glucose and fructosamine (r = 0.45, P<0.05, AlbF (r = 0.54, P<0.01, and HbA1c (r = 0.51, P<0.01. The ISF glucose levels in glucose-containing dialysate increased from approximately 7-8 mg/dL within 1 hour of exchange in contrast to icodextrin dialysate which kept ISF glucose levels unchanged. CONCLUSION: HbA1c and AlbF significantly correlated with the mean ISF glucose levels, indicating that they are reliable indices of glycemic control in DM PD patients. Icodextrin dialysate seems to have a favorable glycemic control effect when compared to the other glucose-containing dialysates.

  15. Comparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients – an observational study

    Directory of Open Access Journals (Sweden)

    Ratanjee Sharad

    2009-03-01

    Full Text Available Abstract Background Patients on peritoneal and hemodialysis have accelerated atherosclerosis associated with an increase in cardiovascular morbidity and mortality. The atherosclerosis is associated with increased arterial stiffness, endothelial dysfunction and elevated oxidative stress and inflammation. The aims of this study are to investigate the effects of peritoneal and hemodialysis on arterial stiffness, vascular function, myocardial structure and function, oxidative stress and inflammation in incident patients with end stage kidney disease. Methods This is an observational study. Eighty stage five CKD patients will be enrolled and followed for one-year. Primary outcome measures will be changes in 1 arterial stiffness measured by aortic pulse wave velocity, 2 oxidative stress assessed by plasma F2 isoprostanes and 3 inflammation measured by plasma pentraxin-3. Secondary outcomes will include additional measures of oxidative stress and inflammation, changes in vascular function assessed using the brachial artery reactivity technique, carotid artery intimal medial thickness, augmentation index and trans thoracic echocardiography to assess left ventricular geometry, and systolic and diastolic function. Patients will undergo these measures at baseline (6–8 weeks prior to starting dialysis therapy, then at six and 12 months after starting dialysis. Discussion The results of this study may guide the choice of dialysis modality in the first year of treatment. It may also lead to a larger study prospectively assessing the effect of dialysis modality on cardiovascular morbidity and mortality. Trial Registration ACTRN12609000049279

  16. Estandarización de cuidados del síndrome metabólico en diálisis peritoneal Standardising care of metabolic syndrome in peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Francisco Cirera Segura

    2012-06-01

    Full Text Available Introducción. Detectamos una gran prevalencia de factores de riesgo cardiovascular en los pacientes incidentes y prevalentes en diálisis peritoneal. Objetivo. Elaborar un plan de cuidados estandarizado para pacientes en diálisis peritoneal que diera respuesta a los problemas derivados del síndrome metabólico. Material y Método. La población objeto fueron los pacientes en diálisis peritoneal. Se realizó una valoración de las necesidades según Marjory Gordon, y se utilizaron las taxonomías NANDA, NIC y NOC para establecer los diagnósticos, intervenciones y criterios de resultados más frecuentes. Resultados. Los diagnósticos más prevalentes fueron: Conocimientos deficientes, Manejo inefectivo del régimen terapéutico, Desequilibrio nutricional por exceso y Deterioro de la movilidad física. Se elaboraron las intervenciones a realizar en la consulta de Enfermería, así como los criterios de resultados esperados. Las intervenciones se basaron en la educación del paciente sobre la modificación del estilo de vida, manejo adecuado de alimentación, realización de ejercicio físico adecuado a su edad, y en los aspectos relativos a la patología de base y tratamiento, como administración y manejo de los fármacos y líquidos de diálisis peritoneal. Conclusión. Hemos estandarizado mediante un plan de cuidados, la atención a los problemas de salud derivados del síndrome metabólico, en los pacientes en programa de diálisis peritoneal.Introduction: We detected a high prevalence of cardiovascular risk factors in both incidental and prevalent cases in peritoneal dialysis. Aim: To draw up a standardised care plan for patients in peritoneal dialysis to deal with the problems arising from metabolic syndrome. Material and Method: The target population consisted of patients in peritoneal dialysis. A needs assessment was carried out using Marjory Gordon's approach, in which the NANDA, NIC and NOC classifications were used to establish the

  17. Evaluation of a single-item screening question to detect limited health literacy in peritoneal dialysis patients.

    Science.gov (United States)

    Jain, Deepika; Sheth, Heena; Bender, Filitsa H; Weisbord, Steven D; Green, Jamie A

    2014-01-01

    Studies have shown that a single-item question might be useful in identifying patients with limited health literacy. However, the utility of the approach has not been studied in patients receiving maintenance peritoneal dialysis (PD). We assessed health literacy in a cohort of 31 PD patients by administering the Rapid Estimate of Adult Literacy in Medicine (REALM) and a single-item health literacy (SHL) screening question "How confident are you filling out medical forms by yourself?" (Extremely, Quite a bit, Somewhat, A little bit, or Not at all). To determine the accuracy of the single-item question for detecting limited health literacy, we performed sensitivity and specificity analyses of the SHL and plotted the area under the receiver operating characteristic (AUROC) curve using the REALM as a reference standard. Using a cut-off of "Somewhat" or less confident, the sensitivity of the SHL for detecting limited health literacy was 80%, and the specificity was 88%. The positive likelihood ratio was 6.9. The SHL had an AUROC of 0.79 (95% confidence interval: 0.52 to 1.00). Our results show that the SHL could be effective in detecting limited health literacy in PD patients.

  18. Evaluation of the Relationship of Hepcidin Levels with Anemia and Inflammatory Markers in Patients on Peritoneal Dialysis: A Controlled Study

    Directory of Open Access Journals (Sweden)

    Zeki AYDIN

    2012-01-01

    Full Text Available OBJECTIVE: Hepcidin, a small peptide hormone synthesized in the liver, plays a central role in the regulation of iron metabolism. In addition, it acts as an intermediary in body defense and inflammation. Our aim in this study was to investigate the relationship of hepsidin levels with inflammation and iron indices in patients on peritoneal dialysis (PD.MATERIAL and METHODS: Nondiabetic PD patients were involved. Primary kidney disease, biochemical parameters, complete blood count, iron, total iron binding capacity (TIBC, ferritin, high sensitive C-reactive protein (hsCRP, fibrinogen, parathormone, interleukin (IL-6 and hepcidin levels were recorded as well as demographic parameters.RESULTS: Twenty-one PD patients (mean age 47.7±12.1 years and 17 healthy volunteers (mean age 54.0±7.2 years were involved. HepCidin levels were higher in the PD group (148.2±35.0 vs. 93.8±21.9; p<0.001. There was a positive correlation of hepcidin with urea, creatinine, phosphorus, ferritin, fibrinogen, IL-6 and parathormone; and a negative correlation with albumin, transaminases, calcium, TIBC, GFR, hemoglobin and hematocrit levels.CONCLUSION: Hepcidin levels increase with deepening anemia and show a positive correlation with inflammatory markers. Theurapeutic interventions regarding the effects of hepcidin on inflammatory status may play a role in the treatment of anemia due to inflammation. It may be beneficial to measure hepcidin levels together with ferritin, especially in patients with functional iron defficiency.

  19. Biofilm formation by Staphylococcus epidermidis on peritoneal dialysis catheters and the effects of extracellular products from Pseudomonas aeruginosa

    DEFF Research Database (Denmark)

    Pihl, Maria; Arvidsson, Anna; Skepö, Marie;

    2013-01-01

    Biofilm formation by Staphylococcus epidermidis is a cause of infections related to peritoneal dialysis (PD). We have used a PD catheter flow-cell model in combination with confocal scanning laser microscopy and atomic force microscopy to study biofilm formation by S. epidermidis. Adherence...... to serum-coated catheters was four times greater than to uncoated ones, suggesting that S. epidermidis binds to serum proteins on the catheter surface. Pseudomonas aeruginosa biofilm supernatant interfered with the formation of a serum protein coat thereby reducing the capacity for biofilm formation in S. epidermidis....... Supernatants from ΔpelA, ΔpslBCD and ΔrhlAB strains of P. aeruginosa showed no differences from the wild-type supernatant indicating that the effect on serum coat formation was not due to rhamnolipids or the PelA and PslBCD polysaccharides. Supernatant from P. aeruginosa also dispersed established S. epidermidis...

  20. Effects of Improving Physical Activity Level on Quality of Life and Functional Status of Patients Receiving Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Deran OSKA

    2014-01-01

    Full Text Available OBJECTIVE: The aim of this study was to determine whether patients receiving peritoneal dialysis (PD experience an improvement in physical activity, quality of life and functional status as a result of exercise training at home by motivation about benefi ts of exercising. MATERIAL and METHODS: Twenty-one PD patients of 46.7±14.1 years participated in the study. Participants were encouraged by a physiotherapist to walk for 30 minutes, 3 days a week and motivated by explaining benefi ts of exercising. We assessed quality of life by Kidney Disease Quality of Life Questionnaire-Turkish Version (KDQOL-SF, functional status by Six Minute Walk Test (SMW, physical activity level by International Physical Activity Questionnaire – Long Form (IPAQ-LF. The antropometric measurements were performed with the bioelectrical impedance. Assessments were done at the beginning and 3 months later. RESULTS: Total physical activity score of IPAQ-LF increased signifi cantly 3 months later (p0.05. Improvements in pain and emotional score of KDQOL-SF were statistically signifi cant (p<0.05. CONCLUSION: Regular exercise should be allocated in the PD standard care. Participation of the patient into such a program could be possible by explaining the benefi ts of exercising at the beginning of the treatment.

  1. Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients

    Directory of Open Access Journals (Sweden)

    Aya Eguchi

    2012-01-01

    Full Text Available Hepcidin is the key mediator of renal anemia, and reliable measurement of serum hepcidin levels has been made possible by the ProteinChip system. We therefore investigated the iron status and serum hepcidin levels of peritoneal dialysis (PD patients who had not received frequent doses of an erythrocytosis-stimulating agent (ESA and had not received iron therapy. In addition to the usual iron parameters, the iron status of erythrocytes can be determined by measuring reticulocyte hemoglobin (RET-He. The mean serum hepcidin level of the PD patients (n=52 was 80.7 ng/mL. Their serum hepcidin levels were significantly positively correlated with their serum ferritin levels and transferrin saturation (TSAT levels, but no correlations were found between their serum hepcidin levels and RET-He levels, thereby suggesting that hepcidin has no effect on the iron dynamics of reticulocytes. Since low serum levels of CRP and IL-6, biomarkers of inflammation, were not correlated with the serum hepcidin levels, there is likely to be a threshold for induction of hepcidin expression by inflammation.

  2. Effect of Peritoneal Dialysis Treatment on Left Ventricular Systolic and Diastolic Functions in Patients with End-Stage Renal Disease

    Directory of Open Access Journals (Sweden)

    Feridun KAVUNCUOĞLU

    2014-09-01

    Full Text Available OBJECTIVE: To analyze the effect of peritoneal dialysis (PD treatment on left ventricular systolic and diastolic function in patients with end-stage renal disease (ESRD. MATERIAL and METHODS: The study population consisted of 51 patients with ESRD. Before a PD catheter was inserted, the patients were evaluated by echocardiography and Doppler tissue imaging (DTI. Then, a PD catheter was inserted. After 6 months, the second echocardiographic evaluations were performed. Left ventricular systolic and diastolic function parameters were compared. RESULTS: The mean age was 47 ± 13 years and 38 (74.5% of the patients were male. No significant difference was found in echocardiographic parameters including ejection fraction, fractional shortening, left ventricular mass, left ventricular mass index, left ventricular posterior wall thickness, inter ventricular septal thickness, left atrial diameter, early diastolic filling/late diastolic filling ratio before and after the period of PD. Left ventricular end-systolic diameter and left ventricular end-diastolic diameter values were significantly lower found in the period after PD. CONCLUSION: Our findings appear to reflect somewhat the favourable changes in LV diastolic and systolic functions in PD patients.

  3. Biphasic Regulation of Lipid Metabolism: A Meta-Analysis of Icodextrin in Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Yan-Feng Huang

    2015-01-01

    Full Text Available Objectives. The objective of this systematic meta-analysis was to study the impact of icodextrin (ICO on lipid profiles. Methods. MEDLINE, PubMed, Embase, Chinese Biomedical Literature, and the Cochrane Library and Reference lists were searched (last search September 2014 in accordance with the Cochrane Handbook for Systematic Reviews of Interventions. Results. Searches identified 13 eligible trials with a total of 850 patients. The differentials of total cholesterol (TC and free fatty acid (FFA in the ICO group were greater than those in the GLU group. Metaregression analysis showed that TC levels positively correlated with its baseline levels. In the subgroup of patients with dialysis duration more than 6 months, TC and TG in the ICO group were less. In pooled data from cross-sectional studies, differential of TG in the ICO group was less. In the subgroup of patients with diabetes (Martikainen et al., 2005, Sniderman et al., 2014, and Takatori et al., 2011, differential of high-density lipoprotein cholesterol (HDL-C in the ICO group was less. There was no significant effect on low-density lipoprotein cholesterol (LDL-C, very low-density lipoprotein cholesterol (VLDL-C, or lipoprotein(a. Conclusions. ICO may be beneficial to lipid metabolism, especially for its biphasic regulation of plasma TC levels.

  4. Blood pressure management in peritoneal dialysis patients%浅谈腹膜透析患者的血压管理

    Institute of Scientific and Technical Information of China (English)

    丁小强; 吉俊

    2016-01-01

    腹膜透析患者的高血压患病率达80%以上,难治性高血压导致卒中、心血管事件发病率不断增加,是患者死亡和退出腹膜透析的主要原因。2015年国际腹膜透析协会(ISPD)关于成人腹膜透析患者心血管和代谢指南指出,持续腹膜透析患者目标血压应<140/90 mmHg,并与年龄无关。腹膜透析患者血压控制不佳的影响因素纷繁复杂,但常见原因是容量超负荷和残肾功能减退。腹膜透析患者高血压防治策略包括容量负荷的准确评估与干预、残余肾功能的有效保护、透析处方的及时调整,降压药物的正确选择以及以病人为中心的团队管理等五个方面。%Hypertension is extremely common in patients on peritoneal dialysis (PD),with a prevalence of more than 80%.Moreover,refractory hypertension accounts for the increasing incidence of stroke and cardiovascular events which are the leading causes for death and peritoneal dialysis dropout.The 2015 International Society of Peritoneal Dialysis cardiovascular and metabolic guidelines for adult peritoneal dialysis patients recommended that the target of blood pressure in continuous ambulatory PD patients should be <140 mmHg systolic and <90 mmHg diastolic,irrespective of age.There are various factors that contribute to the poor control of hypertension in PD patients,of which hypervolumia and reduced residual renal function are the most common ones.Therapeutic strategies for blood pressure management in PD patients include 5 aspects:appropriate assessment on volume status,effective protection of residual renal function,flexible adjustment of dialysis prescription,right choice of anti-hypertensive drugs,and patient-centered team management.

  5. Value of serum procalcitonin in diagnosis of infectious peritonitis due to peritoneal dialysis%血清降钙素原在患者腹膜透析感染性腹膜炎中的诊断价值

    Institute of Scientific and Technical Information of China (English)

    陶瑾; 申新宏; 艾永红; 杨玉霞

    2015-01-01

    OBJECTIVE To explore the clinical significance of serum procalcitonin (PCT ) in detection of complicated infectious peritonitis due to peritoneal dialysis so as to provide guidance for early detection of the complicated infec‐tious peritonitis due to peritoneal dialysis .METHODS A total of 126 patients who underwent the peritoneal dialy‐sis in the peritoneal dialysis center from Mar 2011 to Mar 2013 were enrolled in the study and divided into the peri‐toneal dialysis‐related peritonitis group with 62 cases and the non‐peritoneal dialysis‐related peritonitis group with 64 cases according to the results of electrochemiluminescence immunoassay ,meanwhile ,60 healthy people who re‐ceived physical examination were recruited as the control group .The level of serum PCT was determined ,the C‐reactive protein (CRP) and white blood cells (WBC) counts were compared among the three groups of partici‐pants .RESULTS The level of PCT of the peritonitis group was (5 .25 ± 1 .72)μg/L ,the non‐peritonitis group (0 .68 ± 0 .16)μg/L ,the control group (0 .51 ± 0 .13)μg/L ;the positive rate of PCT of the peritonitis group was 88 .71% ,the non‐peritonitis group 4 .69% ,the control group 3 .33% ;both the PCT level and the positive rate of the peritonitis group were significantly higher than those of the non‐peritonitis group and the control group (P<0 .05) .The level of expression of serum PCT and positive rate of the patients with peritoneal dialysis‐related infec‐tious peritonitis were significantly reduced after the treatment ,as compared with those before the treatment (P<0 .05) .CONCLUSION The level of serum PCT of the patients with peritoneal dialysis‐related infectious peritonitis is significently elevated ,and it is an effective indicator for differential diagnosis of the peritoneal dialysis‐related in‐fectious peritonitis and the surveillance of efficacy .%目的:探讨腹膜透析并发感染性腹膜炎患者血清降钙素原(PC T

  6. Desenvolvimento e avaliação da esterilidade de sistema de diálise peritoneal pediátrico fechado Development and assessment of sterility of a closed-system pediatric peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Ana Paula Pereira Biazi

    2009-03-01

    Full Text Available OBJETIVO: Desenvolver um sistema de diálise peritoneal pediátrico totalmente fechado, de fácil manejo e avaliar o nível de garantia de esterilidade. MÉTODOS: No período de fevereiro a dezembro de 2008, foi idealizado e desenvolvido junto ao Setor de Bioengenharia da Braile Biomédica Indústria, Comércio e Representações S/A® um sistema de diálise peritoneal pediátrico fechado. Foram construídos 20 sistemas submetidos a testes quanto à garantia do nível de esterilidade, sendo divididos em grupo A (n=10, utilizando-se teste de esterilidade, e B (n=10, penetração do gás óxido de etileno. RESULTADOS: No grupo A, o teste de esterilidade foi negativo para a proliferação de bactérias e fungos em 14 dias, em todos os sistemas. No grupo B, o teste de penetração de gás demonstrou que houve penetração de gás em todos os pontos avaliados. CONCLUSÃO: Foi possível desenvolver um novo sistema de diálise peritoneal pediátrico fechado de fácil manuseio e garantir sua esterilização.OBJECTIVE: To develop an easy-handling totally closed pediatric peritoneal dialysis system and assess the sterility assurance level. METHODS: From February to December 2008 was designed and developed a closed-system pediatric peritoneal dialysis at the Bioengineering Division of Braile Biomédica Indústria, Comércio e Representações S/A®. Twenty systems were manufactured and submitted to sterility assurance level testing, and were divided into Group A (10 - using the sterility test - and B (10 - ethylene oxide gas penetration. RESULTS: In Group A, the sterility test was negative for bacteria and fungi proliferation within 14 days in all systems. In Group B, the gas penetration test showed that there was gas penetration in all points assessed. CONCLUSIONS: It was possible to develop a new easy-handling closed-system pediatric peritoneal dialysis and ensure its sterility.

  7. Hemodialysis versus peritoneal dialysis: a case control study of survival in patients with chronic kidney disease stage 5

    DEFF Research Database (Denmark)

    Maier, Alexandra; Stocks, Franziska; Pommer, Wolfgang;

    2009-01-01

    It is still controversial whether the mode of dialysis or preexisting comorbidities may influence the prognosis of patients with chronic kidney disease stage 5. Therefore, we performed a prospective case control study to evaluate whether the mode of dialysis may influence outcome. We found 25 cases...... dialysis, predicted death in patients with chronic kidney disease. It is concluded that age and comorbidities but not mode of dialysis are important to predict survival in patients with chronic kidney disease stage 5....

  8. The influence of simvastatin in induced peritoneal fibrosis in rats by peritoneal dialysis solution with glucosis 4.25% Influência da sinvastatina na fibrose peritoneal induzida em ratos pelo uso de solução de diálise peritoneal com glicose a 4,25%

    Directory of Open Access Journals (Sweden)

    Gilberto Baroni

    2012-04-01

    Full Text Available PURPOSE: To investigate the influence of using simvastatin on the peritoneal fibrosis induced in rats using peritoneal dialysis solution with glucoses 4.25%. METHODS: Prospective controlled study in 20 non-uremic Wistar rats. The animals received a peritoneal infusion of 10 ml/100 g of peritoneal dialysis solution glucose 4.25% on a daily basis. The animals were divided in two groups: experimental and control. The experimental group received simvastatin 4 mg/kg/d, by a gastric tube. The control group did not receive any drug. The follow-up was 21 and 49 days. At the end, one surgical procedure was performed to get histological samples of visceral and parietal peritoneum. The samples were analyzed using Hematoxylin Eosin and Sirius Red, to evaluate the severity of the fibrosis. RESULTS: The analysis showed that the intensity of the fibrosis, the peritoneal thickness and the cell number in experimental and control groups were not statistically significant different in experimental and control groups. CONCLUSION: The simvastatin do not decrease the intensity of fibrosis on the peritoneal membrane that happens on rats on peritoneal dialysis.OBJETIVO: Investigar a influência do uso da sinvastatina na fibrose peritoneal induzida em ratos pelo uso de solução de diálise peritoneal rica em glicose. MÉTODOS: Estudo prospectivo controlado, em ratos Wistar não urêmicos. Foram estudados 20 animais. Os animais foram submetidos diariamente à punção abdominal, sendo infundida solução de diálise peritoneal com glicose a 4,25% na dose de 10 ml/100 g de peso. Os animais foram divididos em dois grupos: experimental e controle. O grupo experimental recebeu sinvastatina na dose de 4 mg/kg/dia por gavagem. O grupo controle não recebeu nenhuma droga. Foram acompanhados por 21 e 49 dias. Ao final do período foram submetidos à procedimento cirúrgico para retirada de peritônio parietal e visceral. As amostras obtidas foram analisadas histologicamente

  9. Periton Diyalizi Hastasında Kolonoskopi Sonrası Gelişen Peritonit

    Directory of Open Access Journals (Sweden)

    Ali TAMER

    2012-01-01

    Full Text Available Peritonitis in peritoneal dialysis patients after colonoscopy is a rare complication. We present a peritoneal dialysis patient who developed peritonitis shortly after colonoscopy together with a discussion on diagnosis, management and the current literature.

  10. Resorption and tolerance of the high doses of ferrous sulfate and ferrous gluconate in the patients on peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Laušević Mirjana

    2006-01-01

    Full Text Available Background/Aim. Iron supplementation plays a crucial role in peritoneal dialysis (PD patients. Oral iron substitution is more convenient than intravenous therapy in PD patients, but impaired absorption and adverse effects may be limiting factors for oral treatment. The aim of this study was to compare the absorption and side effects of high doses ferrous sulphate and ferrous gluconate in PD patients. Methods. Blood samples were taken from 29 PD patients at baseline, as well as 2, 4 and 8 hours after oral intake of 4 ferrous sulphate tablets (containing 105 mg elemental iron per tablet. The test was repeated using 8 ferrous gluconate drinkable ampoules (containing 50 mg elemental iron per ampoule. Results. The maximal increase in serum iron level during the test with iron sulphate was 113.51±103.37% versus the initial values of 183.87±37.38% during the ferrous gluconate test. The maximal values of serum iron after the intake of ferrous sulphate were 26.23±9.95 µmol/l versus 30.97±8.65 µmol/l after the intake of ferrous gluconate. There was a statistically significant difference between these two groups. Six patients showed an increase in serum iron of more than 300% after a high ferrous gluconate dose, while in 15 of the patients serum iron increased between 100% and 300%, and in 8 of the patients serum iron levels increased by less than 100%. Side effects occurred more frequently after the intake of ferrous sulphate than ferrous gluconate. Conclusion. High doses of oral iron were well absorbed and tolerated in PD patients. Ferrous gluconate was better absorbed and tolerated than ferrous sulphate, thus we recommend it for oral iron supplementation in PD patients.

  11. [ASSOCIATION OF SERUM ALBUMIN AND SUBJECTIVE GLOBAL ASSESSMENT ON INCIDENT PERITONEAL DIALYSIS PATIENTS].

    Science.gov (United States)

    Yanowsky-Escatell, Francisco Gerardo; Pazarín-Villaseñor, Leonardo; Andrade-Sierra, Jorge; Zambrano-Velarde, Miguel Angel; Preciado-Figueroa, Francisco Martin; Santana-Arciniega, Christian Jesús; Galeno-Sánchez, Rogelio Ignacio

    2015-12-01

    Introducción: la albúmina sérica es el biomarcador más frecuentemente utilizado como uno de los tres criterios bioquímicos para el diagnóstico del desgaste proteico energético (DPE). Sin embargo, como parámetro nutricional es poco fiable en la enfermedad renal crónica (ERC). La valoración global subjetiva (VGS) ha sido recomendada para la evaluación nutricional y del DPE en ERC. Objetivo: determinar la asociación de los niveles de albúmina sérica y la VGS en pacientes con insuficiencia renal crónica terminal (IRCT) que iniciaron diálisis peritoneal (DP). Métodos: estudio transversal analítico en pacientes con IRCT que fueron evaluados previo a iniciar DP. Se determinaron niveles de albúmina sérica y se realizó una evaluación nutricional mediante la VGS. Resultados: 69 pacientes, 46 (67%) hombres y 23 (33%) mujeres, con una media de edad de 39,97 ± 18,30 años, albúmina sérica 2,75 ± 0,65 g/dl, creatinina 18,91 ± 10,98 mg/dl, urea 314,80 ± 152,74 mg/dl e IMC 23,37 ± 3,79 kg/m2, la mediana de TFG 3 (1-12) mL/min/1,73m2. La VGS mostró que el 34,8% estaba bien nutrido, el 40,6% tenía riesgo de DPE o moderado y el 24,6% presentaba un DPE severo. No existió asociación (p = ns) entre los niveles de albúmina sérica y la VGS. Conclusión: el presente estudio muestra que la hipoalbuminemia y el DPE son muy frecuentes. La identificación de los niveles de albúmina sérica y la VGS al iniciar DP en nuestra población pudieran ser predictores de mortalidad. La albúmina sérica no es una herramienta útil para la evaluación nutricional en pacientes con IRCT que iniciarán DP.

  12. Relationship between Kt/V urea-based dialysis adequacy and nutritional status and their effect on the components of the quality of life in incident peritoneal dialysis patients

    Directory of Open Access Journals (Sweden)

    Chen Jin-Bor

    2012-06-01

    Full Text Available Abstract Background It is well known that the quality of life of patients with chronic kidney disease can be improved by dialysis. While previous studies have used retrospective designs and adhered to a standard target prescribed by clinical guidelines, our study prospectively investigates the association between the adequacy of peritoneal dialysis (PD and measures of nutritional status on quality-of-life domains in a cohort of incident PD patients. Methods It was a prospective 6-month observational study. Eighty incident PD participants who were treated in a hospital-based PD center were enrolled. The period of enrollment was January 2009–June 2010; follow-up continued until December 2010. PD adequacy indices, including Kt/V urea, weekly Ccr (WCcr, measures of nutritional status (albumin, BMI, and nPCR were measured at 1 month and 6 months after PD initiation. SF-36 health survey questionnaires were used to measure the quality of life. The outcomes were used to measure the changes in the domains of the SF-36 after 6 months of PD therapy. Results Seventy-seven incident patients who underwent PD for 6 months were included in the study. The mean age was 47.3 years, and the male-to-female ratio was 38:39. A peritoneal Kt/V urea value of 1.2, which was also the baseline cutoff value, was found to have the highest influence on SF-36 domains. Patients with baseline peritoneal Kt/V urea value of Limitations A small cohort and a short observation period. Conclusions The baseline level of peritoneal Kt/V urea affected the components of the quality of life after PD initiation. In contrast, a lower baseline nPCR level was associated with deterioration in the quality of life after PD therapy.

  13. Factors Associated with the Serum Myostatin Level in Patients Undergoing Peritoneal Dialysis: Potential Effects of Skeletal Muscle Mass and Vitamin D Receptor Activator Use.

    Science.gov (United States)

    Yamada, Shunsuke; Tsuruya, Kazuhiko; Yoshida, Hisako; Tokumoto, Masanori; Ueki, Kenji; Ooboshi, Hiroaki; Kitazono, Takanari

    2016-07-01

    Myostatin is a member of the transforming growth factor-β family, which regulates synthesis and degradation of skeletal muscle proteins and is associated with the development of sarcopenia. It is up-regulated in the skeletal muscle of chronic kidney disease patients and is considered to be involved in the development of uremic sarcopenia. However, serum myostatin levels have rarely been determined, and the relationship between serum myostatin levels with clinical and metabolic factors remains unknown. This cross-sectional study investigated the association between serum myostatin level and clinical factors in 69 outpatients undergoing peritoneal dialysis. Serum myostatin level was determined by commercially available enzyme-linked immunosorbent assay (ELISA). Univariable and multivariable analysis were conducted to determine factors associated with serum myostatin levels. The factors included age, sex, diabetes mellitus, dialysis history, body mass index, residual kidney function, peritoneal dialysate volume, serum biochemistries, and the use of vitamin D receptor activators (VDRAs). Mean serum myostatin level was 7.59 ± 3.37 ng/mL. There was no association between serum myostatin level and residual kidney function. Serum myostatin levels were significantly and positively associated with lean body mass measured by the creatinine kinetic method and negatively associated with the use of VDRAs after adjustment for potential confounding factors. Our study indicated that serum myostatin levels are associated with skeletal muscle mass and are lower in patients treated with VDRAs. Further studies are necessary to determine the significance of measuring serum myostatin level in patients undergoing peritoneal dialysis. PMID:26895008

  14. Spontaneous retroperitoneal hemorrhage presenting as hemoperitoneum secondary to renal cyst rupture in a peritoneal dialysis patient with acquired cystic kidney disease.

    Science.gov (United States)

    Biyik, Z; Solak, Y; Gaipov, A; Ozbek, O; Esen, H; Turk, S

    2015-01-01

    Spontaneous retroperitoneal hemorrhage (SRH) is a rare and potentially fatal condition. Acquired cystic kidney disease (ACKD) may cause SRH in hemodialysis patients. However, presentation of retroperitoneal hematoma as hemoperitoneum in peritoneal dialysis (PD) patients is exceedingly rare. We report a 44-year-old male PD patient who presented with hemoperitoneum secondary to retroperitoneal hematoma. The reason of SRH was rupture of the cysts of ACKD. The patient underwent unilateral nephrectomy with subsequent disappearance of hemoperitoneum. The importance of this case lies in the fact that the patients who have been receiving dialysis for a long time should be under surveillance in terms of ACKD development and potential associated complications such as cyst hemorrhage and malignancy.

  15. The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment

    Directory of Open Access Journals (Sweden)

    Onder Yavascan

    2011-01-01

    Full Text Available Peritonitis and catheter exit- site infections (ESI are important causes of hospitalization and catheter loss in patients undergoing chronic peritoneal dialysis (CPD. The frequency of infection can be reduced by scrupulous exit- site care with or without topical antiseptics. There are no studies showing any benefit in the use of povidone-iodine or normal saline for care of exit- sites in long- term CPD patients. In this study, we aimed to determine the potential effectiveness of the application of povidone-iodine or normal saline at the catheter exit- site in preventing ESI and peritonitis in children on CPD. A total of 98 patients treated with either povidone-iodine or normal saline were included in this study. Group I (34 patients used povidone-iodine and group II (64 patients simply cleansed the exit- site with normal saline (0.9% NaCl. Dressings were changed 2 to 3 times in a week. The total cumulative follow- up time was 3233 patient- months. ESIs occurred in 10 (29.4% of 34 patients using povidone-iodine and in 10 (15.6% of 64 patients using normal saline. The frequency of ESI was significantly high in group I (povidone-iodine patients. The mean rate of ESI was 1 episode/60.8 patient- months for group I versus 1 episode/144 patient- months for group II (P 0.05. In conclusion, exit- site care with normal saline is an effective strategy in reducing the incidence of ESI in children on CPD. It can thus significantly reduce morbidity, catheter loss, and the need to transfer patients on peritoneal dialysis to hemodialysis.

  16. The Influence Factors Analysis of Itchy Skin for Peritoneal Dialysis Patients%腹膜透析患者皮肤瘙痒影响因素分析

    Institute of Scientific and Technical Information of China (English)

    翁文娟; 陈东晓

    2015-01-01

    目的:探讨腹膜透析患者皮肤瘙痒影响因素。方法:选取2013年1月-2015年1月广东省汕头大学医学院第二附属医院肾内科住院部腹膜透析随访患者126例,采用问卷调查方式采集临床资料,采用单因素与Logistic多因素回归分析腹膜透析患者皮肤瘙痒影响因素。结果:皮肤瘙痒累及全身各个部位,常见的受累部位为背部、腹部、头部、四肢,分别占69.84%、46.03%、43.65%、42.86%,对称性皮肤瘙痒占84.92%,泛发性皮肤瘙痒(累及全身皮肤≥50%)占25.40%。皮肤瘙痒持续时间(t)<1个月、1个月≤t<6个月、6个月≤t<1年、t≥1年分别占7.14%、42.86%、10.32%、39.68%。126例腹膜透析患者中皮肤瘙痒发生率为61.11%(77/126),单因素分析结果显示,腹膜透析患者皮肤瘙痒与年龄、糖尿病、腹膜透析时间、皮肤干燥、城市居民、睡眠质量、家务劳动、合并不良情绪及血磷、钙磷乘积及血清PTH水平相关(P<0.05)。Logistic多因素回归分析显示,年龄≥50岁、糖尿病、腹膜透析时间和血清PTH水平是腹膜透析患者皮肤瘙痒患者的独立危险因素(P<0.001)。结论:腹膜透析患者皮肤瘙痒主要受年龄、腹膜透析时间及血清PTH水平等多种因素影响。%Objective:To investigate the influence factors of itchy skin for peritoneal dialysis patients. Method:126 peritoneal dialysis patients in the nephrology department of the Second Affiliated Hospital of Shantou University Medical College from January 2013 to January 2015 were selected,the clinical data were collected by questionnaire survey method,the influence factors analysis of itchy skin for peritoneal dialysis patients were analyzed by the single factor and Logistic multifactor regression analysis.Result:Itchy skin were dragged in whole body each place, affected areas to back,abdomen,the head,limbs,were respectively commonly accounted for 69

  17. Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching.

    Directory of Open Access Journals (Sweden)

    Che-Yi Chou

    Full Text Available Chronic kidney disease (CKD patients are at risk for developing new-onset diabetes mellitus (NODM even after hemodialysis (HD and peritoneal dialysis (PD treatment. It is not clear if the incidence for NODM is different in CKD patients receiving HD and PD. This study compared the risk of NODM in PD patients and HD patients.All HD and PD patients in Taiwan Renal Registry Database from 1997 to 2005 were included and all patients were followed to December 31, 2008. The risk of NODM was analyzed in PD patients and propensity score matched HD patients using logistic regression for early type NODM (6 months after dialysis.A total of 2548 PD patients and 10192 HD patients who had no diabetes on the initiation of dialysis were analyzed. The incidence for NODM was 3.7 per 100 patient/year for HD and 2.4 for PD patients. HD patients are more at risk for developing early type NODM (p<0.001 with an adjusted odds ratio of 1.41 [95% confidence interval (CI 1.12-1.78]. HD patients are more at risk for late type NODM (p<0.001 with an adjusted hazard ratio of 2.01 (95% CI: 1.77-2.29. Patient's age was negatively associated with risk of early type of NODM (p<0.001 but positively associated with risk of late type NODM (p<0.001.Chronic kidney disease patients receiving hemodialysis are more at risk for developing new-onset diabetes mellitus compared to those receiving peritoneal dialysis.

  18. One Example Peritoneal Dialysis Concurrent Peritonitis Patient's Nursing ExperienceAbstract%1例腹膜透析并发腹膜炎患者的护理体会

    Institute of Scientific and Technical Information of China (English)

    蓝辉娆

    2012-01-01

      本文报告1例腹膜透析并发腹膜炎患者护理体会,并取得了较好的效果。腹膜透析并发腹膜炎的护理范围涉及用药指导、生活护理、心理和行为问题的干预等多方面。通过对本患者的护理,笔者体会到本病的全面康复,不仅需要有效的药物治疗,更要发挥健康的家庭功能支持作用,对疾病伴发的心理、行为问题进行护理干预。%  This text reports a peritoneum dialysis sufferer's nursing erupting peritonitis realizes, and obtained better effect.The range that the peritoneum is dialysis to erupt the nursing of peritonitis involves to guide with the medicine, live nursing, mental state and behavior question of multiaspects like interruption,etc.Pass the nursing to this sufferer, the writer realizes completely recovering from ilness of this disease and not only needs an useful medicine treatment, but also wants to develop healthy home function to favor an action, vs the mental state, behavior question of the disease companion hair progress nursing interruption.

  19. Quality of life, mental health and health beliefs in haemodialysis and peritoneal dialysis patients: Investigating differences in early and later years of current treatment

    Directory of Open Access Journals (Sweden)

    Tomaras V

    2008-11-01

    Full Text Available Abstract Background The study examines differences regarding quality of life (QoL, mental health and illness beliefs between in-centre haemodialysis (HD and continuous ambulatory peritoneal dialysis (CAPD/PD patients. Differences are examined between patients who recently commenced treatment compared to patients on long term treatment. Methods 144 End-Stage Renal Disease (ESRD patients were recruited from three treatment units, of which 135 provided full data on the variables studied. Patients consisted of: a 77 in-centre haemodialysis (HD and 58 continuous ambulatory peritoneal dialysis (CAPD/PD patients, all currently being treated by dialysis for varied length of time. Patients were compared for differences after being grouped into those who recently commenced treatment ( 4 years. Next, cases were selected as to form two equivalent groups of HD and CAPD/PD patients in terms of length of treatment and sociodemographic variables. The groups consisted of: a 41 in-centre haemodialysis (HD and b 48 continuous ambulatory peritoneal dialysis (CAPD/PD patients, fitting the selection criteria of recent commencement of treatment and similar sociodemographic characteristics. Patient-reported assessments included: WHOQOL-BREF, GHQ-28 and the MHLC, which is a health locus of control inventory. Results Differences in mean scores were mainly observed in the HD patients with > 4 years of treatment, providing lower mean scores in the QoL domains of physical health, social relationships and environment, as well as in overall mental health. Differences in CAPD/PD groups, between those in early and those in later years of treatment, were not found to be large and significant. Concerning the analysis on equivalent groups derived from selection of cases, HD patients indicated significantly lower mean scores in the QoL domain of environment and higher scores in the GHQ-28 subscales of anxiety/insomnia and severe depression, indicating more symptoms in these areas

  20. 腹膜透析患者死亡危险因素分析%Analysis of risk factors of death in patients with peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    黄群; 李德天

    2016-01-01

    目的:分析腹膜透析患者的死亡危险因素,指导临床诊治。方法回顾性分析该院2008年6月—2013年9月收治的并在该院初次行腹膜透析、随访3个月以上的患者143例,其中死亡35例,存活108例,存活患者中肾移植6例,拔管12例,失访2例,采用多变量 COX 回归分析方法分析患者接受腹膜透析前各项临床指标对其预后的影响。结果原发病中,以慢性肾小球肾炎为主,63例(44.06%),糖尿病肾病46例(32.17%),高血压肾损伤21例(14.68%),马兜铃酸肾病5例(3.5%),止痛剂肾病3例(2.1%),多囊肾2例(1.4%),血管炎肾损伤、梗阻性肾病各1例(0.7%),原因不明的患者1例(0.7%)。死亡患者中,死于心血管疾病10例(28.57%),脑血管疾病7例(20%),腹膜炎5例(14.29%),肺内感染4例(11.43%),消化道出血2例(5.71%),原因不明4例(11.43%),肿瘤、营养不良、多器官功能衰竭各1例(2.86%)。总体透析时间(28.3±16.42)个月,死亡组平均透析时间(24.53±17.13)个月。单因素分析显示,进入腹膜透析时的年龄大、既往脑血管疾病病史为腹膜透析患者死亡的危险因素,再进行多因素 COX 回归,结果显示透析前高龄、高磷为腹膜透析患者死亡的独立危险因素。结论(1)腹膜透析患者原发病仍是以慢性肾小球肾炎为主(44.06%),符合我国目前慢性肾功能不全原发病构成;(2)该透析中心腹膜透析患者死亡疾病构成、生存率与国际报道接近;(3)腹膜透析前患者高龄、血磷升高为腹膜透析患者死亡的独立危险因素。%Objective Analysis of risk factors of death in patients with peritoneal dialysis to guide the clinical diagnosis and treat-ment.Methods 143 cases who recived first row of peritoneal dialysis, admitted in

  1. 甘草酸二胺对腹膜透析大鼠腹膜纤维化的影响%Effect of diammonium glycyrrhizinate on peritoneal fibrosis in rats receiving peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    卫志锋; 李多; 陆继芳; 刘圣君; 李素敏

    2013-01-01

    Objective To investigate the effect of diammonium glycyrrhizinate on peritoneal fibrosis in rats receiving peritoneal dialysis. Methods The male SD rats ( clean grade ) were randomly divided into 5 group, the rats in normal control group were not given any intervention ; the rats in NS group were given 0 9% sodium chloride injection 20ml by intraperitoneal injection daily ;the rats in model group were given 4. 25% peritoneal dialysis solution 20ml daily, meanwhile, were given lipopolysaccharide (LPS) 0. 6mg/kg,3 times a week by intraperitoneal injection; the rats in pentoxifylline treatment group , on the basis of model group , were given pentoxifylline 6mg/kg daily by intraperitoneal injection ;the rats in diammonium glycyrrhizinate treatment group ,on the basis of model group , were given diammonium glycyrrhizinate 10mg/kg daily by intraperitoneal injection The trial was performed for continuous 28 days, at the 30th day, 2h peritoneal equilibration test was adopted to determine the rats'peritoneum function ,and the partial peritoneum tissues of rats were collected and the changes of pathological morphous were observed under light microscope . The experimental data were analyzed with SPSS 13. 0. Results There were no significant changes in peritoneum function and structure in normal control group and NS group, however , which in model group were severely damaged ( P 0.05). Conclusion The 4. 25% peritoneal dialysis solution can cause peritoneal fibrosis in rats, however, diammonium glycyrrhizinate can improve peritoneal fibrosis and relieve the aggravation of peritoneum structure and function.%目的 探讨甘草酸二铵对腹膜透析大鼠腹膜纤维化的影响.方法 将清洁级雄性SD大鼠随机分成正常对照组,不给采取干预措施;生理盐水组,每日腹腔注射0.9%氯化钠注射液20 ml;模型组,每日腹腔注射4.25%腹膜透析液20 ml,同时腹腔内注射脂多糖(lipopolysaccharide,LPS)0.6 mg/kg,3次/周;已酮可可碱治疗组,除

  2. Economic impact of extended time on peritoneal dialysis as a result of using polyglucose: the application of a Markov chain model to forecast changes in the development of the ESRD programme over time

    NARCIS (Netherlands)

    T.J. Weijnen; H.W. van Hamersvelt; P.M. Just; D.G. Struijk; P.M. ter Wee (Piet); Y.I. Tjandra; F.Th. de Charro

    2003-01-01

    textabstractBACKGROUND: The use of polyglucose as a peritoneal dialysis (PD) fluid extends time on PD treatment. It is anticipated, therefore, that the share of patients treated with PD will be positively influenced. The relationship between extension of PD treatment time and an in

  3. Pathogenic bacteria and therapy experience of peritoneal dialysis-related peritonitis%腹膜透析相关性腹膜炎致病菌菌谱分析及治疗体会

    Institute of Scientific and Technical Information of China (English)

    周毓; 钟伟强; 蔡迅

    2008-01-01

    目的 探讨持续性不卧床腹膜透析时发生腹膜炎的病原学机制及治疗方法.方法 对我院84例腹膜透析相关性腹膜炎患者的透出液均做细菌、真菌培养及药物敏感(简称药敏)试验,根据临床表现经验性使用抗生素并根据药敏结果选择抗生素治疗.结果 培养出细菌54例,阳性率为64.29%,阳性率最高为G+球菌40.74%,其次G-杆菌37.04%,真菌9.26%,其中大肠埃希氏菌25.93%,表皮葡萄球菌16.67%,金黄色葡萄球菌12.96%,铜绿假单胞菌、G+杆菌和近平滑念珠菌均为5.56%,通过经验性治疗并根据药敏试验选择敏感抗生素治疗,治愈率为79.76%,退出率15.48%,病死率4.76%.结论 对患者做好宣教及培训,规范操作方法,减少接触污染,注意饮食卫生,对出现腹膜炎症状及体征的患者及早进行透出液的检测及培养,早期经验性使用抗生素以及根据病原学选择合理的抗生素治疗是保证腹膜透析顺利进行的重要因素.%Objective To research the etiology and treatment of Continuous ambulatory peritoneal dialysis peritonitis.Methods Dialysate of 84 continuous ambulatory peritoneal dialysis peritonitis patients of last five years were collected,which received bacterium-culture eumycete-culture and susceptibility testing.Patients received empirical antibiotics according to clinical manifestation or pathogen-directed treatments according to susceptibility testing results.Results Fifty-four csses were cultured with bacteria,the positive-culture rate is 64.29%,the highest is Gram staining positive coecobacteria,40.74%,the second is Gram staining negative bacillus,37.04%,and fungus is 9.26%.Among those,25.93%is cultured with E.coli,16.67%is Staphylococcus epidermidis,12.96%is Staphylococcus aureus.The culrum rate of Pseudomonas aeruginosa,Gram staining positive bacillus and Candida parapsilosis are all 5.56%.By the application of empirical antibiotics or treatment with sensitive antibiotics according to

  4. 不同心态类型的老年腹膜透析患者的心理健康教育对策%Mental health education strategies of elderly patients with peritoneal dialysis of different type of mood

    Institute of Scientific and Technical Information of China (English)

    蔡坤; 董雅梦; 苏红梅

    2014-01-01

    作为终末期肾衰竭患者的一种有效替代疗法,腹膜透析在临床已成为有效治疗终末期肾衰竭的措施之一。老年肾衰竭患者的体质差,血流动力学不稳定,不适宜肾移植,临床常采用腹膜透析进行肾脏替代治疗。腹膜透析可有效清除尿毒症毒素,提高患者的生活质量,延长患者的生命,因此研究影响腹膜透析患者生存期的相关因素,对进一步提高腹膜透析疗效,改善尿毒症患者的生存质量有重要意义。本研究通过对不同心态类型的老年腹膜透析患者的心理健康教育对策的观察与分析,提出针对性强的心理健康教育方式能降低老年腹膜透析患者的住院率及减少并发症。%As an effective replacement therapy for patients with end-stage renal failure,peritoneal dialysis becomes one of the effective treatment of end-stage renal failure.The constitution of elderly patients with renal failure is poor with hemodynamic instability, therefore patients is not suitable for kidney transplantation, clinical often uses peritoneal dialysis in renal replacement therapy. Peritoneal dialysis can effectively remove the uremic toxins,improve the life qual-ity of patients,prolong life of patients,therefore study the related factors influencing the peritoneal dialysis patient surial has an important significance for further improving the quality of peritoneal dialysis curative effect,improving the sur-vival of patients with uremia.The study puts forward that the proper psychological health education could reduce the hospitalization rate and complications of old patients with peritoneal dialysis through the observation and analysis of psychological health education countermeasure for elderly patients with peritoneal dialysis of different type of mood.

  5. 精细化管理在腹膜透析患者护理中的应用%Role of Fine Management in Peritoneal Dialysis Patient Care

    Institute of Scientific and Technical Information of China (English)

    徐春华; 廖玉梅; 高敏; 何艳

    2016-01-01

    目的:探讨精细化管理在腹膜透析患者护理中的作用。方法选择我院2014年5月~2015年4月随访腹透患者256例为观察组、2013年5月-2014年4月随访腹透患者254例为对照组,观察组采取精细化管理方法,对照组采取常规护理管理方法,比较两组患者腹透管组异常发生率、腹膜炎发生率、患者随访率、服药正确率、心衰发生率等指标有无差异。结果实施精细化管理前腹透患者管组异常发生率、腹膜炎发生率、患者随访率、用药正确率、心衰发生率分别为8.2%、57.5病人月/次、88%、92%、9.1%,实施精细化管理后腹透患者管组异常发生率、腹膜炎发生率、患者随访率、用药正确率、心衰发生率分别为3.9%、93.1病人月/次、96%、98%、3.9%,以上5组指标在实施精细化管理前后比较上均有统计学差异。结论精细化管理能提高护士安全意识和患者依从性、减少患者并发症发生。%Objective To study the role of ifne management in peritoneal dialysis (PD) patient care. Methods A total of 256 patients with PD followed in our hospital from May 2014 to April 2015 were enrolled in the observation group, while 254 PD patients followed in our hospital from May 2013 to April 2014 served as the control group. The ifne management and routine management were adopted for patient care in the observation and the control groups, respectively. Incidence of abdominal catheter abnormalities, incidence of peritonitis, the rate of follow-up, and medication accuracy index and incidence of heart failure were compared between the two groups. Results Before the ifne management, peritoneal dialysis patient’s incidence of abdominal catheter abnormalities, incidence of peritonitis, the rate of follow-up, medication accuracy index and incidence of heart failure were 8.2%, 57.5 episodes per patient-month, 88%, 92%and 9.1%. After the fine management, peritoneal dialysis patient

  6. The causes and nursing for exposure of Dacron cuff on peritoneal dialysis catheter%腹膜透析管浅涤纶套外露的形成原因分析与护理

    Institute of Scientific and Technical Information of China (English)

    费利燕; 王颖

    2012-01-01

    Objective To analysis the causes for the exposure of Dacron cuff on peritoneal dialysis catheter and the nursing experience on the exposure. Method We collected 380 peritoneal dialysis patients from Jan. 2005 to Jan. 2010 in this hospital, and retrospectively analyzed the causes for the exposure of Dacron cuff on peritoneal dialysis catheter in 10 cases among the 380 peritoneal dialysis patients. All of the peritoneal dialysis patients were treated with routine operation and routine nursing after the operation. Baxter goose neck peritoneal dialysis catheter and Baxter double dialysate were used for these patients. The causes for Dacron cuff exposure were analyzed in association with the factors of operation, nursing, patients and others. Result Dacron cuff exposure caused by operation factor was found in one case, nursing factor in one case, and patients' factor in 8 cases. Conclusion The exposure of Dacron cuff on peritoneal dialysis catheter is uncommon. We should carefully monitor the happening of this complication because of its influences to life quality, survival rate and persistency of peritoneal dialysis in peritoneal dialysis patients. Careful dressing change, appropriate education, better nutrition and extension of subcutaneous tunnel are effective measures to prevent this sever complication and its consequences such as peritonitis and catheter loss.%目的 分析腹膜透析患者腹膜透析管浅涤纶套外露的原因及护理体会.方法 收集解放军第四五五医院肾脏科2005年1月至2010年1月间腹膜透析患者380例,回顾性分析其中发生腹膜透析管浅涤纶套外露的10例患者的形成原因.380例腹膜透析患者均采用常规的腹膜透析手术方法,术后常规护理.采用百特鹅颈腹膜透析管,百特双联腹膜透析液.将其中发生了浅涤纶套外露的10例患者按手术因素,护理因素,自身因素与其他因素进行分析阐述.结果 因手术因素造成涤纶套外露的1例,护理

  7. 老年腹膜透析患者的营养管理%Nutrition management for elderly patients under peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    章倩莹; 任红

    2016-01-01

    Malnutrition is one of the common complications in elderly patients under peritoneal dialysis (PD),and closely correlated with poor prognosis,the reasons of which are complex.Besides the influences on appetite by uremic toxins and loss of nutrients during peritoneal dialysis periods,elderly PD patients tend to undergo malnutrition because of the increased prevalence of other complications such as cardiovascular diseases and diabetes,and special factors of physiology,psychology,and sociology.Regular rational assessments on nutritional status in elderly PD patients help to find the causes and prevent malnutrition in time.For treatment,the specific intervention plan must be formulated according to the individual circumstances.%营养不良是老年腹膜透析患者的常见并发症之一,且与患者预后不佳有关。老年腹膜透析患者营养不良的原因多样,除尿毒症毒素影响食欲及腹膜透析造成的营养物质流失外,老年患者由于心血管、糖尿病等合并症增多,且存在生理、心理以及社会学等方面的特殊因素,更易发生营养不良。定期合理评估老年腹膜透析患者的营养状态有助于及时发现诱因,预防营养不良发生。治疗需根据个体情况制定具体干预方案。

  8. The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.

    Science.gov (United States)

    Wang, I-K; Wu, Y-Y; Yang, Y-F; Ting, I-W; Lin, C-C; Yen, T-H; Chen, J-H; Wang, C-H; Huang, C-C; Lin, H-C

    2015-01-01

    Inflammatory markers such as interleukin (IL)-6 and tumour necrosis factor-alpha (TNF-α) are elevated in dialysis patients and can predict cardiovascular events and all-cause mortality. Endotoxin is an important source and also another marker of inflammation in patients with chronic kidney disease. The aim of this study was to evaluate the impact of oral probiotics on serum levels of endotoxemia and cytokines in peritoneal dialysis (PD) patients. The decline of residual renal function, peritonitis episodes, and cardiovascular events were also recorded. From July 2011 to June 2012, a randomised, double-blind, placebo-controlled trial was conducted in PD patients. The intervention group received one capsule of probiotics containing 10(9) cfu Bifobacterium bifidum A218, 10(9) cfu Bifidobacterium catenulatum A302, 10(9) cfu Bifidobacterium longum A101, and 10(9) cfu Lactobacillus plantarum A87 daily for six months, while the placebo group received similar capsules containing maltodextrin for the same duration. Levels of serum TNF-α, interferon gamma, IL-5, IL-6, IL-10, IL-17, and endotoxin were measured before and six months after intervention. 39 patients completed the study (21 in the probiotics group and 18 in the placebo group). In patients receiving probiotics, levels of serum TNF-α, IL-5, IL-6, and endotoxin significantly decreased after six months of treatment, while levels of serum IL-10 significantly increased. In contrast, there were no significant changes in levels of serum cytokines and endotoxin in the placebo group after six months. In addition, the residual renal function was preserved in patients receiving probiotics. In conclusion, probiotics could significantly reduce the serum levels of endotoxin, pro-inflammatory cytokines (TNF-α and IL-6), IL-5, increase the serum levels of anti-inflammatory cytokine (IL-10), and preserve residual renal function in PD patients.

  9. Relación entre la presión intrabdominal en diálisis peritoneal con las hernias y fugas The link between intra-abdominal pressure in peritoneal dialysis and hernias and fugues

    Directory of Open Access Journals (Sweden)

    Concepción Blasco Cabañas

    2012-06-01

    ±253 ml/m². Un 23.5 % tenían una presión intrabdominal mayor a 20 cm. de H2O. En sedestación la media fue de 28±5.5 cm. de H2O y en bipedestación de 43.7±5.3 cm. de H2O. Los enfermos con presión intrabdominal > 20 cm. H2O tenían más porcentaje de hernias (50% vs 12 % y fugas pericatéter (37 % vs. 12 %. Como principales conclusiones, podemos destacar que los niveles de presión intrabdominal de nuestros pacientes son algo más elevados que en otras series. A mayor edad, mayor comorbilidad y mayor índice de masa corporal, la presión intrabdominal es más elevada. Los enfermos con presión intrabdominal elevada presentaron más episodios de hernias y fugas.Normal intra-abdominal pressure is equal to atmospheric pressure (zero. In peritoneal dialysis the introduction of intra-peritoneal liquid increases intra-abdominal pressure. In various studies it is recommended that this does not exceed 16-20cm H2O. In addition to possible abdominal discomfort, high intra-abdominal pressure can be linked to problems with the abdominal wall, such as hernias and fugues, and have implications for peritoneal transport and ultrafiltration deficit. The aims of this study were the following: to find out the intra-abdominal pressure levels in the prevalent type of patients in peritoneal dialysis, to assess the factors influencing the values for this pressure and to study the relationship between intra-abdominal pressure and the development of hernias and fugues, retrospectively. A transversal, observational and retrospective study was conducted to measure intra-abdominal pressure in the prevalent, stable patients who had been on peritoneal dialysis for more than three months. Intra-abdominal pressure was measured using the method described by Durand: patient in a supine position, with diurnal peritoneal volume. The final intra-abdominal pressure is the average of the measurements taken during inspiration and expiration, is expressed in cm H2O and the volume drained is

  10. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study.

    Science.gov (United States)

    Lindberg, Jill S; Culleton, Bruce; Wong, Gordon; Borah, Michael F; Clark, Roderick V; Shapiro, Warren B; Roger, Simon D; Husserl, Fred E; Klassen, Preston S; Guo, Matthew D; Albizem, Moetaz B; Coburn, Jack W

    2005-03-01

    Management of secondary hyperparathyroidism is challenging with traditional therapy. The calcimimetic cinacalcet HCl acts on the calcium-sensing receptor to increase its sensitivity to calcium, thereby reducing parathyroid hormone (PTH) secretion. This phase 3, multicenter, randomized, placebo-controlled, double-blind study evaluated the efficacy and safety of cinacalcet in hemodialysis (HD) and peritoneal dialysis (PD) patients with PTH > or =300 pg/ml despite traditional therapy. A total of 395 patients received once-daily oral cinacalcet (260 HD, 34 PD) or placebo (89 HD, 12 PD) titrated from 30 to 180 mg to achieve a target intact PTH (iPTH) level of or =30% reduction in iPTH from baseline (65 versus 13%), and proportion of patients with > or =20, > or =40, or > or =50% reduction from baseline. Cinacalcet had comparable efficacy in HD and PD patients; 50% of PD patients achieved a mean iPTH < or =300 pg/ml. Cinacalcet also significantly reduced serum calcium, phosphorus, and Ca x P levels compared with control treatment. The most common side effects, nausea and vomiting, were usually mild to moderate in severity and transient. Once-daily oral cinacalcet was effective in rapidly and safely reducing PTH, Ca x P, calcium, and phosphorus levels in patients who received HD or PD. Cinacalcet offers a new therapeutic option for controlling secondary hyperparathyroidism in patients with chronic kidney disease on dialysis.

  11. 家庭腹膜透析病人的护理和指导%The Nursing and Guidance Measures of Home Peritoneal Dialysis

    Institute of Scientific and Technical Information of China (English)

    郭桂芝

    2011-01-01

    Objective: We investigated the nursing and guidance measures in uremic patients undergoing home peritoneal dialysis. Methods: Thirty-five patients with end-stage renal disease (ESRD) treated with CAPD were recruited from the Dialysis Center of first people,hospital in XuZhou to participate in retrospective analysis.By analyzing their clinical date,we got a number of nursing experience. Results: Compared with the previous, the quality of life in the parents with good compliance were improved by a series of comprehensive measures, which contain dietary guidance,emphasizes aseptic, health education, psychological care,life guidance and family support. Conclusions: The nursing measures for the patients with end-stage renal disease (ESRD) treated with CAPD could improve their quality of dialysis and life.%目的:探讨家庭腹膜透析病人的护理和指导措施.方法:回顾性分析我科35 例腹膜透析患者的临床资料,总结护理经验.结果:通过做饮食指导、强调无菌操作、健康教育、心理护理和生活指导,家庭的大力支持等一系列综合性护理措施,依从性好的患者生活质量较前有所提高.结论:对居家腹膜透析患者实施护理干预,对提高透析质量和生活质量具有重要意义.

  12. Do the outcomes of living donor renal allograft recipients differ with peritoneal dialysis and hemodialysis as a bridge renal replacement therapy?

    Directory of Open Access Journals (Sweden)

    Narayan Prasad

    2014-01-01

    Full Text Available This study was undertaken to compare the outcomes of living donor renal transplant recipients using peritoneal dialysis (PD and hemodialysis (HD as a bridge modality for renal replacement therapy till renal transplantation. The demographic profiles of the recipients and donors, the patients′ native kidney disease (diabetic versus non-diabetic, duration on dialysis, requirement of anti-hypertensive drugs, number of blood transfusions, human leukocyte antigen (HLA mismatch status, pre- and post-transplant infectious complications, and post-transplant outcomes of patients were compared between the two groups. The demographic features of the study patients were similar in the two groups. The duration of dialysis prior to transplant was significantly longer in the PD group than in the HD group of patients. The anti-hypertensive drug requirement was lower and the hemoglobin level and residual urine volume at the time of transplant were relatively better in the PD patients compared to the HD patients. The number of acute rejection episodes, delayed graft function, surgical complications, glomerular filtration rate at one month and at the last follow-up, were also similar in both groups. The short-term and long-term graft survival was similar in both groups of patients. The one-, two-, five-, and eight-year death-censored graft survival rates of the PD patients were 98, 95, 85, and 73%, respectively, and in the HD group of patients, they were 100, 93, 84, and 79%, respectively. The one-, two-, five-, and eight-year patient survival rates in the PD group were 97, 92, 77, and 66%, respectively, and in the HD group, they were 97, 92, 79, and 69%, respectively. Our study suggests that the outcomes of the living donor renal allograft recipients did not differ between the groups of patients who used PD or HD as renal replacement therapy prior to renal transplantation.

  13. Expression of membrane complement regulators, CD46, CD55 and CD59, in mesothelial cells of patients on peritoneal dialysis therapy.

    Science.gov (United States)

    Sei, Yumi; Mizuno, Masashi; Suzuki, Yasuhiro; Imai, Masaki; Higashide, Keiko; Harris, Claire L; Sakata, Fumiko; Iguchi, Daiki; Fujiwara, Michitaka; Kodera, Yasuhiro; Maruyama, Shoichi; Matsuo, Seiichi; Ito, Yasuhiko

    2015-06-01

    We investigated the expression of membrane complement regulators (CRegs), CD46, CD55 and CD59 in human mesothelial cells, and correlated with clinical background and level of complement (C) activation products in peritoneal dialysis (PD) fluids (PDF) to clarify influence of the C activation system in PD patients. Expression of CRegs was assessed on primary cultures of mesothelial cells (HPMC) harvested from PD fluid of 31 PD patients. Because expression of CD55 but not CD46 and CD59 in mesothelial cells was significantly correlated to value of dialysate-to-plasma creatinine concentration ratio (D/P Cre) (p<0.005) as an indicator of peritoneal function, we focused on analysis of CD55 expression of HPMCs in comparison with levels of C activation products in the PDF of the PD patients, and their background factors. When comparing expression of the CRegs between systemic neutrophils and HPMC, no correlation was observed, supporting that change of CRegs' expression in HPMC was independently occurring in the peritoneum. Expression of CD55 protein in HPMC was closely correlated with expression at the mRNA level (p<0.0001) and was inversely correlated with levels of sC5b-9 (p<0.05), but not C3, C4, IL6 and CA125 in the PDF. Complications of diabetes, usage of icodextrin and residual renal function were not correlated with change of CD55 expression in HPMCs. Our data show that the process of PD therapy modifies expression of CD55 on peritoneal mesothelium and triggers local C activation. These findings support efforts to modify PD therapy to limit effects on activation and regulation of the C system.

  14. Vivendo entre o pesadelo e o despertar: o primeiro momento no enfrentamento da diálise peritoneal Viviendo entre la pesadilla y el despertar: el primer enfrentamiento de la diálisis peritoneal Living between the nightmare and the awakening: the first time in dealing with peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Felipe Kaezer dos Santos

    2011-03-01

    idea de muerte y haciendo una clara distinción entre la enfermedad renal crónica y la diálisis. Si antes, las dos percepciones parecían solo una, el despertar presenta la diálisis peritoneal como el "anti-muerte", como un renacer para la vida.This article originates from a dissertation whose object was the significance of facing the customer carrier of chronic kidney disease by initiating peritoneal dialysis. The study subjects were considered from the perspective of symbolic interactionism, which emphasizes the significance of the elements of the world as determinants for the interaction. Following the methodological procedures of Grounded Theory were established paradigms of the five elements of analysis: Causes, Context, Factors Actors, Strategies for Action/Interaction and Consequences. The purpose of this discussion is finding ways by which the customer carrier faces chronic kidney disease on peritoneal dialysis, on the verge of realizing this method. Facing this new situation, the customer goes to a wake, abandoning the idea of death and making a clear distinction between chronic kidney disease and dialysis. If before, the two perceptions seemed to be just one, the awakening has peritoneal dialysis as the "anti-death" like a rebirth for life.

  15. Scintigraphic diagnosis of infectious complications in renal failure patients undergoing hemodialysis, continuous ambulatory peritoneal dialysis or renal transplant

    Energy Technology Data Exchange (ETDEWEB)

    Garcia Vicente, Ana Maria; Ruiz Solis, Sebastian; Soriano Castrejon, Angel; Poblete Garcia, Victor Manuel; Talavera Rubio, Maria del Prado; Rodado Marina, Sonia; Cortes Romera, Montserrat [Ciudad Real General Hospital (Spain). Dept. of Nuclear Medicine

    2005-10-15

    Patients with end-stage renal disease have two therapeutic options, dialysis and renal transplantation. Infectious complications occurring in such patients will not only condition the effectiveness of such treatments, but are among the main causes of morbidity and mortality in such cases. Knowledge of the advantages and limitations of nuclear techniques is essential for management of these conditions. (author)

  16. Analysis of the Pathogenic Bacteria of Peritoneal Dialysis Related Peritonitis and Their Drug Resistance%腹膜透析相关性腹膜炎致病菌及其耐药性分析

    Institute of Scientific and Technical Information of China (English)

    李慧敏; 彭月萍

    2014-01-01

    Objective To explore the pathogenic bacteria of peritoneal dialysis related peritonitis and their drug resistance so as to guide the clinical medication. Methods The culture and result of drug susceptibility test of 70 cases of peritoneal dialysis effluent in our peritoneal dialysis center from December, 2009 to August, 2013 were analyzed retrospectively. Of the patients, there were 50 males, 20 females, aged from 21 to 77, the average age was 46.8±26.3. Results Among them, reoccurrence occurred in 3 cases, relapse occurred in 1 case, 23 cases of positive drug susceptibility, the positive rate was 38.3%; including 10 cases of gram-posi-tive bacteria (43.5%), 12 cases of gram-negative bacteria (52.2%), 1 case of fungus (4.3%);gram-positive bacteria were sensitive to vancomycin, the drug resistance rate of penicillin was as high as 80%, the resistance rate of oxacillin was 83.3%, that of ery-thromycin was 100%;gram-negative bacteria were sensitive to meropenem, imipenem, amikacin, piperacillin sodium and tazobac-tam sodium, the sensitive rate of ceftazidime was higher (90%), but were resistant to ampicillin. Conclusion The proportion of gram-positive bacteria and gram-negative bacteria is almost the same, both of them are resistant to ampicillin. Gram-positive bac-teria are sensitive to vancomycin, and gram-negative bacteria are sensitive to meropenem, imipenem, amikacin, piperacillin sodium and tazobactam sodium.%目的:探讨腹膜透析相关性腹膜炎的致病菌及细菌耐药情况,指导临床用药。方法回顾性分析该腹膜透析中心2009年12月-2013年8月共70例腹膜炎患者的腹膜透析流出液培养+药敏结果。其中男性50例,女性20例,年龄21~77岁,平均(46.8±26.3)岁。结果其中复发3例,再发1例,药敏培养阳性23例,阳性率为38.3%,其中革兰氏阳性菌占10例(43.5%),革兰氏阴性菌12例(52.2%),真菌1例(4.3%);革兰阳性球菌对万古霉素均敏感,

  17. The Effect of Shen Kang Injection on Peritoneal Dialysis and Oxidative Stress in Rats%肾康注射液对大鼠腹膜透析功能及氧化应激的影响

    Institute of Scientific and Technical Information of China (English)

    程世平; 查艳; 袁静; 沈燕; 林鑫; 李惠

    2013-01-01

    目的:研究肾康注射液(SKI)对腹膜透析液(peritoneal dialysis solution,PDS)诱导的大鼠腹膜透析功能减退及氧化应激的影响.方法:50只SD大鼠,随机分为正常对照组、4.25% PDS组和SKI低、中、高剂量(SKI组都加入4.25% PDS)组,8周后进行腹膜功能实验,量取透出液体积,腹主动脉取血检测血清中的超氧化物歧化酶(SOD)、丙二醛(MDA)的含量,并计算超滤量(UF)、葡萄糖转运量(MTG)及葡萄糖清除率(C).结果:与PDS组比较,SKI中、高剂量组的UF、C、SOD含量显著增加(P<0.05),SKI各剂量组的MTG、MDA含量显著下降(P<0.05).结论:腹膜透析液中加入SKI具有改善PDS诱导的腹膜透析功能减退和抑制氧化应激的作用.%Objective: To investigate the influence of Shen Kang injection (SKI) on decrease of peritoneal dialysis effect caused by peritoneal dialysis solution (PDS) and oxidative stress in rats. Methods: Fifty SD rats were randomly divided into normal control group, 4. 25% PDS group, and groups of 4.25% PDS + low, moderate and high doses of SKI respectively. Peritoneal function test was performed in rats of each group in 8 weeks after intraperitoneal injection with PDS or/and SKI. The volume of peritoneal effluent was detected, and blood samples were taken from abdominal aorta. Serum levels of superoxide dismutase (SOD), malondialdehyde (MDA) were measured. Ultrafiltration a-mount (UF), mass transfer amount of glucose (MTG) and clearance rates of glucose (C) were detected. Results: UF, C and serum levels of SOD in SKI groups were higher than those in group PDS (P <0.05). Serum levels of MDA and MTG in SKI groups were lower than those in group PDS (P < 0. 05). Conclusions: SKI may be helpful in ameliorating peritoneal dialysis function decrease caused by PDS and inhibiting oxidative stress in peritoneal dialysis rats.

  18. Motivo de "escolha" de diálise peritoneal: exaustão de acesso vascular para hemodiálise? Reason for "choosing" peritoneal dialysis: exhaustion of vascular access for hemodialysis?

    Directory of Open Access Journals (Sweden)

    Paulo Novis Rocha

    2010-03-01

    Full Text Available INTRODUÇÃO: Pouco se conhece sobre a evolução de pacientes que iniciam DP como única alternativa. OBJETIVOS: Descrever o perfil clínico-demográfico e a ocorrência de peritonite em uma amostra de pacientes convertidos de HD para DP por exaustão de acesso vascular. MÉTODOS: Revisão dos prontuários de todos os pacientes do programa de DP do HGRS. RESULTADOS: Foram estudados 22 pacientes com idade mediana de 47,9 anos, 54,5% de homens, 84,2% de negros ou mulatos, 68,2% procedentes do interior da Bahia. DP foi a modalidade inicial de TRS em apenas quatro pacientes. Os 18 pacientes restantes iniciaram TRS através de HD; neste grupo, predominou o início de HD de forma emergencial e através de cateter duplo-lúmen (CDL. Em uma mediana de 7,7 meses em HD, a maioria dos pacientes (64,7% usou mais de quatro CDL. Em apenas 7/18 (39% pacientes, a conversão de HD para DP foi feita por escolha do paciente; na maioria dos casos, 11/18 (61%, o motivo de conversão foi exaustão de acesso vascular para HD. Peritonite foi mais frequente nos pacientes que entraram em HD por exaustão de acesso vascular que no restante do grupo. CONCLUSÕES: O início de TRS de forma emergencial através de HD utilizando CDL pode levar a uma rápida exaustão de acesso vascular, deixando a DP como única alternativa viável. Este modo inadequado de "seleção" de pacientes para DP está associado a maiores chances de ocorrência de peritonite.INTRODUCTION: Little is known about the prognosis of patients beginnig peritoneal dialysis (PD as their last alternative. OBJECTIVES: To describe the clinical-demographic profile of patients switching from hemodialysis (HD to PD, due to exhaustion of the HD vascular access, and the occurrence of peritonitis among them. METHODS: Review of the medical records of all patients in the PD program of the Hospital Roberto Santos in the city of Salvador, state of Bahia, Brazil. RESULTS: The study comprised 22 patients (median age, 47

  19. Repercussões cardiorrespiratórias da diálise peritoneal em crianças graves Cardiorespiratory repercussions of the peritoneal dialysis in critically ill children

    Directory of Open Access Journals (Sweden)

    Patrícia Gombai Barcellos

    2008-03-01

    Full Text Available JUSTIFICATIVA E OBJETIVOS: A diálise peritoneal (DP é um procedimento freqüentemente indicado para crianças graves com insuficiência renal aguda, sua finalidade é substituir a filtração glomerular e melhorar o controle do equilíbrio hidroeletrolítico e ácido-básico. Entretanto, podem ocorrer alterações cardiorrespiratórias durante o procedimento. Desta forma, o objetivo deste estudo foi descrever as repercussões cardiorrespiratórias da DP em Pediatria e o nível de evidência dos estudos que abordam as repercussões. MÉTODO: Revisão bibliográfica de artigos que abordassem as repercussões cardiorrespiratórias da DP em Pediatria. Pesquisa nos bancos de dados Medline, Ovid e Lilacs, analisando artigos publicados entre 1990 e 2007, com as seguintes palavras-chave, nos idiomas português, inglês e espanhol, respectivamente: diálise peritoneal, efeitos hemodinâmicos, complicações respiratórias, complicações cardíacas, Pediatria; peritoneal dialysis, hemodynamic effects, respiratory complications, cardiac complications, Pediatric; peritoneal diálisis, efecto hemodinámico, complicaciones respiratorias, complicaciones cardiacas, Pediatria. Os artigos encontrados foram classificados em nível de evidências segundo Cook e col. 1992. RESULTADOS: Foram encontrados 13 artigos, sendo que oito deles abordaram as repercussões cardiocirculatórias e cinco abordaram as repercussões no sistema respiratório da DP. Esses estudos avaliaram pacientes na faixa etária de recém-nascidos a adolescentes graves, totalizando 178 crianças. Dentre as complicações respiratórias mais freqüentes durante a DP encontrou-se a redução da complacência pulmonar e da pressão parcial arterial de oxigênio, aumento da resistência das vias aéreas e da pressão parcial arterial de gás carbônico; após a infusão de fluído na DP os estudos demonstraram um aumento da relação entre a pressão parcial e a fração inspirada de oxig

  20. Evaluation and analysis of peritoneal dialysis patients' dialysate exchange procedures%78例腹膜透析患者换液操作考核分析

    Institute of Scientific and Technical Information of China (English)

    赵艳; 任晓英; 苏春燕

    2010-01-01

    目的 分析78例腹膜透析患者换液操作考核情况,探讨换液操作考核成绩与透析龄的关系.方法 采用自设问卷对腹透患者或照顾者进行换液操作考核,并进行统计分析.结果 78例患者考核总平均分(79.15±14.87),合格率为42.3%,其中紫外线照射、桌面和地面的消毒、洗手及戴口罩等操作前准备步骤合格率低;透析龄≤12月与透析龄>12个月患者进行比较,两组得分差异有统计学意义(t=3.975,P<0.01);操作前准备、操作过程及考核总分与透析龄之间呈负相关(P<0.01).结论 应加强透析患者,尤其是透析龄较长的患者再教育与培训,预防因操作引起相关并发症的发生,从而提高其生活质量.%Objective To evaluate dialysate exchange procedures of patients on peritoneal dialysis,and analyze the relationship between dialysate exchange skills and dialysis duration. Methods A self-designed evaluation form was used to check the patients' dialysate exchange procedure when they came to the clinic for transfer set change, and the data were analyzed using statistical mehods. Results The global score of assessment was 79. 15 ± 14.87,42.3% patients passed the test. Patients did not have good adherence to Ultraviolet radiation, environment cleaning, hand washing, and masks wearing. The global score for patients on PD more than one yearwas lower than the others (76.52 ± 15.34 vs 87.94 ±8.84, P<0.01 ). The score of preparation procedure, operation process, and global score had significantly negative correlation with dialysis duration(P <0.01). Conclusions PD patients may not adhere adequately to dialysate exchange procedures at home. And this problem may become more sever along with their dialysis duration. Periodically retraining is thus very needed for the long term PD patients.

  1. The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker?

    OpenAIRE

    Karadag, Serhat; Ozturk, Savas; Gursu, Meltem; Gurdal, Ahmet; Basinoglu, Filiz; Yigit, Servet; Zeki AYDIN; Uzun, Sami; Sumnu, Abdullah; Oflaz, Huseyin; Kazancioglu, Rumeyza

    2014-01-01

    Background Many markers have been proposed for CVD risk assessment in dialysis population. Apelin is a peptide that has roles in cardiovascular functions and volume regulation namely vasodilation, decreased blood pressure (BP), positive inotropic effect and inhibition of antidiuretic hormone release. The aim of this study was to examine relationship of apelin levels with echocardiographic findings and laboratory parameters related with cardiovascular function and bone mineral metabolism among...

  2. Effect of sulodexide on peritoneal morphology and function of peritoneal dialysis rats%舒洛地特对腹膜透析大鼠腹膜结构和功能的作用

    Institute of Scientific and Technical Information of China (English)

    韦永光; 林沁; 戢晴; 郑丰

    2011-01-01

    Objective To investigate the effect of sulodexide on the peritoneal morphology and function of long-term peritoneal dialysis rats. Methods Adult male Sprague-Dawley rats were randomly divided into the following four groups:control group(n= 6), model group(n= 10), low-dose sulodexide group (n= 10) and high-dose sulodexide group(n = 10). A 1 hour peritoneal equilibration test was performed after an eight-week peritoneal dialysis in each group. The dialysate samples were subjected to examination by hemocytometer for determination of 1 h dialysate urea(Durea ), dialysate protein(Dtp ), initial dialysate glucose(D0 ) and 1 h dialysate glucose( D1 ), plasma urea nitrogen(Purea )and total plasma protein(Ptp ); and the D/P (parameter for clearance rate of urea nitrogen), D/Ptp (parameter for total protein loss in dialysate), and D1/D0 (parameter for peritoneal ultrafiltration)were calculated. The parietal peritoneum tissues of rats were harvested and stained by Hematoxylineosin and Masson trichrome for observation of the peritoneal structure. The vessels and leukocytes in peritoneum tissue were counted (n/mm2) using stained sections. Leukocytes in dialysate samples were evaluated using hemocytometer. The levels of inflammatory cytokine (MCP-1, TNFα) in dialysate samples were measured by enzyme-linked immunosorbent assay(ELISA)and the expression of TGF-β1 in parietal peritoneum was detected by immunohistoehemistry assay. Results Compared with the control group, rats in the model group had decreased peritoneal mesothelial cells, thickened sub-mesothelial matrix, increased inflammatory cells, and angiogenesis (P<0.05). The ultrafilitration volume (UF) and glucose reabsorption (D1 /D0 ) were significantly lower and the dialysate-to-plasma urea ratio (D/Purea) and dialysate-to-plasma total protein ratio(D/Ptp ) were significantly higher in model group than those in the control group (P<0.05). Counts of leukocytes and levels of MCP-1 and TNFα in dialysate samples were

  3. 腹膜透析并发感染性腹膜炎患者血清降钙素原检测的临床意义%Peritoneal Dialysis Concurrent Infectious Peritonitis in Patients with Serum Calcitonin Original Clinical Significance of Detection

    Institute of Scientific and Technical Information of China (English)

    宋新宇

    2016-01-01

    目的:探讨分析腹膜透析并发感染性腹膜炎患者血清降钙素原检测的临床意义。方法选取我院2013年1月至2015年7月期间腹膜透析中心24例接受腹膜透析的患者作为研究分析对象,同时,所选24例患者均接受电化学发光免疫分析法进行检测,依据检测结果将其分为非腹膜炎组(12例)、腹膜炎组(12例),并选取同时期到我院体检健康者12例作为对照组,三组研究对象均接受血清降钙素原检验,比较三组研究对象检测结果。结果非腹膜炎组和腹膜炎组比较血清 PCT 指数,腹膜炎组明显高于非腹膜炎组,组间数据有统计学意义(P0.05);非腹膜炎组和腹膜炎组比较,血清 CRP 指数明显升高(P0.05)。结论腹膜透析并发感染性腹膜炎患者的血清降钙素原检测指数有明显升高趋势,临床中,对腹膜透析并发感染性腹膜炎疾病的判定有一定作用,同时也可用来评价临床治疗状况。%Objective To investigate the clinical significance of serum levels of calcitonin in patients with peritoneal dialysis complicated with infection. Methods 2013 January to July 2015 during peritoneal dialysis center 24 cases accepted peritoneal dialysis patients as the analysis object, at the same time, the selected 24 patients underwent electrochemical luminescence immunoassay was used to detect the. Based on the test results will be classified as non peritonitis group (12 cases), the peritonitis group (12 cases), and select the same period in our hospital for a medical examination of the health and 12 cases as control group, three groups of subjects were treated with serum procalcitonin test, were compared among the three groups of research object detection results. Results The peritonitis group and peritonitis group serum PCT index, peritonitis group was significantly higher than that in non peritonitis group was statistically significant between two groups of data

  4. Home Dialysis: A Dutch Perspective

    NARCIS (Netherlands)

    E.W. Boeschoten; W.M. Michels

    2011-01-01

    For patients with end-stage renal disease who are not (yet) eligible for renal transplantation, treatment with dialysis is mandatory for survival. Home dialysis modalities (home hemodialysis or peritoneal dialysis) offer patients more flexibility compared with in-center treatment and have been advoc

  5. Application of authorized education in enhancing the compliance of patients accepting peritoneal dialysis%授权教育在提高腹膜透析病人依从性中的应用

    Institute of Scientific and Technical Information of China (English)

    张慧; 林征

    2011-01-01

    [目的]探讨授权教育在提高腹膜透析病人依从性中的应用.[方法]选择2006年1月-2010年6月在苏州市立医院接受过治疗的60例腹膜透析的病人,对其实施3个月授权教育,观察教育前后饮食依从性、服药依从性、透析依从性及自我效能感的改变.[结果]授权教育后,60例腹膜透析病人饮食依从性、服药依从性、透析依从性、自我效能感均有明显提高.[结论]授权教育有助于提高腹膜透析病人的治疗依从性,增强其自我效能及自我管理能力.%Objective:To probe into applying authoriged education in enhan cing the compliance of patients accepting peritoneal dialysis. Method:A to tal of 60 cases accepted peritoneal dialysis in municipal hospital of Suzhou city from Jan. 2006 to Jun 2010 were selected. They had been carried out authoriged education for 3 months. They had been carried out authoriged education for 3 months. Then changes of diet compliance, medicine taking compliance,and self - efficacy feeling of all patients were observed before and after the education. Result: After the authoriged education, the diet compliance,medicine taking compliance and self -efficacy feeling of all 60 cases accepted peritoneal dialysis bad enhanced remarkably. Conclusion: Authoriged education can help to enhance the treatment compliance of pa tients accepting peritoneal dialysis and to streng then their self- efficacy and self - management ability.

  6. Geografia da diálise peritoneal no Brasil: análise de uma coorte de 5.819 pacientes (BRAZPD Geography of peritoneal dialysis in Brazil: analysis of a cohort of 5,819 patients (BRAZPD

    Directory of Open Access Journals (Sweden)

    Natália Maria da Silva Fernandes

    2010-09-01

    Full Text Available INTRODUÇÃO: O Brasil é um país continental com grande diversidade demográfica, social e cultural. Esse fator pode determinar diferenças demográficas, clínicas e no desfecho apresentado por pacientes portadores de doença renal crônica em diálise peritoneal (DP. OBJETIVO: Avaliar as características clínicas e os desfechos apresentados por pacientes em DP nas diversas regiões do Brasil, analisando uma coorte de pacientes (BRAZPD no período de dezembro de 2004 a outubro de 2007. PACIENTES E MÉTODOS: Os dados foram coletados mensalmente e os pacientes foram acompanhados até o desfecho (óbito, transplante renal, recuperação da função renal, transferência para hemodiálise ou perda de seguimento. RESULTADOS: Avaliados 5.819 pacientes incidentes e prevalentes. A maioria dos pacientes realizava terapia renal substitutiva (TRS no Sudeste, onde a média de tempo de acompanhamento foi maior (12,3 meses e há maior percentual de idosos (36,4%. A prevalência de diabetes mellitus é maior no Sudeste e Sul do país (38,1% e 37%, respectivamente. A maioria dos pacientes da região Norte realizou hemodiálise previamente, 66,2%. A taxa de saída por óbito foi maior na região Norte (30,1%, assim como por falência da técnica (22,3%. CONCLUSÃO: Os dados revelam diferenças demográficas, clínicas e em taxas de mortalidade e falência da técnica de DP refletindo as peculiaridades demográficas e sociais do Brasil. A geografia da DP no Brasil demonstra ser um espelho da geografia do Brasil. Portanto, políticas de saúde devem levar em conta as características de cada região para que possamos melhorar a sobrevida dos pacientes e da técnica em diálise peritoneal.INTRODUCTION: Brazil is a continental country with great diversity of population, social and cultural. This factor may determine different demographic, clinical and outcome presented by patients with chronic kidney disease on peritoneal dialysis (PD. OBJECTIVE: To evaluate the

  7. 67例腹膜透析相关性腹膜炎患者临床特点分析%Clinical Characteristics of 67 Peritoneal Dialysis Correlative Peritonitis Patients

    Institute of Scientific and Technical Information of China (English)

    王宁方; 赵崇山; 尤月明; 陈超; 麦李明; 王丽; 石峰

    2016-01-01

    Objective :The aim of this study was to investigate the distribution and drug resistance of bacteria in 67 pa‐tients of peritoneal dialysis correlative peritonitis .As well as the clinical characteristics in Single Infection (SI) ,Multi‐ple Infection 1 (MI1) ,Multiple Infection 2 (MI2) groups was analyzed .Methods :A retrospective analysis with the in‐fection of 67 patients with peritoneal dialysis correlative peritonitis was carried out ,as well as the clinical character differences in different groups .Results:The major infective bacteria were Gram positive bacteria .In Gram positive bac‐teria the highest resistant percentage drug was penicillin G ,and in Gram negative bacteria was ampicillin .In SI ,MI1 , MI2 groups ,the white blood cell (WBC) of ascites on first day decreased .Thrombocyte (PLT ) and thrombocytocrit (PCT) decreased slowly .However the mean platelet volume (MPV) ,platelet distribution width (PDW) ,percentage of large thrombocyte (P‐LCR) was increased significantly ,as well as the albumin .All the P value were lower than 0 .05 . Conclusion:The major infective bacteria were Gram positive bacteria .The WBC in ascites and WBC ,PLT ,PCT ,MPV , PDW ,P‐LCR in peripheral blood may be used to predict multiple infections .%目的:分析67例腹膜透析相关性腹膜炎患者感染菌分布及耐药情况,并比较单发感染(Single Infection ,SI)、多发感染1(Multiple Infection 1,MI1)、多发感染2(Multiple Infection 2,MI2)组临床特点间的差异。方法:回顾性分析67例腹膜透析腹膜炎患者感染情况,并分析不同感染组间临床特点的差异。结果:腹膜透析相关性腹膜炎感染菌以革兰氏阳性菌为主。革兰阳性菌对青霉素G耐药率最高,革兰阴性菌对氨苄西林耐药率最高。S I、M I1、M I2各组间,第1天腹水常规白细胞逐渐下降。血小板、血小板压积逐渐减少,而血小板体积、血小板分布宽度、大型血小板

  8. 腹膜透析患者蛋白质-能量消耗对腹膜炎的影响%The effect of the peritonitis incidence with protein - energy consumption in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    罗敏虹; 袁丽萍; 曾海鸥; 陈圳炜; 伍强; 杨铁城

    2015-01-01

    目的:探讨腹膜透析患者蛋白质-能量消耗(PEW)与腹膜炎发生率的相关性。方法对行维持性腹膜透析(PD)的患者运用改良 SGA 法评分系统(MQSGA)、营养不良-炎症评分(MIS)和血清总蛋白、白蛋白等进行营养评估,采用酶联免疫方法(ELISA)检测血清超敏 C 反应蛋白(Hs - CRP)、白细胞介素-6(IL -6)浓度进行微炎症状态评估,同时检测患者人体学指标、生化指标以及24 h 腹透液蛋白丢失量、瘦素等指标。随后将所有患者依据 PEW 不同分为合并 PEW 组和非 PEW 组,比较两组间腹膜炎的发生率。结果 MQSGA 和 MIS 与 Hs - CRP、IL -6显著正相关。MQSGA 和 MIS 与身体质量指数(BMI)、中臂围(MAC)、肱三头肌皮褶厚度(TSF)、中臂肌围(MAMC)、白蛋白(ALB)、血肌酐(Scr)、血红蛋白(Hb)、尿素氮(BUN)、转铁蛋白(TF)、总铁结合力(TIBC)显著负相关。60例 PD 患者中,PEW 者30例,非 PEW 者30例。与非 PEW 组相比,PEW 组的 MQSGA 分值更高,MIS 分值更高,PEW 组患者 BMI、ALB、Scr 显著降低,hs - CRP、IL -6、24 h 腹透液蛋白丢失量及瘦素显著升高,两组比较差异具有统计学意义( P <0.05)。PEW 组与非 PEW 组腹膜炎发生率分别为44.7%和10.0%,PEW 组腹膜炎发生率显著高于非 PEW 组( P <0.01)。结论①MQSGA 和 MIS 可较好评价慢性肾脏病 PD 患者的 PEW,合并 PEW 的 PD 患者,其腹膜炎发生率也较高,PEW 可预测 PD患者发生腹膜炎的风险。②PEW 与瘦素水平、24 h 腹透液蛋白丢失量、微炎症状态等相关。%Objective To evaluate the correlation of the peritonitis incidence with protein - energy consumption(PEW)in peritoneal di-alysis patients. Methods In the patients with continuous ambulatory peritoneal dialysis,nutritional assessment was applied by the method of im-proved SGA score system

  9. [Peritoneal dialysis in a patient with right hemiparesis, lupus nephritis, significant insufficiency of arteries of aortic arch and celiac disease: case report].

    Science.gov (United States)

    Altabas, Karmela; Crne, Natasa; Franjić, Björn Dario; Pavlović, Drasko; Josipović, Josipa

    2012-10-01

    Peritoneal dialysis (PD) is a method of choice in patients in whom there are difficulties concerning creation of AV fistula. A 38-year old female patient came to our hospital because of a need of making an AV fistula. She had end-stage renal insufficiency of unknown origin. She had a right hemiparesis with a contracture of the right fist and epilepsy because of the stroke she suffered in 1993. After doing the diagnostics, we have found that patient had lupus nephritis, occlusion of brachiocephalic trunk, right and left common carotid artery and left subclavian artery. We also diagnosed celiac disease and a significant anemia. It was not possible to form an AV fistula, as it was not possible to do an assisted PD. Because of the right hemiparesis and contracture of the right fist, the possibility of performing PD independently was questionable. Despite the handicap, the patient had strong motivation and she managed to master the technique of PD independently. Even though it was estimated that she had a high risk score for applying anesthesia (ASA IV), the insertion of the peritoneal catheter went without complications. Because of the comorbidity, especially because of the significant stenosis and occlusions of the arteries of aortic arch, the kidney transplantation will not be performed. In the last fifteen months, the patient is performing PD independently, without any infectious complications, she is feeling well and is satisfied with the quality of her life. The consequences of the renal insufficiency are under control, systemic lupus erythematosus is, with a low dose of corticosteroids, in a steady state, malnutrition is corrected, but there is still hypoalbuminemia noted.

  10. 丙酮酸盐在腹膜透析液中优于乳酸盐%Advantages of pyruvate over lactate in peritoneal dialysis solutions

    Institute of Scientific and Technical Information of China (English)

    周方强

    2001-01-01

    This review discusses effects of both lactate and pyruvate, and high glucose in peritoneal dialysis solutions (PDS) on leukocytes, mainly on intracellular pH ( [pH]i ), glucose metabolic pathways, and apoptosis.Lactate-based PDS (L-PDS) are bioincompatible primarily due to the low pH, high lactate, and glucose excess in both individual and combination. High lactate in an acidi milieu would induce severe intracellular acidosis of leukocytes, and high glucose may disturb glucose metabolic pathways and activate protein kinase C (PKC) and nuclear factor-kappa B (NF-κ B) of the cells, leading to apoptosis. Pymvate-based PDS (P-PDS) are novel experimental PDS. Evidence shows that P-PDS are superior in biocompatibility. Pyruvate protection of cells has been confirmed in many fields besides the PDS area.Although the underlying mechanism whereby P-PDS preserve cell function is not fully understood, it may be associated with the maintenance of [ pH ]i close to physiological, due to its low buffering capacity, improvement of cellular glucose metabolic pathways and redox state,and sustainment of intracellular calcium ([ Ca2+ ]i )homeostasis in high glucose concentrations. It may also inhibit PKC and NF-c B activation in high glucose. In addition, pyruvate is a strong antioxidant, a scavenger of hydrogen peroxide (H2O2). However, exogenous pyruvate in PDS could not be an energy source for cells and also the Crabtree effect might not occur in neutrophils.Pyruvate is a hopeful candidate of buffers in PDS in the near future. Further observation of P-PDS is strongly needed with peritoneal cells to verify the cell protection both in vitro and in vivo before clinic trials.

  11. Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis fluids on leukocytes cell functions.

    Science.gov (United States)

    Mahiout, A; Matata, B M; Brunkhorst, R

    1997-03-01

    A new peritoneal dialysate containing pyruvate anions has been tested for its effects on cell functions and compared with conventional lactate and bicarbonate based solutions. The dialysate has a final pH of 5.4 to 5.6 and is composed of 1.36 to 3.86% glucose-monohydrate, 132 mmol/liter sodium, 1.75 mmol/liter calcium, 0.75 mmol/liter magnesium, 102 mmol/liter chloride and 35 mmol/liter pyruvate. For cytotoxicity testing peritoneal macrophages and peripheral blood mononuclear cells (PBMC) were exposed to conventional lactate dialysate, pyruvate dialysate, bicarbonate dialysate and a control medium RPMI 1640 (Biochrom KG, Berlin, Germany), followed by activation with different bacterial stimuli. In addition, the study further investigated the effect of varying glucose concentration in the different dialysates ranging from 0 to 3.86% and pH changes between 5.2 and 7.4 on the cytotoxicity effect on the selected cells. Mononuclear cells exposed to pyruvate-based dialysate before stimulation with endotoxin exhibited a tumor necrosis factor (TNF)-mRNA signal comparable to those of cells exposed to RPMI. In contrast, exposure to lactate-based dialysate completely inhibited TNF-mRNA synthesis. In addition, cytokine synthesis in macrophages and PBMCs after exposure to pyruvate was less inhibited when compared to the corresponding levels measured after exposure to lactate. The chemotactic response of polymorphonuclear cells and O-2 generation in all tested cell types after exposure to pyruvate was found not to be inhibited, whereas a complete inhibition was observed after exposure to lactate. The results demonstrate that cytotoxicity effects of peritoneal dialysate on cell lines can be minimized by using a new dialysate formulation containing pyruvate anions instead of lactate.

  12. Brevibacterium casei isolated as a cause of relapsing peritonitis

    OpenAIRE

    Althaf, Mohammed Mahdi; Abdelsalam, Mohamed Said; Alsunaid, Mohammed Sunaid; Hussein, Maged Hassan

    2014-01-01

    We report a case of relapsing peritonitis in a 33-year-old woman on automated peritoneal dialysis. End-stage renal disease was secondary to systemic lupus erythematosus complicated with lupus nephritis. The organism isolated was Brevibacterium casei that was not readily identified, delaying appropriate management with an extended antibiotic course. Definite management of B casei peritonitis was peritoneal dialysis catheter removal.

  13. Qualidade de Vida: comparação entre diálise peritoneal automatizada e hemodiálise Calidad de vida: comparación entre diálisis peritoneal automatizada y hemodiálisis Quality of Life: comparison between patients on automated peritoneal dialysis and patients on hemodialysis

    Directory of Open Access Journals (Sweden)

    Valquiria Greco Arenas

    2009-01-01

    Full Text Available OBJETIVO: Avaliar a Qualidade de Vida relacionada à saúde em pacientes submetidos à Diálise Peritoneal Automatizada (DPA e Hemodiálise em um centro de diálise satélite no Município de São Paulo. MÉTODOS: Este estudo observacional transversal, incluiu 101 pacientes com idade entre 18-75 anos, em terapia há mais de 90 dias e que compreenderam o questionário. RESULTADOS: O grupo em Hemodiálise (n=79 estava em terapia há mais tempo (p=0.001 e tinha albumina sérica maior (pOBJETIVO: Evaluar la Calidad de Vida relacionada a la salud de pacientes sometidos a Diálisis Peritoneal Automatizada (DPA y Hemodiálisis en un centro de diálisis del Municipio de Sao Paulo. MÉTODOS: Este estudio observacional transversal, incluyó a 101 pacientes con edades comprendidas entre los 18 y 75 años, que se encontraban en terapia hace más de 90 días y que comprendieran el cuestionario. RESULTADOS: El grupo en Hemodiálisis (n=79 estaba en terapia hace más de un tiempo (p=0.001 y tenía albúmina sérica mayor (pOBJECTIVE: To evaluate the health-related quality of life in patients from a satellite dialysis center in São Paulo city undergoing Automated Peritoneal Dialysis (APD or Hemodialysis. METHODS: This cross-sectional descriptive study included 101 patients with ages ranging from 18 to 75 years-old, who were in dialysis treatment over 90 days and able to understand the items of the SF-36 questionnaire in Portuguese. RESULTS: The Hemodialysis group (n=79 had been in dialysis treatment longer (p=0.001 and had higher serum albumin level (p<0.001 than the APD group (n=22. The SF-36 scores of the two groups were similar in all dimensions, except for the physical functioning dimension, on which the hemodialysis group had higher scores than the APD group (p=0.03. There were no statistically significant interactions between the SF-36 score and the other variables of the study. CONCLUSION: There were no differences in quality of life between patients on

  14. The experience of nursing for 82 cases of peritoneal dialysis patients%82例腹膜透析患者的护理

    Institute of Scientific and Technical Information of China (English)

    李娜; 邱新华

    2013-01-01

    This paper summarizes the nursing experience of 82 cases of peritoneal dialysis (PD) patients. Primary nursing methods in-clude: setting up full-time PD nursing system, carrying out a variety of nursing education activities, following up PD patients regularly, teaching them with PD knowledge, dynamic tracking and analysis of patients' nursing issues in order to take the appropriate nursing methods to solve the problems. Implement the nurse responsibility system, which is managed by PD treatment team, can effectively promote the social rehabilitation of PD patients and improve their life quality and satisfaction.%总结了82例腹膜透析(PD)患者的护理体会。主要护理措施有设立专职PD护士,开展多种形式的护理教育活动,定期随访患者,对其进行PD知识的宣教,并从中动态跟踪分析患者的护理问题,从而采取相应护理措施解决问题。认为实行PD治疗团队管理下的护士责任制,可有效促进PD患者的社会回归,提高他们的生活质量和生活满意度。

  15. Quantification of reactive carbonyl compounds in icodextrin-based peritoneal dialysis fluids by combined UHPLC-DAD and -MS/MS detection.

    Science.gov (United States)

    Gensberger-Reigl, Sabrina; Huppert, Jochen; Pischetsrieder, Monika

    2016-01-25

    During heat sterilization of peritoneal dialysis (PD) fluids, the glucose component is partially degraded. The formed glucose degradation products impair biocompatibility and limit the long-term application of PD fluids. As an alternative to glucose, icodextrin, a polyglucose, is used as osmotic agent in PD fluids. After targeted screening for reactive carbonyl compounds, NMR- and MS-analyses very recently revealed 4-deoxyglucosone (4-DG), 3-deoxyglucosone (3-DG), 3-deoxygalactosone (3-DGal), 3,4-dideoxypentosone (3,4-DDPS), and 5-hydroxymethylfurfural (5-HMF) as main polyglucose degradation products (pGDPs) in icodextrin-based PD fluids. Now, the present study established and validated a UHPLC method with DAD as well as a UHPLC-MS/MS method for the first-time quantification of those five major pGDPs in commercial icodextrin PD fluids after derivatization with o-phenylenediamine. Thus, 4-DG was identified to be the main degradation product (in concentrations up to 20 μM). In contrast to the values measured in glucose-based products, the concentration of 3-DGal (≤ 16 μM) was higher than the concentration of 3-DG (≤ 7 μM) indicating different reaction pathways starting from polyglucose compared to glucose. The compounds 3,4-DDPS and 5-HMF were present in minor quantities (≤ 0.3 μM each). PMID:26540628

  16. Effect of traveling abroad for a short period on peritoneal dialysis patients' health status%短期出国旅行对腹膜透析病人健康状况的影响

    Institute of Scientific and Technical Information of China (English)

    聂建东; 张枫; 韩庆烽; 汪涛; 苏春燕

    2009-01-01

    目的 探讨腹膜透析病人集体短期出国旅行的可行性,以及出国旅行对腹膜透析病人健康状况的影响.方法 组织11例腹膜透析稳定的病人进行为期4 d的出国旅行,对旅行前后病人的主、客观生活质量,生活满意度评分,康复状况,躯体症状及超滤量、尿量、血压的变化进行观察.结果 旅行前后病人的主、客观生活质量,生活满意度方面评分提高,但差异无统计学意义(P>0.05);病人的超滤量、尿量等变化差异无统计学意义(P>0.05),但血压控制更为理想.结论 透析稳定的腹膜透析病人可以耐受短期集体出国旅行,而且旅行可以增强病人对生活的自信心,提高自我管理能力,是一种很好的康复干预方式.%Objective To explore the feasibility of traveling abroad for a short period, and analyze the effect on peritoneal dialysis patients' health status. Methods A four-day long travel to Jeju island was organized. Eleven peritoneal dialysis patients whose health status was stable participated in this activity. Their dialysis regimen, total fluid removal, clinical symptoms, quality of life and rehabilitation status were evaluated before and after the travel. Results Three patients had some clinical symptoms, such us edema and nausea before travel, and all of them eased or disappeared after travel. Their dialysis doses and total fluid removal unchanged between pre-and post-travel, hut volume status improved and hypertension was better controlled (P 0. 05), and rehabilitation status improved. Conclusions The stable dialyzed peritoneal dialysis patients can endure short period travel abroad. And their self management capacity improved after travel. Travd outside is an effective way to promote peritoneal dialysis patients rehabilitation.

  17. Application of peritoneal dialysis in the treatment of children with low cardiac output after cardiosurgery%腹膜透析在小儿先天性心脏病术后低心排的应用

    Institute of Scientific and Technical Information of China (English)

    王风

    2014-01-01

    Objective To investigate the effect of peritoneal dialysis in the treatment of children with low cardiac output after cardiosurgery .Methods A retrospective analysis was performed on the therapeutic effect of 12 children with low cardiac output after surgery of congenital heart disease by the early peritoneal dialysis in our hospital , 2.5%low calcium peritoneal dialysis solution was selected .The single amount of peritoneal dialysis was 15~20 ml/kg, and dialysis fluid retention time was 20~30 min.After 30 min reservation, dialysis fluid was drained for about 20 min according to the blood pressure .Peritoneal dialysis interval time was extended gradually after the urine occurred .Re-tention time of peritoneal dialysis was extended if patients were suffered from hyperlactacidemia .The frequency of di-alysis was adjusted according to the the level of serum creatinine and lactate .The blood glucose , electrolytes as well as arterial and venous blood gas was monitored , and the colloid was supplied when necessary .The peritoneal dialysis start, duration and the urine recovery time was recorded .Results The urine recovery time was 5~22 h.The appli-cation time of ventilator was 70~128 h, and the time in ICU was 5~18 d.The complications of peritoneal dialysis included catheter blockage (3 cases), hypoglycemia(3 cases), hyperglycemia(1 case) and hypokalemia (2 cases). No patients suffered from peritonitis and intestinal perforation .Two cases of tetralogy of fallot were died of severe low cardiac output and multiple organ dysfunction .Conclusion Early application of peritoneal dialysis can reduce the burden of heart , lung and kidney , maintain the stability of internal environment , and reduce mortality .%目的观察腹膜透析对小儿先天性心脏病术后的低心排治疗效果。方法回顾性分析该院12例先天性心脏病术后低心排早期治疗使用腹膜透析效果。腹透液选择百特公司2.5%低钙腹膜透析液。单次腹膜透析量15

  18. Sclerosing peritonitis with gross calcification: case report

    Energy Technology Data Exchange (ETDEWEB)

    Kim, Cheung Sook; Kim, Young Jae; Min, Seon Jeong; Cho, Seong Whi; Lee, Gyung Kyu; Lee, Eil Seong; Kang, Ik Won [Hallym University College of Medicine, Seoul (Korea, Republic of)

    2003-09-01

    Sclerosing peritonitis is an uncommon complication of continuous ambulatory peritoneal dialysis (CAPD) and can lead to small bowel dysfunction involving abdominal pain, progressive loss of ultrafiltration, and small intestinal obstruction. Peritoneal thickening, in which calcification can develop, often starts as al small plaque which gradually becomes larger. We report a case of CAPD-related calcifying peritonitis.

  19. Long QT, alteration of calcium-phosphate product, prevalence of ventricular arrhythmias and sudden death in peritoneal dialysis patients: a Holter study

    Directory of Open Access Journals (Sweden)

    Pierluigi Di Loreto

    2013-03-01

    Full Text Available Materials and methods We studied 79 patients on peritoneal dialysis. Each underwent 24-h electrocardiography (Holter monitoring and measurement of the rate-corrected QT interval (QTc. We analyzed the correlation between QTc and plasma levels of Ca++, PO4−, K+, Na+, Mg++, and parathyroid hormone (PTH. Results The mean QTc was 0.445 ± 0.04 s. In 55 patients, the QTc was prolonged (> 0.45 s. Mean laboratory values for the group were: PTH 344 ± 25 pg/mL, Ca++ 9.27 ± 0.11 mg/dL, PO4− 5.5 ± 1.5 mg/dL, Na+ 139.6 ± 3.4 mmol/L, K+ 4.04 ± 0.64 mmol/L, and Mg++ 2.52 ± 0.43 mg/dL. Holter monitoring revealed complex premature ventricular contractions in 44 patients, monomorphic premature ventricular contractions in 16, and nonsustained ventricular tachycardia (NSVT in 10. The QTc was significantly correlated with plasma levels of PO4− (r = 0.045, p < 0.05, PTH (r = 0.077, p < 0.02, and Ca++ (r = 0.076, p < 0.02. Eleven patients had Lown class 4a or 4b ventricular arrhythmias, and their mean QTc was 465 ± 0.02 ms. Ten had NSVT and their QTc was 464 ± 0.03 ms. Eleven patients died suddenly (mean QTc 465 ± 0.03 ms; all 11 had either NSTV or Lown class 4 ventricular arrhythmias. Conclusions Long QTc seems to be associated with an increased prevalence of ventricular arrhythmias that may be the cause of sudden cardiac death.

  20. Effects of telmisartan in combined with L-carnitine on the oxidative stress and micro-inflammation status in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    Jin-Xiu Cheng; Xing Pan; Cui-Lan Liu; Hua Liu; Sheng-Jun Liu; Ling-Ling Wang

    2016-01-01

    Objective:To explore the effects of telmisartan in combined with L-carnitine on the oxidative stress and micro-inflammation status in peritoneal dialysis (PD) patients. Methods:A total of 80 patients with chronic renal failure (CRF) who were admitted in our hospital from November, 2011 to January, 2014 for PD were included in the study and randomized into the treatment group and the control group. The patients in the two groups were routinely performed with PD. The patients in the treatment group were given L-carnitine oral liquid, 10 mL/time, 3 times/d, and telmisartan, 80 mg/time, 1 time/d. The patients in the control group were given L-carnitine oral liquid, 10 mL/time, 3 times a day. The patients in the two groups were treated for 24 weeks continuously. A volume of 5 mL morning fasting venous blood before and after treatment was extracted, and centrifuged for serum. The levels of hs-CRP, IL-6, IL-8, TNF-α, MDA, and GSH-Px were determined.Results:After treatment, the levels of hs-CRP, IL-6, IL-8, and TNF-α were reduced, and the reduced degree in the treatment group was significantly superior to that in the control group. After treatment, MDA was reduced, GSH-Px was elevated, and the reduced degree and elevated degree in the treatment group were significantly superior to those in the control group.Conclusions:Telmisartan in combined with L-carnitine can probably become an ideal therapeutic measure for inhibiting the micro-inflammation state and oxidative stress reaction in PD patients, thus reducing the risk of cardiovascular events, which can provide an evidence for the clinical application in the future.

  1. 持续性不卧床腹膜透析相关性腹膜炎的影响因素研究%Risk Factors for Continuous Ambulatory Peritoneal Dialysis-Related Peritonitis

    Institute of Scientific and Technical Information of China (English)

    杨军; 张燕; 许清玉

    2012-01-01

    目的 探讨持续性不卧床腹膜透析(CAPD)相关性腹膜炎(CAPD-related peritonitis,CAPDrp)发生的影响因素.方法 从患者的文化程度、发病季节、基础疾病、1年内复诊次数、营养状况及致病菌种类6个方面,回顾性分析我科近7年来收治的136例次CAPDrp的可能原因.结果 高中和高中以上文化程度者CAPDrp发生的年平均例次明显低于高中以下文化者(P<0.05);每年5~9月发病者CAPDrp发生的年平均例次明显高于其他月份发病者(P<0.05);1年内复诊≥6次的患者CAPDrp发生的年平均例次低于<6次的患者(P<0.05).血红蛋白≤80 g/L者与血红蛋白> 80 g/L比较,清蛋白≤28 g/L者与清蛋白>28 g/L者比较,CAPDrp发生的年平均例次间差异均有统计学意义(P< 0.05).革兰阴性杆菌和真菌的感染率有上升趋势.结论 CAPDrp的发生与患者文化程度、发病季节、基础疾病、1年内复诊次数、营养状况关系密切;与终末期肾病(ESRD)的基础疾病关系不明显.%Objective To investigate the risk factors for continuous ambulatory peritoneal dialysis ( CAPD ) - related peritonitis ( CAPDrp ). Methods The clinical data of 136 patients who suffered from CAPDrp in our center during the past 7 years were retrospectively analyzed in terms of education background, disease - onset season, underlying diseases, visits per year, nutritional status, and pathogen species. Results Patients with a higher education background ( high school or higher ) tended to have lower incidence of CAPDrp ( P 80g/Lvs. ≤80 g/L ) and serum albumin > 28 g/L vs. ≤28 g/L ( bothP <0. 05 ). In addition, it also showed an increasing tendency after tuberculous bacillus and fungus infections. Conclusion CAPDrp is closely related with the patients' education background, disease - onset seasons, underlying diseases, visits per year, and nutritional status; however, it shows no correlation with the underlying diseases of offend - stage ESRD.

  2. Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial

    Directory of Open Access Journals (Sweden)

    Isbel Nicole M

    2009-07-01

    Full Text Available Abstract Background The main hypothesis of this study is that oral heme iron polypeptide (HIP; Proferrin® ES administration will more effectively augment iron stores in erythropoietic stimulatory agent (ESA-treated peritoneal dialysis (PD patients than conventional oral iron supplementation (Ferrogradumet®. Methods Inclusion criteria are peritoneal dialysis patients treated with darbepoietin alpha (DPO; Aranesp®, Amgen for ≥ 1 month. Patients will be randomized 1:1 to receive either slow-release ferrous sulphate (1 tablet twice daily; control or HIP (1 tablet twice daily for a period of 6 months. The study will follow an open-label design but outcome assessors will be blinded to study treatment. During the 6-month study period, haemoglobin levels will be measured monthly and iron studies (including transferring saturation [TSAT] measurements will be performed bi-monthly. The primary outcome measure will be the difference in TSAT levels between the 2 groups at the end of the 6 month study period, adjusted for baseline values using analysis of covariance (ANCOVA. Secondary outcome measures will include serum ferritin concentration, haemoglobin level, DPO dosage, Key's index (DPO dosage divided by haemoglobin concentration, and occurrence of adverse events (especially gastrointestinal adverse events. Discussion This investigator-initiated multicentre study has been designed to provide evidence to help nephrologists and their peritoneal dialysis patients determine whether HIP administration more effectively augments iron stores in ESP-treated PD patients than conventional oral iron supplementation. Trial Registration Australia New Zealand Clinical Trials Registry number ACTRN12609000432213.

  3. 腹膜透析患者自我管理行为及健康状况的相关性研究%Study on the relationship between self-management behavior and health status of peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    刘鹏飞; 骆素萍

    2010-01-01

    目的 了解目前国内腹膜透析患者自我管理行为的状况和健康状况,探讨患者自我管理行为与其健康状况的关系.方法 采用问卷调查的方法,结合实验室检查,对151例腹膜透析患者的自我管理行为和健康状况进行调查,分析自我管理行为与健康状况的关系,提出提高患者自我管理行为的护理措施.结果 腹膜透析患者自我管理行为得分为(28.8±5.32)分,患者自我管理行为与其生理和心理的健康状况密切相关.自我管理行为与Karnofsky活动指数、白蛋白水平呈正相关(P<0.01),与躯体症状、舒张压、血磷和抑郁水平呈负相关(P<0.01).结论 腹膜透析患者自我管理行为与其生理和心理的健康状况密切相关,自我管理行为的提高,有助于健康状况的改善.%Objective To explore the status of self-management behavior and health among peritoneal dialysis patients and their relationship. Methods A total of 151 cases with peritoneal dialysis were investigated with questionnaire for their self-management behavior and health status, in order to analyze the relationship between them and propose the nursing measurements of improving the nursing measurements. Results The self-management behavior score for peritoneal dialysis patient was (28. 8±5. 32), their self-management behavior was correlated with physical and mental health. There showed pisitive correlation between self-management behavior and Kamofsky activity index, albumin levels ( P < 0. 01), while negtive correlation with somatic symptoms, diastolic blood pressure, blood phosphorus and the level of depression (P <0. 01). Conclusions Self management behaviors among peritoneal dialysis patients are closely related to their physical and mental health. The improvement of self management behavior is helpful to the improvement of health.

  4. 腹膜透析患者全程护理管理的做法与效果%Methods and effects of whole progress nursing management in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    史兰英

    2011-01-01

    目的 探讨对腹膜透析患者的全程护理管理的做法与效果.方法 对2008年1月至2011年10月进行维持性腹膜透析的31例患者进行全程护理管理,并在入院当日、出院前1d、出院后1周测评患者疾病知识掌握情况和心理健康状况.结果 通过实施全程护理管理,患者掌握了腹膜透析知识;出院后1周,除躯体化、偏执和精神性因子外,其他因子得分与入院当日和出院前1d比较,差异具有统计学意义(P<0.01或P<0.05).结论 腹膜透析患者的全程护理管理有助于提高患者的知识水平,提高患者心理健康水平.%Objective To explore the methods and effects of whole progress nursing management in patients with peritoneal dialysis. Methods Thirth -one patients with maintenance peritoneal dialysis from January 2008 to October 2011 received whole process nursing management, and in the first day of admission, the day before discharge and one week after discharge, patients'status of disease knowledge and psychological health condition were evaluated. Results After implemented the whole progress nursing management,the patients mastered peritoneal dialysis knowledge. One week after dischange,excepe somatization,paranoia and psychiatric symptoms, other factors'scores was compared with the first day of admission and the day before discharge, the differences were statistically significant ( P < 0. 01 or P < 0. 05 ) . Conclusion Whole progress nursing management in patients with peritoneal dialysis can raise their level of disease knowledge, improve their mental health.

  5. 中性pH值、低葡萄糖降解产物腹膜透析液的生物相容性%Review about the biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions

    Institute of Scientific and Technical Information of China (English)

    马坤岭

    2011-01-01

    传统腹膜透析(PD)液的高浓度葡萄糖、高葡萄糖降解产物、高糖基化终产物、低pH值等生物不相容性是影响PD疗效、导致PD技术失败的主要原因.因此研制生物相容性更好的透析液,已成为改进PD质量的重要内容.使用中性pH值、低葡萄糖降解产物(neutral pH、low-GDP,NpHLGDP)的透析液可延长腹膜寿命、提高疗效.本文主要针对NpHLGDP透析液的生物相容性、评价生物相容性的生物标志物及可能的临床预后作一简述.%The development of peritonitis, the decline of residual kidney function, and the loss of peritoneal membrane function are central events for patients with peritoneal dialysis and affect technique survival. These are closely correlated with the poor biocompatibility of conventional peritoneal dialysis (PD) solutions containing high concentration of glucose,glucose degradation products (GDPs) coupled with the hyperosmolarity, reduced pH,and use of lactate as the buffer. Therefore, the use of neutral pH, low-GDP ( NpHLGDP) , bicarbonate-buffered PD solutions may represent a promising strategy to attenuate some of these adverse effects. In this article, we will highlight evidence regarding the biocompatibility of NpHLGDP PD solutions and compare the advantage and disadvantage of NpHLGDP solutions with traditional PD solutions, review the utility of current biomarkers in the evaluation of biocompatibility, and discuss the clinical outcome data with these solutions.

  6. 不同透析方式对山区透析患者生活质量的影响及相关因素分析%Comparison of quality of life in patients undergoing blood dialysis or peritoneal dialysis in mountain area

    Institute of Scientific and Technical Information of China (English)

    吴峰芬; 季晓英; 邱晓园; 蒋良炎; 蔡建伟

    2013-01-01

    目的:探讨不同透析方式对山区维持性透析患者生活质量的影响及相关因素分析。方法选取进行维持性透析患者90例(腹膜透析和血液透析患者各45例),使用KDQOL- SFTM量表对两者进行生活质量评价,比较两种透析患者生活质量的差异,并对其临床资料进行分析,探讨其影响因素。结果腹膜透析组患者总体健康、疼痛评分、活力、心理健康总分以及KDTA总分、症状影响、睡眠质量均明显优于血液透析患者(均P<0.05)。透析年限、文化程度及年龄是36项健康相关生存质量调查(SF-36)的影响因素(P<0.05或0.01),透析年限、文化程度是KDTA的影响因素(P<0.05)。结论山区终末期肾病患者进行腹膜透析其生活质量明显优于血液透析。%Objective To evaluate the quality of life and relevant factors in patients with maintenance dialysis in mountain area. Methods Ninety patients with end- stage renal diseases undergoing maintenance dialysis were enrol ed, including 45 cases receiving blood dialysis and 45 cased receiving peritoneal dialysis. The quality of life was evaluated by using the question-naire KDQOL- SFTM in two groups and the relevant factors were analyzed. Results The patients undergoing peritoneal dialysis had better SF- 36 and KDTA scores than those of blood dialysis patients, including the items of general health, bodily pain, vitality, dialysis- related symptoms and sleep quality (P<0.05). Factors affecting KDTA scores were the period of dialysis, education background(P<0.05);and the factors affecting SF- 36 scores were mainly the period of dialysis,the age, and the education back-ground (P<0.05 or 0.01). Conclusion Patients in mountain area with end- stage renal disease have a better quality of life, if they receive peritoneal dialysis rather than blood dialysis.

  7. Processo de cuidar do idoso em Diálise Peritoneal Ambulatorial Contínua no domicílio Proceso de cuidar del anciano, que hace Diálisis Peritoneal Ambulatorial Contínua en el domicilio Home care for the elderly undergoing Continuous Ambulatory Peritoneal Dialysis

    Directory of Open Access Journals (Sweden)

    Daniele Favaro Ribeiro

    2009-12-01

    DPAC.Objectives: To describe the elders with end stage renal disease (ESRD undergoing continuous ambulatory peritoneal dialysis (CAPD, their caregivers, and the care the caregivers provide to the elders. Methods: This was a qualitative study with 9 caregivers. Data were collected through oral history. Data analysis consisted of thematic content analysis. Results: The sample consisted of 5 male and 4 female elders and all them were dependent on caregivers to change the dialysis collection bag. The mean age of the participants was 70 years. Among the caregivers, 8 of them were female with a mean age of 41.5 years and they provided 8 hours of care to the elders daily. The main theme emerging from the content analysis was "home care for the elderly undergoing continuous ambulatory peritoneal dialysis." Conclusion: Caregivers need support for the development of knowledge and skills to deal with the elders' demand of care, particularly in regard to the management of CAPD.

  8. 脂代谢异常对腹膜透析超滤衰竭的影响%The Impact of dyslipidemia on ultrafiltration failure in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    张庆芳; 安惠霞; 陈晓

    2013-01-01

    目的 探讨血脂异常对腹膜透析患者超滤衰竭的影响.方法 随机选取124例规律腹膜透析12个月以上的患者,测定患者的白蛋白(ALb)、血红蛋白(Hb)、总胆固醇(T-Ch)、三酰甘油(TG)、低密度脂蛋白(LDL-C)、高密度脂蛋白(HDL-C)、尿素氮(BUN)、肌酐(Cr)、血糖(Glu)水平,计算残肾功能,记录透析龄,根据患者血脂结果分为血脂异常组和血脂正常组,比较2组腹膜透析超滤衰竭的发生率,并以超滤衰竭与否分组,比较2组的血脂水平、肾功能、Glu、ALB、Hb的差异;结果血脂异常组腹膜透析超滤衰竭的发生率明显高于血脂正常组(P=0.008);超滤衰竭组的透析龄长于超滤正常组(t=7.93,P0.000);超滤衰竭组的收缩压和舒张压明显高于超滤正常组(t收缩压=7.360,P收缩压=0.000,t舒张压=4.51,P舒张压=0.000);超滤衰竭组的T-Ch、TG水平明显高于超滤衰竭正常组(tTCh=3.450,PT-Ch=0.001;tTG=6.760,PTG=0.000),而HDL-C水平明显低于超滤正常组(t-7.53,p=0.000);血脂异常组低转运水平发生率明显高于血脂正常组(P0.021);多因素分析显示透析龄长、低水平的HDL为腹膜透析超滤衰竭发生的独立危险因素(p透析龄长=0.034、P低水平的HDL=0.048) 结论 ①腹膜透析患者血脂异常是超滤衰竭发生的原因之一,血脂异常患者腹膜透析超滤衰竭的发生与高TG、T-Ch水平、低HDL-C水平有关;②血脂异常患者腹膜透析超滤衰竭可能是通过降低腹膜转运能力而发生的;③透析龄长、低水平的HDL为腹膜透析超滤衰竭发生的独立危险因素.%Objective To explore the impact of dyslipidemia on ultrafiltration failure (UFF) in peritoneal dialysis patients.Method We randomly recruited 124 patients who treated with peritoneal dialysis regularly for more than 12 months.Their plasma ALB,Hb,total cholesterol (T-C),Triglyceride (TG),LDL-cholesterol (LDL-C),HDL-cholesterol (HDL-C),BUN,Cr,and glucose (Glu) were

  9. Effects of inflammation and infection on peritoneal transport

    NARCIS (Netherlands)

    S. van Esch

    2014-01-01

    Peritoneal dialysis (PD) allows solute and water transport. Adequate PD depends on a good function of the peritoneal membrane. Peritoneal morphological and functional alterations mostly develop with time on PD. Glucose based dialysis solutions, inflammation and infections are conceivable enemies for

  10. The identification and treatment of malnutrition in peritoneal dialysis patients%腹膜透析患者营养不良的诊断及治疗

    Institute of Scientific and Technical Information of China (English)

    宁雅娴

    2013-01-01

    腹膜透析(PD)患者普遍存在的蛋白质-能量营养不良(PEM)是导致患者死亡的危险因素,PEM及其相关的能量消耗(PEM/W)与持续炎症状态和糖代谢异常等多种因素有关,虽然有较多评估PD患者营养状况的评估的研究较多,但尚无单一有效的评价方法,常需要结合多个营养指标.传统营养支持与食欲兴奋剂、抗炎制剂等新型营养策略相结合,为改善PEM/W提供了更好的方法.本文就PEM/W的原因,及不同原因导致PEM/W的识别和处理方法作一简述.%Protein-energy malnutrition ( PEM) is very prevalent in peritoneal dialysis ( PD) patients, and is a strong predictor of mortality. The various factors can lead to the PD patients PEM and related energy consumption (PEM/W) ,wherein the sustained inflammatory state and diabetes has been identified as leading to two of the main reasons of the PEM/W. It has been reported that part of the method can be used for early detection of PEM/W, and provide appropriate interventions. Although the assessment of the nutritional status in PD patients has been greatly improved, but no single method was used to assess nutritional status. PEM/W in PD patients is more complex, and can be evaluated by a number of different indicators of nutrition. Therefore, the traditional methods such as nutritional support, non-traditional strategies,appetite stimulants,anti-inflammatory drugs preparations combination are provided a better method to improve the PEM/W. This review briefly discusses the reasons of PEM/W and provides a way for the identification and management of different causes of PEM/W.

  11. First case of CAPD-related peritonitis caused by Morganella morganii.

    Science.gov (United States)

    Atalay, H; Güney, I; Solak, Y; Almaz, E

    2010-01-01

    Morganella morganii, a gram-negative bacillus, is a rare cause of peritonitis. In this article we report a 55-year-old female patient with peritonitis due to Morganella morganii who was receiving continuous ambulatory peritoneal dialysis (CAPD).

  12. 腹膜透析患者的转归及其危险因素分析%The analysis of outcome and the risk factors for mortality in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    周巍; 王葳; 韩国锋; 孙晶; 张金元

    2012-01-01

    Objective To analyze the outcome and the risk factors for mortality in the peritoneal dialysis (PD) patients in a single peritoneal dialysis in a period of 27 years, and to discuss the approaches to obtain a better prognosis. Methods We retrospectively analyzed patients on PD for more than one month during the period from January 1985 to December 2011 in this hospital. We collected and analyzed their outcomes, the cause of dropout from PD, demographic characteristics, laboratory data, dialysis adequacy, residual renal function, peritoneal transport characteristics, and nutritional status. Results A total of 841 patients were enrolled, of whom 431 were females (51.2%). The mean age at the begining of PD was 58.53 + 16.67 years. The primary diseases for end stage renal disease were glomerulonephritis (52.3%), hypertension (16.6%), and diabetes (15.3%), in which glomerulonephritis was the most important primary disease. The mean peritoneal dialysis duration was 18.63 + 20.35 months. Up to December 2011, the patients remained on PD in 246 cases (29.2%), died in 296 cases (35.2%), changed to hemodialysis in 152 cases (18.1%), treated with kidney transplant in 64 cases (7.6%), and lost for follow-up in 83 cases (9.9%). The main cause of death was cardiovascular events (41.6%), followed by infection (33.0%) including pulmonary infection (23.2%) and peritonitis (9.8%), and cerebral vascular accident (9.5%). The major reason (59.2%)changing from PD to hemodialysis was the PD associated infection, followed by functional abnormalities of peritoneal catheter (25.7%) such as occlusion and drift, and insufficient peritoneal dialysis (7.2%). Cox proportional hazards model analysis indicated that the risk factors for mortality were age (HR: 1.06, P < 0.01), diabetes (HR: 1.88, P< 0.01), change of hemodialysis to PD (HR: 1.49, P< 0.01), lower serum albumin (HR: 2.44, P < 0.01), higher C-reaction protein (HR: 2.07, P< 0.01), lower creatinine clearance rate (HR: 1.89, P < 0.05), and

  13. Evaluación global subjetiva y escala de malnutrición-inflamación para valorar el estado nutricional de pacientes en diálisis peritoneal con hipoalbuminemia Subjective global assessment and malnutrition-inflammation scale to assess the nutritional status of patients on peritoneal dialysis with hypoalbuminaemia

    Directory of Open Access Journals (Sweden)

    Sagrario Jiménez Jiménez

    2012-06-01

    Full Text Available Los pacientes con insuficiencia renal crónica en diálisis peritoneal con frecuencia están mal nutridos o en riesgo de desnutrición, por sus especiales características y favorecido por múltiples factores, como otras patologías asociadas, diálisis inadecuada, estado inflamatorio, pérdida de nutrientes por el dializado, etc. Se han descrito numerosos métodos para evaluar el estado nutricional, siendo las medidas antropométricas y determinaciones de laboratorio las más utilizadas, pero cuando las aplicamos a pacientes renales los resultados obtenidos son muy variables, además algunos de ellos plantean problemas a la hora de su aplicación, por las especiales características de los pacientes en diálisis. Una forma de prevenir la malnutrición es identificar a aquellos pacientes en riesgo de desnutrición y evitar su deterioro progresivo. Nuestro objetivo, es evaluar el estado nutricional de los pacientes en diálisis peritoneal con hipoalbuminemia. Hemos seleccionado 21 pacientes con más de 3 meses en diálisis peritoneal y con tendencia a tener hipoalbuminemia Patients with chronic renal deficiency on peritoneal dialysis are often poorly nourished or at risk of malnutrition due to their special characteristics, and this is exacerbated by a range of factors, including other associated pathologies, unsuitable dialysis, inflammatory state, loss of nutrients due to the dialysate, etc. Numerous methods for assessing nutritional status have been described, among which anthropometric measurements and laboratory determinations are the most widely-used. However, when these are applied to renal patients the results obtained are highly variable, and moreover problems arise with putting some of them into practice, due to the special features of dialysis patients. One way of preventing malnutrition is to identify the patients at risk and avoid their gradual deterioration. The aim here is to assess the nutritional status of patients on peritoneal

  14. Effectiveness of peritonaeal dialysis

    Directory of Open Access Journals (Sweden)

    Jovanović Nataša

    2005-01-01

    Full Text Available Introduction. In the last few years, an increasing number of patients suffering from terminal renal disease of various leading causes was treated with renal replacement therapy. Peritonaeal dialysis involves an exchange of water and solutes between blood in the peritonaeal capillaries and dialysate in the peritonaeal cavum throughout the peritonaeum. Effective dialysis treatment should provide good quality of life, decrease the number of physical complaints, and bring the incidence of morbidity and mortality closer to the incidence of morbidity and mortality in the healthy population. Aim. The aim of this study was the evaluation of peritonaeal transport characteristics and dialysis effectiveness in 58 patients affected by terminal renal disease who underwent peritonaeal dialysis treatment during August 2003 at the Clinic of Nephrology of the Clinical Centre of Serbia. Method. We examined 30 male and 28 female patients, with an average age of 52 years (range 26 to 78 years. The average duration of peritoneal dialysis treatment was 20 months (ranging from 2 to 66 months, and the end-stage renal failure was caused by different leading disease in our patients. We applied different dialysis modalities: continuous ambulatory peritonaeal dialysis (CAPD with three to five 2- or 3-litre exchanges daily, cyclic peritonaeal dialysis (CCPD, intermittent peritonaeal dialysis (IPD, or automatic peritonaeal dialysis (APD, according to the transport characteristics of the peritonaeal membrane, the residual renal function (RRF, and the clinical status of the patients, in order to perform adequate depuration as suggested by the new international criteria. A peritonaeal equilibrium test (PET was performed according to the new international advice; urea and creatinine clearances (Kt/V and Ccr as well as RRF were calculated using the internationally suggested formulas. Results. Most of our patients received effective dialysis treatment, thanks to the modulation of

  15. Systematic barriers to the effective delivery of home dialysis in the United States: a report from the Public Policy/Advocacy Committee of the North American Chapter of the International Society for Peritoneal Dialysis.

    Science.gov (United States)

    Golper, Thomas A; Saxena, Anjali B; Piraino, Beth; Teitelbaum, Isaac; Burkart, John; Finkelstein, Fredric O; Abu-Alfa, Ali

    2011-12-01

    Home dialysis, currently underused in the United States compared with other industrialized countries, likely will benefit from the newly implemented US prospective payment system. Not only is home dialysis less expensive from the standpoint of pure dialysis costs, but overall health system costs may be decreased by more subtle benefits, such as reduced transportation. However, many systematic barriers exist to the successful delivery of home dialysis. We organized these barriers into the categories of educational barriers (patient and providers), governmental/regulatory barriers (state and federal), and barriers specifically related to the philosophies and business practices of dialysis providers (eg, staffing, pharmacies, supplies, space, continuous quality improvement practices, and independence). All stakeholders share the goal of delivering home dialysis therapies in the most cost- and clinically effective and least problematic manner. Identification and recognition of such barriers is the first step. In addition, we have suggested action plans to stimulate the kidney community to find even better solutions so that collectively we may overcome these barriers. PMID:21903316

  16. 血管生成素及其受体在腹膜透析腹膜组织中的表达%Expression of angiopoietin and its receptor in peritoneum of peritoneal dialysis rats

    Institute of Scientific and Technical Information of China (English)

    庄薇; 陈红; 施敏; 钟爱民

    2011-01-01

    目的 分析并研究尿毒症腹膜透析大鼠腹膜血管生成素(Ang)及其受体(Tie)的表达情况及影响因素.方法 SD雄性大鼠5/6肾切除术建立尿毒症模型,成模后腹腔内植入腹透管,随机分为尿毒症组(NS组)及腹透组(PD组).尿毒症组每日给予20 ml生理盐水腹腔灌注,腹透组每日给予20 ml 4.25%百特腹透液腹腔灌注,持续6周.对照组(C组)行假手术且不予液体灌注.实验结束取大鼠腹膜组织,观察腹膜血管新生情况;行免疫组化及RT-PCR检测腹膜组织血管生成素及其受体的表达变化.结果 实验表明PD组相对其他两组新生血管数明显增多,NS组新生血管数较C组为多(P均<0.05).免疫组化显示Ang2及其Tie2阳性细胞数PD组相对于C组和NS组明显增加,NS组较C组亦有增加(P均<0.05).RT-PCR显示PD组Ang2 mRNA和Tie2 mRNA表达较NS组和C组明显上调,而NS组高于C组(P均<0.05).结论 尿毒症本身及腹膜透析液均会上调腹膜的血管生成素及其受体表达,且与血管新生密切相关.%Purpose Long-term peritoneal dialysis ( PD ) can induce ultrafiltration failure , and one of its main factors is angiogenesis.For understanding the cause of peritoneum angiogenesis, the aim of this study was to investigate the change of angiopoietin and its receptor in peritoneum of peritoneal dialysis rats. Methods Uremic rats were established by subtotal nephrectomy in which the rat was implanted a peritoneal dialysis tube. The rats were treated with daily injection of 20 ml physiological saline ( NS group ) and 20 ml 4. 25% peritoneal dialysate ( PD groups ) by transcatheter, respectively, for 6 weeks. Rats with sham operation without peritoneal dialysate were used as control group. The peritoneum was obtained when the experiment was finished. Vessel density of the peritoneum was detected, and the expression levels of angiopoietin and its receptor were examined in the peritoneum by immunohistochemistry and RT-PCR. Results

  17. Encapsulating peritoneal sclerosis: experience of a tertiary referral center.

    LENUS (Irish Health Repository)

    Phelan, P J

    2010-05-01

    Encapsulating peritoneal sclerosis (EPS) is arguably the most serious complication of chronic peritoneal dialysis (PD) therapy with extremely high mortality rates. We aimed to establish the rates of EPS and factors associated with its development in a single center.

  18. 肾移植、血液透析及腹膜透析患者生存质量比较%Comparison of the quality of life in hemodialysis, peritoneal dialysis and kidney transplantation patients

    Institute of Scientific and Technical Information of China (English)

    李珍; 李红梅; 廖云娟; 翁敏

    2014-01-01

    Objective To discuss the influence of three different renal replacement therapy on the quality of life of the end-stage renal disease patients.Methods One hundred and sixty-five patients undergoing maintenance hemodialysis,the continuous ambulatory peritoneal dialysis or the kidney transplant for more than 3 months in the First Affiliated Hospital of Kunming Medical University or the Second Affiliated Hospital of Kunming Medical University from Februmy 2011 to December 2012 were enrolled to assess their quality of life by using KDQOL-SFTM1.2.Results The aggregate score of the kidney transplantation group in SF-36,KDTA and the field of several branches was significantly higher than the group of hemodialysis and peritoneal dialysis (P < 0.05).The peritoneal dialysis group got higher scores than the hemodialysis group in the energy situation,the impact of kidney disease,work status and sleep (P < 0.05).Conclusions The study suggests that the quality of life of the end-stage renal disease patients may be related to the selected replacement therapy.%目的 探讨三种不同肾脏替代治疗方式对终末期肾病患者生存质量的影响.方法 选择2011年2月至2012年12月在昆明医科大学第一附属医院和昆明医科大学第二附属医院进行维持性血液透析、持续不卧床腹膜透析和肾移植3个月以上的165例患者,用KDQOL-SFTM1.2量表对其生存质量进行的评估.结果 肾移植组在SF-36总分、KDrA总分及其多个分支领域得分明显高于血液透析组和腹膜透析组,差异有统计学意义(P<0.05).腹膜透析组精力状况、肾病影响、工作状况及睡眠方面的得分高于血液透析组,差异有统计学意义(P<0.05).结论 终末期肾病患者的生存质量与所选择的替代治疗方式有关.

  19. Using QCC to Reduce Peritoneal Dialysis Catheter Related Complications%运用品管圈降低腹膜透析患者导管并发症分析

    Institute of Scientific and Technical Information of China (English)

    惠菊芬; 薛菲; 李红仙; 施敏敏; 王颖

    2014-01-01

    目的:探讨品管圈对提高腹膜透析(简称:腹透)患者透析管维护质量、降低导管相关并发症发生率的作用。方法按品管圈理论进行现状把握、计划拟定、目标设定、要因分析、对策拟定、实施检讨、效果确认、标准化。结果导管堵塞,移位,管周渗漏,相关感染等发生率均下降,且前后差异具有统计学意义(P<0.05)。结论品管圈可以提高透析管维护质量,降低透析管相关并发症发生率;具有主动管理的优点,能够更好地促进临床实际问题的解决,促进透析管维护管理制度、标准化操作流程的建立和完善。%Objective To explore the effect of application of Quality Control Circle(QCC)to improve the quality of maintaining catheter in peritoneal dialysis patients and reduce the rate of catheter related compilation. Methods according to the QCC theory to master states, formulate plans, set goals, analysis, make decisions, re-view implementation confirm the effect and standardize procedure.Results The rates of catheter occlusion, drift, leakage, infection were lower in QCC group thou in non-QCC group( P<0.05) .Conclusions using the QCC to protect and manage the dialysis catheter is good for improving the quality of dialysis tube and reducing the incidence of catheter related compilations.It has the advantage of managing actively, and is a benefit to resolve some denial problems.It is able to contribute to the establishment and improvement of peritoneal dialysis standard operating pro-cedure.

  20. 腹膜透析和血液透析对尿毒症患者血钾的影响%Effects of peritoneal dialysis and hemodialysis on blood potassium concentrations in patients with uremia

    Institute of Scientific and Technical Information of China (English)

    林明增; 范佳妮; 陈霄峰; 陈文芬

    2014-01-01

    目的:探讨血液透析与腹膜透析对尿毒症患者血钾的影响。方法对97例血液透析及45例腹膜透析均治疗3个月以上的患者进行血钾、血钠、血氯测定和比较,并调查当月患者的尿量及住院情况。结果腹膜透析组的低钾、低钠、低氯血症发生率分别为20.0%、15.6%、37.8%,而血液透析组分别为2.1%、4.1%、16.5%,两组差异有统计学意义(P<0.05)。血液透析组的高钾血症发生率为28.9%,而腹膜透析组为11.1%,两组差异有统计学意义(P<0.05)。血液透析组患者的血钾、血氯分别为(5.076±1.093)、(99.660±3.889)mmol/L ,腹膜透析组分别为(4.435±0.99)、(96.910±3.646)mmol/L ,两组差异均有统计学意义(均P<0.05)。尿量>500ml者腹膜透析组占55.6%,血液透析组占6.2%,两组差异有统计学意义(P<0.05)。两组患者住院率的差异无统计学意义(P>0.05)。结论腹膜透析组低钾血症发生率高,血液透析组的高钾血症发生率高,需要对不同透析方式的患者饮食状况进行相应的指导,不能忽视患者在使用一些药物时对血钾异常可能产生的影响。%Objective To investigate the effects of peritoneal dialysis and hemodialysis on blood potassium concentration in patients with uremia. Methods The levels of serum potassium, sodium and chloride were measured in 45 uremic patients un-dergoing peritoneal dialysis and 97 patients undergoing hemodialysis for more than three months. In addition, the urine output and hospitalization of patients were also documented. Results The incidence rate of hypokalemia, hyponatremia and low chlo-rine in peritoneal dialysis group was 20.0%, 15.6%and 37.8%;and in peritoneal dialysis group was 2.1%, 4.1%, 16.5%respec-tively (P500ml in peritoneal dialysis and hemodialysis groups accounted for 55.6% and 6.2%, respectively (P<0.05). These was no difference in hospitalization between two

  1. The cause of dropout in peritoneal dialysis patients%腹膜透析患者退出原因分析

    Institute of Scientific and Technical Information of China (English)

    高妍婷; 段斌; 王晓明; 侯冰

    2009-01-01

    目的 探讨持续性非卧床腹膜透析患者退出腹膜透析的原因及其影响因素,为改善持续性非卧床腹膜透析患者的预后提供依据.方法 分析在我院进行持续性非卧床腹膜透析的终末期肾脏病患者的临床资料,统计退出腹膜透析患者例数并分析其原因.结果 95例入选患者中有39例患者退出腹膜透析,退出率为41.1%,退出原因死亡为56.4%(22/39)、改血液透析为20.5%(8/39)和肾移植为15.4%(6/39).患者死亡的主要原因为心力衰竭(54.5%)和肺部感染(27.3%).死亡组患者高龄、开始透析时的残余肾功能差、营养不良及贫血程度较重;此外死亡组患者原发病为糖尿病比例与对照组比较差异有统计学意义(P<0.05),且使用血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂控制血压与对照组比较差异也有统计学意义(P<0.05).腹膜炎是导致患者改血液透析的主要原因.结论 死亡是持续性非卧床腹膜透析患者退出腹膜透析的主要原因,患者死亡的主要原因为心血管疾病和感染、高龄、糖尿病、残余肾功能差、贫血和营养不良是影响患者生存的危险因素,早期肾脏替代治疗、积极改善贫血和营养状况以及使用血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂可改善持续性非卧床腹膜透析患者的预后.%Objective To investigate the cause of dropout in patients with continuous ambulatory peritoneal dialysis (CAPD). Methods Ninety - five CAPD patients were enrolled. Their dropout was reviewed. Results Among the 39 patients who dropped out, 22 cases died, 8 cases switched to hemodialysis, 6 cases received renal transplantation. The major cause of death was heart failure (54.5%) and lung infec-lion (27.3%). The death cases had older age, lower lever residual renal function(RRF), more serious mal-nutrition and anemia (P <0.05). Besides, diabetic patients were more general in the death cases (P <0

  2. Brevibacterium casei isolated as a cause of relapsing peritonitis.

    Science.gov (United States)

    Althaf, Mohammed Mahdi; Abdelsalam, Mohamed Said; Alsunaid, Mohammed Sunaid; Hussein, Maged Hassan

    2014-01-01

    We report a case of relapsing peritonitis in a 33-year-old woman on automated peritoneal dialysis. End-stage renal disease was secondary to systemic lupus erythematosus complicated with lupus nephritis. The organism isolated was Brevibacterium casei that was not readily identified, delaying appropriate management with an extended antibiotic course. Definite management of B casei peritonitis was peritoneal dialysis catheter removal. PMID:24648477

  3. 不同超滤功能的持续不卧床腹膜透析患者腹膜液体转运功能评估%Ultrafiltration capacity and peritoneal fluid kinetics in continuous ambulatory peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    者星炜; 罗洁; 刘振华; 白云凯; 熊丽炎; 单亦升; 程磊; 田信奎; 汪涛

    2012-01-01

    目的 容量控制对于腹膜透析至关重要.腹膜平衡实验(peritoneal equilibration test,PET)可以评估腹膜小分子溶质转动功能,对优化腹膜透析存腹时间提供依据,但是不能预测腹膜液体转运功能.所以,本研究使用计算机拟合对不同超滤功能腹膜透析患者的腹膜液体转运功能进行评估.方法 纳入研究患者包括每天使用3~4袋2.5%葡萄糖透析液者(为腹膜超滤功能差组)和使用3~4袋1.5%葡萄糖透析液者(为腹膜功能好组),两组患者在上述透析处方下都能达到足够的液体清除.所有入组的患者都要求详细记录自己每天的腹膜透析换液情况,以评估腹膜液体转运功能.结果 本研究包括了17名持续不卧床腹膜透析患者(continuous ambulatory peritoneal dialysis,CAPD),其中9名为超滤功能差组,8名为超滤功能好组.与超滤功能好组相比,超滤功能差组的患者每天更多的处于高葡萄糖(P<0.01)环境中,透析液/血浆肌酐比值(D/Pcre)更高(P<0.05),有更高的腹膜液体吸收率(Ke)(P<0.01). 结论 与超滤功能好的患者相比超滤功能差的患者的腹膜小分子溶质转运率更高,更为重要的是,超滤能力差的患者腹膜液体吸收率更高.%Objective Volume control is critical for peritoneal dialysis. Although peritoneal equilibration test (PET) has been used to clarify the peritoneal membrane characteristics, it is unable to adequately predict peritoneal fluid removal and appropriately optimize the dwelling time. In the present study, we applied computer simulation and performed a more detailed evaluation of the fluid kinetics in patients with different ultrafiltration (UF) capacity. Methods Patients who used three to four exchanges of 2.5% glucose dialysate per day (poor UF capacity group) and patients who used three to four exchanges of 1.5% glucose dialysate per day (good UF capacity group) to achieve adequate amount of peritoneal fluid removal were

  4. 低成本腹膜透析治疗方案的探讨%Exploring the Most Economical Peritoneal Dialysis Prescription

    Institute of Scientific and Technical Information of China (English)

    吕晶; 薛武军; 尹爱萍; 靳引红; 梁嫦娜; 李昭; 杨亚丽

    2011-01-01

    者出现下肢轻度水肿,1例患者出现心衰.SGA评估营养不良的发生率由8/12降低为4/12(P<0.05=.治疗12个月时,6例患者康复情况良好,每月平均医疗费用为(2 833.3±1 040 8)元.结论 在保证能量摄入的基础上,给予低蛋白饮食,同时减少透析剂量可最大限度地降低医疗费用.透析早期,严格的水盐控制可避免产生容量超负荷,饮食调整及一些非药物治疗都有利于患者节省开支,提高患者的社会回归状况.但随着残肾功能的丧失,如果透析剂量不能逐渐增加,可能会出现毒素蓄积,营养不良,活动能力减退,水负荷增多的现象.%Objective To explore the possibility of the most economical way of sustained peritoneal dialysis ( PD ) prescription for poor patients. Methods Twelve patients received low dose PD ( <4000 ml/d ) due to poor economic status from our hospital were studied retrospectively. Kt/V, DPI, TDEI, and average cost were investigated. MDRD formula was applied to calculate the baseline GFR and subjective global assessment ( SGA ) was employed to access the nutritious status of the patients. Karnofsky performance score was used to evaluate the physical activity. Serum albumin, hemoglobulin, rehabilitation status and nutritious status were compared at baseline and 12 months after PD treatment. Results Glomeruar filtration rate was ( 5. 2 ± 1. 6 ) ml/min at the start of dialysis and declined to ( 1. 4 ± 1. 1 ) ml/min after 12 months of PD ( P <0. 01 ). After 1 yearofPD, average DPI declined from ( 0. 97 ± 0. 42 ) g · kg-1· d-1 to ( 0. 65 ±0. 12 ) g · kg-1 · d-1 (P<0.05), DEI increased from ( 21. 3 ±2. 0 ) kcal · kg-1 · d-1 to ( 25. 4 ±3. 7 ) kcal· kg-1 · d-1 ( P <0. 05 ), average current total Kt/V decreased from ( 1. 72 ±0. 84 ) to ( 1. 35 ±0. 41 ) ( P <0. 05 ), and urine Kt/v dropped from ( 0. 98 ±0. 45 ) to ( 0. 43 ±0. 30 ) ( P < 0. 01 ). After 9 months of PD treatment, hemoglobin levels increased from ( 78. 6 ± 19. 4 ) g/d to

  5. Diálise peritoneal: a percepção tátil do cliente na convivência com o cateter Diálisis peritoneal: la percepción táctil del cliente en la convivencia con el catéter Peritoneal dialysis: the tactile perception of clients that live with the catheter

    Directory of Open Access Journals (Sweden)

    Doris de Oliveira Araújo Cruz

    2008-01-01

    Full Text Available OBJETIVO: Este estudo objetivou investigar a percepção tátil do cliente na convivência com o cateter de diálise peritoneal indicadora de necessidades de cuidado. MÉTODOS: Estudo de abordagem qualitativa baseado nos princípios da sociopoética e no dispositivo do grupo pesquisador. Realizado no período de março a maio de 2006, empregou dinâmica de criação artística com sete clientes, em um hospital universitário. RESULTADOS: As análises apontaram para a adaptação, a negação, o cuidado, a indiferença, o mal-estar, que revelaram as categorias auto-estima e auto-imagem. CONCLUSÕES: O grupo como sujeito ativo da pesquisa evidenciou experiências através do diálogo. Emergiram através da criatividade os saberes inconscientes, desconhecidos e inesperados.OBJETIVO: En este estudio se tuvo como objetivo investigar la percepción táctil del cliente en la convivencia con el catéter de diálisis peritoneal indicador de necesidades de cuidado. MÉTODOS: Se trata de un estudio con abordaje cualitativo basado en los principios de la sociopoética y en el dispositivo del grupo investigador. Se llevó a cabo en el período de marzo a mayo del 2006, empleándose la dinámica de creación artística con siete clientes, en un hospital universitario. RESULTADOS: Los análisis señalaron la adaptación, la negación, el cuidado, la indiferencia, el malestar, reveladas en las categorías auto-estima y autoimagem. CONCLUSIONES: El grupo como sujeto activo de la investigación evidenció experiencias a través del diálogo. Emergieron por medio de la creatividad los saberes inconscientes, desconocidos e inesperados.OBJECTIVE: The purpose of this study was to investigate the clients' tactile perception toward living with a peritoneal dialysis catheter indicating their care needs. METHODS: This qualitative study was based on the principles of social poetics and according to the research group. It was carried out in the period from March to May

  6. Trabalho e qualidade de vida relacionada à saúde de pacientes em diálise peritoneal Trabajo y Calidad de Vida Relacionada a la Salud de pacientes en Diálisis Peritoneal Work and health-related quality of life of patients on peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Marília Pilotto de Oliveira

    2012-01-01

    pacientes y merece la atención de los profesionales de la salud en la búsqueda de estrategias que favorezcan e incentiven su manutención y reinserción en el mercado de trabajo.OBJECTIVE: To describe and compare Health Related Quality of Life (HRQoL of patients on peritoneal dialysis (PD who had and who did not have paid work. METHODS: A cross-sectional and populational study with 82 patients from the two PD services in Ribeirão Preto (SP, Brazil. Data collection was conducted by interviews between December/2009 and March/2010. The questionnaires for the characterization of patients, the Mini Mental State Examination and the Kidney Disease and Quality of Life-Short Form were used. Analyses were performed using exploratory univariate and bivariate statistics, and the confirmatory bivariate among the independent variables and the dimensions of HRQoL. RESULTS: Patients with paid work presented higher mean scores reflecting better HRQoL for the majority of the dimensions of the instrument used. CONCLUSION: Work is an important facet of life for these patients and merits the attention of health professionals in the search for strategies that promote and incentivize its maintenance and the reintegration of patients into the labor market.

  7. Effect of telephone visit for discharged patients with peritoneal dialysis catheter after surgery%腹膜透析置管术后出院患者电话跟踪访问效果

    Institute of Scientific and Technical Information of China (English)

    张丽英; 张耀全

    2014-01-01

    目的:探讨腹膜透析置管术后患者出院电话访问管理的效果。方法将67例腹膜透析置管术后患者,按随机数字表法随机分为干预组34例和对照组33例。对照组出院时给予常规健康教育,干预组在出院后给予电话跟踪访问,共5次,采用腹膜透析知识测评问卷、健康相关生活质量问卷、患者满意度调查表对两组患者进行调查,评价电话访问的效果。结果干预组知识掌握程度为优52.9%,良38.2%,差8.8%,对照组分别为24.2%,30.3%,45.5%,两组比较差异有统计学意义( Z=-3.252, P=0.001);干预组患者睡眠、躯体活动、精力、疼痛、情绪反应、社会孤独感得分分别为(10.6±6.3),(8.9±5.2),(22.3±0.5),(18.6±7.3),(13.6±9.3),(15.7±7.6)分,均低于对照组,差异有统计学意义(t值分别为5.436,6.532,7.674,8.213,6.567,7.324;P<0.01);干预组患者对科主任、、主诊医师、普通护士满意度均高于对照组,差异有统计学意义(P<0.05)。结论对腹膜透析患者出院后进行电话跟踪访问和指导,可以提升患者腹膜透析相关知识和技能,对患者的生活质量和医护人员的满意度均起到积极作用。%Objective To observe the effect of telephone visit for discharged patients with peritoneal dialysis catheter after surgery .Methods Sixty-seven patients with peritoneal dialysis catheter after surgery were chosen and were divided into the intervention group ( n=34 ) and the control group ( n=33 ) according to the random table .The control group received the routine health education at discharge , and the intervention group received the telephone visit ( 5 times ) after discharge .The effect of telephone visit was evaluated by the peritoneal dialysis knowledge assessment questionnaire , Nottingham health questionnarres and

  8. 腹膜透析患者血清瘦素水平的变化及影响因素分析%Changes of serum leptin levels and the influential factors in peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    晏焕青; 李芸; 谢琼虹; 莫逸; 朱彤莹

    2013-01-01

    目的 探讨腹膜透析患者瘦素水平变化及其影响因素.方法 入选维持性腹膜透析患者76例,分别于腹膜透析治疗开始前及治疗后第3、6、12、18、24个月共6个时间点,随访人体测量(体质量指数、肱三头肌皮脂厚度、腹围)、生化指标[胆固醇、三酰甘油、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、胰岛素抵抗指数(HOMA-IR)等]及血清瘦素水平.结果 在24个月的随访过程中,患者的瘦素水平显著升高(P<0.01),并与体质量指数(r=0.412,P< 0.01)、肱三头肌皮脂厚度(r=0.308,P< 0.01)、腹围(r=0.284,P<0.01)、HOMA-IR(r=0.184,P< 0.01)、三酰甘油(r=0.288,P< 0.01)呈正相关,与高密度脂蛋白胆固醇(r=-0.285,P<0.01)水平呈负相关.多因素分析提示体质量指数(β=0.339,P<0.01)、三酰甘油(β=0.157,P<0.01)和高密度脂蛋白胆固醇(β=-0.126,P<0.05)是影响瘦素水平最重要的因素.结论 瘦素可能与其他代谢指标共同参与了腹膜透析患者心血管事件的发生与发展.%Objective To investigate the changes of serum leptin levels and the influential factors in maintenance peritoneal dialysis patients.Methods Seventy-six peritoneal dialysis patients were chosen at the time before,and 3 months,6 months,12 months,18 months and 24 months after they began the peritoneal dialysis therapy,to examine body mass index (BMI),triceps skinfold thickness (TSF),abdominal circumference,homeostasis model assessment of insulin resistance (HOMA-IR),the plasma lipid profile,and leptin in the same situation.Results For 24 months,these patients showed higher serum leptin level than the values before commencing peritoneal dialysis treatment (P < 0.01).The level of leptin was positively correlated with the BMI(r =0.412,P < 0.01),TSF(r =0.308,P < 0.01),abdominal circumference(r =0.284,P < 0.01),HOMA-IR(r =0.184,P < 0.01) and TG(r =0.288,P < 0.01),negatively corelated with the high-density lipoprotein

  9. 居家腹膜透析操作者规范洗手现状及原因分析%A survey and analysis of the practice of hand hygiene among operators of home peritoneal dialysis

    Institute of Scientific and Technical Information of China (English)

    芦丽霞; 乔捷; 赵慧萍

    2011-01-01

    Objective This study aimed to investigate the practice of hand-washing before bag changing among the operators who did home peritoneal dialysis (PD) and analyze the factors that influenced adherence to hand hygiene protocols. Methods During the month of April 2010, 76 operators, who did home peritoneal dialysis for PD patients in PD center of Peking University People's Hospital, received the survey. A self-designed questionnaire survey on normative hand hygiene before operating and grading standard was used for this study. Results Among peritoneal dialysis operators, the majority are females (64.5%), 65.8% are retirees and most of the dialysis operations were conducted by the patients themselves (73.7%). Only 5 of the operators (6.6%) passed when they were observed the procedures of hand washing. The average time of hand washing was 8 seconds. 57.8% of the operators omitted two parts during washing procedures, and 81.6% of the operators omitted two or more parts. The parts acconnts for higher omission rate in order were: knuckles, fingerwebs, fingertips. 14 operators passed the bacterial colony counts after hand washing, with the pass rate was 18%. The bacterial colony counts were negatively correlated with the hand washing scores, that is, the lower scores of hand washing, the higher colony counts. The operator's age, dialysis duration, education level, occupation, gender, relationship with patients and other factors were not associated with hand washing scores. Conclusion The hand washing practice of the peritoneal dialysis operators are not normative. The professional PD nurses should pay attention to give the PD operators more training about the importance and the procedures of normative hand washing,so as to improve the hand hygiene status.%目的 了解居家腹膜透析操作者操作前规范洗手的现状及其影响因素.方法 采用自行设计的操作前规范洗手调查问卷、规范洗手评分标准,对2010年4月份期间北京

  10. Risk Factors for Cardiovascular Event in Patients with Peritoneal Dialysis%腹膜透析患者发生心血管事件的危险因素分析

    Institute of Scientific and Technical Information of China (English)

    黄振华; 冯振伟; 叶智明; 陆玲娜; 何坤; 施燕春; 项新; 李洁; 黄典胜

    2014-01-01

    目的:探讨持续性腹膜透析患者发生心血管事件的危险因素。方法180例持续性腹膜透析患者,按12个月内有无心血管事件发生分成心血管事件组(73例)和无心血管事件组(107例),对比分析两组患者的临床资料、生化指标等,采用logistic回归分析不良心血管事件的危险因素。结果两组患者在性别、年龄、原发病、透析疗程、透析前血压、吸烟史、血红蛋白水平、营养状况等方面比较差异均无统计学意义( P均>0.05);心血管事件组患者血清总胆固醇、低密度脂蛋白胆固醇( LDL-C )、血清铁、血清铁蛋白、转铁蛋白饱和度、血磷、全段甲状旁腺激素(iPTH)、高敏C反应蛋白(hs-CRP)、同型半胱氨酸(Hcy)、肿瘤坏死因子-α(TNF-α)及铁调素(Hepcidin-25)水平均高于无心血管事件组(P均<0.01)。 logistic回归分析结果显示:血清总胆固醇、血清Hepcidin-25和TNF-α水平是持续性腹膜透析患者发生不良心血管事件的重要危险因素。结论血清总胆固醇、血清Hepcidin-25和TNF-α水平是导致持续性腹膜透析患者发生不良心血管事件的重要危险因素。%Objective To evaluate the risk factors for cardiovascular event in patients with continuous peritoneal dialysis.Methods One hundred and eighty patients with continuous peritoneal dialysis were divided into cardiovascular event group(73 cases) and non-cardiovascular event group (107 cases) according to the occurrence of cardiovascular events in 12 months.The clinical data and biochemical indicators of patients in both groups were analyzed .The logistic regression analysis was used to analyze the risk factors for adverse cardiovascular event .Results There was no significant difference in gender,age,primary disease,dialysis duration,the blood pressure before dialysis treatment ,smoking history, hemoglobin level and nutritional status between

  11. 黄芪注射液对高通透性腹膜透析大鼠透析效能及腹膜结构的影响%Huangqi Injection's Effect on the Dialysis Efficiency and Structure of Peritoneal Dialysis Rat with High Permeable Perineum

    Institute of Scientific and Technical Information of China (English)

    刁金囡; 盛梅笑; 朱萱萱; 王宁皎; 朱长乐; 何伟明

    2011-01-01

    目的 探讨不同浓度黄芪注射液对高通透性腹膜透析大鼠透析效能及腹膜结构的影响.方法 40只SD雄性大鼠,分空白对照组(A组)、单纯腹透组(B组)、黄芪注射液低浓度组(C组)与黄芪注射液高浓度组(D组).除A组外,余3组分别腹腔注射4.25%葡萄糖腹透液、低浓度黄芪腹透液、高浓度黄芪腹透液25mL/d,连续10d.于第11天进行腹膜功能试验,观察各组大鼠透析液留腹0、30、60 、90、120 min尿素氮D/P值(D/P urea)、肌酐D/P值(D/P Cr)、葡萄糖D/D0值(D/D0Glu)的变化,以及透析液留腹120min时尿素清除率(Curea)、肌酐清除率(CCr)、透析超滤量(UF)、净超滤量(NetUF),并采集腹膜组织观察腹膜形态结构的改变.结果 ①各透析组(B、C、D组)各时点D/P Cr高于A组、D/D0Glu低于A组(P<0.05),B组UF、NetUF 低于A组(P<0.05);②C、D组D/P urea留腹60min后各时点均高于B组(P<0.05),D组D/P Cr 留腹60、90min较B组高(P<0.05)、D/D0 Glu留腹60min较B组低(P<0.05);③D组与C组比较,D/P urea、D/P Cr(30、60、90min)与D/D0Glu(30、60min)的变化更明显(P<0.05);④D组Curea、CCr、UF、NetUF均高于 B组(P<0.05);⑤C、D组腹膜增厚及间皮细胞脱落情况较B组改善.结论 4.25%葡萄糖腹透液可造成腹膜间皮层损伤,腹膜的通透性增高,超滤量减少,腹透液中加入黄芪可以保护腹膜间皮层,提高腹膜对尿素、肌酐的清除,提高透析效能,但不增加腹膜对葡萄糖的吸收,高浓度含黄芪腹透液尚能提高腹膜对水的清除,增加透析超滤量.%OBJECTIVE To explore Huangqi injection of different concentration and their dialysis efficiency and structure effect on peritoneal dialysis rat with high permeable perineum. METHODS 40 male SD rats were divided into control group (Group A), simple peritoneal dialysis group (Group A), Huangqi injection with low concentration (Group C) and Huangqi injection with high concentration

  12. Dialysis and contrast media

    International Nuclear Information System (INIS)

    In a previous survey we revealed uncertainty among responders about (a) whether or not to perform hemodialysis in patients with severely reduced renal function who had received contrast medium; and (b) when to perform hemodialysis in patients on regular treatment with hemodialysis or continuous ambulatory dialysis who received contrast medium. Therefore, the Contrast Media Safety Committee of The European Society of Urogenital Radiology decided to review the literature and to issue guidelines. The committee performed a Medline search. Based on this, a report and guidelines were prepared. The report was discussed at the Ninth European Symposium on Urogenital Radiology in Genoa, Italy. Hemodialysis and peritoneal dialysis safely remove both iodinated and gadolinium-based contrast media. The effectiveness of hemodialysis depends on many factors including blood and dialysate flow rate, permeability of dialysis membrane, duration of hemodialysis and molecular size, protein binding, hydrophilicity, and electrical charge of the contrast medium. Generally, several hemodialysis sessions are needed to removal all contrast medium, whereas it takes 3 weeks for continuous ambulatory dialysis to remove the agent completely. There is no need to schedule the dialysis in relation to the injection of iodinated or MR contrast media or the injection of contrast agent in relation to the dialysis program. Hemodialysis does not protect poorly functioning kidneys against contrast-medium-induced nephrotoxicity. Simple guidelines are given. (orig.)

  13. Dialysis and contrast media

    Energy Technology Data Exchange (ETDEWEB)

    Morcos, Sameh K. [Department of Diagnostic Imaging, Northern General Hospital, Sheffield Teaching Hospitals NHS Trust, Sheffield S5 7AU (United Kingdom); Thomsen, Henrik S. [Department of Diagnostic Radiology 54E2, Copenhagen University Hospital at Herlev, Herlev Ringvej 75, 2730 Herlev (Denmark); Webb, Judith A.W. [Department of Diagnostic Imaging, St Bartholomew' s Hospital, London EC1A 7BE (United Kingdom)

    2002-12-01

    In a previous survey we revealed uncertainty among responders about (a) whether or not to perform hemodialysis in patients with severely reduced renal function who had received contrast medium; and (b) when to perform hemodialysis in patients on regular treatment with hemodialysis or continuous ambulatory dialysis who received contrast medium. Therefore, the Contrast Media Safety Committee of The European Society of Urogenital Radiology decided to review the literature and to issue guidelines. The committee performed a Medline search. Based on this, a report and guidelines were prepared. The report was discussed at the Ninth European Symposium on Urogenital Radiology in Genoa, Italy. Hemodialysis and peritoneal dialysis safely remove both iodinated and gadolinium-based contrast media. The effectiveness of hemodialysis depends on many factors including blood and dialysate flow rate, permeability of dialysis membrane, duration of hemodialysis and molecular size, protein binding, hydrophilicity, and electrical charge of the contrast medium. Generally, several hemodialysis sessions are needed to removal all contrast medium, whereas it takes 3 weeks for continuous ambulatory dialysis to remove the agent completely. There is no need to schedule the dialysis in relation to the injection of iodinated or MR contrast media or the injection of contrast agent in relation to the dialysis program. Hemodialysis does not protect poorly functioning kidneys against contrast-medium-induced nephrotoxicity. Simple guidelines are given. (orig.)

  14. Effect of motivational interviewing on the capacity control in ambulatory patients undergoing continuous peritoneal dialysis%动机性访谈对持续非卧床腹膜透析患者容量控制的影响

    Institute of Scientific and Technical Information of China (English)

    刘晓晨; 杨富国; 陈秀荣; 王丹倩; 曹立楠; 梁瑶; 袁玉燕

    2016-01-01

    目的:探讨动机性访谈对持续非卧床腹膜透析患者容量控制的影响。方法:将84例持续非卧床腹膜透析患者随机分为干预组和对照组各42例,对照组给予传统的健康教育,干预组在此基础上给予动机性访谈干预。干预时间均为6个月。干预前及干预后6个月分别评估两组容量控制指标、营养状况指标以及水肿情况。结果:干预6个月后,两组体重、24 h 尿量和24 h 超滤量比较稳定,干预组血压改善情况明显好于对照组(P <0.05),干预组干预后血清前白蛋白明显升高(P <0.05);在患者水肿情况方面,干预组水肿状况改善尤为明显(P <0.05)。结论:以动机性访谈为理论基础的行为干预在持续非卧床腹膜透析患者的容量控制中起到了有效的作用。%Objective:To explore the effect of the motivational interviewing on the capacity control in ambulatory patients undergoing continuous peritoneal dialysis. Methods:84 ambulatory patients undergoing continuous peritoneal dialysis were randomly divided into the in-tervention group and the control group(42 cases in each group). The conventional health education was given to the patients in the control group and the motivational interviewing intervention was additionally provided for the patients in the intervention group,the intervention las-ted 6 months in the two groups. The capacity control index,nutritional status and edema of the patients were evaluated in both groups before and after 6 months of the intervention. Results:The body weight,urine volume and ultrafiltration volume within 24 hours was stable after the intervention for 6 months in the two groups,and the improvement of blood pressure of the patients in the intervention group was significantly better than the control group(P < 0. 05);serum prealbumin increased significantly in the intervention group after the intervention(P <0. 05);remission of edema of the patients

  15. Application of King’s interactive and goal attainment theory in self-care agency of peritoneal dialysis patients%King互动达标理论对腹膜透析患者自护能力的影响

    Institute of Scientific and Technical Information of China (English)

    田瑞杰; 苗金红; 田喜梅; 樊少磊; 孙莉莉

    2013-01-01

    Objective To evaluate the effects of self-care agency of peritoneal dialysis patients by applying King’s interactive and goal attainment theory. Methods 60 peritoneal dialysis patients who were discharged from the first affiliated hospital of Zhengzhou university, department of Nephrology, were assigned into the experimental group (30 cases) and the control group (30 cases). The control group was given general nursing, the experimental group was given interactive and goal attainment intervention. 3 months after the intervention, compared the intervention effects of two groups by the scores of self-care agency scale (ESCA) and investigate the percentage before discharge. Results The scores of self-care agency of two groups have no significant difference (P>0.05) at the time of admission. After the implementation of interactive and goal attainment intervention, the self-care agency scores of the experimental group compared with the control group, the difference was statistical y significant (P﹤0.05). Results Application of King’s interactive and goal attainment theory in peritoneal dialysis patients by nursing intervention can significantly improve the self-care agency of patients, it is worthy of clinical application.%目的:探讨King互动达标理论对腹膜透析患者自我护理能力的影响。方法采用便利抽样法,选择郑州大学第一附属医院肾内科腹膜透析患者60例,随机分为对照组和实验组,每组各30例。对照组患者实施一般护理,实验组患者实施King互动达标护理。干预后3个月,采用自我护理能力测定量表(ESCA)比较两组干预效果。在出院前进行达标率调查。结果两组患者自护能力得分在入院时差异无统计学意义(P>0.05),实验组患者在实施King互动达标护理后,其自护能力得分与对照组相比,差异具有统计学意义(P<0.05),且达标率显著高于对照组(P<0.05)。结论运用King互动达

  16. Research of training management applying character color theory in patients with peritoneal dialysis%腹膜透析患者应用性格色彩理论培训管理的效果评价

    Institute of Scientific and Technical Information of China (English)

    卢素玉; 仉倩; 吴晓磊; 张婉童; 李绍梅

    2015-01-01

    目的:探讨将性格色彩理论应用于腹膜透析患者的培训管理对患者依从性及透析效果的影响。方法对我院腹膜透析中心2013年1月至2014年5月置腹膜透析管的95例患者应用乐嘉设计的性格色彩心理问卷进行性格色彩分析,入选72例。根据入选患者红、黄、蓝、绿性格色彩分成匹配的对照组和实验组,每组各36例。对照组采用传统的培训方式由腹膜透析护士进行腹膜透析培训7 d,每月1次随访管理;实验组根据性格色彩的不同给予因色教育培训、互动学习腹膜透析课程,并因色制订随访时间来管理。观察6个月,对2组患者采用腹膜透析患者自我管理能力行为问卷和美国Stanford 大学慢性病教育研究中心设计的自我效能量表,统计并分析2组患者自我管理能力、自我效能的评分;统计分析患者容量负荷、血压变化、透析充分性以及生化指标的变化。结果对照组和实验组患者自我管理能力总分分别为(5.64±1.57)、(6.75±1.32)分,自我效能总分分别为(5.22±1.48)、(6.69±1.43)分,透析充分性分别为1.64±0.13、1.85±0.13,Z 值分别为-2.969、-3.828、-6.361,均 P<0.01。水肿发生情况对照组24例,实验组11例,χ2=10.071,P<0.05。对照组与实验组收缩压分别为(147.78±15.69)、(135.39±9.01) mmHg(1 mmHg=0.133 kPa),舒张压分别为(95.86±7.50)、(83.94±7.46) mmHg,Z 值分别为-3.843、-5.666,均 P<0.01。结论应用性格色彩特性对腹膜透析患者实施教育培训,调动了患者自我管理的主动性,提高了患者自我护理能力及自我效能,增强患者依从性,能够提高腹膜透析的效果。%Objective To evaluate the effectiveness of training management applying character color theory in patients with peritoneal dialysis on the compliance and dialysis effect. Methods Of 95 patients undergoing catherization for

  17. Effect of reform of perioperative nursing process in peritoneal dialysis%腹膜透析围手术期护理流程改革的临床效果分析

    Institute of Scientific and Technical Information of China (English)

    王青尔; 孙慧敏; 周婷婷; 李晴; 李韬彧; 吕桂兰

    2011-01-01

    目的 探讨对腹膜透析围手术期护理进行流程改革,分析其临床效果.方法 选择行腹膜透析治疗的160例患者为研究对象,按照住院顺序分为实验组和对照组各80例,对照组采用传统护理工作模式管理,实验组采用改进的护理流程,并比较两组患者的临床效果.结果 实验组患者平均住院日缩短(P<0.01),住院费用降低(P<0.05),患者的健康知识评分和满意度提高(P<0.01),术后1个月依从性提高(P<0.01或P<0.05).结论 采用改进的护理流程明显优于常规护理流程,可供临床围手术期护理管理借鉴.%Objective To discuss the effect of reform of perioperative nursing process in peritoneal dialysis. Methods According to the admission order, 160 new peritoneal dialysis patients were divided into observation group and the control group,with 80 cases in each group. The observation group used the reformed nursing process, and the control group used the traditional model of nursing. Then the effects of the two groups were compared after treatment. Results Compared to the control group,the average length of stay was significantly shorter (P<0.01) ,and the hospitalization costs were less (P<0.05) ,and the score of disease -related knowledge and the satisfaction rate of patients were significantly higher in the observation group (P <0. 01 ) ,the improvement of compliance after one month (P < 0. 01 or P < 0.05 ) . Conclusion The reformed nursing process is superior to the traditional model of nursing. So it is worthy of using widely in clinical perioperative nursing management.

  18. Dialysis provision in Malaysia.

    Science.gov (United States)

    Lim, T O; Lee, D G; Zaki, M

    2000-06-01

    We determined the provision for dialysis treatment in Malaysia. There were 181 dialysis centres as at 1st June 1999 (161 Haemodialysis (HD) and 20 Continuous Ambulatory Peritoneal Dialysis (CAPD) centres), providing treatment for 5614 patients. This is equivalent to an estimated prevalence rate of 253 patients per million population (pmp) and new dialysis acceptance rate of 49 patients pmp. Dialysis facilities were widely distributed throughout the country though rather unevenly among states. Penang, Selangor/KL, Malacca led with number of dialysis patients pmp ranging from 417 to 480. Kelantan and Sabah had the lowest provision with 51 and 64 patients pmp respectively. There were more centres and HD capacity in the private sector while the Non-Government Organisation and public sectors had about the same capacity. However the public sector had more patients on account of availability of CAPD and home HD services, as well as low HD capacity to patient ratio. The number ofcentres, HD capacity and patients have increased rapidly especially since 1991; the estimated growth rates were 16.5 centres/year, 658 capacity/year, and 392 patients/year respectively. There was also a trend toward increasing over-capacity in the private and NGO sectors. In conclusion, the level of dialysis provision is increasing, indicating increasing accessibility of dialysis treatment in Malaysia. Over-capacity is a concern in the private and NGO sectors. Thus funding agencies should be encouraged to source provision from those sectors. The public sector still has the crucial role of providing for under-served areas in the country.

  19. Sclerosing peritonitis: report of three cases.

    Science.gov (United States)

    Dequanter, D; Lefebvre, J C; De Pauw, L; Nortier, J; Kinnaert, P

    2003-08-01

    Sclerosing peritonitis is a dramatic complication of continuous ambulatory peritoneal dialysis and chronic peritoneal inflammation. Both visceral and parietal surfaces of the peritoneal cavity are involved. A thickened peritoneum encloses the small intestine in a "cocoon" formation which often leads to intestinal occlusion. CT scan may help obtaining an early diagnosis but diagnosis is often established with some delay or even at the time of laparotomy. Our report describes three cases of this uncommon peritoneal fibrosis syndrome which caused intestinal obstruction requiring surgical intervention. PMID:14524162

  20. Are Diuretics Underutilized in Dialysis Patients?

    Science.gov (United States)

    Trinh, Emilie; Bargman, Joanne M

    2016-09-01

    While oral diuretics are commonly used in patients with chronic kidney disease for the management of volume and blood pressure, they are often discontinued upon initiation of dialysis. We suggest that diuretics are considerably underutilized in peritoneal dialysis and haemodialysis patients despite numerous potential benefits and few side effects. Moreover, when diuretics are used, optimal doses are not always prescribed. In peritoneal dialysis, the use of diuretics can improve volume status and minimize the need for higher glucose-containing solutions. In patients on haemodialysis, diuretics can help lessen interdialytic weight gain, resulting in decreased ultrafiltration rates and fewer episodes of intradialytic hypotension. This paper will review the mechanism of action of diuretics in patients with renal insufficiency, quantify the risk of side effects and elaborate on the potential advantages of diuretic use in peritoneal dialysis and hemodialysis patients with residual kidney function.

  1. Peritoneal Disorders

    Science.gov (United States)

    ... of the peritoneum are not common. They include Peritonitis - an inflammation of the peritoneum Cancer Complications from ... peritoneal fluid to diagnose the problem. Treatment of peritoneal disorders depends on the cause.

  2. 维持性血液透析与腹膜透析患者血压变异性比较%A comparative study on variability of blood pressure in patients treated by maintenance hemodialysis or continuous peritoneal dialysis.

    Institute of Scientific and Technical Information of China (English)

    王刚; 尹乐; 刘文虎

    2013-01-01

    Objective To explore the difference in variability of blood pressure ( BPV ) in patients treated by maintenance hemodialysis ( MHD ) compared with continuous peritoneal dialysis ( CAPD). Methods Thirty patients with MHD and thirty patients with CAPD in this hospital were recruited for this cross - sectional study. The ambulatory blood pressure ( ABP ) monitoring was proceeded in patients with MHD for 44 hours and in patients with CAPD for 24hours. The mean value of systolic blood pressure ( SBP ),diastolic blood pressure ( DBP ), the declining percentage of nocturnal SBP, the mean value of standard deviation ( SD ) and coefficient of variation ( CV ) were compared between patients with MHD and CAPD. These parameters were also compared between dialysis day and non - dialysis day in patients with MHD. Results The mean value of blood pressure of patients with MHD in non - dialysis day was significantly higher than that of patients with CAPD(SBP, 148. 9 ±20. 6 mm-Hg vs. 129.9±16.4 mmHg, P <0.001; DBP, 89.9±12.5 mmHg vs. 82.9±11.5 mmHg, P =0.028 ). The cases of dipper pattern blood pressure in patients with MHD in dialysis day were much higher than those in patients with CAPD ( 5/30 vs. 0, P =0. 029 ). There was no significant difference on both SD and CV between patients with MHD or CAPD. However, the SD level of DBP in non - dialysis day was larger than that in dialysis day, 10.4±2.9 vs. 12.5±5.0, P -0.031. Conclusion The blood pressure of patients with MHD in non - dialysis day is higher than that of patients with CAPD. There are dipper pattern blood pressure in some patients with MHD after hemodialysis. The variability of blood pressure in patients with MHD is larger in non - dialysis day.%目的 对比维持性血液透析(MHD)和连续性非卧床腹膜透析(CAPD)患者血压变异性,观察不同透析方式血压变化的特点.方法 选择MHD和CAPD治疗的非糖尿病尿毒症患者各30例,对MHD患者进行非透析期间的44 h动态

  3. Sclerosing encapsulating peritonitis: a case report

    Energy Technology Data Exchange (ETDEWEB)

    Candido, Paula de Castro Menezes; Werner, Andrea de Freitas; Pereira, Izabela Machado Flores; Matos, Breno Assuncao; Pfeilsticker, Rudolf Moreira; Silva Filho, Raul, E-mail: paulacmcandido@yahoo.com.br [Hospital Felicio Rocho, Belo Horizonte, MG (Brazil)

    2015-01-15

    Sclerosing encapsulating peritonitis, a rare cause of bowel obstruction, was described as a complication associated with peritoneal dialysis which is much feared because of its severity. The authors report a case where radiological findings in association with clinical symptoms have allowed for a noninvasive diagnosis of sclerosing encapsulating peritonitis, emphasizing the high sensitivity and specificity of computed tomography to demonstrate the characteristic findings of such a condition. (author)

  4. 浙江省腹膜透析医疗服务网络构建的SWOT分析%SWOT Analysis on Medical Service Network Building of Peritoneal Dialysis in Zhejiang Province

    Institute of Scientific and Technical Information of China (English)

    胡丹; 王峦; 张璐莹; 程晓明

    2011-01-01

    Objective: Further analysis the building of peritoneal dialysis medical network in Zhejiang, and provide reference for relevant decision-making departments. Methods: SWOT analysis is used to understand its strcngth, weakness, opportunity and threat. Results: There coexist strength, weakness, opportumty and challenge. Conclusion: Relevant departments should make full use ofits strength and opportunity,develop strategies to meet challenge, and eliminate or reduce the adverse effects of disadvantage to avoid or rcsolve existing threat.%目的:进一步对浙江省腹膜透析医疗服务网络构建进行分析,为相关部门决策提供参考依据.方法:采用SWOT分析方法,了解该医疗服务网络构建的优势、劣势、机会和威胁.结果:浙江省腹膜透析医疗服务网络构建的优势、劣势、机遇和挑战并存.结论:相关部门在构建腹膜透析医疗服务网络时,要充分利用内部优势,抓住外部机遇,制定相应策略迎接挑战,消除或减弱劣势带来的不利影响,规避或解决现有威胁.

  5. 利用三级医疗体系推广腹膜透析社区化管理模式的初步研究%Promotion of Community Management Mode of Peritoneal Dialysis based on Third-level Medical System

    Institute of Scientific and Technical Information of China (English)

    刘旭; 张东亮; 王刚; 尹乐; 郭王; 刘文虎

    2012-01-01

    Objective To promote the community management mode of peritoneal dialysis based on the Third - Level medical system. Methods On the basis of academic strength of the Third - Level hospital to help to establish community center for peritoneal dialysis in primary medical institutions and to train professional medical care technicians of peritoneal dialysis. According to relative occupational documents on standardized operating specifications of peritoneal dialysis issued by the Ministry of Health, to formulate operating and managing procedures suitable for primary medical institutions, as well as the procedures and standards of patient referral with the Third - Level hospital. A preliminary evaluation of the model was carried out through the therapeutic effect for the patients, and the feedback from investigation of patients and their family members, and medical staff. Results The duration of this study was one month. All together 10 peritoneal dialysis professionals were trained for primary medical institutions, and the community person - times for clinic visit went up about 500, and 30 uremia patients were treated with peritoneal dialysis. The patients' conditions after the treatment were good, and it is convenient for the patients to seek medical care, the patients' costs were reduced, and the satisfaction rate reached 100%. Conclusion The community management mode of peritoneal dialysis based on Third - Level medical system can promote reasonable disposition and utilization of medical resources , which brings on great social and economic benefits, therefore it is worth popularizing.%目的 利用三级医疗体系推广腹膜透析社区化管理模式.方法 依托三级医院学术力量,协助基层医疗单位建立社区化腹膜透析分中心、培训腹膜透析专业医疗护理技术人员.参照卫生部腹膜透析标准化操作规范等行业文件,制定适合基层医疗单位操作的工作、管理流程,以及三级医疗机构间患者双向

  6. MEK 1/2 inhibitors for the treatment of peritoneal fibrosis

    OpenAIRE

    Pozo Barriuso, Miguel Ángel del; López Cabrera, Manuel; Strippoli, Raffaele

    2008-01-01

    [EN] Drugs useful in the prevention and treatment of fibrosis of the peritoneal membrane (peritoneal opacification, tanned peritoneum syndrome, mural fibrosis and sclerosing peritonitis syndrome), which arises as a consequence of long-term peritoneal dialysis, method for selecting such dmgs and method for collecting data that are useful in the diagnosis of said disease.

  7. 维持性腹膜透析患者腹膜转运类型与血清C反应蛋白的关系%Relationship between peritoneal transport type and serum C-reactive protein in maintenance peritoneal dialysis patients

    Institute of Scientific and Technical Information of China (English)

    刘桂凌; 李丹丹; 王道洋; 郝丽

    2013-01-01

    目的 分析维持性腹膜透析(MPD)患者的腹膜转运类型与血清C反应蛋白(CRP)的关系.方法 将行MPD且规律(每3个月)随访的56例患者(MPD组)行标准腹膜平衡试验(PET),根据其D/P值分为高通透性组(D/P> 0.65,18例)和低通透性组(D/P≤0.65,38例).于PET当天行血清肌酐、尿素氮、尿酸、CRP等及透析液肌酐、尿素氮、尿酸等的检测,计算患者尿素清除指数和内生肌酐清除率.根据PET结果制定透析处方,使尿素清除指数≥1.7,内生肌酐清除率≥50 L/(周·1.73 m2).MPD 6个月后再次检测上述指标.并与尿毒症非透析患者30例(尿毒症非透析组)和健康体检者20例(对照组)进行比较.结果 高通透性组、低通透性组、尿毒症非透析组血清CRP均高于对照组[(54.41±17.77)、(43.34±18.07)、(39.10±17.86) mg/L比(2.00±0.36) mg/L,P<0.05],高通透性组血清CRP高于低通透性组(P<0.05).MPD组与尿毒症非透析组血清CRP比较差异无统计学意义(P>0.05).高通透性组和低通透性组MPD6个月后血清CRP与PET当天比较差异无统计学意义(P>0.05).且MPD 6个月后,有6例低通透性患者转为高通透性,该6例患者置管1个月后的血清CRP明显高于其他32例腹膜转运类型仍为低通透性患者[(64.45±13.05) mg/L比(39.38±16.12) mg/L,P<0.05].结论 尿毒症患者体内存在微炎性反应状态.MPD患者腹膜转运特性以低通透性为主.腹膜转运特性为高通透性患者体内存在的微炎性反应状态严重于低通透性患者.MPD不能改变尿毒症患者的CRP水平.尿毒症患者的原始微炎性反应状态或许影响了其腹膜转运功能.%Objective To evaluate the relationship between peritoneal transport type and serum C-reactive protein (CRP) in maintenance peritoneal dialysis (MPD) patients.Methods Standard peritoneal equilibration test (PET) was performed in 56 MPD patients (MPD group) with regular follow-up.According to D/P values,56 patients

  8. Diálise peritoneal (DP como tratamento da insuficiência cardíaca congestiva (ICC em pacientes com doença renal crônica estágio IV Peritoneal dialysis for treating congestive heart failure in patients with stage IV chronic kidney disease

    Directory of Open Access Journals (Sweden)

    Carlos Alberto Prompt

    2009-09-01

    Full Text Available A Insuficiência Cardíaca Congestiva (ICC é uma patologia com incidência crescente e que representa uma condição de grande impacto na saúde pública, com alta morbidade e mortalidade. O excesso de volume é uma complicação prevalente, presente em 80% dos pacientes atendidos com o diagnóstico de ICC. Estratégias farmacológicas e não farmacológicas no manejo terapêutico da ICC visam ao melhor manejo do volume e à redução no uso de diuréticos. A ultrafiltração extracorpórea tem evidenciado melhor controle de peso, redução nos dias de hospitalização e re-hospitalização dos pacientes com ICC. Neste artigo, relatamos dois casos atendidos no Hospital de Clínicas de Porto Alegre, relativos a pacientes com diagnóstico de ICC tratados com diálise peritoneal.Congestive heart failure (CHF has a growing incidence, a great impact on public health, and high morbidity and mortality. Excessive blood volume is a prevalent complication present in 80% of the patients diagnosed with CHF. Pharmacological and non-pharmacological strategies in the treatment of CHF aim to better manage blood volume and reduce the use of diuretics. Extracorporeal ultrafiltration has evidenced better weight control, and a reduction in the length of hospitalization and re-hospitalization of patients with CHF. We report the cases of 2 patients diagnosed with CHF and treated with peritoneal dialysis at Hospital de Clínicas de Porto Alegre.

  9. Survival influencing factors and the interventional strategy in patients with peritoneal dialysis%影响腹膜透析生存的因素及干预策略

    Institute of Scientific and Technical Information of China (English)

    阳晓; 余学清

    2013-01-01

    腹膜透析(PD)是终末期肾脏疾病(ESRD)的主要替代治疗方法之一.心血管疾病(CVD)是PD患者死亡的主要原因.慢性肾脏病(CKD)患者存在非传统的、自身疾病特有的心血管危险因素,包括贫血、矿物质代谢紊乱、炎症和氧化应激状态及蛋白质能量消耗,这些都与CKD增加的全因死亡率和心血管疾病死亡率相关.提高PD患者长期生存率的策略包括纠正传统与非传统的心血管危险因素,如血压、血糖、血脂控制,戒烟,纠正贫血、钙磷代谢紊乱,纠正炎症和氧化应激及蛋白质能量消耗,同时必须高度重视PD患者存在的可纠正的影响生存的因素,如残余肾功能、腹膜完整性和PD中心规模.%Peritoneal dialysis (PD) is one of renal replacement therapeutics for patients with end-stage renal disease (ESRD).PD patients mainly died of cardiovascular disease.Patients with chronic kidney disease (CKD) have risks of cardiovascular disorders,which are non-traditional and related to the disease itself,including anemia,mineral metabolic disturbance,inflammation,oxidative stress,and protein energy wasting.These factors are correlated with the increased mortality of all causes as well as cardiovascular causes.Strategies to improve the long-term survivals of these patients include:managing of traditional and non-traditional cardiovascular factors such as blood pressure,blood glucose,blood lipid,smoking,anemia and calcium-phosphorus metabolic disturbance;and decreasing inflammation,oxidation stress and protein energy wasting.Meanwhile,high attention should be paid to the survival influencing factors that can be corrected such as residual renal function,peritoneal integrity and size of PD centers.

  10. Relevância do estado de hidratação na interpretação de parâmetros nutricionais em diálise peritoneal Relevance of hydration status on the interpretation of nutritional parameters in peritoneal dialysis

    Directory of Open Access Journals (Sweden)

    Aline de Araujo Antunes

    2011-02-01

    determinants of the hydration status of chronic peritoneal dialysis patients and investigated the effects of fluid overload on their nutritional status. METHODS: A cross-sectional study was conducted in 2006 to evaluate 27 chronic peritoneal dialysis patients from the Dialysis Center of the Medical School Hospital of Botucatu (SP, considering clinical, dialytic, laboratory, anthropometric and bioimpedance parameters. A linear multiple regression model was used to evaluate the influence of these parameters on hydration status. The sample was stratified according to hydration status, given by the ratio between extracellular water and total body water (0.47 for males and 0.52 for females, obtained by bioelectrical impedance. Analysis of covariance, Mann-Whitney test, chi-square test, and Fisher's exact test were used for making comparisons. The significance level was set at 5% (p≤0.05. RESULTS: Patients with greater urine volume and receiving automatic dialysis presented better hydration status. Patients with higher fluid overload, compared with those with lower overload, presented lower phase angle (M=4.2, SD=0.9 vs. M=5.7, SD=0.7º; p=0.006, lower albumin levels (M=3.06, SD=0.46 vs. M=3.55, SD=0.52g/dL; p=0.05, and higher percentage of triceps skinfold thickness (M=75.3, SD=36.9 vs. M= 92.1, SD=56.9; p=0.058. No other anthropometric differences were observed. CONCLUSION: Low levels of albumin and phase angle in patients with higher fluid overload were not related to worse nutritional status. This result suggests that one must consider the set of variables obtained by many methods and relate and interpret them comprehensively in order to obtain a reliable nutritional diagnosis of patients with fluid overload.

  11. 持续不卧床腹膜透析患者需要状况的质性研究%The qualitative research on needs of continuous ambulatory peritoneal dialysis patients.

    Institute of Scientific and Technical Information of China (English)

    洪菲菲; 孟繁洁

    2011-01-01

    目的:了解持续不卧床腹膜透析患者的需要状况,为临床护理措施实施提供依据.方法:运用现象学的方法,对13例实施持续性不卧床腹膜透析3个月以上患者进行深入访谈.采用类属分析法将收集到的资料依据马斯洛人类基本需要层次论进行整理、归类和分析.结果:持续性不卧床腹膜透析患者存在各种需要无法满足的状况,随着透析时间的延长这种状况更加突出.结论:护理人员应针对持续性不卧床腹膜透析患者不同阶段实施个性化护理,以最大限度地满足患者的各种需要,提高其生活质量.%Objective:To know about the needs of continous ambulatory peritoneal dialysis patients,in order to provide basis for clinical nursing. Methods: A total of 13 CAPD patients were investigated in depth by adopting phenomenology mothd. And data collected from them were sorted out, categorized and analyzed by abraham maslow requirement layer theory in analysis on classifications. Results:There are various un - satisfied conditions in CAPD patients. And this conditions is becoming increasingly conspicuous as time prolonging. Conclusion:Nursing staff should provide personalization services at different stage of CAPD to meet needs of patients in maximum and improve their quality of life.

  12. Influence of Astragalus Combined With Telmisartan on the Insulin Resistance of Nondiabetic Peritoneal Dialysis Patients%黄芪联合替米沙坦对非糖尿病腹膜透析患者胰岛素抵抗的影响研究

    Institute of Scientific and Technical Information of China (English)

    官继超; 龚淑文; 吴秀娟

    2015-01-01

    Objective To investigate the clinical effect of astragalus combined with telmisartan on the insulin resistance of nondiabetic peritoneal dialysis patients.Methods Enrolled 81 nondiabetic patients with stable condition who underwent continuous ambulatory peritoneal dialysis ( CAPD ) in Shaoxing People′s Hospital for more than three months from January 2012 to June 2014.Using random number table method , the patients were divided into control group , telmisartan group and combined group , with 27 patients in each group.Control group was given antihypertensive drugs apart from ACEI and ARB;telmisartan group was given oral administration of telmisartan tablets by 80 mg/d; combined group was given telmisartan tablets plus the oral administration of astragalus granules by 4 g/time and 2 times/day.All patients were treated with 1.5% or 2.5%glucose peritoneal dialysate produced by Baxter.A series of indicators of the three groups were recorded , including age , BMI, triacylglycerol , total cholesterol level , time of peritoneal dialysis , peritoneal dialysis solution dosage , exposure value of peritoneal dialysis solution and urine amount.Blood pressure , Hb, hs-CRP, iPTH, Kt/V, Ccr and HOMA-IR were determined at baseline , 3 months and 6 months during treatment.Results The three groups were not significantly different in gender, the usage rate of statins, age, BMI, triacylglycerol, total cholesterol level, time of peritoneal dialysis, peritoneal dialysis dosage, the exposure value of peritoneal dialysis and urine amount (P>0.05) .There was no interaction effect between the treatment methods of systolic pressure , diastolic blood pressure , Hb, iPTH, Kt/V and Ccr and treatment duration ( P>0.05);the three groups were not significantly different in systolic pressure , diastolic pressure , Hb, iPTH, Kt/V and Ccr ( P>0.05);systolic pressure, diastolic pressure, Hb and iPTH changed significantly with different time points (P0.05) .There was intervention effect between the

  13. Computed tomography appearances of sclerosing encapsulating peritonitis

    Energy Technology Data Exchange (ETDEWEB)

    George, C. [Department of Radiology, Hull Royal Infirmary, Hull (United Kingdom)]. E-mail: cheriangeorge@hotmail.com; Al-Zwae, K. [Department of Radiology, Hull Royal Infirmary, Hull (United Kingdom); Nair, S. [Department of Radiology, Hull Royal Infirmary, Hull (United Kingdom); Cast, J.E.I. [Department of Radiology, Hull Royal Infirmary, Hull (United Kingdom)

    2007-08-15

    Sclerosing encapsulating peritonitis (SEP) is a serious complication of peritoneal dialysis (PD) characterized by thickened peritoneal membranes, which lead to decreased ultra-filtration and intestinal obstruction. Its early clinical features are nonspecific, and it is often diagnosed late following laparotomy and peritoneal biopsy, when the patient develops small bowel obstruction, which can be a life-threatening complication. However, this is changing with increasing awareness of computed tomography (CT) findings in SEP. CT can yield an early, non-invasive diagnosis that may improve patient outcome. We present a review of the CT appearances of SEP.

  14. 循证护理在预防腹膜透析并发症中的应用%The application of evidence-based nursing in the prevention of peritoneal dialysis-related complications</